0001193125-22-280137.txt : 20221108 0001193125-22-280137.hdr.sgml : 20221108 20221108160441 ACCESSION NUMBER: 0001193125-22-280137 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 98 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221108 DATE AS OF CHANGE: 20221108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAGNACHIP SEMICONDUCTOR Corp CENTRAL INDEX KEY: 0001325702 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 830406195 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34791 FILM NUMBER: 221368815 BUSINESS ADDRESS: STREET 1: C/O MAGNACHIP SEMICONDUCTOR S.A. STREET 2: 74, RUE DE MERL CITY: LUXEMBOURG STATE: N4 ZIP: L-2146 BUSINESS PHONE: (352) 45-62-62 MAIL ADDRESS: STREET 1: C/O MAGNACHIP SEMICONDUCTOR S.A. STREET 2: 74, RUE DE MERL CITY: LUXEMBOURG STATE: N4 ZIP: L-2146 FORMER COMPANY: FORMER CONFORMED NAME: MAGNACHIP SEMICONDUCTOR LLC DATE OF NAME CHANGE: 20110304 FORMER COMPANY: FORMER CONFORMED NAME: MAGNACHIP SEMICONDUCTOR Corp DATE OF NAME CHANGE: 20110303 FORMER COMPANY: FORMER CONFORMED NAME: MAGNACHIP SEMICONDUCTOR LLC DATE OF NAME CHANGE: 20100701 10-Q 1 d306034d10q.htm 10-Q 10-Q
Table of Contents
falseQ30001325702--12-31truec/o MagnaChip Semiconductor S.A. 1 0001325702 2022-09-30 0001325702 2021-12-31 0001325702 2022-07-01 2022-09-30 0001325702 2021-07-01 2021-09-30 0001325702 2022-01-01 2022-09-30 0001325702 2021-01-01 2021-09-30 0001325702 2021-09-30 0001325702 2022-10-31 0001325702 2021-01-01 2021-12-31 0001325702 2022-03-31 0001325702 2021-12-21 0001325702 2021-12-21 2021-12-21 0001325702 2021-12-20 2021-12-20 0001325702 2021-12-20 0001325702 2022-06-30 0001325702 2021-06-30 0001325702 2020-12-31 0001325702 mx:ZeroCostCollarsMember us-gaap:OtherCurrentLiabilitiesMember 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember mx:ZeroCostCollarsMember 2022-09-30 0001325702 mx:NomuraFinancialInvestmentCoLtdMember mx:ZeroCostCollarAndForwardContractsMember 2022-09-30 0001325702 us-gaap:IntellectualPropertyMember 2022-09-30 0001325702 us-gaap:BuildingAndBuildingImprovementsMember 2022-09-30 0001325702 us-gaap:MachineryAndEquipmentMember 2022-09-30 0001325702 mx:FinanceLeaseRightOfUseAssetsMember 2022-09-30 0001325702 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2022-09-30 0001325702 mx:StandardCharteredBankKoreaLimitedMember mx:ZeroCostCollarAndForwardContractsMember 2022-09-30 0001325702 mx:ZeroCostCollarOneMember 2022-09-30 0001325702 mx:ZeroCostCollarTwoMember 2022-09-30 0001325702 mx:ZeroCostCollarThreeMember 2022-09-30 0001325702 mx:ZeroCostCollarFourMember 2022-09-30 0001325702 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherCurrentLiabilitiesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0001325702 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:OtherNoncurrentLiabilitiesMember 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 mx:OperatingLeaseRightOfUseAssetsMember 2022-09-30 0001325702 us-gaap:PropertyPlantAndEquipmentMember 2022-09-30 0001325702 mx:CurrentOperatingLeaseLiabilitiesMember 2022-09-30 0001325702 us-gaap:OtherCurrentLiabilitiesMember 2022-09-30 0001325702 mx:NonCurrentoperatingLeaseLiabilitiesMember 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember 2022-09-30 0001325702 mx:ZeroCostCollarsMember 2022-09-30 0001325702 mx:SeriesA1Member 2022-09-30 0001325702 mx:PassiveInstitutionalInvestorMember 2022-09-30 0001325702 mx:AcquiringPersonMember 2022-09-30 0001325702 mx:TerminationAgreementMember 2022-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:OtherCurrentLiabilitiesMember 2021-12-31 0001325702 mx:ZeroCostCollarsMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001325702 mx:NomuraFinancialInvestmentCoLtdMember 2021-12-31 0001325702 mx:StandardCharteredBankKoreaLimitedMember 2021-12-31 0001325702 us-gaap:IntellectualPropertyMember 2021-12-31 0001325702 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0001325702 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001325702 mx:FinanceLeaseRightOfUseAssetsMember 2021-12-31 0001325702 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2021-12-31 0001325702 mx:ZeroCostCollarOneMember 2021-12-31 0001325702 mx:ZeroCostCollarTwoMember 2021-12-31 0001325702 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:OtherCurrentLiabilitiesMember 2021-12-31 0001325702 us-gaap:OtherCurrentLiabilitiesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001325702 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001325702 mx:OperatingLeaseRightOfUseAssetsMember 2021-12-31 0001325702 us-gaap:PropertyPlantAndEquipmentMember 2021-12-31 0001325702 mx:CurrentOperatingLeaseLiabilitiesMember 2021-12-31 0001325702 us-gaap:OtherCurrentLiabilitiesMember 2021-12-31 0001325702 mx:NonCurrentoperatingLeaseLiabilitiesMember 2021-12-31 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001325702 mx:ZeroCostCollarsMember 2021-12-31 0001325702 mx:ZeroCostCollarAndForwardContractsMember mx:StandardCharteredBankKoreaLimitedMember 2021-12-31 0001325702 mx:OtherReceivableMember 2021-12-31 0001325702 mx:DisplaySolutionsMember mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001325702 mx:PowerSolutionsMember mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001325702 mx:FabThreeFoundryServicesMember 2022-07-01 2022-09-30 0001325702 country:KR mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 country:US mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 srt:EuropeMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember mx:OtherCountriesMember 2022-07-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:EmployeeAndNonEmployeeStockOptionMember 2022-07-01 2022-09-30 0001325702 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember mx:AsiaPacificOtherThanKoreaMember 2022-07-01 2022-09-30 0001325702 us-gaap:SalesRevenueNetMember country:VN us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 us-gaap:SalesRevenueNetMember mx:TopTenCustomersMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:TopCustomerOneMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 us-gaap:CashFlowHedgingMember mx:ZeroCostCollarsMember 2022-07-01 2022-09-30 0001325702 us-gaap:SalesMember us-gaap:CashFlowHedgingMember mx:ZeroCostCollarsMember 2022-07-01 2022-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2022-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0001325702 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:CashFlowHedgingMember mx:ZeroCostCollarsMember 2022-07-01 2022-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001325702 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0001325702 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001325702 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001325702 mx:StockRepurchaseProgramMember 2022-07-01 2022-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:StandardProductsBusinessMember mx:DisplaySolutionsMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember mx:PowerSolutionsMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0001325702 mx:FabThreeFoundryServicesMember 2021-01-01 2021-09-30 0001325702 country:KR mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember mx:AsiaPacificOtherThanKoreaMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember country:US 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember srt:EuropeMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember mx:OtherCountriesMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:EmployeeAndNonEmployeeStockOptionMember 2021-01-01 2021-09-30 0001325702 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001325702 us-gaap:GeographicConcentrationRiskMember mx:ChinaAndHongKongMember us-gaap:SalesRevenueNetMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:SalesRevenueNetMember country:VN us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember mx:TopTenCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001325702 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mx:StandardProductsBusinessMember mx:TopCustomerOneMember 2021-01-01 2021-09-30 0001325702 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mx:StandardProductsBusinessMember mx:TopCustomerTwoMember 2021-01-01 2021-09-30 0001325702 us-gaap:CashFlowHedgingMember mx:ZeroCostCollarsMember 2021-01-01 2021-09-30 0001325702 us-gaap:SalesMember us-gaap:CashFlowHedgingMember mx:ZeroCostCollarsMember 2021-01-01 2021-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001325702 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:CashFlowHedgingMember mx:ZeroCostCollarsMember 2021-01-01 2021-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001325702 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001325702 us-gaap:TreasuryStockMember 2021-01-01 2021-09-30 0001325702 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:StandardProductsBusinessMember mx:DisplaySolutionsMember 2021-07-01 2021-09-30 0001325702 mx:PowerSolutionsMember mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001325702 mx:FabThreeFoundryServicesMember 2021-07-01 2021-09-30 0001325702 country:KR mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember country:US 2021-07-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember srt:EuropeMember 2021-07-01 2021-09-30 0001325702 mx:OtherCountriesMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:EmployeeAndNonEmployeeStockOptionMember 2021-07-01 2021-09-30 0001325702 us-gaap:RestrictedStockUnitsRSUMember 2021-07-01 2021-09-30 0001325702 mx:ChinaAndHongKongMember mx:StandardProductsBusinessMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0001325702 us-gaap:SalesRevenueNetMember country:VN us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 us-gaap:SalesRevenueNetMember mx:TopTenCustomersMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mx:StandardProductsBusinessMember mx:TopCustomerOneMember 2021-07-01 2021-09-30 0001325702 mx:TopCustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember 2021-07-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2021-07-01 2021-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-07-01 2021-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-07-01 2021-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001325702 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001325702 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember mx:DisplaySolutionsMember 2022-01-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember mx:PowerSolutionsMember 2022-01-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-09-30 0001325702 mx:FabThreeFoundryServicesMember 2022-01-01 2022-09-30 0001325702 country:KR mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember mx:AsiaPacificOtherThanKoreaMember 2022-01-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember country:US 2022-01-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember srt:EuropeMember 2022-01-01 2022-09-30 0001325702 mx:OtherCountriesMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:EmployeeAndNonEmployeeStockOptionMember 2022-01-01 2022-09-30 0001325702 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001325702 country:KR srt:MinimumMember 2022-01-01 2022-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember mx:StandardProductsBusinessMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-09-30 0001325702 us-gaap:SalesRevenueNetMember country:VN mx:StandardProductsBusinessMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-09-30 0001325702 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mx:TopTenCustomersMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember mx:StandardProductsBusinessMember mx:TopCustomerOneMember 2022-01-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember mx:TopCustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001325702 us-gaap:CustomerConcentrationRiskMember mx:TopCustomerOneMember us-gaap:AccountsReceivableMember 2022-01-01 2022-09-30 0001325702 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember mx:TopCustomerTwoMember 2022-01-01 2022-09-30 0001325702 us-gaap:CashFlowHedgingMember mx:ZeroCostCollarsMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarOneMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarTwoMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarThreeMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarFourMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2022-01-01 2022-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001325702 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:CashFlowHedgingMember mx:ZeroCostCollarsMember 2022-01-01 2022-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001325702 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001325702 us-gaap:TreasuryStockMember 2022-01-01 2022-09-30 0001325702 srt:MinimumMember 2022-01-01 2022-09-30 0001325702 srt:MaximumMember 2022-01-01 2022-09-30 0001325702 us-gaap:OtherCurrentAssetsMember 2022-01-01 2022-09-30 0001325702 us-gaap:PreferredStockMember 2022-01-01 2022-09-30 0001325702 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001325702 mx:ReclassifiedAsATreasuryStockFromAdditionalPaidInCapitalMember us-gaap:TreasuryStockMember 2022-01-01 2022-09-30 0001325702 srt:SubsidiariesMember 2021-09-30 0001325702 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember mx:TopCustomerOneMember 2021-01-01 2021-12-31 0001325702 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember mx:TopCustomerTwoMember 2021-01-01 2021-12-31 0001325702 mx:ZeroCostCollarOneMember 2021-01-01 2021-12-31 0001325702 mx:ZeroCostCollarTwoMember 2021-01-01 2021-12-31 0001325702 us-gaap:OtherCurrentAssetsMember 2021-01-01 2021-12-31 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001325702 mx:AcceleratedStockRepurchaseProgramMember 2021-12-21 2021-12-21 0001325702 mx:AcceleratedStockRepurchaseProgramMember 2021-12-21 0001325702 mx:ReclassifiedAsATreasuryStockFromAdditionalPaidInCapitalMember us-gaap:TreasuryStockMember 2022-03-31 2022-03-31 0001325702 mx:ReclassifiedAsATreasuryStockFromAdditionalPaidInCapitalMember us-gaap:TreasuryStockMember 2022-03-31 0001325702 mx:TerminationAgreementMember 2022-04-04 0001325702 mx:TerminationAgreementMember 2022-08-05 0001325702 us-gaap:SubsequentEventMember mx:TerminationAgreementMember 2022-10-31 0001325702 mx:StockRepurchaseProgramMember 2022-08-31 0001325702 srt:ScenarioPreviouslyReportedMember mx:StockRepurchaseProgramMember 2022-08-31 0001325702 mx:DueOnOrBeforeDecember232022Member mx:LetterAgreementMember us-gaap:SubsequentEventMember 2022-10-28 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001325702 us-gaap:CommonStockMember 2022-06-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001325702 us-gaap:RetainedEarningsMember 2022-06-30 0001325702 us-gaap:TreasuryStockMember 2022-06-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001325702 us-gaap:CommonStockMember 2022-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001325702 us-gaap:RetainedEarningsMember 2022-09-30 0001325702 us-gaap:TreasuryStockMember 2022-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001325702 us-gaap:CommonStockMember 2020-12-31 0001325702 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001325702 us-gaap:RetainedEarningsMember 2020-12-31 0001325702 us-gaap:TreasuryStockMember 2020-12-31 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001325702 us-gaap:CommonStockMember 2021-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001325702 us-gaap:RetainedEarningsMember 2021-09-30 0001325702 us-gaap:TreasuryStockMember 2021-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-06-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001325702 us-gaap:CommonStockMember 2021-06-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001325702 us-gaap:RetainedEarningsMember 2021-06-30 0001325702 us-gaap:TreasuryStockMember 2021-06-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001325702 us-gaap:CommonStockMember 2021-12-31 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001325702 us-gaap:RetainedEarningsMember 2021-12-31 0001325702 us-gaap:TreasuryStockMember 2021-12-31 iso4217:USD xbrli:shares xbrli:pure utr:Year iso4217:USD xbrli:shares mx:BusinessLines
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
or
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
.
Commission File Number:
001-34791
 
 
 

Magnachip Semiconductor Corporation
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
83-0406195
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
c/o MagnaChip Semiconductor S.A.
1, Allée Scheffer,
L-2520
Luxembourg, Grand Duchy of Luxembourg
(352)
45-62-62
(Address, zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
 
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, par value $0.01 per share
Preferred Stock Purchase Rights
 
MX
 
New York Stock Exchange
New York Stock Exchange
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒  
Yes
    ☐  No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to
submit such files).    ☒  Yes    ☐  No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer  
   Accelerated filer  
       
Non-accelerated filer      Smaller reporting company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ☐  Yes    
  No
As of October 31, 2022, the registrant had
 44,175,252 shares of common stock outstanding.
 
 
 
 


Table of Contents

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES

TABLE OF CONTENTS

 

         Page No.  
PART I FINANCIAL INFORMATION      3  

Item 1.

  Interim Consolidated Financial Statements (Unaudited)      3  
  Magnachip Semiconductor Corporation and Subsidiaries Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021      3  
  Magnachip Semiconductor Corporation and Subsidiaries Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2022 and 2021      4  
  Magnachip Semiconductor Corporation and Subsidiaries Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2022 and 2021      5  
  Magnachip Semiconductor Corporation and Subsidiaries Consolidated Statements of Changes in Stockholders’ Equity for the Three and Nine Months Ended September 30, 2022 and 2021      6  
  Magnachip Semiconductor Corporation and Subsidiaries Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021      7  
  Magnachip Semiconductor Corporation and Subsidiaries Notes to Consolidated Financial Statements      8  

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations      25  

Item 3.

  Quantitative and Qualitative Disclosures About Market Risk      50  

Item 4.

  Controls and Procedures      51  
PART II OTHER INFORMATION      52  

Item 1.

  Legal Proceedings      52  

Item 1A.

  Risk Factors      52  

Item 2.

  Unregistered Sales of Equity Securities and Use of Proceeds      52  

Item 3.

  Defaults Upon Senior Securities      52  

Item 4.

  Mine Safety Disclosures      52  

Item 5.

  Other Information      52  

Item 6.

  Exhibits      53  
SIGNATURES      54  

 

2


Table of Contents
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
PART I—FINANCIAL INFORMATION
 
Item 1.
Interim Consolidated Financial Statements (Unaudited)
MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (Unaudited)
 
 
  
September 30,
2022
 
 
 
 
  
December 31,
2021
 
 
  
 
 
 
 
 
  
 
 
 
  
(In thousands of U.S. dollars, except share data)
 
Assets
  
 
 
     
  
 
Current assets
  
 
 
     
  
 
Cash and cash equivalents
   $ 250,831
 
 
     
  
$
279,547  
Accounts receivable, net
     36,759
 
 
     
  
 
50,954  
Inventories, net
     37,298
 
 
     
  
 
39,370  
Other receivables (Note 16)
     8,248
 
 
     
  
 
25,895  
Prepaid expenses
     10,322
 
 
     
  
 
7,675  
Hedge collateral (Note 7)
     15,370
 
 
     
  
 
3,060  
Other current assets (Note 17)
     20,208
 
 
     
  
 
2,619  
    
 
 
 
 
 
 
 
  
 
 
 
Total current assets
     379,036
 
 
     
  
 
409,120  
Property, plant and equipment, net
     94,411
 
 
     
  
 
107,882  
Operating lease
right-of-use
assets
     4,928
 
 
     
  
 
4,275  
Intangible assets, net
     1,770
 
 
     
  
 
2,377  
Long-term prepaid expenses
     11,382
 
 
     
  
 
8,243  
Deferred income taxes
     34,299
 
 
     
  
 
41,095  
Other
non-current
assets
     10,382
 
 
     
  
 
10,662  
    
 
 
 
 
 
 
 
  
 
 
 
Total assets
   $ 536,208
 
 
     
  
$
583,654  
    
 
 
 
 
 
 
 
  
 
 
 
Liabilities and Stockholders’ Equity
        
 
     
  
     
Current liabilities
        
 
     
  
     
Accounts payable
   $ 26,545
 
 
     
  
$
37,593  
Other accounts payable
     14,809
 
 
     
  
 
6,289  
Accrued expenses (Note 6)
     15,800
 
 
     
  
 
20,071  
Accrued income taxes
    
 
 
     
  
 
11,823  
Operating lease liabilities
     1,324
 
 
     
  
 
2,323  
Other current liabilities (Notes 7 and 8)
     15,881
 
 
     
  
 
7,382  
    
 
 
 
 
 
 
 
  
 
 
 
Total current liabilities
     74,359
 
 
     
  
 
85,481  
Accrued severance benefits, net
     28,036
 
 
     
  
 
33,064  
Non-current
operating lease liabilities
     3,811
 
 
     
  
 
1,952  
Other
non-current
liabilities
     16,787
 
 
     
  
 
10,395  
    
 
 
 
 
 
 
 
  
 
 
 
Total liabilities
     122,993
 
 
     
  
 
130,892  
    
 
 
 
 
 
 
 
  
 
 
 
Commitments and contingencies (Note 17)
        
 
     
  
     
Stockholders’ equity
        
 
     
  
     
Common stock, $0.01 par value, 150,000,000 shares authorized, 56,234,774 shares issued
and 44,579,075 outstanding at September 30, 2022 and 55,905,320 shares issued and
45,659,304 outstanding at December 31, 2021
     562
 
 
     
  
 
559  
Additional
paid-in
capital
     264,510
 
 
     
  
 
241,197  
Retained earnings
     332,535
 
 
     
  
 
343,542  
Treasury stock, 11,655,699 shares at September 30, 2022 and 10,246,016 shares at December 31, 2021, respectively
     (152,161
 
     
  
 
(130,306
Accumulated other comprehensive loss
     (32,231
 
     
  
 
(2,230
    
 
 
 
 
 
 
 
  
 
 
 
Total stockholders’ equity
     413,215
 
 
     
  
 
452,762  
    
 
 
 
 
 
 
 
  
 
 
 
Total liabilities and stockholders’ equity
   $ 536,208
 
 
     
  
$
583,654  
    
 
 
 
 
 
 
 
  
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
3

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
 
 
  
Three Months Ended
 
 
Nine Months Ended
 
 
  
September 30,
2022
 
 
September 30,
2021
 
 
September 30,
2022
 
 
September 30,
2021
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
(In thousands of U.S. dollars, except share data)
 
Revenues:
        
Net sales – standard products business
   $ 62,771     $ 117,415     $ 248,069     $ 333,589  
Net sales – transitional Fab 3 foundry services
     8,428       9,585       28,599       30,306  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total revenues
     71,199       127,000       276,668       363,895  
Cost of sales:
                                
Cost of sales – standard products business
     45,497       71,641       165,197       221,297  
Cost of sales – transitional Fab 3 foundry services
     8,477       8,772       26,305       27,659  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total cost of sales
     53,974       80,413       191,502       248,956  
    
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
     17,225       46,587       85,166       114,939  
Operating expenses:
                                
Selling, general and administrative expenses
     11,411       12,550       38,310       39,185  
Research and development expenses
     13,321       12,270       38,685       39,015  
Merger-related costs
              1,552                13,842  
Other charges, net
     2,501       214       3,298       3,360  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
     27,233       26,586       80,293       95,402  
    
 
 
   
 
 
   
 
 
   
 
 
 
Operating income (loss)
     (10,008     20,001       4,873       19,537  
Interest expense
     (278     (113     (888     (1,239
Foreign currency loss, net
     (12,809     (7,579     (20,511     (12,000
Other income, net
     1,958       1,608       4,163       2,839  
    
 
 
   
 
 
   
 
 
   
 
 
 
Income (loss) before income tax expense
     (21,137     13,917       (12,363     9,137  
Income tax expense (benefit)
     (3,942     3,149       (1,356     6,040  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net income (loss)
   $ (17,195   $ 10,768     $ (11,007   $ 3,097  
    
 
 
   
 
 
   
 
 
   
 
 
 
Basic earnings (loss) per common share—
   $ (0.38   $ 0.23     $ (0.24   $ 0.07  
Diluted earnings (loss) per common share—
   $ (0.38   $ 0.23     $ (0.24   $ 0.07  
Weighted average number of shares—
                                
Basic
     44,865,266       46,449,234       45,119,214       44,377,250  
Diluted
     44,865,266       47,808,457       45,119,214       45,811,792  
The accompanying notes are an integral part of these consolidated financial statements.
 
4

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)

 
  
Three Months Ended
 
 
Nine Months Ended
 
 
  
September 30,
2022
 
 
September 30,
2021
 
 
September 30,
2022
 
 
September 30,
2021
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
(In thousands of U.S. dollars)
 
Net income (loss)
   $ (17,195   $ 10,768     $ (11,007   $ 3,097  
    
 
 
   
 
 
   
 
 
   
 
 
 
Other comprehensive income (loss)
                                
Foreign currency translation adjustments
     (5,974     (860     (15,881     (2,809
Derivative adjustments
                                
Fair valuation of derivatives
     (11,757     (3,271     (19,498     (4,964
Reclassification adjustment for loss (gain) on derivatives included in net income (loss)
     2,820       653       5,378       (333
    
 
 
   
 
 
   
 
 
   
 
 
 
Total other comprehensive loss
     (14,911     (3,478     (30,001     (8,106
    
 
 
   
 
 
   
 
 
   
 
 
 
Total comprehensive income (loss)
   $ (32,106   $ 7,290     $ (41,008   $ (5,009
    
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
5

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Unaudited)

 
  
Common Stock
 
  
Additional
Paid-In

Capital
 
 
Retained
Earnings
 
 
Treasury
Stock
 
 
Accumulated
Other
Comprehensive
Loss
 
 
Total
 
(In thousands of U.S. dollars, except share data)
  
Shares
 
 
Amount
 
Three Months Ended September 30, 2022:
                                                         
Balance at June 30, 2022
     44,903,718     $ 562      $ 263,698     $ 349,730     $ (148,523   $ (17,320   $ 448,147  
Stock-based compensation
     —         —          861       —         —         —         861  
Settlement of restricted stock units
     —         —          (49     —         —         —         (49
Acquisition of treasury stock
     (324,643     —          —         —         (3,638     —         (3,638
Other comprehensive loss, net
     —         —          —         —         —         (14,911     (14,911
Net loss
     —         —          —         (17,195     —         —         (17,195
    
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at September 30, 2022
     44,579,075     $ 562      $ 264,510     $ 332,535     $ (152,161   $ (32,231   $ 413,215  
    
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Three Months Ended September 30, 2021:
                                                         
Balance at June 30, 2021
     46,350,945     $ 556      $ 253,244     $ 279,163     $ (109,407   $ (925   $ 422,631  
Stock-based compensation
     —         —          2,005       —         —         —         2,005  
Exercise of stock options
     112,944       1        1,370       —         —         —         1,371  
Settlement of restricted stock units
     1,000       0        (0     —         —         —         —    
Other comprehensive loss, net
     —         —          —         —         —         (3,478     (3,478
Net income
     —         —          —         10,768       —         —         10,768  
    
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at September 30, 2021
     46,464,889     $ 557      $ 256,619     $ 289,931     $ (109,407   $ (4,403   $ 433,297  
    
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 

 
  
Common Stock
 
  
Additional
Paid-In
 
 
Retained
Earnings
 
 
Treasury
 
 
Accumulated
Other
Comprehensive
 
 
 
 
(In thousands of U.S. dollars, except share data)
  
Shares
 
 
Amount
 
  
Capital
 
 
Stock
 
 
Income (Loss)
 
 
Total
 
Nine Months Ended September 30, 2022:
                                                         
Balance at December 31, 2021
     45,659,304     $ 559      $ 241,197     $ 343,542     $ (130,306   $ (2,230   $ 452,762  
Stock-based compensation
     —         —          4,487       —         —         —         4,487  
Exercise of stock options
     152,326       1        1,785       —         —         —         1,786  
Settlement of restricted stock units
     177,128       2        (176     —         —         —         (174
Acquisition of treasury stock
     (378,107     —          —         —         (4,638     —         (4,638
Accelerated stock repurchase
     (1,031,576     —          17,217       —         (17,217     —         —    
Other comprehensive loss, net
     —         —          —         —         —         (30,001     (30,001
Net loss
     —         —          —         (11,007     —         —         (11,007
    
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at September 30, 2022
     44,579,075     $ 562      $ 264,510     $ 332,535     $ (152,161   $ (32,231   $ 413,215  
    
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Nine Months Ended September 30, 2021:
                                                         
Balance at December 31, 2020
     35,783,347     $ 450      $ 163,010     $ 286,834     $ (108,397   $ 3,703     $ 345,600  
Stock-based compensation
     —         —          6,056       —         —         —         6,056  
Exchange of exchangeable senior note
     10,144,131       101        83,639       —         —         —         83,740  
Exercise of stock options
     289,704       3        3,917       —         —         —         3,920  
Settlement of restricted stock units
     299,162       3        (3     —         —         —         —    
Acquisition of treasury stock
     (51,455     —          —         —         (1,010     —         (1,010
Other comprehensive loss, net
     —         —          —         —         —         (8,106     (8,106
Net income
     —         —          —         3,097       —         —         3,097  
    
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at September 30, 2021
     46,464,889     $ 557      $ 256,619     $ 289,931     $ (109,407   $ (4,403   $ 433,297  
    
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
6

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
 
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
 
September 30,
2021
 
 
  
(In thousands of U.S. dollars)
 
Cash flows from operating activities
                
Net income (loss)
   $ (11,007   $ 3,097  
Adjustments to reconcile net income (loss) to net cash provided by operating activities
                
Depreciation and amortization
     11,225       10,576  
Provision for severance benefits
     5,163       5,514  
Amortization of debt issuance costs and original issue discount
     —         261  
Loss on foreign currency, net
     66,335       32,607  
Provision for inventory reserves
     7,730       1,484  
Stock-based compensation
     4,487       6,056  
Other, net
     631       442  
Changes in operating assets and liabilities
                
Accounts receivable, net
     7,805       6,696  
Inventories
     (13,208     (4,561
Other receivables
     17,115       (5,287
Other current assets
     (14,117     7,933  
Accounts payable
     (14,792     (16,192
Other accounts payable
     (6,215     (3,729
Accrued expenses
     5,866       (1,641
Accrued income taxes
     (11,483     (8,308
Other current liabilities
     (1,583     555  
Other
non-current
liabilities
     523       (666
Payment of severance benefits
     (4,181     (4,772
Other, net
     (50     (49
    
 
 
   
 
 
 
Net cash provided by operating activities
     50,244       30,016  
Cash flows from investing activities
                
Proceeds from settlement of hedge collateral
     2,805       3,995  
Payment of hedge collateral
     (15,282     (2,744
Purchase of property, plant and equipment
     (11,812     (13,368
Payment for intellectual property registration
     (301     (455
Collection of guarantee deposits
     —         3,192  
Payment of guarantee deposits
     (2,075     (4,960
Other, net
     792       (103
    
 
 
   
 
 
 
Net cash used in investing activities
     (25,873     (14,443
Cash flows from financing activities
                
Proceeds from exercise of stock options
     1,786       3,920  
Acquisition of treasury stock
     (5,065     (1,653
Repayment of financing related to water treatment facility arrangement
     (381     (427
Repayment of principal portion of finance lease liabilities
     (50     (49
    
 
 
   
 
 
 
Net cash provided by (used in) financing activities
     (3,710     1,791  
Effect of exchange rates on cash and cash equivalents
     (49,377     (21,003
    
 
 
   
 
 
 
Net decrease in cash and cash equivalents
     (28,716     (3,639
Cash and cash equivalents
                
Beginning of the period
     279,547       279,940  
    
 
 
   
 
 
 
End of the period
   $ 250,831     $ 276,301  
    
 
 
   
 
 
 
Supplemental cash flow information
                
Cash paid for interest
   $ —       $ 2,094  
Cash paid for income taxes
   $ 17,856     $ 12,609  
Non-cash
investing activities
                
Property, plant and equipment additions in other accounts payable
   $ 3,957     $ 11,513  
Non-cash
financing activities
                
Exchange of exchangeable senior notes into common stock
   $ —       $ 83,740  
Unsettled common stock repurchases
   $ (399   $ —    
The accompanying notes are an integral part of these consolidated financial statements.
 
7

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(TABULAR DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
1. Business, Basis of Presentation and Significant Accounting Policies
Business
Magnachip Semiconductor Corporation (together with its subsidiaries, the “Company”) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, Internet of Things (“IoT”) applications, consumer, computing, industrial and automotive applications.
The Company’s standard products business includes its Display Solutions and Power Solutions business lines. The Company’s Display Solutions products provide panel display solutions to major suppliers of large and small rigid and flexible panel displays, and mobile, automotive applications and home appliances. The Company’s Power Solutions products include discrete and integrated circuit solutions for power management in communications, consumer, computing, servers, automotive, and industrial applications.
On September 1, 2020, the Company completed the sale of the Company’s Foundry Services Group business and its fabrication facility located in Cheongju, Korea, known as “Fab 4”. Following the consummation of the sale, and for up to three years, the Company is expected to provide transitional foundry services associated with its fabrication facility located in Gumi, Korea, known as “Fab 3”, at an agreed upon cost plus
mark-up
(the “Transitional Fab 3 Foundry Services”).
Basis of Presentation
The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). These interim consolidated financial statements include normal recurring adjustments and the elimination of all intercompany accounts and transactions which are, in the opinion of management, necessary to provide a fair statement of the Company’s financial condition and results of operations for the periods presented. These interim consolidated financial statements are presented in accordance with Accounting Standards Codification (“ASC”) 270, “Interim Reporting” and, accordingly, do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, except for the changes below. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for a full year or for any other periods.
The December 31, 2021 balance sheet data was derived from the Company’s audited financial statements, but does not include all disclosures required by U.S. GAAP. The interim consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the fiscal year ended December 31, 2021.
There have been no material changes to the Company’s significant accounting policies as of and for the nine months ended September 30, 2022 as compared to the significant accounting policies described in the Company’s Annual Report on Form
10-K
for the fiscal year ended December 31, 2021.
Recently Adopted Accounting Pronouncements
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
No. 2020-06,
“Debt—Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40)”
(“ASU
2020-06”),
which updates various codification topics to simplify the accounting guidance for certain financial instruments with characteristics of liabilities and equity, with a specific focus on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and amends the diluted EPS computation for these instruments. The Company adopted ASU
2020-06
as of January 1, 2022, and the adoption of ASU
2020-06
did not have an impact on the Company’s consolidated financial statements.
In May 2021, the FASB issued ASU
No. 2021-04,
“Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic
470-50)”,
Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
815-40):
Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU
2021-04”),
ASU
2021-04
clarifies the accounting for modifications or exchanges of freestanding equity-classified written call options so that the transaction should be treated as an exchange of the original instrument for a new instrument. The Company adopted ASU
2021-04
as of January 1, 2022, and the adoption of ASU
2021-04
did not have an impact on the Company’s consolidated financial statements.
 
8

2. Inventories
Inventories as of September 30, 2022 and December 31, 2021 consist of the following (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Finished goods
   $ 6,828      $ 9,594  
Semi-finished goods and
work-in-process
     32,431        25,968  
Raw materials
     9,282        9,443  
Materials
in-transit
     295        95  
Less: inventory reserve
     (11,538      (5,730
    
 
 
    
 
 
 
Inventories, net
   $ 37,298      $  39,370  
    
 
 
    
 
 
 
Changes in inventory reserve for the three and nine months ended September 30, 2022 and 2021 are as follows (in thousands):

 
 
  
Three Months
Ended
 
  
Nine Months
Ended
 
  
Three Months
Ended
 
  
Nine Months
Ended
 
  
September 30, 2022
 
  
September 30, 2021
 
Beginning balance
   $  (10,206    $  (5,730    $  (8,101    $  (5,901
Change in reserve
                                   
Inventory reserve charged to costs of sales
     (3,199      (10,899      (242      (5,592
Sale of previously reserved inventory
     672        2,996        2,099        4,076  
    
 
 
    
 
 
    
 
 
    
 
 
 
       (2,527      (7,903      1,857        (1,516
Write off
     16        311        180        1,110  
Translation adjustments
     1,179        1,784        328        571  
    
 
 
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (11,538    $  (11,538    $  (5,736    $  (5,736
    
 
 
    
 
 
    
 
 
    
 
 
 
Inventory reserve represents the Company’s best estimate in value lost due to excessive inventory level, physical deterioration, obsolescence, changes in price levels, or other causes based on individual facts and circumstances. Inventory reserve relates to inventory items including finished goods, semi-finished goods,
work-in-process
and raw materials. Write off of this reserve is recognized only when the related inventory has been disposed or scrapped.
 
9

3. Property, Plant and Equipment
Property, plant and equipment as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Buildings and related structures
   $ 21,484      $ 24,273  
Machinery and equipment
     94,152        105,300  
Finance lease
right-of-use
assets
     340        316  
Others
     29,233        32,396  
    
 
 
    
 
 
 
       145,209        162,285  
Less: accumulated depreciation
     (86,281      (94,119
Land
     11,513        13,898  
Construction in progress
     23,970        25,818  
    
 
 
    
 
 
 
Property, plant and equipment, net
   $ 94,411      $  107,882  
    
 
 
    
 
 
 
Aggregate depreciation expenses totaled $10,699 thousand and $10,018 thousand for the nine months ended September 30, 2022 and 2021, respectively.
4. Intangible Assets
Intangible assets as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):

 
  
September 30, 2022
 
  
Gross
amount
 
  
Accumulated
amortization
 
  
Net
amount
 
Intellectual property assets
   $ 8,040      $ (6,270    $ 1,770  
    
 
 
    
 
 
    
 
 
 
Intangible assets
   $ 8,040      $ (6,270    $ 1,770  
    
 
 
    
 
 
    
 
 
 

 
  
December 31, 2021
 
  
Gross
amount
 
  
Accumulated
amortization
 
  
Net
amount
 
Intellectual property assets
   $ 9,312      $ (6,935    $ 2,377  
    
 
 
    
 
 
    
 
 
 
Intangible assets
   $ 9,312      $ (6,935    $ 2,377  
    
 
 
    
 
 
    
 
 
 
Aggregate amortization expenses for intangible assets totaled $526 thousand and $558 thousand for the nine months ended September 30, 2022 and 2021, respectively.
 
10

5. Leases
The Company has operating and finance leases for buildings and other assets such as vehicles and office equipment. The Company’s leases have remaining lease terms ranging from 1 year to 5 years.
The tables below present financial information related to the Company’s leases.
Supplemental balance sheets information related to leases as of September 30, 2022 and December 31, 2021 are as follows (in thousands):

Leases
  
Classification
 
  
September 30,
2022
 
  
December 31,
2021
 
Assets
  
 
 
 
             
Operating lease
  
 
Operating lease right-of-use assets
 
   $  4,928      $  4,275  
Finance lease
  
 
Property, plant and equipment, net
 
     141        126  
    
 
 
 
  
 
 
    
 
 
 
Total lease assets
  
 
 
 
   $ 5,069      $ 4,401  
    
 
 
 
  
 
 
    
 
 
 
Liabilities
  
 
 
 
                 
Current
  
 
 
 
                 
Operating
  
 
Operating lease liabilities
 
   $ 1,324      $ 2,323  
Finance
  
 
Other current liabilities
 
     78        68  
Non-current
  
 
 
 
                 
Operating
  
 
Non-current operating lease liabilities
 
     3,811        1,952  
Finance
  
 
Other
non-current
liabilities
 
     73        73  
    
 
 
 
  
 
 
    
 
 
 
Total lease liabilities
  
 
 
 
   $ 5,286      $ 4,416  
    
 
 
 
  
 
 
    
 
 
 
The following table presents the weighted average remaining lease term and discount rate:

 
 
  
September 30,
2022
 
 
December 31,
2021
 
Weighted average remaining lease term
                
Operating leases
     3.9 years       2.4 years  
Finance leases
     2.5 years       2.0 years  
Weighted average discount rate
                
Operating leases
     6.58     4.20
Finance leases
     7.63     7.75
The components of lease cost included in the Company’s consolidated statements of operations, are as follows (in thousands):

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Operating lease cost
   $  557      $  691      $  1,738      $  2,098  
Finance lease cost
                                   
Amortization of
right-of-use
assets
     18        17        48        50  
Interest on lease liabilities
     2        4        7        11  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total lease cost
   $ 577      $ 712      $ 1,793      $ 2,159  
    
 
 
    
 
 
    
 
 
    
 
 
 
The above table does not include an immaterial cost of short-term leases for the nine months ended September 30, 2022 and 2021.
 
11

Other lease information is as follows (in thousands):


 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Cash paid for amounts included in the measurement of lease liabilities
                                   
Operating cash flows from operating leases
   $  561      $  691      $  1,742      $  2,098  
Operating cash flows from finance leases
     2        4        7        11  
Financing cash flows from finance leases
     18        16        50        49  
The aggregate future lease payments for operating and finance leases as of September 30, 2022 are as follows (in thousands):

 
 
  
Operating
Leases
 
  
Finance
Leases
 
Remainder of 2022
   $ 508      $ 22  
2023
     1,449        86  
2024
     1,330        24  
2025
     1,218        23  
2026
     846        11  
2027
     585            
    
 
 
    
 
 
 
Total future lease payments
     5,936        166  
Less: Imputed interest
     (801      (15
    
 
 
    
 
 
 
Present value of future payments
   $  5,135      $  151  
    
 
 
    
 
 
 
6. Accrued Expenses
Accrued expenses as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):
 
    
September 30,

2022
    
December 31,

2021
 
Payroll, benefits and related taxes, excluding severance benefits
   $  10,552      $ 9,548  
Withholding tax attributable to intercompany interest income
     3,345        1,950  
Outside service fees
     1,608        1,088  
Merger-related costs
               7,035  
Others
     295        450  
    
 
 
    
 
 
 
Accrued expenses
   $ 15,800      $  20,071  
    
 
 
    
 
 
 
 
12

7. Derivative Financial Instruments
The Company’s Korean subsidiary from time to time has entered into zero cost collar contracts to hedge the risk of changes in the functional-currency-equivalent cash flows attributable to currency rate changes on U.S. dollar denominated revenues.
Details of the zero cost collar contracts as of September 30, 2022 are as follows (in thousands):
 
Date of transaction
  
Total notional amount
    
Month of settlement
August 13, 2021
   $ 15,000     
October 202
2
to December 2022
January 04, 2022
   $ 39,000      October 2022 to June 2023
March 07, 2022
   $ 24,000      July 2023 to December 2023
April 27, 2022
   $ 51,000      October 2022 to December 2023
Details of the zero cost collar contracts as of December 31, 2021 are as follows (in thousands):
 
Date of transaction
  
Total notional amount
    
Month of settlement
May 13, 2021
   $ 39,000      January 2022 to September 2022
August 13, 2021
   $ 48,000      January 2022 to December 2022
The zero cost collar contracts qualify as cash flow hedges under ASC 815, “Derivatives and Hedging,” since at both the inception of the contracts and on an ongoing basis, the hedging relationship was and is expected to be highly effective in achieving offsetting cash flows attributable to the hedged risk during the term of the contracts.
The fair values of the Company’s outstanding zero cost collar contracts recorded as liabilities as of September 30, 2022 and December 31, 2021 are as follows (in thousands):

Derivatives designated as hedging instruments:
  
 
 
  
September 30,
2022
 
  
December 31,
2021
 
Liability Derivatives:
                          
Zero cost collars
     Other current liabilities      $ 12,744      $ 2,020  
Zero cost collars
    
Other non-current liabilities
     $ 2,318      $     
Offsetting of derivative liabilities as of September 30, 2022 is as follows (in thousands):

 
As of September 30, 2022
  
Gross amounts of
recognized
liabilities
 
  
Gross amounts
offset in the
balance sheets
 
  
Net amounts of
liabilities
presented in the
balance sheets
 
  
Gross amounts not offset
in the balance sheets
 
 
Net amount
 
  
Financial
instruments
 
  
Cash collateral
pledged
 
Liability Derivatives:
                                                    
Zero cost collars
   $ 15,062      $         $ 15,062      $         $ (14,370   $ 692  
Offsetting of derivative liabilities as of December 31, 2021 is as follows (in thousands):

As of December 31, 2021
  
Gross amounts of
recognized
liabilities
 
  
Gross amounts
offset in the
balance sheets
 
  
Net amounts of
liabilities
presented in the
balance sheets
 
  
Gross amounts not offset
in the balance sheets
 
 
Net amount
 
  
Financial
instruments
 
  
Cash collateral
pledged
 
Liability Derivatives:
                                                    
Zero cost collars
   $ 2,020      $         $ 2,020      $         $ (2,060   $ (40

1
3

For derivative instruments that are designated and qualify as cash flow hedges, gains or losses on the derivative aside from components excluded from the assessment of effectiveness are reported as a component of accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative, representing hedge components excluded from the assessment of effectiveness, are recognized in current earnings.
The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the three months ended September 30, 2022 and 2021 (in thousands):
 
Derivatives in ASC
815 Cash Flow Hedging
Relationships
  
Amount of Loss
Recognized in
AOCI on
Derivatives
 
 
Location/Amount of Loss
Reclassified from AOCI
Into Statement of Operations
 
 
Location/Amount of Gain
Recognized in
Statement of Operations on Derivatives
 
 
  
Three Months Ended
September 30,
 
 
 
 
  
Three Months Ended
September 30,
 
 
 
 
  
Three Months Ended
September 30,
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
  
2021
 
Zero cost collars
   $ (11,757   $ (3,271     Net sales      $ (2,820)     $   (653)     Other income, net      $ 146      $ 237  
The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the nine months ended September 30, 2022 and 2021 (in thousands).
 
Derivatives in ASC
815 Cash Flow Hedging
Relationships
  
Amount of Loss
Recognized in
AOCI on
Derivatives
 
 
Location/Amount of Gain (Loss)
Reclassified from AOCI
Into Statement of Operations
 
  
Location/Amount of Gain
Recognized in
Statement of Operations on Derivatives
 
 
  
Nine Months Ended
September 30,
 
 
 
 
  
Nine Months Ended
September 30,
 
  
 
 
  
Nine Months Ended
September 30,
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
 
2021
 
  
 
 
  
2022
 
  
2021
 
Zero cost collars
   $ (19,498   $ (4,964     Net sales      $ (5,378)     $ 333        Other income, net      $ 201      $ 94  
As of September 30, 2022, the amount expected to be reclassified from accumulated other comprehensive loss into loss within the next 12 months is $13,262 thousand.
The Company set aside cash deposits to the counterparties, Nomura Financial Investment (Korea) Co., Ltd. (“NFIK”) and Standard Chartered Bank Korea Limited (“SC”), as required for the zero cost collar contracts. These cash deposits are recorded as hedge collateral on the consolidated balance sheets. Cash deposits as of September 30, 2022 and December 31, 2021 are as follows (in
thousands):
 
Counterparties
  
September 30,
2022
 
  
December 31,
2021
 
SC
   $ 1,000      $ 1,000  
The Company is required to deposit additional cash collateral with NFIK and SC for any exposure in excess of $500 thousand. As of September 30, 2022, $11,670 thousand and $2,700 thousand of additional cash collateral was required by NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance sheet. As of December 31, 2021, $760 thousand and $1,300 thousand of additional cash collateral was required by NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance sheet.
These zero cost collar contracts may be terminated by the counterparties if the Company’s total cash and cash equivalents is less than $30,000 thousand at the end of a fiscal quarter, unless a waiver is obtained.
 
1
4

8. Fair Value Measurements
Fair Value of Financial Instruments
As of September 30, 2022, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in thousands):

 
 
  
Carrying Value
September 30, 2022
 
  
Fair Value
Measurement
September 30, 2022
 
  
Quoted Prices in
Active Markets
for Identical
Liability (Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Unobservable
Inputs
(Level 3)
 
Liabilities:
                                            
Derivative liabilities (other current liabilities)
   $ 12,744      $ 12,744        —        $ 12,744        —    
Derivative liabilities (other
non-current
liabilities)
   $ 2,318      $ 2,318        —        $ 2,318        —    
As of December 31, 2021, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in
thousands):
 
 
  
Carrying Value
December 31, 2021
 
  
Fair Value
Measurement
December 31, 2021
 
  
Quoted Prices in
Active Markets
for Identical
Liability (Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Unobservable
Inputs
(Level 3)
 
Liabilities:
                                            
Derivative liabilities (other current liabilities)
   $ 2,020      $ 2,020        —        $ 2,020        —    
Items not reflected in the table above include cash equivalents, accounts receivable, other receivables, accounts payable, and other accounts payable, fair value of which approximate carrying values due to the short-term nature of these instruments. The fair value of assets and liabilities whose carrying value approximates fair value is determined using Level 2 inputs.
 
1
5

9. Accrued Severance Benefits
The majority of accrued severance benefits are for employees in the Company’s Korean subsidiary. Pursuant to the Employee Retirement Benefit Security Act of Korea, eligible employees and executive officers with one or more years of service are entitled to severance benefits upon the termination of their employment based on their length of service and rate of pay. As of September 30, 2022, 97% of all employees of the Company were eligible for severance benefits.
Changes in accrued severance benefits are as follows (in thousands):
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
September 30, 2022
 
 
September 30, 2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
Beginning balance
  
$ 47,586     $ 51,567      $ 53,105      $ 54,452  
Provisions
  
  1,923       5,163        2,007        5,514  
Severance payments
  
  (1,247     (4,181      (1,936      (4,772
Translation adjustments
  
  (4,730     (9,017      (2,441      (4,459
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
  
  43,532       43,532        50,735        50,735  
Less: Cumulative contributions to
severance insurance deposit
accounts

  
  (15,292     (15,292      (12,739      (12,739
The National Pension Fund

  
  (40     (40      (55      (55
Group severance insurance plan

  
  (164     (164      (200      (200
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Accrued severance benefits,
 
net
  
$ 28,036     $ 28,036      $ 37,741      $ 37,741  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The severance benefits funded through the Company’s National Pension Fund and group severance insurance plan will be used exclusively for payment of severance benefits to eligible employees. These amounts have been deducted from the accrued severance benefit balance.
Beginning in July 2018, the Company contributes to certain severance insurance deposit accounts a certain percentage of severance benefits that are accrued for eligible employees for their services from January 1, 2018. These accounts consist of time deposits and other guaranteed principal and interest, and are maintained at insurance companies, banks or security companies for the benefit of employees. The Company deducts the contributions made to these severance insurance deposit accounts from its accrued severance benefits.
The Company is liable to pay the following future benefits to its
non-executive
employees upon their normal retirement age (in thousands):
 
 
  
Severance benefit
 
Remainder of 2022
   $ 212  
2023
     534  
2024
     769  
2025
     1,273  
2026
     1,772  
2027
     1,463  
2028 – 2032
     17,223  
The above amounts were determined based on the
non-executive
employees’ current salary rates and the number of service years that will be accumulated upon their retirement dates. These amounts do not include amounts that might be paid to
non-executive
employees that will cease working with the Company before their normal retirement ages.
Korea’s mandatory retirement age is 60 years of age or older under the Employment Promotion for the Aged Act. The Company sets the retirement age of employees at 60.
 
1
6

10. Foreign Currency Loss, Net
Net foreign currency gain or loss includes
non-cash
translation gain or loss associated with intercompany balances. A substantial portion of the Company’s net foreign currency gain or loss is
non-cash
translation gain or loss associated with intercompany long-term loans to the Company’s Korean subsidiary. The loans are denominated in U.S. dollars and are affected by changes in the exchange rate between the Korean won and the U.S. dollar. As of September 30, 2022 and December 31, 2021, the outstanding intercompany loan balances including accrued interest between the Korean subsidiary and the Dutch subsidiary were $356,746 thousand and $344,411 thousand, respectively. The Korean won to U.S. dollar exchange rates were 1,434.8:1 and 1,185.5:1 using the first base rate as of September 30, 2022 and December 31, 2021, respectively, as quoted by the KEB Hana Bank.
11. Income Taxes
The Company and its subsidiaries file income tax returns in Korea, the U.S. and in various other jurisdictions. The Company is subject to income or
non-income
tax examinations by tax authorities of these jurisdictions for all open tax years.
For the three and nine months ended September 30, 2022, the Company recorded an income tax benefit of $3,942 thousand and $1,356 
thousand, respectively, primarily attributable to a decrease in its Korean subsidiary’s
pre-tax
income for the respective period due to the foreign currency translation loss recorded in its Korean subsidiary in connection with intercompany loans.
For the three and nine months ended September 30, 2021, the Company recorded an income tax expense of $3,149 thousand and $6,040 
thousand, respectively, primarily attributable to the Company’s Korean subsidiary based on its estimated taxable income for the respective period, combined with its ability to utilize net operating loss carryforwards
up to 60%, and interest on intercompany loan balances.
 
1
7

12. Geographic and Other Information
The following sets forth information relating to the single operating segment (in thousands):


 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Revenues
                                   
Standard products business
                                   
Display Solutions
   $ 6,355      $ 58,528      $ 63,876      $  164,024  
Power Solutions
     56,416        58,887        184,193        169,565  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total standard products business
     62,771        117,415        248,069        333,589  
Transitional Fab 3 foundry services
     8,428        9,585        28,599        30,306  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenues
   $  71,199      $  127,000      $  276,668      $ 363,895  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Gross Profit
                                   
Standard products business
   $  17,274      $  45,773      $  82,872      $  112,291  
Transitional Fab 3 foundry services
     (49      814        2,294        2,648  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total gross profit
   $ 17,225      $ 46,587      $ 85,166      $ 114,939  
    
 
 
    
 
 
    
 
 
    
 
 
 
The following is a summary of net sales—standard products business (which does not include the Transitional Fab 3 Foundry Services) by geographic region, based on the location to which the products are billed (in thousands):

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Korea
   $  23,867      $ 29,664      $ 86,065      $ 86,966  
Asia Pacific (other than Korea)
     34,612        84,220        148,940        237,312  
United States
     2,718        1,756        8,074        4,393  
Europe
     1,574        1,398        4,990        3,847  
Others
            377               1,071  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 62,771      $  117,415      $  248,069      $  333,589  
    
 
 
    
 
 
    
 
 
    
 
 
 
For the three months ended September 30, 2022 and 2021, of the Company’s net sales – standard products business in Asia Pacific (other than Korea), net sales – standard products business in China and Hong Kong represented 74.2% and 72.0%, respectively, and net sales—standard products business in Vietnam represented 2.4% and 19.6%, respectively. For the nine months ended September 30, 2022 and 2021, of the Company’s net sales – standard products business in Asia Pacific (other than Korea), net sales – standard products business in China and Hong Kong represented 66.4% and 63.4%, respectively, and net sales—standard products business in Vietnam represented 16.2% and 29.5%, respectively.
Net sales from the Company’s top ten largest customers in the standard products business (which does not include the Transitional Fab 3 Foundry Services) accounted for 64% and 81% for the three months ended September 30, 2022 and 2021, respectively, and 70% and 81% for the nine months ended September 30, 2022 and 2021, respectively.
For the three months ended September 30, 2022, the Company had one customer that represented 16.2% of its net sales – standard products business. For the nine months ended September 30, 2022, the Company had two customers that represented 20.6% and 13.9% of its net sales – standard products business. For the three months ended September 30, 2021, the Company had two customers that represented 44.7% and 10.1% of its net sales – standard products business. For the nine months ended September 30, 2021, the Company had two customers that represented 44.6% and 10.6% of its net sales – standard products business.
As of September 30, 2022, two customers of the Company’s standard products business accounted for 24.1% and 11.8% of its accounts receivable – standard products business (which does not include the Transitional Fab 3 Foundry Services), respectively. As of December 31, 2021, two customers of the Company’s standard products business accounted for 31.5% and 16.1% of its accounts receivable – standard products business (which does not include the Transitional Fab 3 Foundry Services), respectively.
 
1
8

13. Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss consists of the following as of September 30, 2022 and December 31, 2021, respectively (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Foreign currency translation adjustments
   $  (16,651    $ (770
Derivative adjustments
     (15,580      (1,460
    
 
 
    
 
 
 
Total
   $  (32,231    $  (2,230
    
 
 
    
 
 
 
Changes in accumulated other comprehensive loss for the three months ended September 30, 2022 and 2021 are as follows (in
thousands):
 
Three Months Ended September 30, 2022
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $  (10,677    $  (6,643    $  (17,320
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (5,974      (11,757      (17,731
Amounts reclassified from accumulated other comprehensive loss
     —          2,820        2,820  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (5,974      (8,937      (14,911
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (16,651    $  (15,580    $  (32,231
    
 
 
    
 
 
    
 
 
 
 
Three Months Ended September 30, 2021
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ 120      $  (1,045    $ (925
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (860      (3,271      (4,131
Amounts reclassified from accumulated other comprehensive loss
            653        653  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (860      (2,618      (3,478
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (740    $  (3,663    $  (4,403
    
 
 
    
 
 
    
 
 
 
Changes in accumulated other comprehensive loss for the nine months ended September 30, 2022 and 2021 are as follows (in
thousands):
 
Nine Months Ended September 30, 2022
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ (770    $  (1,460    $  (2,230
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (15,881      (19,498      (35,379
Amounts reclassified from accumulated other comprehensive loss
     —          5,378        5,378  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (15,881      (14,120      (30,001
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (16,651    $  (15,580    $  (32,231
    
 
 
    
 
 
    
 
 
 
 
Nine Months Ended September 30, 2021
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ 2,069      $ 1,634      $ 3,703  
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (2,809      (4,964      (7,773
Amounts reclassified from accumulated other comprehensive income
     —          (333      (333
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (2,809      (5,297      (8,106
    
 
 
    
 
 
    
 
 
 
Ending balance
   $ (740    $  (3,663    $  (4,403
    
 
 
    
 
 
    
 
 
 
 
1
9

14. Stock Repurchases
On December 21, 2021, the Board of Directors authorized the Company to repurchase up to $75,000 thousand of the Company’s outstanding common stock and the Company entered into an accelerated stock repurchase agreement (the “ASR Agreement”) with JPMorgan Chase Bank, National Association (“JPM”) to repurchase an aggregate of $37,500 thousand of the Company’s common stock.
Pursuant to the terms of the ASR Agreement dated December 21, 2021, the Company paid to JPM $37,500 thousand in cash and received an initial delivery of 994,695 shares of its common stock in the open market for an aggregate purchase price of $20,073 thousand and a price per share of $20.18 on December 22, 2021.
As of December 31, 2021, the Company accounted for the remaining portion of the ASR Agreement as a forward contract indexed to its own common stock and recorded $17,427 thousand in additional
paid-in
capital in stockholders’ equity in its consolidated balance sheets.
In March 2022, the previously announced repurchase of $37,500 thousand of the Company’s common stock was completed pursuant to the ASR Agreement, and as a result, the Company additionally received 1,031,576 shares of its common stock for an aggregate purchase price of $ 17,217 thousand at a price per share of $16.69, which was reclassified as treasury stock from additional
paid-in
capital in stockholder’s equity in the Company’s consolidated balance sheets.
On August 31, 2022, the Board of Directors has authorized an expansion of the Company’s previously announced stock repurchase program from $75,000 thousand to $87,500 thousand of the Company’s common stock.
In September 2022, the Company repurchased
 
324,643
shares of its common stock in the open market for an aggregate purchase price of $
3,638 
thousand and a price per share of $
11.21
under the stock repurchase program.
 
20

15. Earnings (Loss) Per Share
The following table illustrates the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2022 and
2021:
 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(In thousands of U.S. dollars, except share data)
 
Basic earnings (loss) per share
                                   
Net income (loss)
   $ (17,195    $ 10,768      $ (11,007    $ 3,097  
Basic weighted average common stock outstanding
     44,865,266        46,449,234        45,119,214        44,377,250  
Basic earnings (loss) per common share
   $ (0.38    $ 0.23      $ (0.24    $ 0.07  
Diluted earnings (loss) per share
                                   
Net income (loss)
   $ (17,195    $ 10,768      $ (11,007    $ 3,097  
Basic weighted average common stock outstanding
     44,865,266        46,449,234        45,119,214        44,377,250  
Net effect of dilutive equity awards
               1,359,223                  1,434,542  
    
 
 
    
 
 
    
 
 
    
 
 
 
Diluted weighted average common stock outstanding
     44,865,266        47,808,457        45,119,214        45,811,792  
Diluted earnings (loss) per share
   $ (0.38    $ 0.23      $ (0.24    $ 0.07  
The following outstanding instruments were excluded from the computation of diluted earnings (loss) per share, as they have an anti-dilutive effect on the calculation:

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
Options
     1,141,551        50,000        1,141,551        50,000  
Restricted Stock Units
     1,014,124                  1,014,124            
For the nine months ended September 30, 2021, 1,906,786 shares, of potential common stock from the assumed conversion of Exchangeable Notes were also excluded from the computation of diluted loss per share as the effect were anti-dilutive for the period.
Rights Plan
The Company entered into a Rights Agreement, dated as of December 13, 2021, between the Company and American Stock Transfer & Trust Company, LLC, as rights agent (the “Rights Agreement”), and the Board of Directors of the Company authorized and declared a dividend of one preferred stock purchase right (a “Right” and collectively, the “Rights”) for each share of the Company’s common stock, par value $0.01 per share, outstanding at the close of business on December 23, 2021. Each Right, once exercisable, will entitle the registered holder to purchase from the Company one
one-thousandth
of a share of Series
A-1
Junior Participating Preferred Stock, par value $0.01 per share, at a purchase price of $80, subject to adjustment (the “Purchase Price”). The Rights are not presently exercisable and remain attached to the shares of common stock unless and until the occurrence of the earlier of the following (the “Distribution Date”): (i) the tenth day after the public announcement or disclosure by the Company or any person or group of affiliated or associated persons that any person or group of affiliated or associated persons has become an “Acquiring Person” by obtaining beneficial ownership of 12.5% (or 20% in the case of a “passive institutional investor,” which is defined generally as any person who has reported beneficial ownership of shares of common stock on Schedule 13G under the Securities Exchange Act of 1934) or more of the Company’s outstanding common stock, subject to certain exceptions; or (ii) the tenth business day (or such later date as the Company’s Board of Directors may designate before a person or group of affiliated or associated persons becomes an Acquiring Person) after (and not including) the commencement of, or first public announcement of the intent of any person to commence, a tender or exchange offer by any person or group of affiliated or associated persons, which would, if consummated, result in such person or group becoming an Acquiring Person. The Board of Directors may redeem all of the Rights for $0.001 per Right at any time before any person or group of affiliated or associated persons becomes an Acquiring Person. In addition, at any time on or after any person or group of affiliated or associated persons becomes an Acquiring Person (but before any person or group of affiliated or associated persons becomes the owner of 50% or more of the Company’s outstanding common stock), the Board of Directors may exchange all or part of the Rights (other than the Rights beneficially owned by the Acquiring Person and certain affiliated persons) for shares of common stock at an exchange ratio of one share of common stock per Right. The Rights will expire at the close of business on December 12, 2022, unless redeemed or exchanged prior to that time.
 
21


If any person or group of affiliated or associated persons becomes an Acquiring Person, then, after the Distribution Date, each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons or transferees thereof) will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock having a market value of twice the Purchase Price. Alternatively, if, after any person or group of affiliated or associated persons becomes an Acquiring Person, (1) the Company is involved in a merger or other business combination in which the Company is not the surviving corporation or its common stock is changed into or exchanged for other securities or assets; or (2) the Company or one or more of its subsidiaries sell or otherwise transfer assets or earning power aggregating more than 50% of
the
assets or earning power of the Company and its subsidiaries, taken as a whole, then each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons) will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock of the other party to such business combination or sale (or in certain circumstances, an affiliate) having a market value of twice the Purchase Price.
16. Merger Agreement
On March 25, 2021, the Company, South Dearborn Limited, an exempted company incorporated in the Cayman Islands with limited liability (“Holdco”), formed by an affiliate of Wise Road Capital LTD (“Wise Road”), and Michigan Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Holdco (“Merger Sub”), entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”), providing for, among other things and subject to the terms and conditions thereof, the merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Holdco.
The closing of the Merger was subject to certain conditions, including clearance by the Committee on Foreign Investment in the United States (“CFIUS”) under the Defense Production Act of 1950, as amended. The Company and Holdco were advised that CFIUS clearance of the Merger would not be forthcoming and received permission from CFIUS to withdraw their joint filing. In connection therewith, the Company and Holdco entered into a Termination and Settlement Agreement, dated December 13, 2021 (the “Termination Agreement”), pursuant to which Holdco agreed to pay
$70,200 thousand (the “Termination Fee”) to the Company on the terms specified in the Termination Agreement in satisfaction of Holdco’s obligation
to
 
pay a termination fee in connection with the termination of the Merger Agreement. On December 20, 2021, the Merger Agreement was terminated pursuant to the Termination Agreement after the Company’s receipt of a fee of $51,000 thousand from Holdco and a standby letter of credit, which
secures a deferred fee of $19,200 thousand from Holdco due on or before March 31, 2022. As of December 31, 2021, of the Termination Fee, $19,200 thousand deferred fee was recorded as other receivables. In connection therewith, the Company, Holdco and Wise Road entered into a First Amendment to the Termination Agreement, dated April 4, 2022, pursuant to which Holdco paid $14,400 thousand on April 4, 2022, with

$4,800 thousand remaining outstanding. The Company, Holdco and Wise Road entered into a Second Amendment to the Termination Agreement, dated August 5, 2022 pursuant to which Holdco paid $3,000 thousand on August 5, 2022, of the deferred fee and payment of the remaining $1,800 thousand is
due on or before October 31, 2022.
 The Company, Holdco and Wise Road entered into a Letter Agreement, dated October 28, 2022 pursuant to which
the parties agreed to defer the remaining $1,800 thousand due on or before December 23,
2022. As of September 30, 2022, the remaining fee of $1,800 thousand was recorded as other receivables. Other than in respect of this receivable, the Company has no further relationship with Holdco.
For the three and nine months ended September 30, 2021, the Company incurred $1,552 thousand and $13,842 thousand, respectively, of professional fees and certain transaction related-expenses incurred in connection with the Merger, which were recognized in merger-related costs in the consolidated statements of operations.
 
2
2

17. Commitments and Contingencies
Advances to Suppliers
The Company, from time to time, may make advances in form of prepayments or deposits to suppliers, including external foundries, to meet its planned production. The Company recorded advances of $9,532 thousand and $1,708 thousand as other current assets as of September 30, 2022 and December 31, 2021, respectively.
COVID-19
Pandemic
In December 2019, a strain of coronavirus causing a disease known as
COVID-19
surfaced in Wuhan, China, resulting in significant disruptions among Chinese manufacturing and other facilities and travel throughout China. In March 2020, the World Health Organization declared the
COVID-19
outbreak a pandemic. Governmental authorities throughout the world have implemented numerous containment measures, including travel bans and restrictions, quarantines,
shelter-in-place
orders, and business restrictions and shutdowns, resulting in rapidly changing market and economic conditions. Although some of these restrictions and other containment measures have since been lifted or scaled back, ongoing surges of
COVID-19
have in some cases resulted in the
re-imposition
of certain restrictions and containment measures, and may continue to lead to other restrictions being
re-implemented
in the foreseeable future in response to efforts to reduce the rapid spread of
COVID-19.
The Company experienced some minor disruption in its Power Solutions business from assembly and test subcontractors located in China in the first quarter of 2020 as a result of the
COVID-19
pandemic. To date, its external Display Solutions business contractors and
sub-contractors
have not been materially impacted by the
COVID-19
pandemic. The Company is, however, unable to accurately predict the full impact that the
COVID-19
pandemic will have on its future results of operations due to numerous uncertainties. The extent to which the
COVID-19
pandemic impacts the Company’s business, results of operations and financial condition will depend on future developments, which, despite progress in vaccination efforts, are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information that may emerge concerning the severity of the
COVID-19
pandemic, such as new strains of the virus, including the Delta and Omicron variants and any future variants that may emerge, which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines and the extent and effectiveness of actions to contain the
COVID-19
pandemic or treat its impact, including vaccination campaigns and lockdown measures, among others. In addition, recurrences or additional waves of
COVID-19
cases could cause other widespread or more severe impacts depending on where infection rates are highest. The Company cannot presently predict the scope and severity of any potential business shutdowns or disruptions, but if the Company or any of its customers and suppliers were to experience prolonged business shutdowns or other disruptions, its ability to conduct its business could be materially and negatively affected, which could have a material adverse impact on its business, results of operations and financial condition.
The Company continues to closely monitor and evaluate the nature and scope of the impact of the
COVID-19
pandemic to its business, consolidated results of operations, and financial condition, and may take further actions altering its business operations and managing its costs and liquidity that the Company deems necessary or appropriate to respond to this ongoing and uncertain global health crisis and the resulting global economic consequences.
 
2
3


Table of Contents

FORWARD LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 27A of the Securities Act of 1933, as amended, that involve risks and uncertainties. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify these statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. All statements other than statements of historical facts included in this report that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements.

These forward-looking statements are largely based on our expectations and beliefs concerning future events, which reflect estimates and assumptions made by our management. These estimates and assumptions reflect our best judgment based on currently known market conditions and other factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Although we believe our estimates and assumptions to be reasonable, they are inherently uncertain and involve a number of risks and uncertainties that are beyond our control. In addition, management’s assumptions about future events may prove to be inaccurate. Management cautions all readers that the forward-looking statements contained in this report are not guarantees of future performance, and we cannot assure any reader that those statements will be realized or the forward-looking events and circumstances will occur. Actual results may differ materially from those anticipated or implied in the forward-looking statements due to the factors listed in this section, in “Part II: Item 1A. Risk Factors” herein and in “Part I: Item 1A. Risk Factors” in our Annual Report on Form 10-K for our fiscal year ended December 31, 2021 filed on February 23, 2022 (“2021 Form 10-K”) (including that the impact of the COVID-19 pandemic may also exacerbate the risks discussed therein).

All forward-looking statements speak only as of the date of this Report. We do not intend to publicly update or revise any forward-looking statements as a result of new information or future events or otherwise, except as required by law. These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our behalf.

Statements made in this Report, unless the context otherwise requires, that include the use of the terms “we,” “us,” “our” and “Magnachip” refer to Magnachip Semiconductor Corporation and its consolidated subsidiaries. The term “Korea” refers to the Republic of Korea or South Korea.

 

24


Table of Contents
Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the unaudited consolidated financial statements and the related notes included elsewhere in this Report.

Overview

We are a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, IoT applications, consumer, computing, industrial and automotive applications. We have a proven record with more than 40 years of operating history, a portfolio of approximately 1,100 registered patents and pending applications and extensive engineering and manufacturing process expertise.

Our standard products business includes our Display Solutions and Power Solutions business lines.

Our Display Solutions line of products provide flat panel display solutions to major suppliers of large and small flat panel displays. These products include source and gate drivers and timing controllers that cover a wide range of flat panel displays used in mobile communications, automobiles, entertainment devices, notebook PCs, monitors and liquid crystal display (LCD), organic light emitting diodes (OLED) and Micro light emitting diode (Micro LED) televisions. Our Display Solutions products support some of the industry’s most advanced display technologies, such as OLEDs, low temperature polysilicons thin film transistors (LTPS TFTs), as well as high-volume display technologies such as amorphous silicon thin film transistors (a-Si TFTs). Since 2007, we have designed and manufactured OLED display driver integrated circuit (IC) products. Our current portfolio of OLED solutions address a wide range of resolutions ranging from HD (High Definition) to WQHD (Wide Quadruple High Definition) for wide range of applications including smartphones, TVs, automotives and IT applications such as monitors, notebook PCs, tablet PCs as well as AR/VRs.

Our Power Solutions business line produces power management semiconductor products including discrete and integrated circuit solutions for power management in communications, consumer, computing, servers, automotive, and industrial applications. These products include metal oxide semiconductor field effect transistors (MOSFETs), insulated-gate bipolar transistors (IGBTs), AC-DC/DC-DC converters, LED drivers, regulators and power management integrated circuits (PMICs) for a range of devices, including televisions, smartphones, mobile phones, wearable devices, desktop PCs, notebooks, tablet PCs, other consumer electrics, automotive, and industrial applications such as power suppliers, e-bikes, solar inverters, LED lighting and motor drives.

Our wide variety of analog and mixed-signal semiconductor products combined with our mature technology platform allow us to address multiple high-growth end markets and rapidly develop and introduce new products and services in response to market demands. Our design center and substantial manufacturing operation in Korea place us at the core of the global electronics device supply chain. We believe this enables us to quickly and efficiently respond to our customers’ needs, and allows us to better serve and capture additional demand from existing and new customers. Certain of our OLED products are produced using external 12-inch foundries. Through a strategic cooperation with external 12-inch foundries, we are managing to ensure outsourcing wafers at competitive price and produce quality products.

To maintain and increase our profitability, we must accurately forecast trends in demand for electronics devices that incorporate semiconductor products we produce. We must understand our customers’ needs as well as the likely end market trends and demand in the markets they serve. We must also invest in relevant research and development activities and purchase necessary materials on a timely basis to meet our customers’ demand while maintaining our target margins and cash flow.

The semiconductor markets in which we participate are highly competitive. The prices of our products tend to decrease regularly over their useful lives, and such price decreases can be significant as new generations of products are introduced by us or our competitors. We strive to offset the impact of declining selling prices for existing products through cost reductions and the introduction of new products that command selling prices above the average selling price of our existing products. In addition, we seek to manage our inventories and manufacturing capacity so as to mitigate the risk of losses from product obsolescence.

Demand for our products and services is driven by overall demand for communications, IoT, consumer and industrial products and can be adversely affected by periods of weak consumer and enterprise spending or by market share losses by our customers. In order to mitigate the impact of market volatility on our business, we continually strive to diversify our portfolio of products, customers, and target applications. We also expect that new competitors will emerge in these markets that may place increased pressure on the pricing for our products and services. While we believe we are well positioned competitively to compete in these markets and against these new competitors as a result of our long operating history, existing manufacturing capacity and our worldwide customer base, if we are not effective in competing in these markets, our operating results may be adversely affected.

 

25


Table of Contents

Net sales for our standard products business are driven by design wins in which we are selected by an electronics original equipment manufacturer (OEM) or other potential customer to supply its demand for a particular product. A customer will often have more than one supplier designed into multi-source components for a particular product line. Once we have design wins and the products enter into mass production, we often specify the pricing of a particular product for a set period of time, with periodic discussions and renegotiations of pricing with our customers. In any given period, our net sales depend heavily upon the end-market demand for the goods in which our products are used, the inventory levels maintained by our customers and, in some cases, allocation of demand for components for a particular product among selected qualified suppliers.

In contrast to completely fabless semiconductor companies, our internal manufacturing capacity provides us with greater control over certain manufacturing costs and the ability to implement process and production improvements for our internally manufactured products, which can favorably impact gross profit margins. Our internal manufacturing capacity also allows for better control over delivery schedules, improved consistency over product quality and reliability and improved ability to protect intellectual property from misappropriation on these internally manufactured products. However, having internal manufacturing capacity exposes us to the risk of under-utilization of manufacturing capacity that results in lower gross profit margins, particularly during downturns in the semiconductor industry.

Our standard products business requires investments in capital equipment. Analog and mixed-signal manufacturing facilities and processes are typically distinguished by the design and process implementation expertise rather than the use of the most advanced equipment. Many of these processes also tend to migrate more slowly to smaller geometries due to technological barriers and increased costs. For example, some of our products use high-voltage technology that requires larger geometries and that may not migrate to smaller geometries for several years, if at all. As a result, our manufacturing base and strategy do not require substantial investment in leading edge process equipment for those products, allowing us to utilize our facilities and equipment over an extended period of time with moderate required capital investments. In addition, we are less likely to experience significant industry overcapacity, which can cause product prices to decline significantly. In general, we seek to invest in manufacturing capacity that can be used for multiple high-value applications over an extended period of time. In addition, we outsource manufacturing of those products which do require advanced technology and 12-inch and 8-inch wafer capacity, such as organic light emitting diodes (OLED). We believe this balanced capital investment strategy enables us to optimize our capital investments and facilitates more diversified product and service offerings.

Since 2007, we had designed and manufactured OLED display driver ICs in our internal manufacturing facilities. As we expanded our design capabilities to products that require lower geometries unavailable at our existing manufacturing facilities, we began outsourcing manufacturing of certain OLED display driver ICs to external 12-inch foundries starting in the second half of 2015 and we have started outsourcing 8-inch wafer for OLED TV IC after the sale of our fabrication facility located in Cheongju in 2020. This additional source of manufacturing is an increasingly important part of our supply chain management. By outsourcing manufacturing of OLED products to external foundries, we are able to adapt dynamically to changing customer requirements and address growing markets without substantial capital investments by us. However, relying on external foundries exposes us to the risk of being unable to secure manufacturing capacity, particularly under the current global shortage of foundry services. Although we are working strategically with external foundries to ensure long-term wafer capacity, if these efforts are unsuccessful, our ability to deliver products to our customers may be negatively impacted, which would adversely affect our relationship with customers and opportunities to secure new design-wins.

Our success going forward will depend upon our ability to adapt to future challenges such as the emergence of new competitors for our products and services or the consolidation of current competitors. Additionally, we must innovate to remain ahead of, or at least rapidly adapt to, technological breakthroughs that may lead to a significant change in the technology necessary to deliver our products and services. We believe that our established relationships and close collaboration with leading customers enhance our awareness of new product opportunities, market and technology trends and improve our ability to adapt and grow successfully.

 

26


Table of Contents

Recent Developments

Expanded Stock Repurchase Program

On August 31, 2022, our Board of Directors authorized an expansion of the previously announced stock repurchase program from $75.0 million to $87.5 million of our common stock. We have already repurchased shares worth $37.5 million under the program through an accelerated stock repurchase agreement on December 21, 2021 with JPMorgan Chase Bank, National Association. The remaining $50.0 million of the expanded $87.5 million program will be repurchased in the open market or through privately negotiated transactions. In connection with the repurchase program, we have established a stock trading plan with Oppenheimer & Co. Inc. in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

In September 2022, we repurchased 324,643 shares of our common stock in the open market for an aggregate purchase price of $3.6 million and a price per share of $11.21 under the stock repurchase program.

Global Semiconductor Industry Trends

Increases in demand for semiconductor products resulted in a global shortage of manufacturing capacity in recent periods. As a result, we may experience increased costs to manufacture our products and may not be able to manufacture and deliver all of the orders placed by our customers. Specifically, if we are unable to secure manufacturing capacity from the external foundries we rely on, our ability to deliver products to our customers may be negatively impacted. Also, shortage of manufacturing capacity may lead to an increase in our manufacturing costs. Our principal pricing strategy is to pass on the increased manufacturing costs to our customers; however, we may not be fully able to do this in all cases. Total revenues for the three and nine months ended September 30, 2022 were severely impacted by these persisting supply shortages, in particular for 28nm 12-inch OLED wafers, which impacted design-in projects from our large panel customer in Korea that are typically given 9 to 12 months in advance.

In an effort to minimize the potential adverse impact of the supply shortage, we are working strategically with certain external foundries to help ensure long-term wafer capacity. If these efforts are unsuccessful, however, such shortage could limit our ability to meet demand for our products in the future, which would adversely affect our reputation and competitive position, resulting in a negative impact on results of operations.

We are not able to foresee when the shortage of manufacturing capacity will subside, but we are beginning to see some indicators of improvement of such supply shortage situation. However, the global shortage for semiconductor products over the prior two years has led to overbooking backordered demand and oversupply. As a result, the current global macroeconomic conditions, including COVID-19 lockdowns in China, higher inflation and interest rates and uncertainty caused by the Russian-Ukraine war, have led to weaker end-market demand and an oversupply of inventory. We continue to monitor these trends and uncertainties, and any decline in end-market demand and increase in inventory levels could negatively impact our financial condition and results of operations.

COVID-19 Pandemic

In December 2019, a strain of coronavirus causing a disease known as COVID-19 surfaced in Wuhan, China, resulting in significant disruptions among Chinese manufacturing and other facilities and travel throughout China. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. Governmental authorities throughout the world have implemented numerous containment measures, including travel bans and restrictions, quarantines, shelter-in-place orders, and business restrictions and shutdowns, resulting in rapidly changing market and economic conditions. Although some of these restrictions and other containment measures have since been lifted or scaled back, ongoing surges of COVID-19 have, in some cases, resulted in the re-imposition of certain restrictions and containment measures, and may continue to lead to other restrictions being re-implemented in the foreseeable future in response to efforts to reduce the rapid spread of COVID-19.

We experienced some minor disruption in our Power Solutions business line from assembly and test subcontractors located in China in the first quarter of 2020 as a result of the COVID-19 pandemic. To date, our external Display Solutions business line contractors and sub-contractors have not been materially impacted by the COVID-19 pandemic. We are, however, unable to accurately predict the full impact that the COVID-19 pandemic will have on future results of operations due to numerous uncertainties. The extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on future developments, which, despite progress in vaccination efforts, are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information that may emerge concerning the severity of the COVID-19 pandemic, such as new strains of the virus, including the Delta and Omicron variants and any future variants that may emerge, which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines and the extent and effectiveness of actions to contain the COVID-19 pandemic or treat its impact, including vaccination campaigns and lockdown measures, among others. In addition, recurrences or additional waves of COVID-19 cases could cause other widespread or more

 

27


Table of Contents

severe impacts depending on where infection rates are highest. We cannot presently predict the scope and severity of any potential business shutdowns or disruptions, but if we or any of our customers and suppliers were to experience prolonged business shutdowns or other disruptions, our ability to conduct our business could be materially and negatively affected, which could have a material adverse impact on our business, results of operations and financial condition.

We continue to closely monitor and evaluate the nature and scope of the impact of the COVID-19 pandemic to our business, consolidated results of operations, and financial condition, and may take further actions altering our business operations and managing our costs and liquidity that we deem necessary or appropriate to respond to this ongoing and uncertain global health crisis and the resulting global economic consequences.

 

28


Table of Contents

Explanation and Reconciliation of Non-U.S. GAAP Measures

Adjusted EBITDA, Adjusted Operating Income and Adjusted Net Income

We use the terms Adjusted EBITDA, Adjusted Operating Income and Adjusted Net Income (including on a per share basis) in this Report. Adjusted EBITDA, as we define it, is a non-U.S. GAAP measure. We define Adjusted EBITDA for the periods indicated as EBITDA (as defined below), adjusted to exclude (i) equity-based compensation expense, (ii) foreign currency loss, net, (iii) derivative valuation gain, net, (iv) inventory reserve related to Huawei impact of downstream trade restrictions, (v) Merger-related costs and (vi) other charges, net. EBITDA for the periods indicated is defined as net income (loss) before interest income, net, income tax expense (benefit), and depreciation and amortization.

See the footnotes to the table below for further information regarding these items. We present Adjusted EBITDA as a supplemental measure of our performance because:

 

   

we believe that Adjusted EBITDA, by eliminating the impact of a number of items that we do not consider to be indicative of our core ongoing operating performance, provides a more comparable measure of our operating performance from period-to-period and may be a better indicator of future performance;

 

   

we believe that Adjusted EBITDA is commonly requested and used by securities analysts, investors and other interested parties in the evaluation of a company as an enterprise level performance measure that eliminates the effects of financing, income taxes and the accounting effects of capital spending, as well as other one time or recurring items described above; and

 

   

we believe that Adjusted EBITDA is useful for investors, among other reasons, to assess a company’s period-to-period core operating performance and to understand and assess the manner in which management analyzes operating performance.

We use Adjusted EBITDA in a number of ways, including:

 

   

for planning purposes, including the preparation of our annual operating budget;

 

   

to evaluate the effectiveness of our enterprise level business strategies;

 

   

in communications with our Board of Directors concerning our consolidated financial performance; and

 

   

in certain of our compensation plans as a performance measure for determining incentive compensation payments.

We encourage you to evaluate each adjustment and the reasons we consider them appropriate. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. Adjusted EBITDA is not a measure defined in accordance with U.S. GAAP and should not be construed as an alternative to income from continuing operations, cash flows from operating activities or net income, as determined in accordance with U.S. GAAP. A reconciliation of net income (loss) to Adjusted EBITDA is as follows:

 

     Three Months
Ended
September 30,
2022
     Nine Months
Ended
September 30,
2022
     Three Months
Ended
September 30,
2021
     Nine Months
Ended
September 30,
2021
 
                             
     (Dollars in millions)  

Net income (loss)

   $ (17.2    $ (11.0    $ 10.8      $ 3.1  

Interest income, net

     (1.5      (2.7      (0.4      (0.5

Income tax expense (benefit)

     (3.9      (1.4      3.1        6.0  

Depreciation and amortization

     3.6        11.2        3.6        10.6  
  

 

 

    

 

 

    

 

 

    

 

 

 

EBITDA

   $ (19.0    $ (3.8    $ 17.1      $ 19.2  

Adjustments:

           

Equity-based compensation expense(a)

     0.9        4.5        2.0        6.1  

Foreign currency loss, net(b)

     12.8        20.5        7.6        12.0  

Derivative valuation gain, net(c)

     (0.1      (0.2      (0.2      (0.1

Inventory reserve related to Huawei impact of downstream trade restrictions(d)

     —          —          (1.1      (1.1

Merger-related costs(e)

     —          —          1.6        13.8  

Other charges, net(f)

     2.5        3.3        (0.5      2.6  
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted EBITDA

   $ (3.0    $ 24.3      $ 26.4      $ 52.6  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

29


Table of Contents
(a)

This adjustment eliminates the impact of non-cash equity-based compensation expenses. Although we expect to incur non-cash equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these non-cash expenses as supplemental information.

(b)

This adjustment mainly eliminates the impact of non-cash foreign currency translation associated with intercompany debt obligations and foreign currency denominated receivables and payables, as well as the cash impact of foreign currency transaction gains or losses on collection of such receivables and payment of such payables. Although we expect to incur foreign currency translation gains or losses in the future, we believe that analysts and investors will find it helpful to review our operating performance without the effects of these primarily non-cash gains or losses, which we cannot control. Additionally, we believe the isolation of this adjustment provides investors with enhanced comparability to prior and future periods of our operating performance results.

(c)

This adjustment eliminates the impact of gain or loss recognized in income on derivatives, which represents derivatives value changes excluded from the risk being hedged. We enter into derivative transactions to mitigate foreign exchange risks. As our derivative transactions are limited to a certain portion of our expected cash flows denominated in U.S. dollars, and we do not enter into derivative transactions for trading or speculative purposes, we do not believe that these charges or gains are indicative of our core operating performance.

(d)

For the three and nine months ended September 31, 2021, this adjustment eliminates the impact of a partial sales of inventories for which excess and obsolete reserves were previously recognized in relation to the U.S. Government’s export restrictions on Huawei, which is a downstream customer of some of our direct customers, as a portion of reserved inventory was subsequently sold to certain other customers. As this adjustment meaningfully impacted our operational results and are not expected to represent an ongoing operating expense subject to our ability to foresee and control, we believe our operating performance results are more meaningfully compared if this adjustment is excluded.

(e)

For the three and nine months ended September 30, 2021, this adjustment eliminates professional service fees and expenses incurred in connection with the contemplated Merger transaction (see “Note 16. Merger Agreement” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements”). As this adjustment meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if this adjustment is excluded.

(f)

For the three and nine months ended September 30, 2022, this adjustment eliminates $2.8 million of one-time employee incentives, in each period, and professional service fees and expenses of $0.2 million and $1.0 million, respectively, incurred in connection with certain strategic evaluations, both of which were offset in part by a $0.5 million gain on sale of certain legacy equipment of the closed back-end line in our fabrication facility in Gumi. For the three and nine months ended September 30, 2021, this adjustment eliminates professional service fees and expenses of $0.2 million and $3.4 million, respectively, incurred in connection with the regulatory requests, both of which were offset in part by a $0.7 million legal settlement gain related to certain expenses incurred in prior periods in connection with our legacy Fab 4 (which was sold during the year ended December 31, 2020) and awarded in the third quarter. As these adjustments meaningfully impacted our operating results and are not expected to represent ongoing operating expenses to us, we believe our operating performance results are more usefully compared if these adjustments are excluded.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:

 

   

Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;

 

   

Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

 

   

Adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt;

 

   

although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often need to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;

 

   

Adjusted EBITDA does not consider the potentially dilutive impact of issuing equity-based compensation to our management team and employees;

 

   

Adjusted EBITDA does not reflect the costs of holding certain assets and liabilities in foreign currencies; and

 

   

other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.

 

30


Table of Contents

We present Adjusted Operating Income as supplemental measures of our performance. We prepare Adjusted Operating Income by adjusting operating income (loss) to eliminate the impact of equity-based compensation expenses and other items that may be either one time or recurring that we do not consider to be indicative of our core ongoing operating performance. We believe that Adjusted Operating Income is useful to investors to provide a supplemental way to understand our underlying operating performance and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations.

Adjusted Operating Income is not a measure defined in accordance with U.S. GAAP and should not be construed as an alternative to operating income, income from continuing operations, cash flows from operating activities or net income, as determined in accordance with U.S. GAAP. We encourage you to evaluate each adjustment and the reasons we consider them appropriate. Other companies in our industry may calculate Adjusted Operating Income differently than we do, limiting its usefulness as a comparative measure. In addition, in evaluating Adjusted Operating Income, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. We define Adjusted Operating Income for the periods indicated as operating income adjusted to exclude (i) equity-based compensation expense (ii) inventory reserve related to Huawei impact of downstream trade restrictions, (iii) Merger-related costs and (iv) other charges, net.

The following table summarizes the adjustments to operating income that we make in order to calculate Adjusted Operating Income (Loss) for the periods indicated:

 

     Three Months
Ended
September 30,
2022
     Nine Months
Ended
September 30,
2022
     Three Months
Ended
September 30,
2021
     Nine Months
Ended
September 30,
2021
 
                             
     (Dollars in millions)  

Operating income (loss)

   $ (10.0    $ 4.9      $ 20.0      $ 19.5  

Adjustments:

           

Equity-based compensation expense(a)

     0.9        4.5        2.0        6.1  

Inventory reserve related to Huawei impact of

downstream trade restrictions(b)

     —          —          (1.1      (1.1

Merger-related costs(c)

     —          —          1.6        13.8  

Other charges, net(d)

     2.5        3.3        0.2        3.4  
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted Operating Income (Loss)

   $ (6.6    $ 12.7      $ 22.7      $ 41.7  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a)

This adjustment eliminates the impact of non-cash equity-based compensation expenses. Although we expect to incur non-cash equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these non-cash expenses as supplemental information.

(b)

For the three and nine months ended September 31, 2021, this adjustment eliminates the impact of a partial sales of inventories for which excess and obsolete reserves were previously recognized in relation to the U.S. Government’s export restrictions on Huawei, which is a downstream customer of some of our direct customers, as a portion of reserved inventory was subsequently sold to certain other customers. As this adjustment meaningfully impacted our operational results and are not expected to represent an ongoing operating expense subject to our ability to foresee and control, we believe our operating performance results are more meaningfully compared if this adjustment is excluded.

(c)

For the three and nine months ended September 30, 2021, this adjustment eliminates professional service fees and expenses incurred in connection with the contemplated Merger transaction (see “Note 16. Merger Agreement” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements”). As this adjustment meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if this adjustment is excluded.

(d)

For the three and nine months ended September 30, 2022, this adjustment eliminates $2.8 million of one-time employee incentives, in each period, and professional service fees and expenses of $0.2 million and $1.0 million, respectively, incurred in connection with certain strategic evaluations, both of which were offset in part by a $0.5 million gain on sale of certain legacy equipment of the closed back-end line in our fabrication facility in Gumi. For the three and nine months ended September 30, 2021, this adjustment eliminates professional service fees and expenses of $0.2 million and $3.4 million, respectively, incurred in connection with the regulatory requests. As these adjustments meaningfully impacted our operating results and are not expected to represent ongoing operating expenses to us, we believe our operating performance results are more usefully compared if these adjustments are excluded.

 

31


Table of Contents

We present Adjusted Net Income (including on a per share basis) as a further supplemental measure of our performance. We prepare Adjusted Net Income (including on a per share basis) by adjusting net income (loss) to eliminate the impact of a number of non-cash expenses and other items that may be either one time or recurring that we do not consider to be indicative of our core ongoing operating performance. We believe that Adjusted Net Income (including on a per share basis) is particularly useful because it reflects the impact of our asset base and capital structure on our operating performance. We present Adjusted Net Income (including on a per share basis) for a number of reasons, including:

 

   

we use Adjusted Net Income (including on a per share basis) in communications with our Board of Directors concerning our consolidated financial performance without the impact of non-cash expenses and the other items as we discussed below since we believe that it is a more consistent measure of our core operating results from period to period; and

 

   

we believe that reporting Adjusted Net Income (including on a per share basis) is useful to readers in evaluating our core operating results because it eliminates the effects of non-cash expenses as well as the other items we discuss below, such as foreign currency gains and losses, which are out of our control and can vary significantly from period to period.

Adjusted Net Income (including on a per share basis) is not a measure defined in accordance with U.S. GAAP and should not be construed as an alternative to income from continuing operations, cash flows from operating activities or net income, as determined in accordance with U.S. GAAP. We encourage you to evaluate each adjustment and the reasons we consider them appropriate. Other companies in our industry may calculate Adjusted Net Income (including on a per share basis) differently than we do, limiting its usefulness as a comparative measure. In addition, in evaluating Adjusted Net Income (including on a per share basis), you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. We define Adjusted Net Income (including on a per share basis); for the periods indicated as net income (loss), adjusted to exclude (i) equity-based compensation expense, (ii) foreign currency loss, net, (iii) derivative valuation loss (gain), net, (iv) inventory reserve related to Huawei impact of downstream trade restrictions, (v) Merger-related costs, (vi) other charges, net and (vii) income tax effect on non-GAAP adjustments.

The following table summarizes the adjustments to net income (loss) that we make in order to calculate Adjusted Net Income (including on a per share basis) from continuing operations for the periods indicated:

 

     Three Months
Ended
September 30,
2022
     Nine Months
Ended
September 30,
2022
     Three Months
Ended
September 30,
2021
     Nine Months
Ended
September 30,
2021
 
                             
     (Dollars in millions, except per share data)  

Net income (loss)

   $ (17.2    $ (11.0    $ 10.8      $ 3.1  

Adjustments:

           

Equity-based compensation expense(a)

     0.9        4.5        2.0        6.1  

Foreign currency loss, net(b)

     12.8        20.5        7.6        12.0  

Derivative valuation gain, net(c)

     (0.1      (0.2      (0.2      (0.1

Inventory reserve related to Huawei impact of downstream trade restrictions(d)

     —          —          (1.1      (1.1

Merger-related costs(e)

     —          —          1.6        13.8  

Other charges, net(f)

     2.5        3.3        (0.5      2.6  

Income tax effect on non-GAAP adjustments(g)

     2.3        7.5        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted Net Income

   $ 1.1      $ 24.6      $ 20.1      $ 36.5  
  

 

 

    

 

 

    

 

 

    

 

 

 

Reported earnings (loss) per share – basic

   $ (0.38    $ (0.24    $ 0.23      $ 0.07  

Reported earnings (loss) per share – diluted

   $ (0.38    $ (0.24    $ 0.23      $ 0.07  

Weighted average number of shares – basic

     44,865,266        45,119,214        46,449,234        44,377,250  

Weighted average number of shares – diluted

     44,865,266        45,119,214        47,808,457        45,811,792  

Adjusted earnings per share – basic

   $ 0.02      $ 0.55      $ 0.43      $ 0.82  

Adjusted earnings per share – diluted

   $ 0.02      $ 0.53      $ 0.42      $ 0.78  

Weighted average number of shares – basic

     44,865,266        45,119,214        46,449,234        44,377,250  

Weighted average number of shares – diluted

     45,747,255        46,134,231        47,808,457        47,718,578  

 

(a)

This adjustment eliminates the impact of non-cash equity-based compensation expenses. Although we expect to incur non-cash equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these non-cash expenses as supplemental information.

(b)

This adjustment mainly eliminates the impact of non-cash foreign currency translation associated with intercompany debt obligations and foreign currency denominated receivables and payables, as well as the cash impact of foreign currency transaction gains or losses on collection of such receivables and payment of such payables. Although we expect to incur foreign currency translation gains or losses in the future, we believe that analysts and investors will find it helpful to review our operating performance without the effects of these primarily non-cash gains or losses, which we cannot control. Additionally, we believe the isolation of this adjustment provides investors with enhanced comparability to prior and future periods of our operating performance results.

 

32


Table of Contents
(c)

This adjustment eliminates the impact of gain or loss recognized in income on derivatives, which represents derivatives value changes excluded from the risk being hedged. We enter into derivative transactions to mitigate foreign exchange risks. As our derivative transactions are limited to a certain portion of our expected cash flows denominated in U.S. dollars, and we do not enter into derivative transactions for trading or speculative purposes, we do not believe that these charges or gains are indicative of our core operating performance.

(d)

For the three and nine months ended September 31, 2021, this adjustment eliminates the impact of a partial sales of inventories for which excess and obsolete reserves were previously recognized in relation to the U.S. Government’s export restrictions on Huawei, which is a downstream customer of some of our direct customers, as a portion of reserved inventory was subsequently sold to certain other customers. As this adjustment meaningfully impacted our operational results and are not expected to represent an ongoing operating expense subject to our ability to foresee and control, we believe our operating performance results are more meaningfully compared if this adjustment is excluded.

(e)

For the three and nine months ended September 30, 2021, this adjustment eliminates professional service fees and expenses incurred in connection with the contemplated Merger transaction (see “Note 16. Merger Agreement” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements”). As this adjustment meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if this adjustment is excluded.

(f)

For the three and nine months ended September 30, 2022, this adjustment eliminates $2.8 million of one-time employee incentives, in each period, and professional service fees and expenses of $0.2 million and $1.0 million, respectively, incurred in connection with certain strategic evaluations, both of which were offset in part by a $0.5 million gain on sale of certain legacy equipment of the closed back-end line in our fabrication facility in Gumi. For the three and nine months ended September 30, 2021, this adjustment eliminates professional service fees and expenses of $0.2 million and $3.4 million, respectively, incurred in connection with the regulatory requests, both of which were offset in part by a $0.7 million legal settlement gain related to certain expenses incurred in prior periods in connection with our legacy Fab 4 (which was sold during the year ended December 31, 2020) and awarded in the third quarter. As these adjustments meaningfully impacted our operating results and are not expected to represent ongoing operating expenses to us, we believe our operating performance results are more usefully compared if these adjustments are excluded.

(g)

For the three and nine months ended September 30, 2022, this adjustment eliminates the income tax effect on non-GAAP adjustments of $2.3 million and $7.5 million, respectively, which mainly related to our Korean subsidiary using a calculation method that we compare the tax expense with and without the non-GAAP adjustments.

We believe that all adjustments to net income (loss) used to calculate Adjusted Net Income was applied consistently to the periods presented.

Adjusted Net Income has limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:

 

   

Adjusted Net Income does not reflect changes in, or cash requirements for, our working capital needs;

 

   

Adjusted Net Income does not consider the potentially dilutive impact of issuing equity-based compensation to our management team and employees;

 

   

Adjusted Net Income does not reflect the costs of holding certain assets and liabilities in foreign currencies; and

 

   

other companies in our industry may calculate Adjusted Net Income differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted Net Income should not be considered as a measure of profitability of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted Net Income only as a supplement.

 

33


Table of Contents

Factors Affecting Our Results of Operations

Net Sales. We derive substantially all of our sales (net of sales returns and allowances) from our standard products business. We outsource manufacturing of mobile OLED products to external 12-inch foundries. Our product inventory is primarily located in Korea and is available for drop shipment globally. Outside of Korea, we maintain limited product inventory, and our sales representatives generally relay orders to our factories in Korea for fulfillment. We have strategically located our sales offices near concentrations of major customers. Our sales offices are located in Korea, Japan, Taiwan and Greater China. Our network of authorized agents and distributors is in the United States, Europe and the Asia Pacific region.

We recognize revenue when a customer obtains control of the product, which is generally upon product shipment, delivery at the customer’s location or upon customer acceptance, depending on the terms of the arrangement. For the nine months ended September 30, 2022 and 2021, we sold products to 169 and 175 customers, respectively, and our net sales to our ten largest customers represented 70% and 81% of our net sales—standard products business, respectively.

We will provide the Transitional Fab 3 Foundry Services up to September 1, 2023 at an agreed upon cost plus a mark-up.

Gross Profit. Our overall gross profit generally fluctuates as a result of changes in overall sales volumes and in the average selling prices of our products and services. Other factors that influence our gross profit include changes in product mix, the introduction of new products and services and subsequent generations of existing products and services, shifts in the utilization of our manufacturing facility and the yields achieved by our manufacturing operations, changes in material, labor and other manufacturing costs including outsourced manufacturing expenses, and variation in depreciation expense.

Average Selling Prices. Average selling prices for our products tend to be highest at the time of introduction of new products which utilize the latest technology and tend to decrease over time as such products mature in the market and are replaced by next generation products. We strive to offset the impact of declining selling prices for existing products through our product development activities and by introducing new products that command selling prices above the average selling price of our existing products. In addition, we seek to manage our inventories and manufacturing capacity so as to preclude losses from product and productive capacity obsolescence.

Material Costs. Our material costs consist of costs of raw materials, such as silicon wafers, chemicals, gases and tape and packaging supplies. We use processes that require specialized raw materials, such as silicon wafers, that are generally available from a limited number of suppliers. If demand increases or supplies decrease, the costs of our raw materials could increase significantly.

Labor Costs. A significant portion of our employees are located in Korea. Under Korean labor laws, most employees and certain executive officers with one or more years of service are entitled to severance benefits upon the termination of their employment based on their length of service and rate of pay. As of September 30, 2022, approximately 97% of our employees were eligible for severance benefits.

Depreciation Expense. We periodically evaluate the carrying values of long-lived assets, including property, plant and equipment and intangible assets, as well as the related depreciation periods. We depreciated our property, plant and equipment using the straight-line method over the estimated useful lives of our assets. Depreciation rates vary from 30-40 years on buildings to 5 to 12 years for certain equipment and assets. Our evaluation of carrying values is based on various analyses including cash flow and profitability projections. If our projections indicate that future undiscounted cash flows are not sufficient to recover the carrying values of the related long-lived assets, the carrying value of the assets is impaired and will be reduced, with the reduction charged to expense so that the carrying value is equal to fair value.

Selling Expenses. We sell our products worldwide through a direct sales force as well as a network of sales agents and representatives to OEMs, including major branded customers and contract manufacturers, and indirectly through distributors. Selling expenses consist primarily of the personnel costs for the members of our direct sales force, a network of sales representatives and other costs of distribution. Personnel costs include base salary, benefits and incentive compensation.

General and Administrative Expenses. General and administrative expenses consist of the costs of various corporate operations, including finance, legal, human resources and other administrative functions. These expenses primarily consist of payroll-related expenses, consulting and other professional fees and office facility-related expenses.

Research and Development. The rapid technological change and product obsolescence that characterize our industry require us to make continuous investments in research and development. Product development time frames vary but, in general, we incur research and development costs one to two years before generating sales from the associated new products. These expenses include personnel costs for members of our engineering workforce, cost of photomasks, silicon wafers and other non-recurring engineering charges related to product design. Additionally, we develop base line process technology through experimentation and through the design and use of characterization wafers that help achieve commercially feasible yields for new products. The majority of research and development expenses of our display business are material and design-related costs for OLED display driver IC product development involving 28-nanometer or finer processes. The majority of research and development expenses of our power business are certain equipment, material and design-related costs for power discrete products and material and design-related costs for power IC products. Power IC uses standard BCD process technologies which can be sourced from multiple foundries.

 

34


Table of Contents

Impact of Foreign Currency Exchange Rates on Reported Results of Operations. Historically, a portion of our revenues and cost of sales and greater than the majority of our operating expenses have been denominated in non-U.S. currencies, principally the Korean won, and we expect that this will remain true in the future. Because we report our results of operations in U.S. dollars converted from our non-U.S. revenues and expenses based on monthly average exchange rates, changes in the exchange rate between the Korean won and the U.S. dollar could materially impact our reported results of operations and distort period to period comparisons. In particular, because of the difference in the amount of our consolidated revenues and expenses that are in U.S. dollars relative to Korean won, depreciation in the U.S. dollar relative to the Korean won could result in a material increase in reported costs relative to revenues, and therefore could cause our profit margins and operating income to appear to decline materially, particularly relative to prior periods. The converse is true if the U.S. dollar were to appreciate relative to the Korean won. Moreover, our foreign currency gain or loss would be affected by changes in the exchange rate between the Korean won and the U.S. dollar as a substantial portion of non-cash translation gain or loss is associated with the intercompany long-term loans to our Korean subsidiary, which is denominated in U.S. dollars. As of September 30, 2022, the outstanding intercompany loan balance including accrued interest between our Korean subsidiary and our Dutch subsidiary was $356.7 million. As a result of such foreign currency fluctuations, it could be more difficult to detect underlying trends in our business and results of operations. In addition, to the extent that fluctuations in currency exchange rates cause our results of operations to differ from our expectations or the expectations of our investors, the trading price of our stock could be adversely affected.

From time to time, we may engage in exchange rate hedging activities in an effort to mitigate the impact of exchange rate fluctuations. Our Korean subsidiary enters into foreign currency zero cost collar contracts in order to mitigate a portion of the impact of U.S. dollar-Korean won exchange rate fluctuations on our operating results. Obligations under these foreign currency zero cost collar contracts must be cash collateralized if our exposure exceeds certain specified thresholds. These zero cost collar contracts may be terminated by a counterparty in a number of circumstances, including if our total cash and cash equivalents is less than $30.0 million at the end of a fiscal quarter unless a waiver is obtained from the counterparty. We cannot assure that any hedging technique we implement will be effective. If our hedging activities are not effective, changes in currency exchange rates may have a more significant impact on our results of operations. See “Note 7. Derivative Financial Instruments” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements” for additional information regarding our foreign exchange hedging activities.

Foreign Currency Gain or Loss. Foreign currency translation gains or losses on transactions by us or our subsidiaries in a currency other than our or our subsidiaries’ functional currency are included in foreign currency gain (loss), net in our statements of operations. A substantial portion of this net foreign currency gain or loss relates to non-cash translation gain or loss related to the principal balance of intercompany balances at our Korean subsidiary that are denominated in U.S. dollars. This gain or loss results from fluctuations in the exchange rate between the Korean won and U.S. dollar.

Income Taxes. We record our income taxes in each of the tax jurisdictions in which we operate. This process involves using an asset and liability approach whereby deferred tax assets and liabilities are recorded for differences in the financial reporting bases and tax basis of our assets and liabilities. We exercise significant management judgment in determining our provision for income taxes, deferred tax assets and liabilities. We assess whether it is more likely than not that the deferred tax assets existing at the period-end will be realized in future periods. In such assessment, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent results of operations. In the event we were to determine that we would be able to realize the deferred income tax assets in the future in excess of their net recorded amount, we would adjust the valuation allowance, which would reduce the provision for income taxes.

We are subject to income- or non-income-based tax examinations by tax authorities of the U.S., Korea and multiple other foreign jurisdictions for all open tax years. Significant estimates and judgments are required in determining our worldwide provision for income- or non-income based taxes. Some of these estimates are based on interpretations of existing tax laws or regulations. The ultimate amount of tax liability may be uncertain as a result.

Capital Expenditures. We primarily invest in manufacturing equipment, software design tools and other tangible assets mainly for fabrication facility maintenance, capacity expansion and technology improvement. Capacity expansions and technology improvements typically occur in anticipation of increases in demand. We typically pay for capital expenditures in partial installments with portions due on order, delivery and final acceptance. Our capital expenditures mainly include our payments for the purchase of property, plant and equipment.

 

35


Table of Contents

Inventories. We monitor our inventory levels in light of product development changes and market expectations. We may be required to take additional charges for quantities in excess of demand, cost in excess of market value and product age. Our analysis may take into consideration historical usage, expected demand, anticipated sales price, new product development schedules, the effect new products might have on the sales of existing products, product age, customer design activity, customer concentration and other factors. These forecasts require us to estimate our ability to predict demand for current and future products and compare those estimates with our current inventory levels and inventory purchase commitments. Our forecasts for our inventory may differ from actual inventory use.

 

36


Table of Contents

Results of Operations – Comparison of Three Months Ended September 30, 2022 and 2021

The following table sets forth consolidated results of operations for the three months ended September 30, 2022 and 2021:

 

     Three Months Ended
September 30, 2022
    Three Months Ended
September 30, 2021
       
     Amount     % of
Total revenues
    Amount     % of
Total revenues
    Change
Amount
 
                                
     (Dollars in millions)  

Revenues

          

Net sales – standard products business

   $ 62.8       88.2   $ 117.4       92.5   $ (54.6

Net sales – transitional Fab 3 foundry services

     8.4       11.8       9.6       7.5       (1.2
  

 

 

     

 

 

     

 

 

 

Total revenues

     71.2       100.0       127.0       100.0       (55.8

Cost of sales

          

Cost of sales – standard products business

     45.5       63.9       71.6       56.4       (26.1

Cost of sales – transitional Fab 3 foundry services

     8.5       11.9       8.8       6.9       (0.3
  

 

 

     

 

 

     

 

 

 

Total cost of sales

     54.0       75.8       80.4       63.3       (26.4
  

 

 

     

 

 

     

 

 

 

Gross profit

     17.2       24.2       46.6       36.7       (29.4

Selling, general and administrative expenses

     11.4       16.0       12.6       9.9       (1.1

Research and development expenses

     13.3       18.7       12.3       9.7       1.1  

Merger-related costs

     —         —         1.6       1.2       (1.6

Other charges, net

     2.5       3.5       0.2       0.2       2.3  
  

 

 

     

 

 

     

 

 

 

Operating income (loss)

     (10.0     (14.1     20.0       15.7       (30.0

Interest expense

     (0.3     (0.4     (0.1     (0.1     (0.2

Foreign currency loss, net

     (12.8     (18.0     (7.6     (6.0     (5.2

Others, net

     2.0       2.8       1.6       1.3       0.4  
  

 

 

     

 

 

     

 

 

 
     (11.1     (15.6     (6.1     (4.8     (5.0
  

 

 

     

 

 

     

 

 

 

Income (loss) before income tax expense

     (21.1     (29.7     13.9       11.0       (35.1

Income tax expense (benefit)

     (3.9     (5.5     3.1       2.5       (7.1
  

 

 

     

 

 

     

 

 

 

Net income (loss)

   $ (17.2     (24.2   $ 10.8       8.5     $ (28.0
  

 

 

     

 

 

     

 

 

 

 

     Three Months Ended
September 30, 2022
    Three Months Ended
September 30, 2021
       
     Amount      % of
Total revenues
    Amount      % of
Total revenues
    Change
Amount
 
                                  
     (Dollars in millions)  

Revenues

            

Net sales – standard products business

            

Display Solutions

   $ 6.4        8.9   $ 58.5        46.1   $ (52.2

Power Solutions

     56.4        79.2       58.9        46.4       (2.5
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total standard products business

     62.8        88.2       117.4        92.5       (54.6

Net sales – transitional Fab 3 foundry services

     8.4        11.8       9.6        7.5       (1.2
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total revenues

   $ 71.2        100.0   $ 127.0        100.0   $ (55.8
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

 

     Three Months Ended
September 30, 2022
    Three Months Ended
September 30, 2021
       
     Amount     % of
Net sales
    Amount      % of
Net sales
    Change
Amount
 
                                 
     (Dollars in millions)  

Gross Profit

           

Gross profit – standard products business

   $ 17.3       27.5   $ 45.8        39.0   $ (28.5

Gross profit – transitional Fab 3 foundry services

     (0.0     (0.6     0.8        8.5       (0.9
  

 

 

     

 

 

      

 

 

 

Total gross profit

   $ 17.2       24.2   $ 46.6        36.7   $ (29.4
  

 

 

     

 

 

      

 

 

 

 

37


Table of Contents

Revenues

Total revenues were $71.2 million for the three months ended September 30, 2022, a $55.8 million, or 43.9%, decrease compared to $127.0 million for the three months ended September 30, 2021. This decrease was primarily due to a decrease in revenue related to our standard products business as described below.

The standard products business. Net sales from our standard products business were $62.8 million for the three months ended September 30, 2022, a $54.6 million, or 46.5%, decrease compared to $117.4 million for the three months ended September 30, 2021. The significant decrease in net sales from our Display Solutions business line was primarily attributable to a decrease in revenue from our mobile OLED display driver ICs stemming from a lower customer demand resulting from a slowdown in the Chinese smartphone market, and a lack of secured manufacturing capacity (in particular for 28nm 12-inch OLED wafers) at external 12-inch foundries, which was offset in part by a higher demand for our auto-LCD display driver ICs and OLED TV display driver ICs. The decrease in net sales from our Power Solutions business line was attributable to a lower demand for MOSFETs primarily for smartphone and e-bikes, which was affected by COVID-19 lockdowns in China. This decrease was almost offset by a strong demand for IGBTs mainly for solar inverters.

The transitional Fab 3 foundry services. Net sales from the transitional Fab 3 foundry services were $8.4 million and $9.6 million for the three months ended September 30, 2022 and 2021, respectively.

Gross Profit

Total gross profit was $17.2 million for the three months ended September 30, 2022 compared to $46.6 million for the three months ended September 30, 2021, a $29.4 million, or 63.0%, decrease. Gross profit as a percentage of net sales for the three months ended September 30, 2022 decreased to 24.2% compared to 36.7% for the three months ended September 30, 2021. The decrease in both gross profit and gross profit as a percentage of net sales was primarily due to our standard products business as further described below.

The standard products business. Gross profit from our standard products business was $17.3 million for the three months ended September 30, 2022, which represented a $28.5 million, or 62.3%, decrease from gross profit of $45.8 million for the three months ended September 30, 2021. The decrease in gross profit was primarily attributable to a significant decrease in net sales from our Display Solutions business line as explained above. Gross profit as a percentage of net sales for the three months ended September 30, 2022 decreased to 27.5% compared to 39.0% for the three months ended September 30, 2021. The decrease in gross profit as a percentage of net sales was primarily attributable to certain inventory reserve and scrap cost related to 12-inch display products resulted from lower demand for China smartphones and a lower utilization rate of our internal fabrication facility. For the three months ended September 30, 2021, a partial sales of inventories for which excess and obsolete reserves were previously recognized in relation to the U.S. Government’s export restrictions on Huawei, which is a downstream customer of some of our direct customers, favorably affected both gross profit and gross profit as a percentage of net sales, as such reserved inventory was subsequently sold to certain other customers in the third quarter of 2021.

 

38


Table of Contents

Net Sales – Standard Products Business by Geographic Region

We report net sales – standard products business by geographic region based on the location to which the products are billed. The following table sets forth our net sales—standard products business by geographic region and the percentage of total net sales—standard products business represented by each geographic region for the three months ended September 30, 2022 and 2021:

 

     Three Months Ended
September 30, 2022
    Three Months Ended
September 30, 2021
       
     Amount      % of
Net sales –
standard
products
business
    Amount      % of
Net sales –
standard
products
business
    Change
Amount
 
                                  
     (Dollars in millions)  

Korea

   $ 23.9        38.0   $ 29.7        25.3   $ (5.8

Asia Pacific (other than Korea)

     34.6        55.1       84.2        71.7       (49.6

United States

     2.7        4.3       1.8        1.5       1.0  

Europe

     1.6        2.5       1.4        1.2       0.2  

Others

     —          —         0.4        0.3       (0.4
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 
   $ 62.8        100.0   $ 117.4        100.0   $ (54.6
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Net sales – standard products business in Korea for the three months ended September 30, 2022 decreased from $29.7 million to $23.9 million compared to the three months ended September 30, 2021, or by $5.8 million, or 19.5%, primarily due to a decrease in revenue from our mobile OLED display driver ICs and weaker demand for power products such as MOSFETs, including high-end MOSFETs, primarily for TVs and smartphone applications, which was offset in part by higher demand for OLED TV display driver ICs.

Net sales – standard products business in Asia Pacific (other than Korea) for the three months ended September 30, 2022 decreased to $34.6 million from $84.2 million in the three months ended September 30, 2021, or by $49.6 million, or 58.9%, primarily due to a decrease in revenue from our mobile OLED display driver ICs stemming from a lower customer demand resulting from a slowdown in the Chinese smartphone market, and a lack of secured manufacturing capacity (in particular for 28nm 12-inch OLED wafers) at external 12-inch foundries, which was offset in part by a higher demand for power products such as IGBTs mainly for solar inverters. The increased demand for our auto-LCD display driver ICs also favorably affected in this quarter.

Operating Expenses

Selling, General and Administrative Expenses. Selling, general and administrative expenses were $11.4 million, or 16.0% of total revenues, for the three months ended September 30, 2022, compared to $12.6 million, or 9.9% of total revenues, for the three months ended September 30, 2021. The decrease of $1.1 million, or 9.1%, was primarily attributable to a decrease in estimated employee compensation reflecting the current year’s financial performance.

Research and Development Expenses. Research and development expenses were $13.3 million, or 18.7% of total revenues, for the three months ended September 30, 2022, compared to $12.3 million, or 9.7% of total revenues, for the three months ended September 30, 2021. The increase of $1.1 million, or 8.6%, was primarily attributable to increase in outside service fees, including those for software design tools, and variable overhead expenses.

Merger-related Costs. For the three months ended September 30, 2021, we recorded $1.6 million of professional service fees and expenses incurred in connection with the contemplated Merger transaction.

Other Charges, Net. For the three months ended September 30, 2022, we recorded $2.8 million of one-time employee incentives and $0.2 million of professional service fees and expenses incurred in connection with certain strategic evaluations, which was offset in part by a $0.5 million gain on sale of certain legacy equipment of the closed back-end line in our fabrication facility in Gumi. For the three months ended September 30, 2021, we recorded $0.2 million of non-recurring professional service fees and expenses incurred in connection with the regulatory requests.

 

39


Table of Contents

Operating Income (Loss)

As a result of the foregoing, operating loss was $10.0 million for the three months ended September 30, 2022 compared to operating income of $20.0 million the three months ended September 30, 2021. As discussed above, the decrease in operating income of $30.0 million resulted primarily from a $29.4 million decrease in gross profit, a $2.3 million increase in other charge, net, and a $1.1 million increase in research and development expenses. This increase was offset in part by a $1.6 million decrease in Merger-related costs and a $1.1 million decrease in selling, general and administrative expenses.

 

40


Table of Contents

Other Income (Expense)

Interest Expense. Interest expenses was $0.3 million and $0.1 million for the three months ended September 30, 2022 and September 30, 2021, respectively.

Foreign Currency Loss, Net. Net foreign currency loss for the three months ended September 30, 2022 was $12.8 million compared to net foreign currency loss of $7.6 million for the three months ended September 30, 2021. The net foreign currency loss for the three months ended September 30, 2022 and September 30, 2021 was due to the depreciation in value of the Korean won relative to the U.S. dollar during the period.

A substantial portion of our net foreign currency gain or loss is non-cash translation gain or loss associated with intercompany long-term loans to our Korean subsidiary, which are denominated in U.S. dollars, and are affected by changes in the exchange rate between the Korean won and the U.S. dollar. As of September 30, 2022 and September 30, 2021, the outstanding intercompany loan balances, including accrued interest between our Korean subsidiary and our Dutch subsidiary, were $357 million and $393 million, respectively. Foreign currency translation gain or loss from intercompany balances were included in determining our consolidated net income since the intercompany balances were not considered long-term investments in nature because management intended to settle these intercompany balances at their respective maturity dates.

Others, Net. Others were primarily comprised of interest income, rental income, and gains and losses from valuation of derivatives which were designated as hedging instruments. Others for the three months ended September 30, 2022 and September 30, 2021 was $2.0 million and $1.6 million, respectively. In the third quarter of 2021, others, net included a $0.7 million legal settlement gain related to certain expenses incurred in prior periods in connection with our legacy Fab 4 (which was sold during the year ended December 31, 2020) and awarded in the current quarter.

Income Tax Expense (Benefit)

Income tax benefit was $3.9 million for the three months ended September 30, 2022, which was primarily attributable to the decrease in the pre-tax income due to foreign currency translation losses associated with intercompany long-term loans in our Korean subsidiary for the respective period.

Income tax expense was $3.1 million for the three months ended September 30, 2021, which was primarily attributable to interest on intercompany loan balances and the estimated taxable income for the respective period in our Korean subsidiary, combined with its ability to utilize net operating loss carryforwards up to 60%.

Net Income (Loss)

As a result of the foregoing, a net loss of $17.2 million was recorded for the three months ended September 30, 2022 compared to a net income of $10.8 million for the three months ended September 30, 2021. As discussed above, the $28.0 million decrease in net income was primarily attributable to a $30.0 million decrease in operating income and $5.2 million increase in net foreign currency loss, which was offset in part by a $7.1 million decrease in income tax expense.

 

41


Table of Contents

Results of Operations – Comparison of Nine Months Ended September 30, 2022 and 2021

The following table sets forth consolidated results of operations for the nine months ended September 30, 2022 and 2021:

 

     Nine Months Ended
September 30, 2022
    Nine Months Ended
September 30, 2021
       
     Amount     % of
Total revenues
    Amount     % of
Total revenues
    Change
Amount
 
                                
     (Dollars in millions)  

Revenues

          

Net sales – standard products business

   $ 248.1       89.7   $ 333.6       91.7   $ (85.5

Net sales – transitional Fab 3 foundry services

     28.6       10.3       30.3       8.3       (1.7
  

 

 

     

 

 

     

 

 

 

Total revenues

     276.7       100.0       363.9       100.0       (87.2

Cost of sales

          

Cost of sales – standard products business

     165.2       59.7       221.3       60.8       (56.1

Cost of sales – transitional Fab 3 foundry services

     26.3       9.5       27.7       7.6       (1.4
  

 

 

     

 

 

     

 

 

 

Total cost of sales

     191.5       69.2       249.0       68.4       (57.5
  

 

 

     

 

 

     

 

 

 

Gross profit

     85.2       30.8       114.9       31.6       (29.8

Selling, general and administrative expenses

     38.3       13.8       39.2       10.8       (0.9

Research and development expenses

     38.7       14.0       39.0       10.7       (0.3

Merger-related costs

     —         —         13.8       3.8       (13.8

Other charges, net

     3.3       1.2       3.4       0.9       (0.1
  

 

 

     

 

 

     

 

 

 

Operating income

     4.9       1.8       19.5       5.4       (14.7

Interest expense

     (0.9     (0.3     (1.2     (0.3     0.4  

Foreign currency loss, net

     (20.5     (7.4     (12.0     (3.3     (8.5

Others, net

     4.2       1.5       2.8       0.8       1.3  
  

 

 

     

 

 

     

 

 

 
     (17.2     (6.2     (10.4     (2.9     (6.8
  

 

 

     

 

 

     

 

 

 

Income (loss) before income tax expense

     (12.4     4.5       9.1       2.5       (21.5

Income tax expense (benefit)

     (1.4     (0.5     6.0       1.7       (7.4
  

 

 

     

 

 

     

 

 

 

Net income (loss)

   $ (11.0     (4.0   $ 3.1       0.9     $ (14.1
  

 

 

     

 

 

     

 

 

 

 

     Nine Months Ended
September 30, 2022
    Nine Months Ended
September 30, 2021
       
     Amount      % of
Total revenues
    Amount      % of
Total revenues
    Change
Amount
 
                                  
     (Dollars in millions)  

Revenues

            

Net sales – standard products business

            

Display Solutions

   $ 63.9        23.1   $ 164.0        45.1   $ (100.1

Power Solutions

     184.2        66.6       169.6        46.6       14.6  
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total standard products business

     248.1        89.7       333.6        91.7       (85.5

Net sales – transitional Fab 3 foundry services

     28.6        10.3       30.3        8.3       (1.7
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total revenues

   $ 276.7        100.0   $ 363.9        100.0   $ (87.2
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

 

     Nine Months Ended
September 30, 2022
    Nine Months Ended
September 30, 2021
       
     Amount      % of
Net sales
    Amount      % of
Net sales
    Change
Amount
 
                                  
     (Dollars in millions)  

Gross Profit

            

Gross profit – standard products business

   $ 82.9        33.4   $ 112.3        33.7   $ (29.4

Gross profit – transitional Fab 3 foundry services

     2.3        8.0       2.6        8.7       (0.4
  

 

 

      

 

 

      

 

 

 

Total gross profit

   $ 85.2        30.8   $ 114.9        31.6   $ (29.8
  

 

 

      

 

 

      

 

 

 

 

42


Table of Contents

Revenues

Total revenues were $276.7 million for the nine months ended September 30, 2022, a $87.2 million, or 24.0%, decrease compared to $363.9 million for the nine months ended September 30, 2021. This decrease was primarily due to a decrease in revenue related to our standard products business as described below.

The standard products business. Net sales from our standard products business were $248.1 million for the nine months ended September 30, 2022, an $85.5 million, or 25.6%, decrease compared to $333.6 million for the nine months ended September 30, 2021. The significant decrease in net sales from our Display Solutions business line was primarily attributable to a decrease in revenue from our mobile OLED display driver ICs stemming from a lower customer demand resulting from a slowdown in the Chinese smartphone market, and a lack of secured manufacturing capacity (in particular for 28nm 12-inch OLED wafers) at external 12-inch foundries, which was offset in part by a higher demand for our OLED TV display driver ICs and auto-LCD display driver ICs. The increase in net sales from our Power Solutions business line was attributable to a strong demand for power products such as MOSFETs, including high-end MOSFETs, primarily for TVs and e-bikes, and IGBTs mainly for solar inverters.

The transitional Fab 3 foundry services. Net sales from the transitional Fab 3 foundry services were $28.6 million and $30.3 million for the nine months ended September 30, 2022 and 2021, respectively.

Gross Profit

Total gross profit was $85.2 million for the nine months ended September 30, 2022 compared to $114.9 million for the nine months ended September 30, 2021, a $29.8 million, or 25.9%, decrease. Gross profit as a percentage of net sales for the nine months ended September 30, 2022 decreased to 30.8% compared to 31.6% for the nine months ended September 30, 2021. The decrease in both gross profit and gross profit as a percentage of net sales was primarily due to our standard products business as further described below.

The standard products business. Gross profit from our standard products business was $82.9 million for the nine months ended September 30, 2022, which represented a $29.4 million, or 26.2%, decrease from gross profit of $112.3 million for the nine months ended September 30, 2021. The decrease in gross profit was primarily attributable to a significant decrease in net sales from our Display Solutions business line as explained above. Gross profit as a percentage of net sales for the nine months ended September 30, 2022 decreased slightly to 33.4% compared to 33.7% for the nine months ended September 30, 2021. The decrease in gross profit as a percentage of net sales was primarily attributable to certain inventory reserve and scrap cost related to 12-inch display products resulted from lower demand for China smartphones, which was offset in part by an improved product mix and an increase in average selling price benefited from the favorable pricing environment, primarily for our Power Solutions business line.

 

43


Table of Contents

Net Sales – Standard Products Business by Geographic Region

We report net sales – standard products business by geographic region based on the location to which the products are billed. The following table sets forth our net sales—standard products business by geographic region and the percentage of total net sales—standard products business represented by each geographic region for the nine months ended September 30, 2022 and 2021:

 

     Nine Months Ended
September 30, 2022
    Nine Months Ended
September 30, 2021
       
     Amount      % of
Net sales –
standard
products
business
    Amount      % of
Net sales –
standard
products
business
    Change
Amount
 
                                  
     (Dollars in millions)  

Korea

   $ 86.1        34.7   $ 87.0        26.1   $ (0.9

Asia Pacific (other than Korea)

     148.9        60.0       237.3        71.1       (88.4

United States

     8.1        3.3       4.4        1.3       3.7  

Europe

     5.0        2.0       3.8        1.2       1.1  

Others

     —          —         1.1        0.3       (1.1
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 
   $ 248.1        100.0   $ 333.6        100.0   $ (85.5
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Net sales – standard products business in Korea for the nine months ended September 30, 2022 decreased from $87.0 million to $86.1 million compared to the nine months ended September 30, 2021, or by $0.9 million, or 1.0%, primarily due to weaker demand for power products such as high-end MOSFETs primarily for TVs and decrease in revenue from our mobile OLED display driver ICs, which was offset in part by an increase in revenue from OLED TV display driver ICs.

Net sales – standard products business in Asia Pacific (other than Korea) for the nine months ended September 30, 2022 decreased to $148.9 million from $237.3 million in the nine months ended September 30, 2021, or by $88.4 million, or 37.2%, primarily due to a significant decrease in revenue from our mobile OLED display driver ICs stemming from a lower customer demand resulting from a slowdown in the Chinese smartphone market, and a lack of secured manufacturing capacity (in particular for 28nm 12-inch OLED wafers) at external 12-inch foundries, which was offset in part by a higher demand for power products such as MOSFETs, including high-end MOSFETs, primarily for TVs and e-bike, and IGBTs mainly for solar inverters. The increased demand for our auto-LCD display driver ICs also favorably affected in this year.

Net sales – standard products business in the United States for the nine months ended September 30, 2022 increased to $8.1 million from $4.4 million compared to the nine months ended September 30, 2021, or by $3.7 million, or 83.8%, primarily due to a change in billing location of a global customer who offers lighting solutions combined with the increase of high-end MOSFET design wins with the customer.

Operating Expenses

Selling, General and Administrative Expenses. Selling, general and administrative expenses were $38.3 million, or 13.8% of total revenues, for the nine months ended September 30, 2022, compared to $39.2 million, or 10.8% of total revenues, for the nine months ended September 30, 2021. The decrease of $0.9 million, or 2.2%, was primarily attributable to a decrease in running royalties recognized based on the revenue of certain mobile OLED display driver ICs.

Research and Development Expenses. Research and development expenses were $38.7 million, or 14.0% of total revenues, for the nine months ended September 30, 2022, which remained almost flat, compared to $39.0 million, or 10.7% of total revenues, for the nine months ended September 30, 2021.

Merger-related Costs. For the nine months ended September 30, 2021, we recorded $13.8 million of professional service fees and expenses incurred in connection with the contemplated Merger transaction.

Other Charges, Net. For the nine months ended September 30, 2022, we recorded $2.8 million of one-time employee incentives and $1.0 million of professional service fees and expenses incurred in connection with certain strategic evaluations, which was offset in part by a $0.5 million gain on sale of certain legacy equipment of the closed back-end line in our fabrication facility in Gumi. For the nine months ended September 30, 2021, we recorded $3.4 million of non-recurring professional service fees and expenses incurred in connection with the regulatory requests.

 

44


Table of Contents

Operating Income

As a result of the foregoing, operating income was $4.9 million for the nine months ended September 30, 2022 compared to operating income of $19.5 million the nine months ended September 30, 2021. As discussed above, the decrease in operating income of $14.7 million resulted primarily from a $29.8 million decrease in gross profit, which was offset in part by a $13.8 million decrease in Merger-related costs, a $0.9 million decrease in selling, general and administrative expenses and a $0.3 million decrease in research and development expenses.

 

45


Table of Contents

Other Income (Expense)

Interest Expense. Interest expenses was $0.9 million and $1.2 million for the nine months ended September 30, 2022 and September 30, 2021, respectively.

Foreign Currency Loss, Net. Net foreign currency loss for the nine months ended September 30, 2022 was $20.5 million compared to net foreign currency loss of $12.0 million for the nine months ended September 30, 2021. The net foreign currency loss for the nine months ended September 30, 2022 and September 30, 2021 was due to the depreciation in value of the Korean won relative to the U.S. dollar during the period.

A substantial portion of our net foreign currency gain or loss is non-cash translation gain or loss associated with intercompany long-term loans to our Korean subsidiary, which are denominated in U.S. dollars, and are affected by changes in the exchange rate between the Korean won and the U.S. dollar. As of September 30, 2022 and September 30, 2021, the outstanding intercompany loan balances, including accrued interest between our Korean subsidiary and our Dutch subsidiary, were $357 million and $393 million, respectively. Foreign currency translation gain or loss from intercompany balances were included in determining our consolidated net income since the intercompany balances were not considered long-term investments in nature because management intended to settle these intercompany balances at their respective maturity dates.

Others, Net. Others were primarily comprised of interest income, rental income and gains and losses from valuation of derivatives which were designated as hedging instruments. Others for the nine months ended September 30, 2022 and September 30, 2021 was $4.2 million and $2.8 million, respectively. In the third quarter of 2021, others, net included a $0.7 million legal settlement gain related to certain expenses incurred in prior periods in connection with our legacy Fab 4 (which was sold during the year ended December 31, 2020) and awarded in the current quarter

Income Tax Expense (Benefit)

Income tax benefit was $1.4 million for the nine months ended September 30, 2022, which was primarily attributable to the decrease in the pre-tax income due to foreign currency translation losses associated with intercompany long-term loans in our Korean subsidiary for the respective period.

Income tax expense was $6.0 million for the nine months ended September 30, 2021, which was primarily attributable to interest on intercompany loan balances and the estimated taxable income for the respective period in our Korean subsidiary, combined with its ability to utilize net operating loss carryforwards up to 60%.

Net Income (Loss)

As a result of the foregoing, a net loss of $11.0 million was recorded for the nine months ended September 30, 2022 compared to a net income of $3.1 million for the nine months ended September 30, 2021. As discussed above, the $14.1 million decrease in net income was primarily attributable to a $14.7 million decrease in operating income and an $8.5 million increase in net foreign currency loss, which was offset in part by a $7.4 million decrease in income tax expense.

 

46


Table of Contents

Liquidity and Capital Resources

Our principal capital requirements are to fund sales and marketing, invest in research and development and capital equipment, and to fund working capital needs. We calculate working capital as current assets less current liabilities.

Our principal sources of liquidity are our cash, cash equivalents, cash flows from operations and financing activities. Our ability to manage cash and cash equivalents may be limited, as our primary cash flows are dictated by the terms of our sales and supply agreements, contractual obligations, debt instruments and legal and regulatory requirements. From time to time, we may sell accounts receivable to third parties under factoring agreements or engage in accounts receivable discounting to facilitate the collection of cash. In addition, from time to time, we may make payments to our vendors on extended terms with their consent. As of September 30, 2022, we did not have any accounts payable on extended terms or payment deferment with our vendors.

As of June 29, 2018, our Korean subsidiary entered into an arrangement whereby it (i) acquired a water treatment facility from SK hynix for $4.2 million to support our fabrication facility in Gumi, Korea, and (ii) subsequently sold the water treatment facility for $4.2 million to a third party management company that we engaged to run the facility for a 10-year term beginning July 1, 2018. As of September 30, 2022, the outstanding obligation of this arrangement is approximately $22.7 million for remaining service term through 2028.

As of September 30, 2022, cash and cash equivalents held by our Korean subsidiary were $241.3 million, which represents 96% of our total cash and cash equivalents on a consolidated basis. We currently believe that we will have sufficient cash reserves from cash on hand and expected cash from operations to fund our operations as well as capital expenditures for the next 12 months and the foreseeable future.

Working Capital

Our working capital balance as of September 30, 2022 was $304.7 million compared to $323.6 million as of December 31, 2021. The $19.0 million decrease was primarily attributable to a $28.7 million decrease in cash and cash equivalents and a $17.6 million decrease in other receivable mainly resulted from receipt of reverse termination fee, which was offset in part by a $11.0 million decrease in account payables, a $12.3 million net increase in hedge collateral and a $7.8 million increase in advance payments to certain suppliers, including external foundries to meet our planned production.

Cash Flows from Operating Activities

Cash inflow provided by operating activities totaled $50.2 million for the nine months ended September 30, 2022, compared to $30.0 million of cash inflow provided by operating activities for the nine months ended September 30, 2021. The net operating cash inflow for the nine months ended September 30, 2022 reflects our net loss of $11.0 million, as adjusted favorably by $95.6 million, which mainly consisted of depreciation and amortization, provision for severance benefits, stock-based compensation and net foreign currency loss, and net unfavorable impact of $34.3 million from changes of operating assets and liabilities.

Cash Flows from Investing Activities

Cash outflow used in investing activities totaled $25.9 million for the nine months ended September 30, 2022, compared to $14.4 million of cash outflow used in investing activities for the nine months ended September 30, 2021. The $11.4 million increase in cash outflow was primarily attributable to a $13.7 million net increase in hedge collateral, which was offset in part by a $1.6 million decrease in purchase of property, plant and equipment.

Cash Flows from Financing Activities

Cash outflow used in financing activities totaled $3.7 million for the nine months ended September 30, 2022, compared to $1.8 million of cash inflow provided by financing activities for the nine months ended September 30, 2021. The financing cash outflow for the nine months ended September 30, 2022 was primarily attributable to a payment of $3.2 million for the repurchases of our common stock in September 2022 pursuant to our stock repurchase program and a payment of $1.8 million for the repurchase of our common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units, which was offset in part by $1.8 million of proceeds received from the issuance of common stock in connection with the exercise of stock options. The financing cash inflow for the nine months ended September 30, 2021 was primarily attributable to $3.9 million of proceeds received from the issuance of common stock in connection with the exercise of stock options, which was offset in part by a payment of $1.7 million for the repurchase of our common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

 

47


Table of Contents

Capital Expenditures

We routinely make capital expenditures for fabrication facility maintenance, enhancement of our existing facility and reinforcement of our global research and development capability. For the nine months ended September 30, 2022, capital expenditures for property, plant and equipment were $11.8 million, a $1.6 million, or 11.6%, decrease from $13.4 million for the nine months ended September 30, 2021. The capital expenditures for the nine months ended September 30, 2022 and 2021 were related to meeting our customer demand and supporting technology and capacity improvement at our fabrication facility.

 

48


Table of Contents

Critical Accounting Policies and Estimates

Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, the reported amounts of revenues and expenses during the reporting periods and the related disclosures in our consolidated financial statements and accompanying notes.

We believe that our significant accounting policies, which are described further in Note 1 to our consolidated financial statements in our Annual Report on Form 10-K for our fiscal year ended December 31, 2021, or our 2021 Form 10-K, are critical due to the fact that they involve a high degree of judgment and estimates about the effects of matters that are inherently uncertain. We base these estimates and judgments on historical experience, knowledge of current conditions and other assumptions and information that we believe to be reasonable. Estimates and assumptions about future events and their effects cannot be determined with certainty. Accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as the business environment in which we operate changes.

A description of our critical accounting policies that involve significant management judgement appears in our 2021 Form 10-K, under “Management’s Discussion and Analysis of Financial Conditions and Reports of Operations—Critical Accounting Policies and Estimates.” There have been no other material changes to our critical accounting policies and estimates as compared to our critical accounting policies and estimates included in our 2021 Form 10-K.

Recent Accounting Pronouncements

For a full description of new accounting pronouncements and recently adopted accounting pronouncements, please see “Item 1. Interim Consolidated Financial Statements—Notes to Consolidated Financial Statements—Note 1. Business, Basis of Presentation and Significant Accounting Policies” in this Report.

 

49


Table of Contents
Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are exposed to the market risk that the value of a financial instrument will fluctuate due to changes in market conditions, primarily from changes in foreign currency exchange rates. In the normal course of our business, we are subject to market risks associated with currency movements on our assets and liabilities.

Foreign Currency Exposures

We have exposure to foreign currency exchange rate fluctuations on net income from our subsidiaries denominated in currencies other than U.S. dollars, as our foreign subsidiaries in Korea, Taiwan, China, Japan and Hong Kong use local currency as their functional currency. From time to time these subsidiaries have cash and financial instruments in local currency. The amounts held in Japan, Taiwan, Hong Kong and China are not material in regards to foreign currency movements. However, based on the cash and financial instruments balance at September 30, 2022 for our Korean subsidiary, a 10% devaluation of the Korean won against the U.S. dollar would have resulted in a decrease of $1.2 million in our U.S. dollar financial instruments and cash balances.

See “Note 7. Derivative Financial Instruments” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements” and “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Factors Affecting Our Results of Operations—Impact of Foreign Currency Exchange Rates on Reported Results of Operations” for additional information regarding our foreign exchange hedging activities.

 

50


Table of Contents
Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

In connection with the preparation of this Report, we carried out an evaluation under the supervision of and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, as of September 30, 2022, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2022.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

51


Table of Contents

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

For a discussion of legal proceedings, see “Part I: Item 3. Legal Proceedings” of our 2021 Form 10-K.

See also “Item 1A. Risk Factors” in this Report and “Part I: Item 1A. Risk Factors” of our 2021 Form 10-K for additional information.

 

Item 1A.

Risk Factors

The Company is subject to risks and uncertainties, any of which could have a significant or material adverse effect on our business, financial condition, liquidity or consolidated financial statements.

In addition to the other information contained in this Report and the other reports and materials the Company files with the SEC, investors should carefully consider the risk factors disclosed in Part I, Item 1A of our 2021 Form 10-K as well as in our subsequent filings with the SEC. The risks described herein and therein are not the only ones we face.

There have been no material changes to the risk factors disclosed in Part I, Item 1A of our 2021 Form 10-K and Part II, Item 1A of our most recent Quarterly Report on Form 10-Q.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

The following table shows the monthly activity related to our repurchases of common stock for the quarter ended September 30, 2022.

 

Period

   Total Number
of Shares
Purchased
     Average
Price Paid
per Share
     Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs(1)
     Approximate dollar
value of Shares that
may yet be
Purchased under the
Plans or Programs
(in thousands)(1)
 

July 2022

     —          —          —          —    

August 2022

     —          —          —          —    

September 2022

     324,643      $ 11.21        324,643      $ 46,362  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

     324,643           324,643      $ 46,362  
  

 

 

       

 

 

    

 

 

 

 

(1)

On August 31, 2022, the Company’s Board of Directors authorized an expansion of the Company’s previously announced stock repurchase program from $75 million to $87.5 million of the Company’s common stock. The Company has already repurchased shares worth $37.5 million under the program through an accelerated stock repurchase agreement on December 21, 2021 with JPMorgan Chase Bank, National Association. The remaining $50.0 million of the expanded $87.5 million program will be repurchased in the open market or through privately negotiated transactions. In connection with the repurchase program, the Company has established a stock trading plan with Oppenheimer & Co. Inc. in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

 

Item 3.

Defaults Upon Senior Securities

Not applicable.

 

Item 4.

Mine Safety Disclosures

Not applicable.

 

Item 5.

Other Information

None.

 

52


Table of Contents
Item 6.

Exhibits.

 

Exhibit

Number

  

Description

10.1‡#   

Form of Restricted Stock Units Agreement (Non-employee Directors)

10.2‡#   

Form of Restricted Stock Units Agreement (CEO and other Section 16 Officers)

10.3‡#   

Form of Restricted Stock Units Agreement—Financial Performance (CEO)

10.4‡#   

Form of Restricted Stock Units Agreement—Financial Performance (Non-CEO Section 16 Officers)

10.5‡#   

Form of Restricted Stock Units Agreement—TSR Performance (CEO)

10.6‡#   

Form of Restricted Stock Units Agreement—TSR Performance (Non-CEO Section 16 Officers)

10.7#   

Second Amendment to Termination and Settlement Agreement, dated as of August 5, 2022, by and between Magnachip Semiconductor Corporation, South Dearborn Limited and Wise Road Capital LTD.

10.8#+   

Patent Cross-License Agreement, with an effective date as of June 15, 2017, by and between Infineon Technologies AG and Magnachip Semiconductor, Ltd.

10.9#+    First Amendment to the Patent Cross-License Agreement, with an effective date as of January 1, 2022, by and between Infineon Technologies AG and Magnachip Semiconductor, Ltd.
31.1#   

Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 of the Chief Executive Officer.

31.2#   

Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 of the Chief Financial Officer.

32.1†   

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of the Chief Executive Officer.

32.2†   

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of the Chief Financial Officer.

101.INS#    Inline XBRL Instance Document.
101.SCH#    Inline XBRL Taxonomy Extension Schema Document.
101.CAL#    Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF#    Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB#    Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE#    Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104#    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

Footnotes:

 

#

Filed herewith

Furnished herewith

Management contract or compensatory plan or arrangement

+

Certain identified information in such exhibit has been omitted pursuant to Item 601(b)(10) of Regulation S-K because such information is both (i) not material and (ii) information that the registrant treats as private or confidential. The registrant hereby undertakes to furnish supplemental copies of the unredacted exhibit upon request by the SEC.

 

53


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

MAGNACHIP SEMICONDUCTOR CORPORATION

(Registrant)

Dated: November 8, 2022     By:   /s/ Young-Joon Kim
      Young-Joon Kim
     

Chief Executive Officer

(Principal Executive Officer)

Dated: November 8, 2022     By:   /s/ Shin Young Park
      Shin Young Park
     

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

54

EX-10.1 2 d306034dex101.htm EX-10.1 EX-10.1

Exhibit 10.1

MAGNACHIP SEMICONDUCTOR CORPORATION

RESTRICTED STOCK UNITS AGREEMENT

Magnachip Semiconductor Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement is attached an Award consisting of Restricted Stock Units subject to the terms and conditions set forth in the Grant Notice and this Restricted Stock Units Agreement, including any additional terms and conditions for the Participant’s country set forth in the appendix attached hereto (the “Appendix” and, together with the Restricted Stock Units Agreement, the “Agreement”). The Participant shall be entitled to Dividend Equivalent Rights with respect to the Award.

The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the Magnachip Semiconductor Corporation 2020 Equity and Incentive Compensation Plan (the “Plan”), as amended from time to time, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prospectus”), (b) accepts the Award subject to all of the terms and conditions of the Grant Notice, this Agreement and the Plan and (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Grant Notice, this Agreement or the Plan.

1. DEFINITIONS AND CONSTRUCTION.

1.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Grant Notice or the Plan.

(a) “Dividend Equivalent Units” mean additional Restricted Stock Units credited pursuant to Section 3.3.

(b) “Units” mean the Restricted Stock Units originally granted pursuant to the Award and the Dividend Equivalent Units credited pursuant to the Award, as both shall be adjusted from time to time pursuant to Section 9.

1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.


2. ADMINISTRATION.

All questions of interpretation concerning the Grant Notice, this Agreement, the Plan or any other form of agreement or other document employed by the Company in the administration of the Plan or the Award shall be determined by the Committee. All such determinations by the Committee shall be final, binding and conclusive upon all persons having an interest in the Award, unless fraudulent or made in bad faith. Any and all actions, decisions and determinations taken or made by the Committee in the exercise of its discretion pursuant to the Plan or the Award or other agreement thereunder (other than determining questions of interpretation pursuant to the preceding sentence) shall be final, binding and conclusive upon all persons having an interest in the Award. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation, or election which is the responsibility of or which is allocated to the Company herein, provided the Officer has actual authority with respect to such matter, right, obligation, or election.

3. THE AWARD.

3.1 Grant of Units. On the Date of Grant, the Participant shall acquire, subject to the provisions of this Agreement, the Total Number of Restricted Stock Units set forth in the Grant Notice, subject to adjustment as provided in Section 3.3 and Section 9. Subject to the terms and conditions set forth in the Grant Notice, this Agreement and the Plan, each Unit represents a right to receive on a date determined in accordance with the Grant Notice and this Agreement one (1) share of Stock.

3.2 No Monetary Payment Required. The Participant is not required to make any monetary payment (other than applicable tax withholding, if any) as a condition to receiving the Units or shares of Stock issued upon settlement of the Units.

3.3 Dividend Equivalent Units. On the date that the Company pays a cash dividend to holders of Stock generally, the Participant shall be credited with a number of additional whole Dividend Equivalent Units determined by dividing (a) the product of (i) the dollar amount of the cash dividend paid per share of Stock on such date and (ii) the total number of Restricted Stock Units and Dividend Equivalent Units previously credited to the Participant pursuant to the Award and which have not been settled or forfeited pursuant to Section 4 below as of such date, by (b) the Fair Market Value per share of Stock on such date. Any resulting fractional Dividend Equivalent Unit shall be rounded to the nearest whole number. Such additional Dividend Equivalent Units shall be subject to the same terms and conditions and shall be settled or forfeited in the same manner and at the same time as the Restricted Stock Units originally subject to the Award with respect to which they have been credited.

4. VESTING OF UNITS.

Units acquired pursuant to this Agreement shall become Vested Units as provided in the Grant Notice. Dividend Equivalent Units shall become Vested Units at the same time as the Restricted Stock Units originally subject to the Award with respect to which they have been credited.

5. FORFEITURE OF UNITS.

Except to the extent expressly provided otherwise in an agreement between the Participant and the Company, in the event that the Participant’s Service terminates for any reason or no reason, with or without cause, insofar as permitted under Local Law the Participant shall forfeit and the Company shall automatically reacquire all Units which are not, as of the time of such termination, Vested Units, and the Participant shall not be entitled to any payment therefor.


6. SETTLEMENT OF THE AWARD.

6.1 Issuance of Shares of Stock. Subject to the provisions of Section 6.3, Section 7 and Section 8, on or as soon as reasonably practicable following the date upon which the Participant’s Service terminates for any reason (the “Termination Date”), but in no event later than the later of (i) the last day of the year in which the Termination Date occurs and (ii) the fifteenth day of the third calendar month following the Termination Date (such applicable date, the “Settlement Date”), the Company shall issue to the Participant with respect to each Unit that is a Vested Unit as of the Termination Date one (1) share of Stock. Shares of Stock issued in settlement of Units shall not be subject to any restriction on transfer other than any such restriction as may be required pursuant to Section 6.3, Section 7 or the Company’s Securities Trading Policy.

6.2 Beneficial Ownership of Shares; Certificate Registration. The Participant hereby authorizes the Company, in its sole discretion, to deposit any or all shares acquired by the Participant pursuant to the settlement of the Award with the Company’s transfer agent, including any successor transfer agent, to be held in book entry form, or to deposit such shares for the benefit of the Participant with any broker with which the Participant has an account relationship of which the Company has notice. Except as provided by the foregoing, a certificate for the shares acquired by the Participant shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant.

6.3 Restrictions on Grant of the Award and Issuance of Shares. The grant of the Award and issuance of shares of Stock upon settlement of the Award shall be subject to compliance with all applicable requirements of United States federal, state law and Local Law with respect to such securities. No shares of Stock may be issued hereunder if the issuance of such shares would constitute a violation of any applicable United States federal, state, or Local Law or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance of any shares subject to the Award shall relieve the Company of any liability in respect of the failure to issue such shares as to which such requisite authority shall not have been obtained. As a condition to the settlement of the Award, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.

6.4 Fractional Shares. The Company shall not be required to issue fractional shares upon the settlement of the Award.

7. TAX WITHHOLDING AND LIMITED CASH SETTLEMENT FOR FOREIGN TAX OBLIGATIONS.

7.1 In General. At the time the Grant Notice is executed, or at any time thereafter as requested by a Participating Company, the Participant hereby authorizes withholding from payroll and any other amounts payable to the Participant, and otherwise agrees to make adequate provision for, any sums required to satisfy the federal, state, local and non-U.S. tax (including any social insurance) withholding obligations of the Participating Company, if any, which arise in connection with the Award, the vesting of Units or the issuance of shares of Stock in settlement thereof. The Company shall have no obligation to deliver shares of Stock until the tax withholding obligations of the Participating Company have been satisfied by the Participant.


7.2 Assignment of Sale Proceeds. Subject to compliance with applicable law and the Company’s Securities Trading Policy, if permitted by the Company, the Participant may satisfy the Participating Company’s tax withholding obligations in accordance with procedures established by the Company providing for delivery by the Participant to the Company or a broker approved by the Company of properly executed instructions, in a form approved by the Company, providing for the assignment to the Company of the proceeds of a sale with respect to some or all of the shares being acquired upon settlement of Units.

7.3 Withholding in Shares. The Company shall have the right, but not the obligation, to require the Participant to satisfy all or any portion of a Participating Company’s tax withholding obligations by deducting from the shares of Stock otherwise deliverable to the Participant in settlement of the Award a number of whole shares having a fair market value, as determined by the Company as of the date on which the tax withholding obligations arise, not in excess of the amount of such tax withholding obligations determined by the applicable minimum statutory withholding rates.

7.4 Limited Cash Settlement for Foreign Tax Obligations. Notwithstanding the issuance schedule set forth in Section 6.1, to the extent Participant is subject to non-U.S. tax obligations (including any social insurance obligations) as a result of the vesting of one or more Units subject to this Award, Participant shall receive a partial cash settlement of this Award in connection with the applicable vesting date(s). The partial cash settlement is intended to enable Participant to pay the tax liability due from Participant to the non-U.S. tax authority when the Award vests. Any partial cash settlement shall occur in accordance with the following:

(a) A number of Vested Units will be forfeited on the applicable vesting date in exchange for a lump sum cash payment from the Company to the Participant in an amount equal to the Fair Market Value of the forfeited Vested Units.

(b) The number of Vested Units to be forfeited will be such number of whole shares of Stock having a Fair Market Value as close to as possible, but in no event to exceed, the tax obligation required to be paid by the Participant to the applicable non-U.S. tax authority as result of the vesting of the Units.

(c) The Fair Market Value of the forfeited Vested Units will be determined pursuant to Section 2(u) of the Plan on the vesting date of the Units.

(d) The lump sum cash payment shall be paid by the Company to the Participant within seven business days from the applicable vesting date.


8. EFFECT OF CHANGE IN CONTROL.

In the event of a Change in Control, all Units granted hereunder shall automatically become Vested Units and shall be settled, paid, continued or substituted, as determined by the Committee, in connection with such Change in Control in accordance with the terms of the Plan.

9. ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE.

Subject to any required action by the stockholders of the Company and the requirements of Section 409A to the extent applicable, in the event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares, or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy) that has a material effect on the Fair Market Value of shares of Stock, or any other corporate transaction or event having an effect similar to any of the foregoing, appropriate and proportionate adjustments shall be made in the number of Units subject to the Award and/or the number and kind of shares or other property to be issued in settlement of the Award, in order to prevent dilution or enlargement of the Participant’s rights under the Award. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any and all new, substituted or additional securities or other property (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy, which shall be treated in accordance with Section 3.3) to which the Participant is entitled by reason of ownership of Units acquired pursuant to this Award will be immediately subject to the provisions of this Award on the same basis as all Units originally acquired hereunder. Any fractional Unit or share resulting from an adjustment pursuant to this Section shall be rounded down to the nearest whole number. Such adjustments shall be determined by the Committee, and its determination shall be final, binding and conclusive.

10. RIGHTS AS A STOCKHOLDER, DIRECTOR, EMPLOYEE OR CONSULTANT.

The Participant shall have no rights as a stockholder with respect to any shares which may be issued in settlement of this Award until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date the shares are issued, except as provided in Section 3.3 and Section 9. Nothing in this Agreement shall confer upon the Participant any right to continue in the Service of a Participating Company or interfere in any way with any right of the Participating Company Group to terminate the Participant’s Service at any time.

11. LEGENDS.

The Company may at any time place legends referencing any applicable United States federal, state or non-U.S. securities law, including Local Law, restrictions on all certificates representing shares of stock issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to this Award in the possession of the Participant in order to carry out the provisions of this Section.


12. COMPLIANCE WITH SECTION 409A.

To the extent applicable, it is intended that any election, payment or benefit which is made or provided pursuant to or in connection with this Award that may result in Section 409A Deferred Compensation shall comply in all respects with the applicable requirements of Section 409A (including applicable regulations or other administrative guidance thereunder, as determined by the Committee in good faith) to avoid the unfavorable tax consequences provided therein for non-compliance. In connection with effecting such compliance with Section 409A, the following shall apply, to the extent applicable:

12.1 Separation from Service; Required Delay in Payment to Specified Employee. Notwithstanding anything set forth herein to the contrary, no amount payable pursuant to this Agreement on account of the Participant’s termination of Service which constitutes a “deferral of compensation” within the meaning of the Treasury Regulations issued pursuant to Section 409A of the Code (the “Section 409A Regulations”) shall be paid unless and until the Participant has incurred a “separation from service” within the meaning of the Section 409A Regulations. Furthermore, to the extent that the Participant is a “specified employee” within the meaning of the Section 409A Regulations as of the date of the Participant’s separation from service, no amount that constitutes a deferral of compensation which is payable on account of the Participant’s separation from service shall paid to the Participant before the date (the “Delayed Payment Date”) which is first day of the seventh month after the date of the Participant’s separation from service or, if earlier, the date of the Participant’s death following such separation from service. All such amounts that would, but for this Section, become payable prior to the Delayed Payment Date will be accumulated and paid on the Delayed Payment Date.

12.2 Other Delays in Payment. Neither the Participant nor the Company shall take any action to accelerate or delay the payment of any benefits under this Agreement in any manner which would not be in compliance with the Section 409A Regulations.

12.3 Separate Payments. To the extent required to comply with the Section 409A Regulations, each amount to be paid or benefit to be provided under this Agreement shall be construed as a separate identified payment for purposes of the Section 409A Regulations.

12.4 Amendments to Comply with Section 409A; Indemnification. Notwithstanding any other provision of this Agreement to the contrary, the Company is authorized to amend this Agreement, to void or amend any election made by the Participant under this Agreement and/or to delay the payment of any monies and/or provision of any benefits in such manner as may be determined by the Company, in its discretion, to be necessary or appropriate to comply with the Section 409A Regulations without prior notice to or consent of the Participant. The Participant hereby releases and holds harmless the Company, its directors, officers and stockholders from any and all claims that may arise from or relate to any tax liability, penalties, interest, costs, fees or other liability incurred by the Participant in connection with the Award, including as a result of the application of Section 409A.


12.5 Advice of Independent Tax Advisor. The Company has not obtained a tax ruling or other confirmation from the Internal Revenue Service with regard to the application of Section 409A to the Award, and the Company does not represent or warrant that this Agreement will avoid adverse tax consequences to the Participant, including as a result of the application of Section 409A to the Award. The Participant hereby acknowledges that he or she has been advised to seek the advice of his or her own independent tax advisor prior to entering into this Agreement and is not relying upon any representations of the Company or any of its agents as to the effect of or the advisability of entering into this Agreement.

13. MISCELLANEOUS PROVISIONS.

13.1 Termination or Amendment. The Committee may terminate or amend the Plan or this Agreement at any time; provided, however, that except as provided in Section 8 in connection with a Change in Control, no such termination or amendment may adversely affect the Participant’s rights under this Agreement without the consent of the Participant unless such termination or amendment is necessary to comply with applicable law or government regulation, including, but not limited to, Section 409A. No amendment or addition to this Agreement shall be effective unless in writing.

13.2 Nontransferability of the Award. Prior to the issuance of shares of Stock on the applicable Settlement Date, neither this Award nor any Units subject to this Award shall be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance, or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. All rights with respect to the Award shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s guardian or legal representative.

13.3 Further Instruments. The parties hereto agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

13.4 Binding Effect. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer set forth herein, be binding upon the Participant and the Participant’s heirs, executors, administrators, successors and assigns.

13.5 Delivery of Documents and Notices. Any document relating to participation in the Plan or any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery at the e-mail address, if any, provided for the Participant by a Participating Company, or upon deposit in the U.S. Post Office or non-U.S. postal service, by registered or certified mail, or with a nationally recognized overnight courier service, with postage and fees prepaid, addressed to the other party at the address of such party set forth in the Grant Notice or at such other address as such party may designate in writing from time to time to the other party.


(a) Description of Electronic Delivery. The Plan documents, which may include but do not necessarily include: the Plan, the Grant Notice, this Agreement, the Plan Prospectus, and any reports of the Company provided generally to the Company’s stockholders, may be delivered to the Participant electronically. In addition, if permitted by the Company, the Participant may deliver electronically the Grant Notice to the Company or to such third party involved in administering the Plan as the Company may designate from time to time. Such means of electronic delivery may include but do not necessarily include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other means of electronic delivery specified by the Company.

(b) Consent to Electronic Delivery. The Participant acknowledges that the Participant has read Section 13.5(a) of this Agreement and consents to the electronic delivery of the Plan documents and, if permitted by the Company, the delivery of the Grant Notice, as described in Section 13.5(a). The Participant acknowledges that he or she may receive from the Company a paper copy of any documents delivered electronically at no cost to the Participant by contacting the Company by telephone or in writing. The Participant further acknowledges that the Participant will be provided with a paper copy of any documents if the attempted electronic delivery of such documents fails. Similarly, the Participant understands that the Participant must provide the Company or any designated third party administrator with a paper copy of any documents if the attempted electronic delivery of such documents fails. The Participant may revoke his or her consent to the electronic delivery of documents described in Section 13.5(a) or may change the electronic mail address to which such documents are to be delivered (if Participant has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised e-mail address by telephone, postal service or electronic mail. Finally, the Participant understands that he or she is not required to consent to electronic delivery of documents described in Section 13.5(a).

13.6 Integrated Agreement. The Grant Notice, this Agreement and the Plan shall constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to the subject matter contained herein or therein and supersede any prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter. To the extent contemplated herein or therein, the provisions of the Grant Notice, this Agreement and the Plan shall survive any settlement of the Award and shall remain in full force and effect.

13.7 Non-U.S. Terms and Conditions. Notwithstanding any other provision of this Agreement to the contrary, the Award shall be subject to the specific terms and conditions, if any, set forth in the Appendix to this Agreement which are applicable to the Participant’s country of residence, the provisions of which are incorporated in and constitute part of this Agreement. Moreover, if the Participant relocates to one of the countries included in the Appendix, the additional terms and conditions applicable to such country will apply to the Award to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan or this Agreement.


13.8 Applicable Law. This Agreement shall be governed by the laws of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties as evidenced by this Agreement, the parties hereby submit to and consent to the jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of the County of Santa Clara, California, or the federal courts of the United States for the Northern District of California, and no other courts, where this Agreement is made and/or performed.

13.9 Language. The Participant acknowledges that the Participant is sufficiently proficient in the English language, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the provisions in this Agreement and the Plan. Further, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.10 Insider Trading / Market Abuse Restrictions. The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions including, but not limited to, the U.S. and the Participant’s country of residence, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of shares or rights to shares (e.g., Units) or rights linked to the value of shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws in the Participant’s country). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s insider trading policy. The Participant is responsible for ensuring compliance with any applicable restrictions.

13.11 Foreign Asset / Account Reporting and Exchange Control Requirements. Certain foreign asset and/or foreign account reporting requirements and exchange controls may affect the Participant’s ability to acquire or hold shares under the Plan or cash received from participating in the Plan in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country through a designated bank or broker and/or within a certain time after receipt. The Participant is responsible for complying with any applicable regulations and should consult the Participant’s personal legal and tax advisors for any details.

13.12 Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by you or any other participant.

13.13 Counterparts. The Grant Notice may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.


13.14 Clawback. The Award will be subject to recoupment in accordance with the clawback policy of the Company, including, without limitation, any clawback or recoupment policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.


APPENDIX

ADDITIONAL TERMS AND CONDITIONS OF

MAGNACHIP SEMICONDUCTOR CORPORATION

RESTRICTED STOCK UNITS AGREEMENT

Capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan, the Grant Notice and/or in the Restricted Stock Units Agreement (the “RSU Agreement”).

TERMS AND CONDITIONS

This Appendix, includes additional terms and conditions that govern the Restricted Stock Units granted to the Participant under the Plan if the Participant resides and/or works in one of the countries listed below. If the Participant is a citizen or resident (or is considered as such for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Restricted Stock Units, the Company shall, in its discretion, determine to what extent the additional terms and conditions contained herein shall be applicable to the Participant.

NOTIFICATIONS

This Appendix may also include information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2022. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix as the only source of information relating to the consequences of the Participant’s participation in the Plan because such information may be out-of-date when the Participant’s Units vest and/or the Participant sells any shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation. As a result, the Company is not in a position to assure the Participant of any particular result. The Participant is therefore advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident (or is considered as such for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Restricted Stock Units, the notifications contained herein may not be applicable to the Participant in the same manner.

Below please find additional terms and conditions, as well as notifications, that apply to Korea.

KOREA

Terms and Conditions

There are no country-specific terms and conditions.


Notifications

If the Participant receives and owns the shares of the Company at the time of delivery through a foreign financial account (i.e., financial account outside of Korea) and the total balance of all accounts of the Participant exceed KRW500 million on any last day of each month during a year, the Participant is required to file a Foreign Financial Account Report in accordance with the Korean tax law.

UNITED STATES

Terms and Conditions for Participants subject to Tax in the United States

The following paragraph is inserted as a new Section 13.15 to the RSU Agreement:

Section 409A of the U.S. Internal Revenue Code. To the extent applicable, it is intended that this Agreement comply with the provisions of Section 409A, so that the income inclusion provisions of Section 409A(a)(1) do not apply. This Agreement shall be administered in a manner consistent with this intent. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall any Participating Company or any of their respective Subsidiary Corporations or Affiliates be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A or otherwise. For purposes of this Agreement, “Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and will also include any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.”

Notifications

There are no country-specific notifications.

EX-10.2 3 d306034dex102.htm EX-10.2 EX-10.2

Exhibit 10.2

MAGNACHIP SEMICONDUCTOR CORPORATION

RESTRICTED STOCK UNITS AGREEMENT

Magnachip Semiconductor Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (this “Agreement”) is attached an Award consisting of Restricted Stock Units subject to the terms and conditions set forth in the Grant Notice and this Agreement. The appendix attached hereto (the “Appendix”) and the terms and conditions for the Participant’s country set forth therein are incorporated by reference into this Agreement. The Participant shall be entitled to Dividend Equivalent Rights with respect to the Award.

The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the Magnachip Semiconductor Corporation 2020 Equity and Incentive Compensation Plan (the “Plan”), as amended from time to time, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prospectus”), (b) accepts the Award subject to all of the terms and conditions of the Grant Notice, this Agreement and the Plan and (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Grant Notice, this Agreement or the Plan.

1. DEFINITIONS AND CONSTRUCTION.

1.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Grant Notice or the Plan.

(a) “Dividend Equivalent Units” mean additional Restricted Stock Units credited pursuant to Section 4.3.

(b) “Units” mean the Restricted Stock Units originally granted pursuant to the Award and the Dividend Equivalent Units credited pursuant to the Award, as both shall be adjusted from time to time pursuant to Section 9.

1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

2. CERTAIN CONDITIONS OF THE AWARD.

2.1 Compliance with Local Law. The Participant agrees that the Participant will not acquire shares pursuant to the Award, or transfer, assign, sell or otherwise deal in such shares except in compliance with Local Law.

 

1


2.2 Service Conditions. By accepting the Award, the Participant acknowledges and agrees that:

(a) Any notice period mandated under Local Law shall not be treated as Service for the purpose of determining the vesting of the Award; and the Participant’s right to receive shares in settlement of the Award after termination of Service, if any, will be measured by the date of termination of the Participant’s active Service and will not be extended by any notice period mandated under Local Law. Subject to the foregoing and the provisions of the Plan, the Company, in its sole discretion, shall determine whether the Participant’s Service has terminated and the effective date of such termination.

(b) Notwithstanding anything to the contrary in the Grant Notice, if the Participant’s employment or service is terminated by the Participating Company to which the Participant renders Service (the “Service Recipient”) without Cause or if the Participant resigns for Good Reason, in each case not in connection with a CIC Qualified Termination (as each capitalized term is defined in the Participant’s employment, consulting or other service contract, which remains in effect at the time such term requires application, with the Participating Company) and prior to full settlement of the Award, the Participant will remain eligible to vest with respect to a pro rata portion of the next tranche of the Units scheduled to vest pursuant to the Grant Notice applicable to such Award. The pro rata portion will be determined by multiplying the number of shares underlying such tranche of the Award by a fraction, (x) the numerator of which is the number of full months (without any rounding) from the Prior Vesting Date (as defined below) to the date of such termination and (y) the denominator of which is the number of full months from the Prior Vesting Date to the next vesting date. All Awards in excess of the pro rata portion thereof that remains outstanding in accordance with the immediately preceding sentence shall immediately be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto. “Prior Vesting Date” means (1) the vesting date immediately preceding the date of such termination or (2) if no such vesting date exists, then the date that is 364 days prior to the next vesting date.

(c) If the Participant incurs a CIC Qualified Termination, all unvested Units will fully vest on the date of such termination.

(d) The vesting of the Award shall cease upon, and no Units shall vest following, the termination of the Participant’s Service for any reason other than as set forth in Section 2.2 (b) or (c). Further, all unvested Units shall be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

(e) The Plan is established voluntarily by the Company. It is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Agreement.

(f) The grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future grants of Awards, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past.

(g) All decisions with respect to future Award grants, if any, will be at the sole discretion of the Company.

 

2


(h) The Participant’s participation in the Plan shall not create a right to further Service with any Participating Company and shall not interfere with the ability of any Participating Company to terminate the Participant’s Service at any time, with or without Cause, insofar as permitted under Local Law.

(i) The Participant is voluntarily participating in the Plan.

(j) The Award and resulting shares, if any, are an extraordinary item that does not constitute compensation of any kind for Service of any kind rendered to any Participating Company, and which is outside the scope of the Participant’s employment, consulting or other service contract, if any.

(k) The Award is not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, payment in lieu of notice, redundancy, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments.

(l) In the event that the Participant does not provide Service to the Participating Company, the Award grant will not be interpreted to form an employment, consulting or other service contract or relationship with the Participating Company.

(m) The future value of the underlying shares is unknown and cannot be predicted with certainty. If the Participant obtains shares upon settlement of the Award, the value of those shares may increase or decrease.

(n) In consideration of the grant of an Award, no claim or entitlement to compensation or damages arises from termination of the Award or diminution in value of the Award or shares acquired upon settlement of the Award resulting from termination of the Participant’s Service (for any reason whether or not in breach of Local Law), and the Participant irrevocably releases the Company and each other Participating Company from any such claim that may arise. If, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen then, by signing this Agreement, the Participant shall be deemed irrevocably to have waived the Participant’s entitlement to pursue such a claim.

(o) Neither the Company nor Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the Award, or any amounts due to the Participant pursuant to the settlement of the Award or the subsequent sale of any shares acquired upon settlement.

2.3 Data Privacy Consent.

(A) THE PARTICIPANT HEREBY EXPLICITLY AND UNAMBIGUOUSLY CONSENTS TO THE COLLECTION, USE AND TRANSFER, IN ELECTRONIC OR OTHER FORM, OF THE PARTICIPANTS PERSONAL DATA AS DESCRIBED IN THIS DOCUMENT BY AND AMONG THE MEMBERS OF THE PARTICIPATING COMPANY GROUP FOR THE EXCLUSIVE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN.

 

3


(B) THE PARTICIPANT UNDERSTANDS THAT THE PARTICIPATING COMPANY GROUP HOLDS CERTAIN PERSONAL INFORMATION ABOUT THE PARTICIPANT, INCLUDING, BUT NOT LIMITED TO, THE PARTICIPANTS NAME, HOME ADDRESS AND TELEPHONE NUMBER, DATE OF BIRTH, SOCIAL SECURITY NUMBER OR OTHER IDENTIFICATION NUMBER, SALARY, NATIONALITY, JOB TITLE, ANY SHARES OR DIRECTORSHIPS HELD IN THE COMPANY, DETAILS OF ALL AWARDS OR ANY OTHER ENTITLEMENT TO SHARES AWARDED, CANCELED, EXERCISED, VESTED, UNVESTED OR OUTSTANDING IN THE PARTICIPANTS FAVOR (COLLECTIVELY, “DATA”), FOR THE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PLAN. THE PARTICIPANT UNDERSTANDS THAT DATA MAY BE TRANSFERRED TO ANY THIRD PARTIES ASSISTING IN THE IMPLEMENTATION, ADMINISTRATION AND MANAGEMENT OF THE PLAN, THAT THESE RECIPIENTS MAY BE LOCATED IN THE PARTICIPANTS COUNTRY OR ELSEWHERE, AND THAT THE RECIPIENTS COUNTRY MAY HAVE DIFFERENT DATA PRIVACY LAWS AND PROTECTIONS THAN THE PARTICIPANTS COUNTRY.

(C) THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY REQUEST A LIST WITH THE NAMES AND ADDRESSES OF ANY POTENTIAL RECIPIENTS OF THE DATA BY CONTACTING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT AUTHORIZES THE RECIPIENTS TO RECEIVE, POSSESS, USE, RETAIN AND TRANSFER THE DATA, IN ELECTRONIC OR OTHER FORM, FOR THE PURPOSES OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN, INCLUDING ANY REQUISITE TRANSFER OF SUCH DATA AS MAY BE REQUIRED TO A BROKER OR OTHER THIRD PARTY WITH WHOM THE PARTICIPANT MAY ELECT TO DEPOSIT ANY SHARES ACQUIRED UPON SETTLEMENT OF THE AWARD. THE PARTICIPANT UNDERSTANDS THAT DATA WILL BE HELD ONLY AS LONG AS IS NECESSARY TO IMPLEMENT, ADMINISTER AND MANAGE THE PARTICIPANTS PARTICIPATION IN THE PLAN. THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY, AT ANY TIME, VIEW DATA, REQUEST ADDITIONAL INFORMATION ABOUT THE STORAGE AND PROCESSING OF DATA, REQUIRE ANY NECESSARY AMENDMENTS TO DATA OR REFUSE OR WITHDRAW THE CONSENTS HEREIN, IN ANY CASE WITHOUT COST, BY CONTACTING IN WRITING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT UNDERSTANDS, HOWEVER, THAT REFUSING OR WITHDRAWING THE PARTICIPANTS CONSENT MAY AFFECT THE PARTICIPANTS ABILITY TO PARTICIPATE IN THE PLAN. FOR MORE INFORMATION ON THE CONSEQUENCES OF THE PARTICIPANTS REFUSAL TO CONSENT OR WITHDRAWAL OF CONSENT, THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY CONTACT THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE.

3. ADMINISTRATION.

All questions of interpretation concerning the Grant Notice, this Agreement, the Plan or any other form of agreement or other document employed by the Company in the administration of the Plan or the Award shall be determined by the Committee. All such determinations by the Committee shall be final, binding and conclusive upon all persons having an interest in the Award, unless fraudulent or made in bad faith. Any and all actions, decisions and determinations taken or made by the Committee in the exercise of its discretion pursuant to the Plan or the Award or other agreement thereunder (other than determining questions of interpretation pursuant to the preceding sentence) shall be final, binding and conclusive upon all persons having an interest in the Award. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation or election which is the responsibility of or which is allocated to the Company herein, provided that the Officer has actual authority with respect to such matter, right, obligation or election.

 

4


4. THE AWARD.

4.1 Grant of Units. The Company hereby grants to the Participant, subject to the provisions of this Agreement, the Total Number of the Units set forth in the Grant Notice, subject to adjustment as provided in Section 4.3 and Section 9. Subject to the terms and conditions set forth in the Grant Notice, this Agreement and the Plan, each Unit represents a right to receive on a date determined in accordance with the Grant Notice and this Agreement one (1) share of Stock.

4.2 No Monetary Payment Required. The Participant is not required to make any monetary payment (other than applicable tax withholding, if any) as a condition to receiving the Units or shares of Stock issued upon settlement of the Units.

4.3 Dividend Equivalent Units. On the date that the Company pays a cash dividend to holders of Stock generally, the Participant shall be credited with a number of additional whole Dividend Equivalent Units determined by dividing (a) the product of (i) the dollar amount of the cash dividend paid per share of Stock on such date and (ii) the total number of Units and Dividend Equivalent Units previously credited to the Participant pursuant to the Award and which have not been settled or forfeited pursuant to Section 6 below as of such date, by (b) the Fair Market Value per share of Stock on such date. Any resulting fractional Dividend Equivalent Unit shall be rounded to the nearest whole number. Such additional Dividend Equivalent Units shall be subject to the same terms and conditions and shall be settled or forfeited in the same manner and at the same time as the Units originally subject to the Award with respect to which they have been credited.

5. VESTING OF UNITS.

Units acquired pursuant to this Agreement shall become Vested Units as provided in the Grant Notice. Dividend Equivalent Units shall become Vested Units at the same time as the Units originally subject to the Award with respect to which they have been credited.

6. FORFEITURE OF UNITS.

In the event that the Participant’s Service is terminated by the Service Recipient for Cause, insofar as permitted under Local Law the Participant shall forfeit, and the Company shall automatically reacquire, all Units (whether vested or unvested), and the Participant shall not be entitled to any payment therefor.

7. SETTLEMENT OF THE AWARD.

7.1 Issuance of Shares of Stock. Subject to the provisions of Section 7.3, as soon as reasonably practicable following the date upon which Units vest (such date, the “Settlement Date”)(but in no event later than March 15th of the calendar year following the calendar year in which the Units vest), the Company shall issue to the Participant with respect to each such Vested Unit one (1) share of Stock. Shares of Stock issued in settlement of Units shall not be subject to any restriction on transfer other than any such restriction as may be required pursuant to Section 7.3, Section 7 or the Company’s Securities Trading Policy or any stock ownership guidelines or holding period guidelines established by the Board from time to time.

 

5


7.2 Beneficial Ownership of Shares; Certificate Registration. The Participant hereby authorizes the Company, in its sole discretion, to deposit any or all shares acquired by the Participant pursuant to the settlement of the Award with the Company’s transfer agent, including any successor transfer agent, to be held in book entry form, or to deposit such shares for the benefit of the Participant with any broker with which the Participant has an account relationship of which the Company has notice. Except as provided by the foregoing, a certificate for the shares acquired by the Participant shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant.

7.3 Restrictions on Grant of the Award and Issuance of Shares. The grant of the Award and issuance of shares of Stock upon settlement of the Award shall be subject to compliance with all applicable requirements of United States federal, state law and Local Law with respect to such securities. No shares of Stock may be issued hereunder if the issuance of such shares would constitute a violation of any applicable United States federal, state or Local Law, or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, or the impracticality of doing so, deemed by the Company’s legal counsel to be necessary to the lawful issuance of any shares subject to the Award shall relieve the Company of any liability in respect of the failure to issue such shares as to which such requisite authority shall not have been obtained. As a condition to the settlement of the Award, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.

7.4 Fractional Shares. The Company shall not be required to issue fractional shares upon the settlement of the Award.

8. TAX WITHHOLDING.

Regardless of any action the Company or the Service Recipient takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), the Participant acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due or deemed legally due by the Participant is and remains the Participant’s responsibility and that the Company and the Service Recipient (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of Units, including the grant and vesting of Units, subsequent delivery of shares or cash related to such Units or the subsequent sale of any shares acquired pursuant to such Units and receipt of any dividend equivalent payments (if any) and (ii) do not commit to structure the terms or any aspect of this grant of Units to reduce or eliminate the Participant’s liability for Tax-Related Items.

 

6


The Participant shall satisfy Tax-Related Items by having the Company or the Service Recipient deduct from shares of Stock otherwise deliverable to the Participant in settlement of the Award a number of whole shares having a Fair Market Value not in excess of the amount of such Tax-Related Items determined by the maximum applicable statutory withholding rates. Notwithstanding the foregoing, the Committee may instead, upon notice to the Participant, require the Participant to pay the Company or the Service Recipient in cash any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold as a result of the Participant’s participation in the Plan or the Participant’s receipt of Units (including, without limitation, by the Service Recipient withholding such amounts from the Participant’s wages, which the Participant hereby authorizes). If the obligation for Tax-Related Items is satisfied by withholding a number of shares as described herein, the Participant understands that he or she will be deemed to have been issued the full number of shares subject to the settled Units, notwithstanding that a number of shares are held back solely for the purpose of paying Tax-Related Items due as a result of the settlement of the Units. Further, if the Participant is subject to tax in more than one jurisdiction, the Participant acknowledges that the Company and/or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

In the event that the amount of the withholding is greater than the amount of Tax-Related Items, the Company or the Service Recipient may refund the amount of the over-withholding to the Participant (with no entitlement to any Stock equivalent), or alternatively, the Company or the Service Recipient may require the Participant to seek a refund from the applicable tax authorities. In the event that the amount of the withholding is less than the amount of Tax-Related Items, the Participant may be required to pay the under-withheld Tax-Related Items to the Company and/or the Service Recipient or directly to the applicable tax authorities.

The Company may refuse to deliver the shares if the Participant fails to comply with the Participant’s obligations in connection with Tax-Related Items.

The Participant acknowledges and understands that the Participant should consult a tax advisor regarding the Participant’s tax obligations prior to such settlement or disposition.

9. ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE.

Subject to any required action by the stockholders of the Company and the requirements of Section 409A, to the extent applicable, in the event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy) that has a material effect on the Fair Market Value of shares of Stock, or any other corporate transaction or event having an effect similar to any of the foregoing, appropriate and proportionate adjustments shall be made in the number of Units subject to the Award and/or the number and kind of shares or other property to be issued in settlement of the Award, in order to prevent dilution or enlargement of the Participant’s rights under the Award. For purposes of the foregoing,

 

7


conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any and all new, substituted or additional securities or other property (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy, which shall be treated in accordance with Section 4.3) to which the Participant is entitled by reason of ownership of Units acquired pursuant to this Award will be immediately subject to the provisions of this Award on the same basis as all Units originally acquired hereunder. Any fractional Unit or share resulting from an adjustment pursuant to this Section shall be rounded down to the nearest whole number. Such adjustments shall be determined by the Committee, and its determination shall be final, binding and conclusive.

10. RIGHTS AS A STOCKHOLDER, DIRECTOR, EMPLOYEE OR CONSULTANT.

The Participant shall have no rights as a stockholder with respect to any shares which may be issued in settlement of this Award until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date the shares are issued, except as provided in Section 4.3 and Section 9. If the Participant is an Employee, the Participant understands and acknowledges that, except as otherwise provided in a separate, written employment contract between the Service Recipient and the Participant, the Participant’s employment is “at will” and is for no specified term unless otherwise required under applicable law. Nothing in this Agreement shall confer upon the Participant any right to continue in the Service of the Service Recipient or interfere in any way with any right of the applicable Service Recipient to terminate the Participant’s Service at any time.

11. LEGENDS.

The Company may at any time place legends referencing any applicable United States federal, state or non-U.S. securities law, including Local Law, restrictions on all certificates representing shares of stock issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to this Award in the possession of the Participant in order to carry out the provisions of this Section.

12. MISCELLANEOUS PROVISIONS.

12.1 Termination or Amendment. The Committee may terminate or amend the Plan or this Agreement at any time; provided, however, that except as set forth in Section 9 or in connection with a Change in Control, no such termination or amendment may adversely affect the Participant’s rights under this Agreement without the consent of the Participant unless such termination or amendment is necessary to comply with applicable law or government regulation. No amendment or addition to this Agreement shall be effective unless in writing.

12.2 Nontransferability of the Award. Prior to the issuance of shares of Stock on the applicable Settlement Date, neither this Award nor any Units subject to this Award shall be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. All rights with respect to the Award shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s guardian or legal representative.

 

8


12.3 Further Instruments. The parties hereto agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

12.4 Binding Effect. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer set forth herein, be binding upon the Participant and the Participant’s heirs, executors, administrators, successors and assigns.

12.5 Delivery of Documents and Notices. Any document relating to participation in the Plan or any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery at the e-mail address, if any, provided for the Participant by a Participating Company, or upon deposit in the U.S. Post Office or non-U.S. postal service, by registered or certified mail, or with a nationally recognized overnight courier service, with postage and fees prepaid, addressed to the other party at the address of such party set forth in the Grant Notice or at such other address as such party may designate in writing from time to time to the other party.

(a) Description of Electronic Delivery. The Plan documents, which may include but do not necessarily include the Plan, the Grant Notice, this Agreement, the Plan Prospectus and any reports of the Company provided generally to the Company’s stockholders, may be delivered to the Participant electronically. In addition, if permitted by the Company, the Participant may deliver electronically the Grant Notice to the Company or to such third party involved in administering the Plan as the Company may designate from time to time. Such means of electronic delivery may include but do not necessarily include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other means of electronic delivery specified by the Company.

(b) Consent to Electronic Delivery. The Participant acknowledges that the Participant has read Section 12.5(a) of this Agreement and consents to the electronic delivery of the Plan documents and, if permitted by the Company, the delivery of the Grant Notice, as described in Section 12.5(a). The Participant acknowledges that he or she may receive from the Company a paper copy of any documents delivered electronically at no cost to the Participant by contacting the Company by telephone or in writing. The Participant further acknowledges that the Participant will be provided with a paper copy of any documents if the attempted electronic delivery of such documents fails. Similarly, the Participant understands that the Participant must provide the Company or any designated third party administrator with a paper copy of any documents if the attempted electronic delivery of such documents fails. The Participant may revoke his or her consent to the electronic delivery of documents described in Section 12.5(a) or may change the electronic mail address to which such documents are to be delivered (if the Participant has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised e-mail address by telephone, postal service or electronic mail. Finally, the Participant understands that he or she is not required to consent to electronic delivery of documents described in Section 12.5(a).

 

9


12.6 Integrated Agreement. The Grant Notice (including its exhibits), this Agreement and the Plan shall constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to the subject matter contained herein or therein and supersede any prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter. To the extent contemplated herein or therein, the provisions of the Grant Notice, this Agreement and the Plan shall survive any settlement of the Award and shall remain in full force and effect.

12.7 Country-Specific Terms and Conditions. Notwithstanding any other provision of this Agreement to the contrary, the Award shall be subject to the additional terms and conditions, if any, set forth in the Appendix to this Agreement which are applicable to the Participant’s country, the provisions of which are incorporated in and constitute part of this Agreement. Moreover, if the Participant relocates to one of the countries included in the Appendix, the additional terms and conditions applicable to such country will apply to the Award to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan or this Agreement.

12.8 Applicable Law. This Agreement shall be governed by the laws of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties as evidenced by this Agreement, the parties hereby submit to and consent to the jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of the County of Santa Clara, California, or the federal courts of the United States for the Northern District of California, and no other courts, where this Agreement is made and/or performed.

12.9 Language. The Participant acknowledges that the Participant is sufficiently proficient in the English language, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the provisions in this Agreement and the Plan. Further, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

12.10 Insider Trading / Market Abuse Restrictions. The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including, but not limited to, the U.S. and the Participant’s country of residence, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of shares or rights to shares (e.g., Units) or rights linked to the value of shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by applicable laws). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s Securities Trading Policy. The Participant is responsible for ensuring compliance with any applicable restrictions.

 

10


12.11 Foreign Asset and Account Reporting and Exchange Control Requirements. Certain foreign asset and foreign account reporting requirements and exchange controls may affect the Participant’s ability to acquire or hold shares under the Plan or cash received from participating in the Plan in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country through a designated bank or broker or within a certain time after receipt. The Participant is responsible for complying with any applicable regulations and should consult the Participant’s personal legal and tax advisors.

12.12 Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement by the Participant shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant.

12.13 Counterparts. The Grant Notice may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

12.14 Clawback. The Award will be subject to recoupment in accordance with the Company’s Clawback Policy or any other clawback or recoupment policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.

 

11


APPENDIX

ADDITIONAL TERMS AND CONDITIONS OF

MAGNACHIP SEMICONDUCTOR CORPORATION

RESTRICTED STOCK UNITS AGREEMENT

Capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan, the Grant Notice and the Agreement.

TERMS AND CONDITIONS

This Appendix includes additional terms and conditions that govern the Units granted to the Participant under the Plan if the Participant resides and/or works in one of the countries listed below. If the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the Company shall, in its discretion, determine to what extent the additional terms and conditions contained herein shall apply to the Participant.

NOTIFICATIONS

This Appendix may also include information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2022. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix as the only source of information relating to the consequences of the Participant’s participation in the Plan because such information may be out-of-date when the Participant’s Units vest and/or the Participant sells any shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation. As a result, the Company is not in a position to assure the Participant of any particular result. The Participant is therefore advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the notifications contained herein may not apply to the Participant in the same manner.

Below please find additional terms and conditions, as well as notifications, that apply to Korea and the United States.

KOREA

Terms and Conditions

 

12


There are no country-specific terms and conditions.

Notifications

If the Participant receives and owns Stocks at the time of delivery through a foreign financial account (i.e., financial account outside of Korea) and the total balance of all accounts of the Participant exceed KRW500 million on any last day of each month during a year, the Participant is required to file a Foreign Financial Account Report in accordance with the Korean tax law.

UNITED STATES

Terms and Conditions for Participants subject to Tax in the United States

1. The following paragraph is inserted as a new Section 12.15 to the Agreement:

Section 409A of the U.S. Internal Revenue Code. To the extent applicable, it is intended that this Agreement comply with the provisions of Section 409A, so that the income inclusion provisions of Section 409A(a)(1) do not apply. This Agreement shall be administered in a manner consistent with this intent. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall any Participating Company or any of their respective Subsidiary Corporations or Affiliates be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A or otherwise. For purposes of this Agreement, “Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and will also include any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.”

Notifications

There are no country-specific notifications.

 

13

EX-10.3 4 d306034dex103.htm EX-10.3 EX-10.3

Exhibit 10.3

MAGNACHIP SEMICONDUCTOR CORPORATION

PERFORMANCE-BASED RESTRICTED STOCK UNITS AGREEMENT

Magnachip Semiconductor Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of Performance-Based Restricted Stock Units (the “Grant Notice”) to which this Performance-Based Restricted Stock Units Agreement (this “Agreement”) is attached an Award consisting of Restricted Stock Units subject to the terms and conditions set forth in the Grant Notice and this Agreement. The appendix attached hereto (the “Appendix”) and the terms and conditions for the Participant’s country set forth therein are incorporated by reference into this Agreement. The Participant shall be entitled to Dividend Equivalent Rights with respect to the Award.

The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the Magnachip Semiconductor Corporation 2020 Equity and Incentive Compensation Plan (the “Plan”), as amended from time to time, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prospectus”), (b) accepts the Award subject to all of the terms and conditions of the Grant Notice, this Agreement and the Plan and (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Grant Notice, this Agreement or the Plan.

 

  1.

DEFINITIONS AND CONSTRUCTION.

1.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Grant Notice or the Plan.

(a) “Dividend Equivalent Units” mean additional Restricted Stock Units credited pursuant to Section 4.3.

(b) “Units” mean the Restricted Stock Units originally granted pursuant to the Award and the Dividend Equivalent Units credited pursuant to the Award, as both shall be adjusted from time to time pursuant to Section 10.

1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

 

  2.

CERTAIN CONDITIONS OF THE AWARD.

2.1 Compliance with Local Law. The Participant agrees that the Participant will not acquire shares pursuant to the Award, or transfer, assign, sell or otherwise deal in such shares except in compliance with Local Law.

 

1


2.2 Service Conditions. By accepting the Award, the Participant acknowledges and agrees that:

(a) Any notice period mandated under Local Law shall not be treated as Service for the purpose of determining the vesting of the Award; and the Participant’s right to receive shares in settlement of the Award after termination of Service, if any, will be measured by the date of termination of the Participant’s active Service and will not be extended by any notice period mandated under Local Law. Subject to the foregoing and the provisions of the Plan, the Company, in its sole discretion, shall determine whether the Participant’s Service has terminated and the effective date of such termination.

(b) Notwithstanding anything to the contrary in the Grant Notice, if the Participant’s employment or service is terminated by the Participating Company to which the Participant renders Service (the “Service Recipient”) without Cause or if the Participant resigns for Good Reason, in each case not in connection with a CIC Qualified Termination (as each capitalized term is defined in the Participant’s employment, consulting or other service contract) prior to full settlement of the Award, the Participant will remain eligible to vest (determined in accordance with the terms set forth in the Grant Notice) in a pro rata portion (which may be the entirety) of the Certified Restricted Stock Units or the Certified Make-Whole Units (each as defined below). “Certified Restricted Stock Units” means the Restricted Stock Units eligible to vest, as determined on the Certification Date following the end of the Performance Period based on actual Company performance. “Certified Make-Whole Units” means the Make-Whole Units (as defined in the Grant Notice) eligible to vest, as determined on the Certification Date following the end of the Performance Period based on actual Company performance. For purposes of this Section 2.2(b), the pro rata portion (which may be the entirety) of the Certified Restricted Stock Units or the Certified Make-Whole Units, as the case may be, shall be determined as set forth in the below table:

 

Case 1    Termination of Service occurs during the Performance Period   

The product calculated by multiplying (a) the total number of Certified Restricted Stock Units by (b) a fraction, (x) the numerator of which is the number of full months (without any rounding) of continuous Service that the Participant provided during the Performance Period and (y) the denominator of which is 12, multiplied by one-third (1/3).

 

  

For Make-Whole Units: The product calculated by multiplying (a) the total number of Certified Make-Whole Units by (b) a fraction, (x) the numerator of which is the number of full months (without any rounding) of continuous Service that the Participant provided during the Performance Period and (y) the denominator of which is 12.

 

Case 2    Termination of Service occurs after the Performance Period but before the Certification Date   

The sum calculated by adding (a) the product of the total number of Certified Restricted Stock Units multiplied by one-third (1/3) (such product, “One Year’s RSUs”) and (b) the product of One Year’s RSUs multiplied by a fraction, (x) the numerator of which is the number of full months (without any rounding) of continuous Service that the Participant provided after the Performance Period and (y) the denominator of which is 12.

 

  

For Make-Whole Units: The total number of Certified Make-Whole Units.

 

2


Case 3    Termination of Service occurs on or after the Certification Date    The product calculated by multiplying One Year’s RSUs by a fraction, (x) the numerator of which is the number of full months (without any rounding) of continuous Service that the Participant provided during the year in which the separation occurred and (y) the denominator of which is 12.

All Units in excess of the pro rata portion determined in accordance the above table shall immediately be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

If a Change in Control occurs upon or following such termination but prior to the end of the Performance Period, then the Units remaining outstanding and unvested immediately prior to the Change in Control (after application of the foregoing provisions in this Section 2.2(b)) shall fully vest and become nonforfeitable at the target level of achievement (determined in accordance with the Grant Notice) immediately upon the occurrence of the Change in Control and the date on which the Change in Control is consummated will be treated as the Settlement Date for purposes of Section 7 hereof.

If a Change in Control occurs upon or following such termination after the end of the Performance Period, then the Units remaining outstanding and unvested immediately prior to the Change in Control (after application of the foregoing provisions in this Section 2.2(b)) shall fully vest and become nonforfeitable based on actual Company performance immediately upon the occurrence of the Change in Control and the date on which the Change in Control is consummated will be treated as the Settlement Date for purposes of Section 7 hereof.

(c) If the Participant incurs a CIC Qualified Termination, all Units that remain outstanding and unvested shall fully vest on the date of such termination at the target level of achievement (determined in accordance with the Grant Notice); provided, however, if such CIC Qualified Termination occurs after the end of the Performance Period, then the aforesaid Units shall vest based on actual Company performance.

(d) The vesting of the Award shall cease upon, and no Units shall vest following, the termination of the Participant’s Service for any reason other than as set forth in Section 2.2 (b) or (c). Further, all unvested Units shall be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

(e) The Plan is established voluntarily by the Company. It is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Agreement.

(f) The grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future grants of Awards, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past.

 

3


(g) All decisions with respect to future Award grants, if any, will be at the sole discretion of the Company.

(h) The Participant’s participation in the Plan shall not create a right to further Service with any Participating Company and shall not interfere with the ability of any Participating Company to terminate the Participant’s Service at any time, with or without Cause, insofar as permitted under Local Law.

(i) The Participant is voluntarily participating in the Plan.

(j) The Award and resulting shares, if any, are an extraordinary item that does not constitute compensation of any kind for Service of any kind rendered to any Participating Company, and which is outside the scope of the Participant’s employment, consulting or other service contract, if any.

(k) The Award is not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, payment in lieu of notice, redundancy, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments.

(l) In the event that the Participant does not provide Service to the Participating Company, the Award grant will not be interpreted to form an employment, consulting or other service contract or relationship with the Participating Company.

(m) The future value of the underlying shares is unknown and cannot be predicted with certainty. If the Participant obtains shares upon settlement of the Award, the value of those shares may increase or decrease.

(n) In consideration of the grant of an Award, no claim or entitlement to compensation or damages arises from termination of the Award or diminution in value of the Award or shares acquired upon settlement of the Award resulting from termination of the Participant’s Service (for any reason whether or not in breach of Local Law), and the Participant irrevocably releases the Company and each other Participating Company from any such claim that may arise. If, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen then, by signing this Agreement, the Participant shall be deemed irrevocably to have waived the Participant’s entitlement to pursue such a claim.

(o) Neither the Company nor Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the Award, or any amounts due to the Participant pursuant to the settlement of the Award or the subsequent sale of any shares acquired upon settlement.

2.3 Data Privacy Consent.

(A) THE PARTICIPANT HEREBY EXPLICITLY AND UNAMBIGUOUSLY CONSENTS TO THE COLLECTION, USE AND TRANSFER, IN ELECTRONIC OR OTHER FORM, OF THE PARTICIPANTS PERSONAL DATA AS DESCRIBED IN THIS DOCUMENT BY AND AMONG THE MEMBERS OF THE PARTICIPATING COMPANY GROUP FOR THE EXCLUSIVE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN.

 

4


(B) THE PARTICIPANT UNDERSTANDS THAT THE PARTICIPATING COMPANY GROUP HOLDS CERTAIN PERSONAL INFORMATION ABOUT THE PARTICIPANT, INCLUDING, BUT NOT LIMITED TO, THE PARTICIPANTS NAME, HOME ADDRESS AND TELEPHONE NUMBER, DATE OF BIRTH, SOCIAL SECURITY NUMBER OR OTHER IDENTIFICATION NUMBER, SALARY, NATIONALITY, JOB TITLE, ANY SHARES OR DIRECTORSHIPS HELD IN THE COMPANY, DETAILS OF ALL AWARDS OR ANY OTHER ENTITLEMENT TO SHARES AWARDED, CANCELED, EXERCISED, VESTED, UNVESTED OR OUTSTANDING IN THE PARTICIPANTS FAVOR (COLLECTIVELY, “DATA”), FOR THE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PLAN. THE PARTICIPANT UNDERSTANDS THAT DATA MAY BE TRANSFERRED TO ANY THIRD PARTIES ASSISTING IN THE IMPLEMENTATION, ADMINISTRATION AND MANAGEMENT OF THE PLAN, THAT THESE RECIPIENTS MAY BE LOCATED IN THE PARTICIPANTS COUNTRY OR ELSEWHERE, AND THAT THE RECIPIENTS COUNTRY MAY HAVE DIFFERENT DATA PRIVACY LAWS AND PROTECTIONS THAN THE PARTICIPANTS COUNTRY.

(C) THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY REQUEST A LIST WITH THE NAMES AND ADDRESSES OF ANY POTENTIAL RECIPIENTS OF THE DATA BY CONTACTING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT AUTHORIZES THE RECIPIENTS TO RECEIVE, POSSESS, USE, RETAIN AND TRANSFER THE DATA, IN ELECTRONIC OR OTHER FORM, FOR THE PURPOSES OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN, INCLUDING ANY REQUISITE TRANSFER OF SUCH DATA AS MAY BE REQUIRED TO A BROKER OR OTHER THIRD PARTY WITH WHOM THE PARTICIPANT MAY ELECT TO DEPOSIT ANY SHARES ACQUIRED UPON SETTLEMENT OF THE AWARD. THE PARTICIPANT UNDERSTANDS THAT DATA WILL BE HELD ONLY AS LONG AS IS NECESSARY TO IMPLEMENT, ADMINISTER AND MANAGE THE PARTICIPANTS PARTICIPATION IN THE PLAN. THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY, AT ANY TIME, VIEW DATA, REQUEST ADDITIONAL INFORMATION ABOUT THE STORAGE AND PROCESSING OF DATA, REQUIRE ANY NECESSARY AMENDMENTS TO DATA OR REFUSE OR WITHDRAW THE CONSENTS HEREIN, IN ANY CASE WITHOUT COST, BY CONTACTING IN WRITING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT UNDERSTANDS, HOWEVER, THAT REFUSING OR WITHDRAWING THE PARTICIPANTS CONSENT MAY AFFECT THE PARTICIPANTS ABILITY TO PARTICIPATE IN THE PLAN. FOR MORE INFORMATION ON THE CONSEQUENCES OF THE PARTICIPANTS REFUSAL TO CONSENT OR WITHDRAWAL OF CONSENT, THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY CONTACT THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE.

 

  3.

ADMINISTRATION.

All questions of interpretation concerning the Grant Notice, this Agreement, the Plan or any other form of agreement or other document employed by the Company in the administration of the Plan or the Award shall be determined by the Committee. All such determinations by the Committee shall be final, binding and conclusive upon all persons having an interest in the Award, unless fraudulent or made in bad faith. Any and all actions, decisions and determinations taken or made by the Committee in the exercise of its discretion pursuant to the Plan or the Award or other agreement thereunder (other than determining questions of interpretation

 

5


pursuant to the preceding sentence) shall be final, binding and conclusive upon all persons having an interest in the Award. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation or election which is the responsibility of or which is allocated to the Company herein, provided that the Officer has actual authority with respect to such matter, right, obligation or election.

 

  4.

THE AWARD.

4.1 Grant of Units. The Company hereby grants to the Participant, subject to the provisions of this Agreement, the Total Number of the Units set forth in the Grant Notice, subject to adjustment as provided in Section 4.3 and Section 10. Subject to the terms and conditions set forth in the Grant Notice, this Agreement and the Plan, each Unit represents a right to receive on a date determined in accordance with the Grant Notice and this Agreement one (1) share of Stock.

4.2 No Monetary Payment Required. The Participant is not required to make any monetary payment (other than applicable tax withholding, if any) as a condition to receiving the Units or shares of Stock issued upon settlement of the Units.

4.3 Dividend Equivalent Units. On the date that the Company pays a cash dividend to holders of Stock generally, the Participant shall be credited with a number of additional whole Dividend Equivalent Units determined by dividing (a) the product of (i) the dollar amount of the cash dividend paid per share of Stock on such date and (ii) the total number of the Units and Dividend Equivalent Units previously credited to the Participant pursuant to the Award and which have not been settled or forfeited pursuant to Section 6 below as of such date, by (b) the Fair Market Value per share of Stock on such date. Any resulting fractional Dividend Equivalent Unit shall be rounded to the nearest whole number. Such additional Dividend Equivalent Units shall be subject to the same terms and conditions and shall be settled or forfeited in the same manner and at the same time as the Units originally subject to the Award with respect to which they have been credited.

 

  5.

VESTING OF UNITS.

Units acquired pursuant to this Agreement shall become Vested Units or Vestable Units as provided in the Grant Notice. Dividend Equivalent Units shall become Vested Units at the same time as the Units originally subject to the Award with respect to which they have been credited.

 

  6.

FORFEITURE OF UNITS.

In the event that the Participant’s Service is terminated by the Service Recipient for Cause, insofar as permitted under Local Law the Participant shall forfeit, and the Company shall automatically reacquire, all Units (whether vested or unvested), and the Participant shall not be entitled to any payment therefor.

 

6


  7.

SETTLEMENT OF THE AWARD.

7.1 Issuance of Shares of Stock. Subject to the provisions of Section 7.3, as soon as reasonably practicable following the date upon which Units satisfy the vesting conditions (such date, the “Settlement Date”) (but in no event later than March 15th of the calendar year following the calendar year in which the Units vest), the Company shall issue to the Participant with respect to each such Vested Unit one (1) share of Stock. Shares of Stock issued in settlement of Units shall not be subject to any restriction on transfer other than any such restriction as may be required pursuant to Section 7.3, Section 7 or the Company’s Securities Trading Policy or any stock ownership guidelines or holding period guidelines established by the Board from time to time.

7.2 Beneficial Ownership of Shares; Certificate Registration. The Participant hereby authorizes the Company, in its sole discretion, to deposit any or all shares acquired by the Participant pursuant to the settlement of the Award with the Company’s transfer agent, including any successor transfer agent, to be held in book entry form, or to deposit such shares for the benefit of the Participant with any broker with which the Participant has an account relationship of which the Company has notice. Except as provided by the foregoing, a certificate for the shares acquired by the Participant shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant.

7.3 Restrictions on Grant of the Award and Issuance of Shares. The grant of the Award and issuance of shares of Stock upon settlement of the Award shall be subject to compliance with all applicable requirements of United States federal, state law and Local Law with respect to such securities. No shares of Stock may be issued hereunder if the issuance of such shares would constitute a violation of any applicable United States federal, state or Local Law, or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, or the impracticality of doing so, deemed by the Company’s legal counsel to be necessary to the lawful issuance of any shares subject to the Award shall relieve the Company of any liability in respect of the failure to issue such shares as to which such requisite authority shall not have been obtained. As a condition to the settlement of the Award, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.

7.4 Fractional Shares. The Company shall not be required to issue fractional shares upon the settlement of the Award.

 

  8.

TAX WITHHOLDING.

Regardless of any action the Company or the Service Recipient takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), the Participant acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due or deemed legally due by the Participant is and remains the Participant’s responsibility and that the Company and the Service Recipient (i) make

 

7


no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of Units, including the grant and vesting of Units, subsequent delivery of shares or cash related to such Units or the subsequent sale of any shares acquired pursuant to such Units and receipt of any dividend equivalent payments (if any) and (ii) do not commit to structure the terms or any aspect of this grant of Units to reduce or eliminate the Participant’s liability for Tax-Related Items.

The Participant shall satisfy Tax-Related Items by having the Company or the Service Recipient deduct from shares of Stock otherwise deliverable to the Participant in settlement of the Award a number of whole shares having a Fair Market Value not in excess of the amount of such Tax-Related Items determined by the maximum applicable statutory withholding rates. Notwithstanding the foregoing, the Committee may instead, upon notice to the Participant, require the Participant to pay the Company or the Service Recipient in cash any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold as a result of the Participant’s participation in the Plan or the Participant’s receipt of Units (including, without limitation, by the Service Recipient withholding such amounts from the Participant’s wages, which the Participant hereby authorizes). If the obligation for Tax-Related Items is satisfied by withholding a number of shares as described herein, the Participant understands that he or she will be deemed to have been issued the full number of shares subject to the settled Units, notwithstanding that a number of shares are held back solely for the purpose of paying Tax-Related Items due as a result of the settlement of the Units. Further, if the Participant is subject to tax in more than one jurisdiction, the Participant acknowledges that the Company and/or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

In the event that the amount of the withholding is greater than the amount of Tax-Related Items, the Company or the Service Recipient may refund the amount of the over-withholding to the Participant (with no entitlement to any Stock equivalent), or alternatively, the Company or the Service Recipient may require the Participant to seek a refund from the applicable tax authorities. In the event that the amount of the withholding is less than the amount of Tax-Related Items, the Participant may be required to pay the under-withheld Tax-Related Items to the Company and/or the Service Recipient or directly to the applicable tax authorities.

The Company may refuse to deliver the shares if the Participant fails to comply with the Participant’s obligations in connection with Tax-Related Items.

The Participant acknowledges and understands that the Participant should consult a tax advisor regarding the Participant’s tax obligations prior to such settlement or disposition.

 

  9.

EFFECT OF CHANGE IN CONTROL.

In the event of a Change in Control, subject to the Participant’s continued Service on the date that such Change in Control is consummated, the Units that remain outstanding and unvested shall fully vest at the target level of achievement; provided, however, if the Change in Control occurs after the end of the Performance Period, then the aforesaid Units shall vest based on actual Company performance. The date on which the Change in Control is consummated will be treated as the Settlement Date for purposes of Section 7 hereof. All Units in excess of the aforesaid vesting shall immediately be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

 

8


  10.

ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE.

Subject to any required action by the stockholders of the Company and the requirements of Section 409A, to the extent applicable, in the event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy) that has a material effect on the Fair Market Value of shares of Stock, or any other corporate transaction or event having an effect similar to any of the foregoing, appropriate and proportionate adjustments shall be made in the number of Units subject to the Award and/or the number and kind of shares or other property to be issued in settlement of the Award, in order to prevent dilution or enlargement of the Participant’s rights under the Award. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any and all new, substituted or additional securities or other property (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy, which shall be treated in accordance with Section 4.3) to which the Participant is entitled by reason of ownership of Units acquired pursuant to this Award will be immediately subject to the provisions of this Award on the same basis as all Units originally acquired hereunder. Any fractional Unit or share resulting from an adjustment pursuant to this Section shall be rounded down to the nearest whole number. Such adjustments shall be determined by the Committee, and its determination shall be final, binding and conclusive.

 

  11.

RIGHTS AS A STOCKHOLDER, DIRECTOR, EMPLOYEE OR CONSULTANT.

The Participant shall have no rights as a stockholder with respect to any shares which may be issued in settlement of this Award until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date the shares are issued, except as provided in Section 4.3 and Section 10. If the Participant is an Employee, the Participant understands and acknowledges that, except as otherwise provided in a separate, written employment contract between the Service Recipient and the Participant, the Participant’s employment is “at will” and is for no specified term unless otherwise required under applicable law. Nothing in this Agreement shall confer upon the Participant any right to continue in the Service of the Service Recipient or interfere in any way with any right of the applicable Service Recipient to terminate the Participant’s Service at any time.

 

9


  12.

LEGENDS.

The Company may at any time place legends referencing any applicable United States federal, state or non-U.S. securities law, including Local Law, restrictions on all certificates representing shares of stock issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to this Award in the possession of the Participant in order to carry out the provisions of this Section.

 

  13.

MISCELLANEOUS PROVISIONS.

13.1 Termination or Amendment. The Committee may terminate or amend the Plan or this Agreement at any time; provided, however, that except as set forth in Section 9 in connection with a Change in Control or in Section 10, no such termination or amendment may adversely affect the Participant’s rights under this Agreement without the consent of the Participant unless such termination or amendment is necessary to comply with applicable law or government regulation. No amendment or addition to this Agreement shall be effective unless in writing.

13.2 Nontransferability of the Award. Prior to the issuance of shares of Stock on the applicable Settlement Date, neither this Award nor any Units subject to this Award shall be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. All rights with respect to the Award shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s guardian or legal representative.

13.3 Further Instruments. The parties hereto agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

13.4 Binding Effect. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer set forth herein, be binding upon the Participant and the Participant’s heirs, executors, administrators, successors and assigns.

13.5 Delivery of Documents and Notices. Any document relating to participation in the Plan or any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery at the e-mail address, if any, provided for the Participant by a Participating Company, or upon deposit in the U.S. Post Office or non-U.S. postal service, by registered or certified mail, or with a nationally recognized overnight courier service, with postage and fees prepaid, addressed to the other party at the address of such party set forth in the Grant Notice or at such other address as such party may designate in writing from time to time to the other party.

(a) Description of Electronic Delivery. The Plan documents, which may include but do not necessarily include the Plan, the Grant Notice, this Agreement, the Plan Prospectus and any reports of the Company provided generally to the Company’s stockholders, may be delivered to the Participant electronically. In addition, if permitted by the Company, the Participant may deliver electronically the Grant Notice to the Company or to such third party

 

10


involved in administering the Plan as the Company may designate from time to time. Such means of electronic delivery may include but do not necessarily include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other means of electronic delivery specified by the Company.

(b) Consent to Electronic Delivery. The Participant acknowledges that the Participant has read Section 13.5(a) of this Agreement and consents to the electronic delivery of the Plan documents and, if permitted by the Company, the delivery of the Grant Notice, as described in Section 13.5(a). The Participant acknowledges that he or she may receive from the Company a paper copy of any documents delivered electronically at no cost to the Participant by contacting the Company by telephone or in writing. The Participant further acknowledges that the Participant will be provided with a paper copy of any documents if the attempted electronic delivery of such documents fails. Similarly, the Participant understands that the Participant must provide the Company or any designated third party administrator with a paper copy of any documents if the attempted electronic delivery of such documents fails. The Participant may revoke his or her consent to the electronic delivery of documents described in Section 13.5(a) or may change the electronic mail address to which such documents are to be delivered (if the Participant has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised e-mail address by telephone, postal service or electronic mail. Finally, the Participant understands that he or she is not required to consent to electronic delivery of documents described in Section 13.5(a).

13.6 Integrated Agreement. The Grant Notice (including its exhibits), this Agreement and the Plan shall constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to the subject matter contained herein or therein and supersede any prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter. To the extent contemplated herein or therein, the provisions of the Grant Notice, this Agreement and the Plan shall survive any settlement of the Award and shall remain in full force and effect.

13.7 Country-Specific Terms and Conditions. Notwithstanding any other provision of this Agreement to the contrary, the Award shall be subject to the additional terms and conditions, if any, set forth in the Appendix to this Agreement which are applicable to the Participant’s country, the provisions of which are incorporated in and constitute part of this Agreement. Moreover, if the Participant relocates to one of the countries included in the Appendix, the additional terms and conditions applicable to such country will apply to the Award to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan or this Agreement.

13.8 Applicable Law. This Agreement shall be governed by the laws of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties as evidenced by this Agreement, the parties hereby submit to and consent to the jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of the County of Santa Clara, California, or the federal courts of the United States for the Northern District of California, and no other courts, where this Agreement is made and/or performed.

 

11


13.9 Language. The Participant acknowledges that the Participant is sufficiently proficient in the English language, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the provisions in this Agreement and the Plan. Further, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.10 Insider Trading / Market Abuse Restrictions. The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including, but not limited to, the U.S. and the Participant’s country of residence, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of shares or rights to shares (e.g., Units) or rights linked to the value of shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by applicable laws). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s Securities Trading Policy. The Participant is responsible for ensuring compliance with any applicable restrictions.

13.11 Foreign Asset and Account Reporting and Exchange Control Requirements. Certain foreign asset and foreign account reporting requirements and exchange controls may affect the Participant’s ability to acquire or hold shares under the Plan or cash received from participating in the Plan in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country through a designated bank or broker or within a certain time after receipt. The Participant is responsible for complying with any applicable regulations and should consult the Participant’s personal legal and tax advisors.

13.12 Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement by the Participant shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant.

13.13 Counterparts. The Grant Notice may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

13.14 Clawback. The Award will be subject to recoupment in accordance with the Company’s Clawback Policy or any other clawback or recoupment policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.

 

12


APPENDIX

ADDITIONAL TERMS AND CONDITIONS OF

MAGNACHIP SEMICONDUCTOR CORPORATION

PERFORMANCE-BASED RESTRICTED STOCK UNITS AGREEMENT

Capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan, the Grant Notice and the Agreement.

TERMS AND CONDITIONS

This Appendix includes additional terms and conditions that govern the Units granted to the Participant under the Plan if the Participant resides and/or works in one of the countries listed below. If the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the Company shall, in its discretion, determine to what extent the additional terms and conditions contained herein shall apply to the Participant.

NOTIFICATIONS

This Appendix may also include information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2022. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix as the only source of information relating to the consequences of the Participant’s participation in the Plan because such information may be out-of-date when the Participant’s Units vest and/or the Participant sells any shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation. As a result, the Company is not in a position to assure the Participant of any particular result. The Participant is therefore advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the notifications contained herein may not apply to the Participant in the same manner.

Below please find additional terms and conditions, as well as notifications, that apply to Korea and the United States.

KOREA

Terms and Conditions

 

13


There are no country-specific terms and conditions.

Notifications

If the Participant receives and owns Stocks at the time of delivery through a foreign financial account (i.e., financial account outside of Korea) and the total balance of all accounts of the Participant exceed KRW500 million on any last day of each month during a year, the Participant is required to file a Foreign Financial Account Report in accordance with the Korean tax law.

UNITED STATES

Terms and Conditions for Participants subject to Tax in the United States

1. The following paragraph is inserted as a new Section 13.15 to the PSU Agreement:

Section 409A of the U.S. Internal Revenue Code. To the extent applicable, it is intended that this Agreement comply with the provisions of Section 409A, so that the income inclusion provisions of Section 409A(a)(1) do not apply. This Agreement shall be administered in a manner consistent with this intent. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall any Participating Company or any of their respective Subsidiary Corporations or Affiliates be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A or otherwise. For purposes of this Agreement, “Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and will also include any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.”

Notifications

There are no country-specific notifications.

 

14

EX-10.4 5 d306034dex104.htm EX-10.4 EX-10.4

Exhibit 10.4

MAGNACHIP SEMICONDUCTOR CORPORATION

PERFORMANCE-BASED RESTRICTED STOCK UNITS AGREEMENT

Magnachip Semiconductor Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of Performance-Based Restricted Stock Units (the “Grant Notice”) to which this Performance-Based Restricted Stock Units Agreement (this “Agreement”) is attached an Award consisting of Restricted Stock Units subject to the terms and conditions set forth in the Grant Notice and this Agreement. The appendix attached hereto (the “Appendix”) and the terms and conditions for the Participant’s country set forth therein are incorporated by reference into this Agreement. The Participant shall be entitled to Dividend Equivalent Rights with respect to the Award.

The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the Magnachip Semiconductor Corporation 2020 Equity and Incentive Compensation Plan (the “Plan”), as amended from time to time, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prospectus”), (b) accepts the Award subject to all of the terms and conditions of the Grant Notice, this Agreement and the Plan and (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Grant Notice, this Agreement or the Plan.

1. DEFINITIONS AND CONSTRUCTION.

1.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Grant Notice or the Plan.

(a) “Dividend Equivalent Units” mean additional Restricted Stock Units credited pursuant to Section 4.3.

(b) “Units” mean the Restricted Stock Units originally granted pursuant to the Award and the Dividend Equivalent Units credited pursuant to the Award, as both shall be adjusted from time to time pursuant to Section 10.

1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

2. CERTAIN CONDITIONS OF THE AWARD.

2.1 Compliance with Local Law. The Participant agrees that the Participant will not acquire shares pursuant to the Award, or transfer, assign, sell or otherwise deal in such shares except in compliance with Local Law.

 

1


2.2 Service Conditions. By accepting the Award, the Participant acknowledges and agrees that:

(a) Any notice period mandated under Local Law shall not be treated as Service for the purpose of determining the vesting of the Award; and the Participant’s right to receive shares in settlement of the Award after termination of Service, if any, will be measured by the date of termination of the Participant’s active Service and will not be extended by any notice period mandated under Local Law. Subject to the foregoing and the provisions of the Plan, the Company, in its sole discretion, shall determine whether the Participant’s Service has terminated and the effective date of such termination.

(b) Notwithstanding anything to the contrary in the Grant Notice, if the Participant’s employment or service is terminated by the Participating Company to which the Participant renders Service (the “Service Recipient”) without Cause or if the Participant resigns for Good Reason, in each case not in connection with a CIC Qualified Termination (as each capitalized term is defined in the Participant’s employment, consulting or other service contract) prior to full settlement of the Award, the Participant will remain eligible to vest (determined in accordance with the terms set forth in the Grant Notice) in a pro rata portion (which may be the entirety) of the Certified Restricted Stock Units or the Certified Make-Whole Units (each as defined below). “Certified Restricted Stock Units” means the Restricted Stock Units eligible to vest, as determined on the Certification Date following the end of the Performance Period based on actual Company performance. “Certified Make-Whole Units” means the Make-Whole Units (as defined in the Grant Notice) eligible to vest, as determined on the Certification Date following the end of the Performance Period based on actual Company performance. For purposes of this Section 2.2(b), the pro rata portion (which may be the entirety) of the Certified Restricted Stock Units or the Certified Make-Whole Units, as the case may be, shall be determined as set forth in the below table:

 

Case 1    Termination of Service occurs during the Performance Period   

The product calculated by multiplying (a) the total number of Certified Restricted Stock Units by (b) a fraction, (x) the numerator of which is the number of full months (without any rounding) of continuous Service that the Participant provided during the Performance Period and (y) the denominator of which is 12, multiplied by one-third (1/3).

 

  

For Make-Whole Units: The product calculated by multiplying (a) the total number of Certified Make-Whole Units by (b) a fraction, (x) the numerator of which is the number of full months (without any rounding) of continuous Service that the Participant provided during the Performance Period and (y) the denominator of which is 12.

 

Case 2    Termination of Service occurs after the Performance Period but before the Certification Date   

The sum calculated by adding (a) the product of the total number of Certified Restricted Stock Units multiplied by one-third (1/3) (such product, “One Year’s RSUs”) and (b) the product of One Year’s RSUs multiplied by a fraction, (x) the numerator of which is the number of full months (without any rounding) of continuous Service that the Participant provided after the Performance Period and (y) the denominator of which is 12.

 

 

2


     

For Make-Whole Units: The total number of Certified Make-Whole Units.

 

Case 3    Termination of Service occurs on or after the Certification Date    The product calculated by multiplying One Year’s RSUs by a fraction, (x) the numerator of which is the number of full months (without any rounding) of continuous Service that the Participant provided during the year in which the separation occurred and (y) the denominator of which is 12.

All Units in excess of the pro rata portion determined in accordance the above table shall immediately be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

If a Change in Control occurs upon or following such termination but prior to the end of the Performance Period, then the Units remaining outstanding and unvested immediately prior to the Change in Control (after application of the foregoing provisions in this Section 2.2(b)) shall fully vest and become nonforfeitable at the target level of achievement (determined in accordance with the Grant Notice) immediately upon the occurrence of the Change in Control and the date on which the Change in Control is consummated will be treated as the Settlement Date for purposes of Section 7 hereof.

If a Change in Control occurs upon or following such termination after the end of the Performance Period, then the Units remaining outstanding and unvested immediately prior to the Change in Control (after application of the foregoing provisions in this Section 2.2(b)) shall fully vest and become nonforfeitable based on actual Company performance immediately upon the occurrence of the Change in Control and the date on which the Change in Control is consummated will be treated as the Settlement Date for purposes of Section 7 hereof.

(c) If the Participant incurs a CIC Qualified Termination, all Units that remain outstanding and unvested (after application of the provisions of Section 9) shall fully vest on the date of such termination, and, in the event that the date of such CIC Qualified Termination occurs prior to the occurrence of any Change in Control, the Units that remain outstanding and unvested shall vest at the target level of achievement (determined in accordance with the Grant Notice); provided, however, if such CIC Qualified Termination occurs after the end of the Performance Period, then the aforesaid Units shall vest based on actual Company performance.

(d) The vesting of the Award shall cease upon, and no Units shall vest following, the termination of the Participant’s Service for any reason other than as set forth in Section 2.2 (b) or (c). Further, all unvested Units shall be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

(e) The Plan is established voluntarily by the Company. It is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Agreement.

 

3


(f) The grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future grants of Awards, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past.

(g) All decisions with respect to future Award grants, if any, will be at the sole discretion of the Company.

(h) The Participant’s participation in the Plan shall not create a right to further Service with any Participating Company and shall not interfere with the ability of any Participating Company to terminate the Participant’s Service at any time, with or without Cause, insofar as permitted under Local Law.

(i) The Participant is voluntarily participating in the Plan.

(j) The Award and resulting shares, if any, are an extraordinary item that does not constitute compensation of any kind for Service of any kind rendered to any Participating Company, and which is outside the scope of the Participant’s employment, consulting or other service contract, if any.

(k) The Award is not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, payment in lieu of notice, redundancy, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments.

(l) In the event that the Participant does not provide Service to the Participating Company, the Award grant will not be interpreted to form an employment, consulting or other service contract or relationship with the Participating Company.

(m) The future value of the underlying shares is unknown and cannot be predicted with certainty. If the Participant obtains shares upon settlement of the Award, the value of those shares may increase or decrease.

(n) In consideration of the grant of an Award, no claim or entitlement to compensation or damages arises from termination of the Award or diminution in value of the Award or shares acquired upon settlement of the Award resulting from termination of the Participant’s Service (for any reason whether or not in breach of Local Law), and the Participant irrevocably releases the Company and each other Participating Company from any such claim that may arise. If, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen then, by signing this Agreement, the Participant shall be deemed irrevocably to have waived the Participant’s entitlement to pursue such a claim.

(o) Neither the Company nor Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the Award, or any amounts due to the Participant pursuant to the settlement of the Award or the subsequent sale of any shares acquired upon settlement.

 

4


2.3 Data Privacy Consent.

(A) THE PARTICIPANT HEREBY EXPLICITLY AND UNAMBIGUOUSLY CONSENTS TO THE COLLECTION, USE AND TRANSFER, IN ELECTRONIC OR OTHER FORM, OF THE PARTICIPANTS PERSONAL DATA AS DESCRIBED IN THIS DOCUMENT BY AND AMONG THE MEMBERS OF THE PARTICIPATING COMPANY GROUP FOR THE EXCLUSIVE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN.

(B) THE PARTICIPANT UNDERSTANDS THAT THE PARTICIPATING COMPANY GROUP HOLDS CERTAIN PERSONAL INFORMATION ABOUT THE PARTICIPANT, INCLUDING, BUT NOT LIMITED TO, THE PARTICIPANTS NAME, HOME ADDRESS AND TELEPHONE NUMBER, DATE OF BIRTH, SOCIAL SECURITY NUMBER OR OTHER IDENTIFICATION NUMBER, SALARY, NATIONALITY, JOB TITLE, ANY SHARES OR DIRECTORSHIPS HELD IN THE COMPANY, DETAILS OF ALL AWARDS OR ANY OTHER ENTITLEMENT TO SHARES AWARDED, CANCELED, EXERCISED, VESTED, UNVESTED OR OUTSTANDING IN THE PARTICIPANTS FAVOR (COLLECTIVELY, “DATA”), FOR THE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PLAN. THE PARTICIPANT UNDERSTANDS THAT DATA MAY BE TRANSFERRED TO ANY THIRD PARTIES ASSISTING IN THE IMPLEMENTATION, ADMINISTRATION AND MANAGEMENT OF THE PLAN, THAT THESE RECIPIENTS MAY BE LOCATED IN THE PARTICIPANTS COUNTRY OR ELSEWHERE, AND THAT THE RECIPIENTS COUNTRY MAY HAVE DIFFERENT DATA PRIVACY LAWS AND PROTECTIONS THAN THE PARTICIPANTS COUNTRY.

(C) THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY REQUEST A LIST WITH THE NAMES AND ADDRESSES OF ANY POTENTIAL RECIPIENTS OF THE DATA BY CONTACTING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT AUTHORIZES THE RECIPIENTS TO RECEIVE, POSSESS, USE, RETAIN AND TRANSFER THE DATA, IN ELECTRONIC OR OTHER FORM, FOR THE PURPOSES OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN, INCLUDING ANY REQUISITE TRANSFER OF SUCH DATA AS MAY BE REQUIRED TO A BROKER OR OTHER THIRD PARTY WITH WHOM THE PARTICIPANT MAY ELECT TO DEPOSIT ANY SHARES ACQUIRED UPON SETTLEMENT OF THE AWARD. THE PARTICIPANT UNDERSTANDS THAT DATA WILL BE HELD ONLY AS LONG AS IS NECESSARY TO IMPLEMENT, ADMINISTER AND MANAGE THE PARTICIPANTS PARTICIPATION IN THE PLAN. THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY, AT ANY TIME, VIEW DATA, REQUEST ADDITIONAL INFORMATION ABOUT THE STORAGE AND PROCESSING OF DATA, REQUIRE ANY NECESSARY AMENDMENTS TO DATA OR REFUSE OR WITHDRAW THE CONSENTS HEREIN, IN ANY CASE WITHOUT COST, BY CONTACTING IN WRITING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT UNDERSTANDS, HOWEVER, THAT REFUSING OR WITHDRAWING THE PARTICIPANTS CONSENT MAY AFFECT THE PARTICIPANTS ABILITY TO PARTICIPATE IN THE PLAN. FOR MORE INFORMATION ON THE CONSEQUENCES OF THE PARTICIPANTS REFUSAL TO CONSENT OR WITHDRAWAL OF CONSENT, THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY CONTACT THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE.

 

5


3. ADMINISTRATION.

All questions of interpretation concerning the Grant Notice, this Agreement, the Plan or any other form of agreement or other document employed by the Company in the administration of the Plan or the Award shall be determined by the Committee. All such determinations by the Committee shall be final, binding and conclusive upon all persons having an interest in the Award, unless fraudulent or made in bad faith. Any and all actions, decisions and determinations taken or made by the Committee in the exercise of its discretion pursuant to the Plan or the Award or other agreement thereunder (other than determining questions of interpretation pursuant to the preceding sentence) shall be final, binding and conclusive upon all persons having an interest in the Award. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation or election which is the responsibility of or which is allocated to the Company herein, provided that the Officer has actual authority with respect to such matter, right, obligation or election.

4. THE AWARD.

4.1 Grant of Units. The Company hereby grants to the Participant, subject to the provisions of this Agreement, the Total Number of the Units set forth in the Grant Notice, subject to adjustment as provided in Section 4.3 and Section 10. Subject to the terms and conditions set forth in the Grant Notice, this Agreement and the Plan, each Unit represents a right to receive on a date determined in accordance with the Grant Notice and this Agreement one (1) share of Stock.

4.2 No Monetary Payment Required. The Participant is not required to make any monetary payment (other than applicable tax withholding, if any) as a condition to receiving the Units or shares of Stock issued upon settlement of the Units.

4.3 Dividend Equivalent Units. On the date that the Company pays a cash dividend to holders of Stock generally, the Participant shall be credited with a number of additional whole Dividend Equivalent Units determined by dividing (a) the product of (i) the dollar amount of the cash dividend paid per share of Stock on such date and (ii) the total number of the Units and Dividend Equivalent Units previously credited to the Participant pursuant to the Award and which have not been settled or forfeited pursuant to Section 6 below as of such date, by (b) the Fair Market Value per share of Stock on such date. Any resulting fractional Dividend Equivalent Unit shall be rounded to the nearest whole number. Such additional Dividend Equivalent Units shall be subject to the same terms and conditions and shall be settled or forfeited in the same manner and at the same time as the Units originally subject to the Award with respect to which they have been credited.

5. VESTING OF UNITS.

Units acquired pursuant to this Agreement shall become Vested Units or Vestable Units as provided in the Grant Notice. Dividend Equivalent Units shall become Vested Units at the same time as the Units originally subject to the Award with respect to which they have been credited.

 

6


6. FORFEITURE OF UNITS.

In the event that the Participant’s Service is terminated by the Service Recipient for Cause, insofar as permitted under Local Law the Participant shall forfeit, and the Company shall automatically reacquire, all Units (whether vested or unvested), and the Participant shall not be entitled to any payment therefor.

7. SETTLEMENT OF THE AWARD.

7.1 Issuance of Shares of Stock. Subject to the provisions of Section 7.3, as soon as reasonably practicable following the date upon which Units satisfy the vesting conditions (such date, the “Settlement Date”) (but in no event later than March 15th of the calendar year following the calendar year in which the Units vest), the Company shall issue to the Participant with respect to each such Vested Unit one (1) share of Stock. Shares of Stock issued in settlement of Units shall not be subject to any restriction on transfer other than any such restriction as may be required pursuant to Section 7.3, Section 7 or the Company’s Securities Trading Policy or any stock ownership guidelines or holding period guidelines established by the Board from time to time.

7.2 Beneficial Ownership of Shares; Certificate Registration. The Participant hereby authorizes the Company, in its sole discretion, to deposit any or all shares acquired by the Participant pursuant to the settlement of the Award with the Company’s transfer agent, including any successor transfer agent, to be held in book entry form, or to deposit such shares for the benefit of the Participant with any broker with which the Participant has an account relationship of which the Company has notice. Except as provided by the foregoing, a certificate for the shares acquired by the Participant shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant.

7.3 Restrictions on Grant of the Award and Issuance of Shares. The grant of the Award and issuance of shares of Stock upon settlement of the Award shall be subject to compliance with all applicable requirements of United States federal, state law and Local Law with respect to such securities. No shares of Stock may be issued hereunder if the issuance of such shares would constitute a violation of any applicable United States federal, state or Local Law, or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, or the impracticality of doing so, deemed by the Company’s legal counsel to be necessary to the lawful issuance of any shares subject to the Award shall relieve the Company of any liability in respect of the failure to issue such shares as to which such requisite authority shall not have been obtained. As a condition to the settlement of the Award, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.

7.4 Fractional Shares. The Company shall not be required to issue fractional shares upon the settlement of the Award.

 

7


8. TAX WITHHOLDING.

Regardless of any action the Company or the Service Recipient takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), the Participant acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due or deemed legally due by the Participant is and remains the Participant’s responsibility and that the Company and the Service Recipient (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of Units, including the grant and vesting of Units, subsequent delivery of shares or cash related to such Units or the subsequent sale of any shares acquired pursuant to such Units and receipt of any dividend equivalent payments (if any) and (ii) do not commit to structure the terms or any aspect of this grant of Units to reduce or eliminate the Participant’s liability for Tax-Related Items.

The Participant shall satisfy Tax-Related Items by having the Company or the Service Recipient deduct from shares of Stock otherwise deliverable to the Participant in settlement of the Award a number of whole shares having a Fair Market Value not in excess of the amount of such Tax-Related Items determined by the maximum applicable statutory withholding rates. Notwithstanding the foregoing, the Committee may instead, upon notice to the Participant, require the Participant to pay the Company or the Service Recipient in cash any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold as a result of the Participant’s participation in the Plan or the Participant’s receipt of Units (including, without limitation, by the Service Recipient withholding such amounts from the Participant’s wages, which the Participant hereby authorizes). If the obligation for Tax-Related Items is satisfied by withholding a number of shares as described herein, the Participant understands that he or she will be deemed to have been issued the full number of shares subject to the settled Units, notwithstanding that a number of shares are held back solely for the purpose of paying Tax-Related Items due as a result of the settlement of the Units. Further, if the Participant is subject to tax in more than one jurisdiction, the Participant acknowledges that the Company and/or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

In the event that the amount of the withholding is greater than the amount of Tax-Related Items, the Company or the Service Recipient may refund the amount of the over-withholding to the Participant (with no entitlement to any Stock equivalent), or alternatively, the Company or the Service Recipient may require the Participant to seek a refund from the applicable tax authorities. In the event that the amount of the withholding is less than the amount of Tax-Related Items, the Participant may be required to pay the under-withheld Tax-Related Items to the Company and/or the Service Recipient or directly to the applicable tax authorities.

The Company may refuse to deliver the shares if the Participant fails to comply with the Participant’s obligations in connection with Tax-Related Items.

The Participant acknowledges and understands that the Participant should consult a tax advisor regarding the Participant’s tax obligations prior to such settlement or disposition.

 

8


9. EFFECT OF CHANGE IN CONTROL.

9.1 Change in Control. Upon the occurrence of a Change in Control during the Performance Period where a Replacement Award (as defined below) is provided to the Participant at the time of the Change in Control in lieu of the Units, the Units that remain outstanding and unvested as of immediately prior to the Change in Control shall remain outstanding and unvested, but the performance conditions with respect thereto shall be deemed satisfied at the target level of achievement. Upon the occurrence of a Change in Control where a Replacement Award is not provided to the Participant in lieu of the Units, the Units shall immediately vest at the target level of achievement; provided, however, if the Change in Control occurs after the end of the Performance Period, then the aforesaid Units shall vest based on actual Company performance. In either case, all Units in excess of the aforesaid vesting shall immediately be forfeited and cancelled, unless otherwise determined by the Committee, and Participant shall not be entitled to any compensation or other amount with respect thereto.

9.2 Replacement Award. A “Replacement Award” is an Award that (i) is the same (i.e., the Award continues) or is of the same type as the Award that is replaced or adjusted by a Replacement Award (the “Replaced Award”) (i.e., restricted stock units); (ii) has a value at least equal to the value of the Replaced Award at the time of the Change in Control; (iii) is subject to the same vesting schedule as the Replaced Award; (iv) relates to equity securities of the Company or its successor upon the Change in Control, or a parent entity of the Company or its successor upon the Change in Control, which securities are subject to an effective registration statement under the Securities Act; (v) if the Participant is subject to U.S. federal income tax under the Code, the tax consequences to the Participant under the Code of the Replacement Award are not less favorable to the Participant than the tax consequences of the Replaced Award; and (vi) its other terms and conditions are not less favorable to the Participant than the terms and conditions of the Replaced Award (including, but not limited to, the provisions that would apply in the event of a subsequent Change in Control). Without limiting the generality of the foregoing, the Replacement Award may take the form of a continuation of the Replaced Award if the requirements of the preceding sentence are satisfied. The determination of whether the requirements for a Replacement Award are satisfied will be made by the Committee, as constituted immediately before the Change in Control, in its good faith discretion (taking into account the requirements of Treasury Regulation 1.409A-3(i)(5)(iv)(B) and compliance of the Replaced Award or Replacement Award with Section 409A).

10. ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE.

Subject to any required action by the stockholders of the Company and the requirements of Section 409A, to the extent applicable, in the event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy) that has a material effect on the Fair Market Value of shares of Stock, or any other corporate transaction or event having an effect similar to any of the foregoing, appropriate and proportionate adjustments

 

9


shall be made in the number of Units subject to the Award and/or the number and kind of shares or other property to be issued in settlement of the Award, in order to prevent dilution or enlargement of the Participant’s rights under the Award. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any and all new, substituted or additional securities or other property (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy, which shall be treated in accordance with Section 4.3) to which the Participant is entitled by reason of ownership of Units acquired pursuant to this Award will be immediately subject to the provisions of this Award on the same basis as all Units originally acquired hereunder. Any fractional Unit or share resulting from an adjustment pursuant to this Section shall be rounded down to the nearest whole number. Such adjustments shall be determined by the Committee, and its determination shall be final, binding and conclusive.

11. RIGHTS AS A STOCKHOLDER, DIRECTOR, EMPLOYEE OR CONSULTANT.

The Participant shall have no rights as a stockholder with respect to any shares which may be issued in settlement of this Award until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date the shares are issued, except as provided in Section 4.3 and Section 10. If the Participant is an Employee, the Participant understands and acknowledges that, except as otherwise provided in a separate, written employment contract between the Service Recipient and the Participant, the Participant’s employment is “at will” and is for no specified term unless otherwise required under applicable law. Nothing in this Agreement shall confer upon the Participant any right to continue in the Service of the Service Recipient or interfere in any way with any right of the applicable Service Recipient to terminate the Participant’s Service at any time.

12. LEGENDS.

The Company may at any time place legends referencing any applicable United States federal, state or non-U.S. securities law, including Local Law, restrictions on all certificates representing shares of stock issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to this Award in the possession of the Participant in order to carry out the provisions of this Section.

13. MISCELLANEOUS PROVISIONS.

13.1 Termination or Amendment. The Committee may terminate or amend the Plan or this Agreement at any time; provided, however, that except as set forth in Section 9 in connection with a Change in Control or in Section 10, no such termination or amendment may adversely affect the Participant’s rights under this Agreement without the consent of the Participant unless such termination or amendment is necessary to comply with applicable law or government regulation. No amendment or addition to this Agreement shall be effective unless in writing.

 

10


13.2 Nontransferability of the Award. Prior to the issuance of shares of Stock on the applicable Settlement Date, neither this Award nor any Units subject to this Award shall be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. All rights with respect to the Award shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s guardian or legal representative.

13.3 Further Instruments. The parties hereto agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

13.4 Binding Effect. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer set forth herein, be binding upon the Participant and the Participant’s heirs, executors, administrators, successors and assigns.

13.5 Delivery of Documents and Notices. Any document relating to participation in the Plan or any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery at the e-mail address, if any, provided for the Participant by a Participating Company, or upon deposit in the U.S. Post Office or non-U.S. postal service, by registered or certified mail, or with a nationally recognized overnight courier service, with postage and fees prepaid, addressed to the other party at the address of such party set forth in the Grant Notice or at such other address as such party may designate in writing from time to time to the other party.

(a) Description of Electronic Delivery. The Plan documents, which may include but do not necessarily include the Plan, the Grant Notice, this Agreement, the Plan Prospectus and any reports of the Company provided generally to the Company’s stockholders, may be delivered to the Participant electronically. In addition, if permitted by the Company, the Participant may deliver electronically the Grant Notice to the Company or to such third party involved in administering the Plan as the Company may designate from time to time. Such means of electronic delivery may include but do not necessarily include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other means of electronic delivery specified by the Company.

(b) Consent to Electronic Delivery. The Participant acknowledges that the Participant has read Section 13.5(a) of this Agreement and consents to the electronic delivery of the Plan documents and, if permitted by the Company, the delivery of the Grant Notice, as described in Section 13.5(a). The Participant acknowledges that he or she may receive from the Company a paper copy of any documents delivered electronically at no cost to the Participant by contacting the Company by telephone or in writing. The Participant further acknowledges that the Participant will be provided with a paper copy of any documents if the attempted electronic delivery of such documents fails. Similarly, the Participant understands that the Participant must provide the Company or any designated third party administrator with a paper copy of any

 

11


documents if the attempted electronic delivery of such documents fails. The Participant may revoke his or her consent to the electronic delivery of documents described in Section 13.5(a) or may change the electronic mail address to which such documents are to be delivered (if the Participant has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised e-mail address by telephone, postal service or electronic mail. Finally, the Participant understands that he or she is not required to consent to electronic delivery of documents described in Section 13.5(a).

13.6 Integrated Agreement. The Grant Notice (including its exhibits), this Agreement and the Plan shall constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to the subject matter contained herein or therein and supersede any prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter. To the extent contemplated herein or therein, the provisions of the Grant Notice, this Agreement and the Plan shall survive any settlement of the Award and shall remain in full force and effect.

13.7 Country-Specific Terms and Conditions. Notwithstanding any other provision of this Agreement to the contrary, the Award shall be subject to the additional terms and conditions, if any, set forth in the Appendix to this Agreement which are applicable to the Participant’s country, the provisions of which are incorporated in and constitute part of this Agreement. Moreover, if the Participant relocates to one of the countries included in the Appendix, the additional terms and conditions applicable to such country will apply to the Award to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan or this Agreement.

13.8 Applicable Law. This Agreement shall be governed by the laws of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties as evidenced by this Agreement, the parties hereby submit to and consent to the jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of the County of Santa Clara, California, or the federal courts of the United States for the Northern District of California, and no other courts, where this Agreement is made and/or performed.

13.9 Language. The Participant acknowledges that the Participant is sufficiently proficient in the English language, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the provisions in this Agreement and the Plan. Further, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.10 Insider Trading / Market Abuse Restrictions. The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including, but not limited to, the U.S. and the Participant’s country of residence, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of shares or rights to shares (e.g., Units) or rights linked to the value of shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by applicable laws). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s Securities Trading Policy. The Participant is responsible for ensuring compliance with any applicable restrictions.

 

12


13.11 Foreign Asset and Account Reporting and Exchange Control Requirements. Certain foreign asset and foreign account reporting requirements and exchange controls may affect the Participant’s ability to acquire or hold shares under the Plan or cash received from participating in the Plan in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country through a designated bank or broker or within a certain time after receipt. The Participant is responsible for complying with any applicable regulations and should consult the Participant’s personal legal and tax advisors.

13.12 Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement by the Participant shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant.

13.13 Counterparts. The Grant Notice may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

13.14 Clawback. The Award will be subject to recoupment in accordance with the Company’s Clawback Policy or any other clawback or recoupment policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.

 

13


APPENDIX

ADDITIONAL TERMS AND CONDITIONS OF

MAGNACHIP SEMICONDUCTOR CORPORATION

PERFORMANCE-BASED RESTRICTED STOCK UNITS AGREEMENT

Capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan, the Grant Notice and the Agreement.

TERMS AND CONDITIONS

This Appendix includes additional terms and conditions that govern the Units granted to the Participant under the Plan if the Participant resides and/or works in one of the countries listed below. If the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the Company shall, in its discretion, determine to what extent the additional terms and conditions contained herein shall apply to the Participant.

NOTIFICATIONS

This Appendix may also include information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2022. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix as the only source of information relating to the consequences of the Participant’s participation in the Plan because such information may be out-of-date when the Participant’s Units vest and/or the Participant sells any shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation. As a result, the Company is not in a position to assure the Participant of any particular result. The Participant is therefore advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the notifications contained herein may not apply to the Participant in the same manner.

Below please find additional terms and conditions, as well as notifications, that apply to Korea and the United States.

KOREA

Terms and Conditions

 

14


There are no country-specific terms and conditions.

Notifications

If the Participant receives and owns Stocks at the time of delivery through a foreign financial account (i.e., financial account outside of Korea) and the total balance of all accounts of the Participant exceed KRW500 million on any last day of each month during a year, the Participant is required to file a Foreign Financial Account Report in accordance with the Korean tax law.

UNITED STATES

Terms and Conditions for Participants subject to Tax in the United States

1. The following paragraph is inserted as a new Section 13.15 to the PSU Agreement:

Section 409A of the U.S. Internal Revenue Code. To the extent applicable, it is intended that this Agreement comply with the provisions of Section 409A, so that the income inclusion provisions of Section 409A(a)(1) do not apply. This Agreement shall be administered in a manner consistent with this intent. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall any Participating Company or any of their respective Subsidiary Corporations or Affiliates be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A or otherwise. For purposes of this Agreement, “Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and will also include any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.”

Notifications

There are no country-specific notifications.

 

15

EX-10.5 6 d306034dex105.htm EX-10.5 EX-10.5

Exhibit 10.5

MAGNACHIP SEMICONDUCTOR CORPORATION

RESTRICTED STOCK UNITS AGREEMENT

(TSR PERFORMANCE)

Magnachip Semiconductor Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of TSR Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (this “Agreement”) is attached an Award consisting of Restricted Stock Units subject to the terms and conditions set forth in the Grant Notice and this Agreement. The appendix attached hereto (the “Appendix”) and the terms and conditions for the Participant’s country set forth therein are incorporated by reference into this Agreement. The Participant shall be entitled to Dividend Equivalent Rights with respect to the Award.

The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the Magnachip Semiconductor Corporation 2020 Equity and Incentive Compensation Plan (the “Plan”), as amended from time to time, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prospectus”), (b) accepts the Award subject to all of the terms and conditions of the Grant Notice, this Agreement and the Plan and (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Grant Notice, this Agreement or the Plan.

1. DEFINITIONS AND CONSTRUCTION.

1.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Grant Notice or the Plan.

(a) “Dividend Equivalent Units” mean additional Restricted Stock Units credited pursuant to Section 4.3.

(b) “Units” mean the Restricted Stock Units originally granted pursuant to the Award and the Dividend Equivalent Units credited pursuant to the Award, as both shall be adjusted from time to time pursuant to Section 10.

1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

2. CERTAIN CONDITIONS OF THE AWARD.

2.1 Compliance with Local Law. The Participant agrees that the Participant will not acquire shares pursuant to the Award, or transfer, assign, sell or otherwise deal in such shares except in compliance with Local Law.

 

1


2.2 Service Conditions. By accepting the Award, the Participant acknowledges and agrees that:

(a) Any notice period mandated under Local Law shall not be treated as Service for the purpose of determining the vesting of the Award; and the Participant’s right to receive shares in settlement of the Award after termination of Service, if any, will be measured by the date of termination of the Participant’s active Service and will not be extended by any notice period mandated under Local Law. Subject to the foregoing and the provisions of the Plan, the Company, in its sole discretion, shall determine whether the Participant’s Service has terminated and the effective date of such termination.

(b) Notwithstanding anything to the contrary in the Grant Notice, if the Participant’s employment or service is terminated by the Participating Company to which the Participant renders Service (“Service Recipient”) without Cause or if the Participant resigns for Good Reason, in each case not in connection with a CIC Qualified Termination (as each capitalized term is defined in the Participant’s employment, consulting or other service contract) prior to the full settlement of the Award, the Participant will remain eligible to vest (determined in accordance with the terms set forth in the Grant Notice) in a pro rata portion of the Units on the Certification Date following the end of the Performance Period based on actual Company performance, with such pro rata portion determined by multiplying the total number of the Units remaining outstanding and unvested immediately prior to such termination by a fraction, (x) the numerator of which is the number of full months (without any rounding) that the Participant provided continuous Service during the Performance Period, and (y) the denominator of which is the number of full months in the full Performance Period. All Units in excess of the pro rata portion thereof that remains outstanding in accordance with the immediately preceding sentence shall immediately be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto. If a Change in Control occurs upon or following such termination and prior to the end of the Performance Period, then the Units that remain outstanding and unvested immediately prior to the Change in Control (after application of the foregoing provisions of this Section 2.2(b)) shall vest and become nonforfeitable at the target level of achievement (determined in accordance with the Grant Notice) immediately upon the occurrence of the Change in Control and the date on which the Change in Control is consummated shall be treated as the Settlement Date for purposes of Section 7 hereof.

(c) If the Participant incurs a CIC Qualified Termination, all Units that remain outstanding and unvested Units (if any) shall fully vest on the date of such termination at the target level of achievement (determined in accordance with the Grant Notice).

(d) The vesting of the Award shall cease upon, and no Units shall vest following, the termination of the Participant’s Service for any reason other than as set forth in Section 2.2 (b) or (c). Further, all unvested Units shall be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

(e) The Plan is established voluntarily by the Company. It is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Agreement.

 

2


(f) The grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future grants of Awards, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past.

(g) All decisions with respect to future Award grants, if any, will be at the sole discretion of the Company.

(h) The Participant’s participation in the Plan shall not create a right to further Service with any Participating Company and shall not interfere with the ability of any Participating Company to terminate the Participant’s Service at any time, with or without Cause, insofar as permitted under Local Law.

(i) The Participant is voluntarily participating in the Plan.

(j) The Award and resulting shares, if any, are an extraordinary item that does not constitute compensation of any kind for Service of any kind rendered to any Participating Company, and which is outside the scope of the Participant’s employment, consulting or other service contract, if any.

(k) The Award is not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, payment in lieu of notice, redundancy, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments.

(l) In the event that the Participant does not provide Service to the Participating Company, the Award grant will not be interpreted to form an employment, consulting or other service contract or relationship with the Participating Company.

(m) The future value of the underlying shares is unknown and cannot be predicted with certainty. If the Participant obtains shares upon settlement of the Award, the value of those shares may increase or decrease.

(n) In consideration of the grant of an Award, no claim or entitlement to compensation or damages arises from termination of the Award or diminution in value of the Award or shares acquired upon settlement of the Award resulting from termination of the Participant’s Service (for any reason whether or not in breach of Local Law), and the Participant irrevocably releases the Company and each other Participating Company from any such claim that may arise. If, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen then, by signing this Agreement, the Participant shall be deemed irrevocably to have waived the Participant’s entitlement to pursue such a claim.

(o) Neither the Company nor Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the Award, or any amounts due to the Participant pursuant to the settlement of the Award or the subsequent sale of any shares acquired upon settlement.

 

3


2.3 Data Privacy Consent.

(A) THE PARTICIPANT HEREBY EXPLICITLY AND UNAMBIGUOUSLY CONSENTS TO THE COLLECTION, USE AND TRANSFER, IN ELECTRONIC OR OTHER FORM, OF THE PARTICIPANTS PERSONAL DATA AS DESCRIBED IN THIS DOCUMENT BY AND AMONG THE MEMBERS OF THE PARTICIPATING COMPANY GROUP FOR THE EXCLUSIVE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN.

(B) THE PARTICIPANT UNDERSTANDS THAT THE PARTICIPATING COMPANY GROUP HOLDS CERTAIN PERSONAL INFORMATION ABOUT THE PARTICIPANT, INCLUDING, BUT NOT LIMITED TO, THE PARTICIPANTS NAME, HOME ADDRESS AND TELEPHONE NUMBER, DATE OF BIRTH, SOCIAL SECURITY NUMBER OR OTHER IDENTIFICATION NUMBER, SALARY, NATIONALITY, JOB TITLE, ANY SHARES OR DIRECTORSHIPS HELD IN THE COMPANY, DETAILS OF ALL AWARDS OR ANY OTHER ENTITLEMENT TO SHARES AWARDED, CANCELED, EXERCISED, VESTED, UNVESTED OR OUTSTANDING IN THE PARTICIPANTS FAVOR (COLLECTIVELY, “DATA”), FOR THE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PLAN. THE PARTICIPANT UNDERSTANDS THAT DATA MAY BE TRANSFERRED TO ANY THIRD PARTIES ASSISTING IN THE IMPLEMENTATION, ADMINISTRATION AND MANAGEMENT OF THE PLAN, THAT THESE RECIPIENTS MAY BE LOCATED IN THE PARTICIPANTS COUNTRY OR ELSEWHERE, AND THAT THE RECIPIENTS COUNTRY MAY HAVE DIFFERENT DATA PRIVACY LAWS AND PROTECTIONS THAN THE PARTICIPANTS COUNTRY.

(C) THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY REQUEST A LIST WITH THE NAMES AND ADDRESSES OF ANY POTENTIAL RECIPIENTS OF THE DATA BY CONTACTING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT AUTHORIZES THE RECIPIENTS TO RECEIVE, POSSESS, USE, RETAIN AND TRANSFER THE DATA, IN ELECTRONIC OR OTHER FORM, FOR THE PURPOSES OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN, INCLUDING ANY REQUISITE TRANSFER OF SUCH DATA AS MAY BE REQUIRED TO A BROKER OR OTHER THIRD PARTY WITH WHOM THE PARTICIPANT MAY ELECT TO DEPOSIT ANY SHARES ACQUIRED UPON SETTLEMENT OF THE AWARD. THE PARTICIPANT UNDERSTANDS THAT DATA WILL BE HELD ONLY AS LONG AS IS NECESSARY TO IMPLEMENT, ADMINISTER AND MANAGE THE PARTICIPANTS PARTICIPATION IN THE PLAN. THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY, AT ANY TIME, VIEW DATA, REQUEST ADDITIONAL INFORMATION ABOUT THE STORAGE AND PROCESSING OF DATA, REQUIRE ANY NECESSARY AMENDMENTS TO DATA OR REFUSE OR WITHDRAW THE CONSENTS HEREIN, IN ANY CASE WITHOUT COST, BY CONTACTING IN WRITING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT UNDERSTANDS, HOWEVER, THAT REFUSING OR WITHDRAWING THE PARTICIPANTS CONSENT MAY AFFECT THE PARTICIPANTS ABILITY TO PARTICIPATE IN THE PLAN. FOR MORE INFORMATION ON THE CONSEQUENCES OF THE PARTICIPANTS REFUSAL TO CONSENT OR WITHDRAWAL OF CONSENT, THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY CONTACT THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE.

 

4


3. ADMINISTRATION.

All questions of interpretation concerning the Grant Notice, this Agreement, the Plan or any other form of agreement or other document employed by the Company in the administration of the Plan or the Award shall be determined by the Committee. All such determinations by the Committee shall be final, binding and conclusive upon all persons having an interest in the Award, unless fraudulent or made in bad faith. Any and all actions, decisions and determinations taken or made by the Committee in the exercise of its discretion pursuant to the Plan or the Award or other agreement thereunder (other than determining questions of interpretation pursuant to the preceding sentence) shall be final, binding and conclusive upon all persons having an interest in the Award. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation or election which is the responsibility of or which is allocated to the Company herein, provided that the Officer has actual authority with respect to such matter, right, obligation or election.

4. THE AWARD.

4.1 Grant of Units. The Company hereby grants to the Participant, subject to the provisions of this Agreement, the Total Number of the Units set forth in the Grant Notice, subject to adjustment as provided in Section 4.3 and Section 10. Subject to the terms and conditions set forth in the Grant Notice, this Agreement and the Plan, each Unit represents a right to receive on a date determined in accordance with the Grant Notice and this Agreement one (1) share of Stock.

4.2 No Monetary Payment Required. The Participant is not required to make any monetary payment (other than applicable tax withholding, if any) as a condition to receiving the Units or shares of Stock issued upon settlement of the Units.

4.3 Dividend Equivalent Units. On the date that the Company pays a cash dividend to holders of Stock generally, the Participant shall be credited with a number of additional whole Dividend Equivalent Units determined by dividing (a) the product of (i) the dollar amount of the cash dividend paid per share of Stock on such date and (ii) the total number of the Units and Dividend Equivalent Units previously credited to the Participant pursuant to the Award and which have not been settled or forfeited pursuant to Section 6 below as of such date, by (b) the Fair Market Value per share of Stock on such date. Any resulting fractional Dividend Equivalent Unit shall be rounded to the nearest whole number. Such additional Dividend Equivalent Units shall be subject to the same terms and conditions and shall be settled or forfeited in the same manner and at the same time as the Units originally subject to the Award with respect to which they have been credited.

5. VESTING OF UNITS.

Units acquired pursuant to this Agreement shall become Vested Units as provided in the Grant Notice. Dividend Equivalent Units shall become Vested Units at the same time as the Units originally subject to the Award with respect to which they have been credited.

 

5


6. FORFEITURE OF UNITS.

In the event that the Participant’s Service is terminated by the Service Recipient for Cause, insofar as permitted under Local Law the Participant shall forfeit, and the Company shall automatically reacquire, all Units (whether vested or unvested), and the Participant shall not be entitled to any payment therefor.

7. SETTLEMENT OF THE AWARD.

7.1 Issuance of Shares of Stock. Subject to the provisions of Section 7.3, as soon as reasonably practicable following the date upon which Units satisfy the vesting conditions (such date, the “Settlement Date”)(but in no event later than March 15th of the calendar year following the calendar year in which the Units vest), the Company shall issue to the Participant with respect to each such Vested Unit one (1) share of Stock. Shares of Stock issued in settlement of Units shall not be subject to any restriction on transfer other than any such restriction as may be required pursuant to Section 7.3, Section 7 or the Company’s Securities Trading Policy or any stock ownership guidelines or holding period guidelines established by the Board from time to time.

7.2 Beneficial Ownership of Shares; Certificate Registration. The Participant hereby authorizes the Company, in its sole discretion, to deposit any or all shares acquired by the Participant pursuant to the settlement of the Award with the Company’s transfer agent, including any successor transfer agent, to be held in book entry form, or to deposit such shares for the benefit of the Participant with any broker with which the Participant has an account relationship of which the Company has notice. Except as provided by the foregoing, a certificate for the shares acquired by the Participant shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant.

7.3 Restrictions on Grant of the Award and Issuance of Shares. The grant of the Award and issuance of shares of Stock upon settlement of the Award shall be subject to compliance with all applicable requirements of United States federal, state law and Local Law with respect to such securities. No shares of Stock may be issued hereunder if the issuance of such shares would constitute a violation of any applicable United States federal, state or Local Law, or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, or the impracticality of doing so, deemed by the Company’s legal counsel to be necessary to the lawful issuance of any shares subject to the Award shall relieve the Company of any liability in respect of the failure to issue such shares as to which such requisite authority shall not have been obtained. As a condition to the settlement of the Award, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.

7.4 Fractional Shares. The Company shall not be required to issue fractional shares upon the settlement of the Award.

 

6


8. TAX WITHHOLDING.

Regardless of any action the Company or the Service Recipient takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), the Participant acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due or deemed legally due by the Participant is and remains the Participant’s responsibility and that the Company and the Service Recipient (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of Units, including the grant and vesting of Units, subsequent delivery of shares or cash related to such Units or the subsequent sale of any shares acquired pursuant to such Units and receipt of any dividend equivalent payments (if any) and (ii) do not commit to structure the terms or any aspect of this grant of Units to reduce or eliminate the Participant’s liability for Tax-Related Items.

The Participant shall satisfy Tax-Related Items by having the Company or the Service Recipient deduct from shares of Stock otherwise deliverable to the Participant in settlement of the Award a number of whole shares having a Fair Market Value not in excess of the amount of such Tax-Related Items determined by the maximum applicable statutory withholding rates. Notwithstanding the foregoing, the Committee may instead, upon notice to the Participant, require the Participant to pay the Company or the Service Recipient in cash any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold as a result of the Participant’s participation in the Plan or the Participant’s receipt of Units (including, without limitation, by the Service Recipient withholding such amounts from the Participant’s wages, which the Participant hereby authorizes). If the obligation for Tax-Related Items is satisfied by withholding a number of shares as described herein, the Participant understands that he or she will be deemed to have been issued the full number of shares subject to the settled Units, notwithstanding that a number of shares are held back solely for the purpose of paying Tax-Related Items due as a result of the settlement of the Units. Further, if the Participant is subject to tax in more than one jurisdiction, the Participant acknowledges that the Company and/or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

In the event that the amount of the withholding is greater than the amount of Tax-Related Items, the Company or the Service Recipient may refund the amount of the over-withholding to the Participant (with no entitlement to any Stock equivalent), or alternatively, the Company or the Service Recipient may require the Participant to seek a refund from the applicable tax authorities. In the event that the amount of the withholding is less than the amount of Tax-Related Items, the Participant may be required to pay the under-withheld Tax-Related Items to the Company and/or the Service Recipient or directly to the applicable tax authorities.

The Company may refuse to deliver the shares if the Participant fails to comply with the Participant’s obligations in connection with Tax-Related Items.

The Participant acknowledges and understands that the Participant should consult a tax advisor regarding the Participant’s tax obligations prior to such settlement or disposition.

 

7


9. EFFECT OF CHANGE IN CONTROL.

In the event of a Change in Control during the Performance Period, subject to the Participant’s continued Service on the date that such Change in Control is consummated, the Target Award (and any Dividend Equivalent Units associated therewith) shall vest and the date that the Change in Control is consummated shall be treated as the Settlement Date for purposes of Section 7 hereof. No Restricted Stock Units in excess of the Target Award shall vest pursuant to this Agreement and all Restricted Stock Units in excess of the Target Award shall immediately be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

10. ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE.

Subject to any required action by the stockholders of the Company and the requirements of Section 409A, to the extent applicable, in the event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy) that has a material effect on the Fair Market Value of shares of Stock, or any other corporate transaction or event having an effect similar to any of the foregoing, appropriate and proportionate adjustments shall be made in the number of Units subject to the Award and/or the number and kind of shares or other property to be issued in settlement of the Award, in order to prevent dilution or enlargement of the Participant’s rights under the Award. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any and all new, substituted or additional securities or other property (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy, which shall be treated in accordance with Section 4.3) to which the Participant is entitled by reason of ownership of Units acquired pursuant to this Award will be immediately subject to the provisions of this Award on the same basis as all Units originally acquired hereunder. Any fractional Unit or share resulting from an adjustment pursuant to this Section shall be rounded down to the nearest whole number. Such adjustments shall be determined by the Committee, and its determination shall be final, binding and conclusive.

11. RIGHTS AS A STOCKHOLDER, DIRECTOR, EMPLOYEE OR CONSULTANT.

The Participant shall have no rights as a stockholder with respect to any shares which may be issued in settlement of this Award until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date the shares are issued, except as provided in Section 4.3 and Section 10. If the Participant is an Employee, the Participant understands and acknowledges that, except as otherwise provided in a separate, written employment contract between the Service Recipient and the Participant, the Participant’s employment is “at will” and is for no specified term unless otherwise required under applicable law. Nothing in this Agreement shall confer upon the Participant any right to continue in the Service of the Service Recipient or interfere in any way with any right of the applicable Service Recipient to terminate the Participant’s Service at any time.

 

8


12. LEGENDS.

The Company may at any time place legends referencing any applicable United States federal, state or non-U.S. securities law, including Local Law, restrictions on all certificates representing shares of stock issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to this Award in the possession of the Participant in order to carry out the provisions of this Section.

13. MISCELLANEOUS PROVISIONS.

13.1 Termination or Amendment. The Committee may terminate or amend the Plan or this Agreement at any time; provided, however, that except as set forth in Section 9 in connection with a Change in Control or in Section 10, no such termination or amendment may adversely affect the Participant’s rights under this Agreement without the consent of the Participant unless such termination or amendment is necessary to comply with applicable law or government regulation. No amendment or addition to this Agreement shall be effective unless in writing.

13.2 Nontransferability of the Award. Prior to the issuance of shares of Stock on the applicable Settlement Date, neither this Award nor any Units subject to this Award shall be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. All rights with respect to the Award shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s guardian or legal representative.

13.3 Further Instruments. The parties hereto agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

13.4 Binding Effect. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer set forth herein, be binding upon the Participant and the Participant’s heirs, executors, administrators, successors and assigns.

13.5 Delivery of Documents and Notices. Any document relating to participation in the Plan or any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery at the e-mail address, if any, provided for the Participant by a Participating Company, or upon deposit in the U.S. Post Office or non-U.S. postal service, by registered or certified mail, or with a nationally recognized overnight courier service, with postage and fees prepaid, addressed to the other party at the address of such party set forth in the Grant Notice or at such other address as such party may designate in writing from time to time to the other party.

 

9


(a) Description of Electronic Delivery. The Plan documents, which may include but do not necessarily include the Plan, the Grant Notice, this Agreement, the Plan Prospectus and any reports of the Company provided generally to the Company’s stockholders, may be delivered to the Participant electronically. In addition, if permitted by the Company, the Participant may deliver electronically the Grant Notice to the Company or to such third party involved in administering the Plan as the Company may designate from time to time. Such means of electronic delivery may include but do not necessarily include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other means of electronic delivery specified by the Company.

(b) Consent to Electronic Delivery. The Participant acknowledges that the Participant has read Section 13.5(a) of this Agreement and consents to the electronic delivery of the Plan documents and, if permitted by the Company, the delivery of the Grant Notice, as described in Section 13.5(a). The Participant acknowledges that he or she may receive from the Company a paper copy of any documents delivered electronically at no cost to the Participant by contacting the Company by telephone or in writing. The Participant further acknowledges that the Participant will be provided with a paper copy of any documents if the attempted electronic delivery of such documents fails. Similarly, the Participant understands that the Participant must provide the Company or any designated third party administrator with a paper copy of any documents if the attempted electronic delivery of such documents fails. The Participant may revoke his or her consent to the electronic delivery of documents described in Section 13.5(a) or may change the electronic mail address to which such documents are to be delivered (if the Participant has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised e-mail address by telephone, postal service or electronic mail. Finally, the Participant understands that he or she is not required to consent to electronic delivery of documents described in Section 13.5(a).

13.6 Integrated Agreement. The Grant Notice (including its exhibits), this Agreement and the Plan shall constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to the subject matter contained herein or therein and supersede any prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter. To the extent contemplated herein or therein, the provisions of the Grant Notice, this Agreement and the Plan shall survive any settlement of the Award and shall remain in full force and effect.

13.7 Country-Specific Terms and Conditions. Notwithstanding any other provision of this Agreement to the contrary, the Award shall be subject to the additional terms and conditions, if any, set forth in the Appendix to this Agreement which are applicable to the Participant’s country, the provisions of which are incorporated in and constitute part of this Agreement. Moreover, if the Participant relocates to one of the countries included in the Appendix, the additional terms and conditions applicable to such country will apply to the Award to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan or this Agreement.

 

10


13.8 Applicable Law. This Agreement shall be governed by the laws of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties as evidenced by this Agreement, the parties hereby submit to and consent to the jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of the County of Santa Clara, California, or the federal courts of the United States for the Northern District of California, and no other courts, where this Agreement is made and/or performed.

13.9 Language. The Participant acknowledges that the Participant is sufficiently proficient in the English language, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the provisions in this Agreement and the Plan. Further, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.10 Insider Trading / Market Abuse Restrictions. The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including, but not limited to, the U.S. and the Participant’s country of residence, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of shares or rights to shares (e.g., Units) or rights linked to the value of shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by applicable laws). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s Securities Trading Policy. The Participant is responsible for ensuring compliance with any applicable restrictions.

13.11 Foreign Asset and Account Reporting and Exchange Control Requirements. Certain foreign asset and foreign account reporting requirements and exchange controls may affect the Participant’s ability to acquire or hold shares under the Plan or cash received from participating in the Plan in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country through a designated bank or broker or within a certain time after receipt. The Participant is responsible for complying with any applicable regulations and should consult the Participant’s personal legal and tax advisors.

13.12 Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement by the Participant shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant.

13.13 Counterparts. The Grant Notice may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

11


13.14 Clawback. The Award will be subject to recoupment in accordance with the Company’s Clawback Policy or any other clawback or recoupment policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.

 

12


APPENDIX

ADDITIONAL TERMS AND CONDITIONS OF

MAGNACHIP SEMICONDUCTOR CORPORATION

RESTRICTED STOCK UNITS AGREEMENT

Capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan, the Grant Notice and the Agreement.

TERMS AND CONDITIONS

This Appendix includes additional terms and conditions that govern the Units granted to the Participant under the Plan if the Participant resides and/or works in one of the countries listed below. If the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the Company shall, in its discretion, determine to what extent the additional terms and conditions contained herein shall apply to the Participant.

NOTIFICATIONS

This Appendix may also include information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2022. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix as the only source of information relating to the consequences of the Participant’s participation in the Plan because such information may be out-of-date when the Participant’s Units vest and/or the Participant sells any shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation. As a result, the Company is not in a position to assure the Participant of any particular result. The Participant is therefore advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the notifications contained herein may not apply to the Participant in the same manner.

Below please find additional terms and conditions, as well as notifications, that apply to Korea and the United States.

 

13


KOREA

Terms and Conditions

There are no country-specific terms and conditions.

Notifications

If the Participant receives and owns Stocks at the time of delivery through a foreign financial account (i.e., financial account outside of Korea) and the total balance of all accounts of the Participant exceed KRW500 million on any last day of each month during a year, the Participant is required to file a Foreign Financial Account Report in accordance with the Korean tax law.

UNITED STATES

Terms and Conditions for Participants subject to Tax in the United States

1. The following paragraph is inserted as a new Section 13.15 to the Agreement:

Section 409A of the U.S. Internal Revenue Code. To the extent applicable, it is intended that this Agreement comply with the provisions of Section 409A, so that the income inclusion provisions of Section 409A(a)(1) do not apply. This Agreement shall be administered in a manner consistent with this intent. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall any Participating Company or any of their respective Subsidiary Corporations or Affiliates be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A or otherwise. For purposes of this Agreement, “Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and will also include any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.”

Notifications

There are no country-specific notifications.

 

14

EX-10.6 7 d306034dex106.htm EX-10.6 EX-10.6

Exhibit 10.6

MAGNACHIP SEMICONDUCTOR CORPORATION

RESTRICTED STOCK UNITS AGREEMENT

(TSR PERFORMANCE)

Magnachip Semiconductor Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of TSR Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (this “Agreement”) is attached an Award consisting of Restricted Stock Units subject to the terms and conditions set forth in the Grant Notice and this Agreement. The appendix attached hereto (the “Appendix”) and the terms and conditions for the Participant’s country set forth therein are incorporated by reference into this Agreement. The Participant shall be entitled to Dividend Equivalent Rights with respect to the Award.

The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the Magnachip Semiconductor Corporation 2020 Equity and Incentive Compensation Plan (the “Plan”), as amended from time to time, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prospectus”), (b) accepts the Award subject to all of the terms and conditions of the Grant Notice, this Agreement and the Plan and (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Grant Notice, this Agreement or the Plan.

1. DEFINITIONS AND CONSTRUCTION.

1.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Grant Notice or the Plan.

(a) “Dividend Equivalent Units” mean additional Restricted Stock Units credited pursuant to Section 4.3.

(b) “Units” mean the Restricted Stock Units originally granted pursuant to the Award and the Dividend Equivalent Units credited pursuant to the Award, as both shall be adjusted from time to time pursuant to Section 10.

1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

2. CERTAIN CONDITIONS OF THE AWARD.

2.1 Compliance with Local Law. The Participant agrees that the Participant will not acquire shares pursuant to the Award, or transfer, assign, sell or otherwise deal in such shares except in compliance with Local Law.

 

1


2.2 Service Conditions. By accepting the Award, the Participant acknowledges and agrees that:

(a) Any notice period mandated under Local Law shall not be treated as Service for the purpose of determining the vesting of the Award; and the Participant’s right to receive shares in settlement of the Award after termination of Service, if any, will be measured by the date of termination of the Participant’s active Service and will not be extended by any notice period mandated under Local Law. Subject to the foregoing and the provisions of the Plan, the Company, in its sole discretion, shall determine whether the Participant’s Service has terminated and the effective date of such termination.

(b) Notwithstanding anything to the contrary in the Grant Notice, if the Participant’s employment or service is terminated by the Participating Company to which the Participant renders Service (“Service Recipient”) without Cause or if the Participant resigns for Good Reason, in each case not in connection with a CIC Qualified Termination (as each capitalized term is defined in the Participant’s employment, consulting or other service contract) prior to the full settlement of the Award, the Participant will remain eligible to vest (determined in accordance with the terms set forth in the Grant Notice) in a pro rata portion of the Units on the Certification Date following the end of the Performance Period based on actual Company performance, with such pro rata portion determined by multiplying the total number of the Units remaining outstanding and unvested immediately prior to such termination by a fraction, (x) the numerator of which is the number of full months (without any rounding) that the Participant provided continuous Service during the Performance Period, and (y) the denominator of which is the number of full months in the full Performance Period. All Units in excess of the pro rata portion thereof that remains outstanding in accordance with the immediately preceding sentence shall immediately be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto. If a Change in Control occurs upon or following such termination and prior to the end of the Performance Period, then the portion of the Units remaining outstanding and unvested immediately prior to the Change in Control (after application of the foregoing provisions of this Section 2.2(b)) that are eligible to vest and become nonforfeitable (“CIC Post-Termination Units”) will be determined as of the date of the Change in Control in accordance with Exhibit A to the Grant Notice and the date of the Change in Control will serve as the last day of the Performance Period for purposes of such determination. The CIC Post-Termination Units, if any, will vest immediately upon the occurrence of the Change in Control and the date on which the Change in Control is consummated shall be treated as the Settlement Date for purposes of Section 7 hereof.

(c) If the Participant incurs a CIC Qualified Termination, all Units that remain outstanding and unvested (after application of the provisions of Section 9) shall fully vest on the date of such termination, and, in the event that the date of such CIC Qualified Termination occurs prior to the occurrence of any Change in Control, the number of vested Units will be determined by the level of actual performance through the date of such CIC Qualified Termination.

 

2


(d) The vesting of the Award shall cease upon, and no Units shall vest following, the termination of the Participant’s Service for any reason other than as set forth in Section 2.2 (b) or (c). Further, all unvested Units shall be forfeited and cancelled, and the Participant shall not be entitled to any compensation or other amount with respect thereto.

(e) The Plan is established voluntarily by the Company. It is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Agreement.

(f) The grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future grants of Awards, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past.

(g) All decisions with respect to future Award grants, if any, will be at the sole discretion of the Company.

(h) The Participant’s participation in the Plan shall not create a right to further Service with any Participating Company and shall not interfere with the ability of any Participating Company to terminate the Participant’s Service at any time, with or without Cause, insofar as permitted under Local Law.

(i) The Participant is voluntarily participating in the Plan.

(j) The Award and resulting shares, if any, are an extraordinary item that does not constitute compensation of any kind for Service of any kind rendered to any Participating Company, and which is outside the scope of the Participant’s employment, consulting or other service contract, if any.

(k) The Award is not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, payment in lieu of notice, redundancy, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments.

(l) In the event that the Participant does not provide Service to the Participating Company, the Award grant will not be interpreted to form an employment, consulting or other service contract or relationship with the Participating Company.

(m) The future value of the underlying shares is unknown and cannot be predicted with certainty. If the Participant obtains shares upon settlement of the Award, the value of those shares may increase or decrease.

(n) In consideration of the grant of an Award, no claim or entitlement to compensation or damages arises from termination of the Award or diminution in value of the Award or shares acquired upon settlement of the Award resulting from termination of the Participant’s Service (for any reason whether or not in breach of Local Law), and the Participant irrevocably releases the Company and each other Participating Company from any such claim that may arise. If, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen then, by signing this Agreement, the Participant shall be deemed irrevocably to have waived the Participant’s entitlement to pursue such a claim.

 

3


(o) Neither the Company nor Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the Award, or any amounts due to the Participant pursuant to the settlement of the Award or the subsequent sale of any shares acquired upon settlement.

2.3 Data Privacy Consent.

(A) THE PARTICIPANT HEREBY EXPLICITLY AND UNAMBIGUOUSLY CONSENTS TO THE COLLECTION, USE AND TRANSFER, IN ELECTRONIC OR OTHER FORM, OF THE PARTICIPANTS PERSONAL DATA AS DESCRIBED IN THIS DOCUMENT BY AND AMONG THE MEMBERS OF THE PARTICIPATING COMPANY GROUP FOR THE EXCLUSIVE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN.

(B) THE PARTICIPANT UNDERSTANDS THAT THE PARTICIPATING COMPANY GROUP HOLDS CERTAIN PERSONAL INFORMATION ABOUT THE PARTICIPANT, INCLUDING, BUT NOT LIMITED TO, THE PARTICIPANTS NAME, HOME ADDRESS AND TELEPHONE NUMBER, DATE OF BIRTH, SOCIAL SECURITY NUMBER OR OTHER IDENTIFICATION NUMBER, SALARY, NATIONALITY, JOB TITLE, ANY SHARES OR DIRECTORSHIPS HELD IN THE COMPANY, DETAILS OF ALL AWARDS OR ANY OTHER ENTITLEMENT TO SHARES AWARDED, CANCELED, EXERCISED, VESTED, UNVESTED OR OUTSTANDING IN THE PARTICIPANTS FAVOR (COLLECTIVELY, “DATA”), FOR THE PURPOSE OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PLAN. THE PARTICIPANT UNDERSTANDS THAT DATA MAY BE TRANSFERRED TO ANY THIRD PARTIES ASSISTING IN THE IMPLEMENTATION, ADMINISTRATION AND MANAGEMENT OF THE PLAN, THAT THESE RECIPIENTS MAY BE LOCATED IN THE PARTICIPANTS COUNTRY OR ELSEWHERE, AND THAT THE RECIPIENTS COUNTRY MAY HAVE DIFFERENT DATA PRIVACY LAWS AND PROTECTIONS THAN THE PARTICIPANTS COUNTRY.

(C) THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY REQUEST A LIST WITH THE NAMES AND ADDRESSES OF ANY POTENTIAL RECIPIENTS OF THE DATA BY CONTACTING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT AUTHORIZES THE RECIPIENTS TO RECEIVE, POSSESS, USE, RETAIN AND TRANSFER THE DATA, IN ELECTRONIC OR OTHER FORM, FOR THE PURPOSES OF IMPLEMENTING, ADMINISTERING AND MANAGING THE PARTICIPANTS PARTICIPATION IN THE PLAN, INCLUDING ANY REQUISITE TRANSFER OF SUCH DATA AS MAY BE REQUIRED TO A BROKER OR OTHER THIRD PARTY WITH WHOM THE PARTICIPANT MAY ELECT TO DEPOSIT ANY SHARES ACQUIRED UPON SETTLEMENT OF THE AWARD. THE PARTICIPANT UNDERSTANDS THAT DATA WILL BE HELD ONLY AS LONG AS IS NECESSARY TO IMPLEMENT, ADMINISTER AND MANAGE THE PARTICIPANTS PARTICIPATION IN THE PLAN. THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY, AT ANY TIME, VIEW DATA, REQUEST ADDITIONAL INFORMATION ABOUT THE STORAGE AND PROCESSING OF DATA, REQUIRE ANY NECESSARY AMENDMENTS TO DATA OR REFUSE OR WITHDRAW THE CONSENTS HEREIN, IN ANY CASE WITHOUT COST, BY CONTACTING IN WRITING THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE. THE PARTICIPANT UNDERSTANDS, HOWEVER, THAT REFUSING OR WITHDRAWING THE PARTICIPANTS CONSENT MAY AFFECT THE PARTICIPANTS ABILITY TO PARTICIPATE IN THE PLAN. FOR MORE INFORMATION ON THE CONSEQUENCES OF THE PARTICIPANTS REFUSAL TO CONSENT OR WITHDRAWAL OF CONSENT, THE PARTICIPANT UNDERSTANDS THAT HE OR SHE MAY CONTACT THE PARTICIPANTS LOCAL HUMAN RESOURCES REPRESENTATIVE.

 

4


3. ADMINISTRATION.

All questions of interpretation concerning the Grant Notice, this Agreement, the Plan or any other form of agreement or other document employed by the Company in the administration of the Plan or the Award shall be determined by the Committee. All such determinations by the Committee shall be final, binding and conclusive upon all persons having an interest in the Award, unless fraudulent or made in bad faith. Any and all actions, decisions and determinations taken or made by the Committee in the exercise of its discretion pursuant to the Plan or the Award or other agreement thereunder (other than determining questions of interpretation pursuant to the preceding sentence) shall be final, binding and conclusive upon all persons having an interest in the Award. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation or election which is the responsibility of or which is allocated to the Company herein, provided that the Officer has actual authority with respect to such matter, right, obligation or election.

4. THE AWARD.

4.1 Grant of Units. The Company hereby grants to the Participant, subject to the provisions of this Agreement, the Total Number of the Units set forth in the Grant Notice, subject to adjustment as provided in Section 4.3 and Section 10. Subject to the terms and conditions set forth in the Grant Notice, this Agreement and the Plan, each Unit represents a right to receive on a date determined in accordance with the Grant Notice and this Agreement one (1) share of Stock.

4.2 No Monetary Payment Required. The Participant is not required to make any monetary payment (other than applicable tax withholding, if any) as a condition to receiving the Units or shares of Stock issued upon settlement of the Units.

4.3 Dividend Equivalent Units. On the date that the Company pays a cash dividend to holders of Stock generally, the Participant shall be credited with a number of additional whole Dividend Equivalent Units determined by dividing (a) the product of (i) the dollar amount of the cash dividend paid per share of Stock on such date and (ii) the total number of the Units and Dividend Equivalent Units previously credited to the Participant pursuant to the Award and which have not been settled or forfeited pursuant to Section 6 below as of such date, by (b) the Fair Market Value per share of Stock on such date. Any resulting fractional Dividend Equivalent Unit shall be rounded to the nearest whole number. Such additional Dividend Equivalent Units shall be subject to the same terms and conditions and shall be settled or forfeited in the same manner and at the same time as the Units originally subject to the Award with respect to which they have been credited.

 

5


5. VESTING OF UNITS.

Units acquired pursuant to this Agreement shall become Vested Units as provided in the Grant Notice. Dividend Equivalent Units shall become Vested Units at the same time as the Units originally subject to the Award with respect to which they have been credited.

6. FORFEITURE OF UNITS.

In the event that the Participant’s Service is terminated by the Service Recipient for Cause, insofar as permitted under Local Law the Participant shall forfeit, and the Company shall automatically reacquire, all Units (whether vested or unvested), and the Participant shall not be entitled to any payment therefor.

7. SETTLEMENT OF THE AWARD.

7.1 Issuance of Shares of Stock. Subject to the provisions of Section 7.3, as soon as reasonably practicable following the date upon which Units vest (such date, the “Settlement Date”)(but in no event later than March 15th of the calendar year following the calendar year in which such vesting occurs), the Company shall issue to the Participant with respect to each such Vested Unit one (1) share of Stock. Shares of Stock issued in settlement of Units shall not be subject to any restriction on transfer other than any such restriction as may be required pursuant to Section 7.3, Section 7 or the Company’s Securities Trading Policy or any stock ownership guidelines or holding period guidelines established by the Board from time to time.

7.2 Beneficial Ownership of Shares; Certificate Registration. The Participant hereby authorizes the Company, in its sole discretion, to deposit any or all shares acquired by the Participant pursuant to the settlement of the Award with the Company’s transfer agent, including any successor transfer agent, to be held in book entry form, or to deposit such shares for the benefit of the Participant with any broker with which the Participant has an account relationship of which the Company has notice. Except as provided by the foregoing, a certificate for the shares acquired by the Participant shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant.

7.3 Restrictions on Grant of the Award and Issuance of Shares. The grant of the Award and issuance of shares of Stock upon settlement of the Award shall be subject to compliance with all applicable requirements of United States federal, state law and Local Law with respect to such securities. No shares of Stock may be issued hereunder if the issuance of such shares would constitute a violation of any applicable United States federal, state or Local Law, or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, or the impracticality of doing so, deemed by the Company’s legal counsel to be necessary to the lawful issuance of any shares subject to the Award shall relieve the Company of any liability in respect of the failure to issue such shares as to which such requisite authority shall not have been obtained. As a condition to the settlement of the Award, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.

 

6


7.4 Fractional Shares. The Company shall not be required to issue fractional shares upon the settlement of the Award.

8. TAX WITHHOLDING.

Regardless of any action the Company or the Service Recipient takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), the Participant acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due or deemed legally due by the Participant is and remains the Participant’s responsibility and that the Company and the Service Recipient (i) make no representations nor undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this grant of Units, including the grant and vesting of Units, subsequent delivery of shares or cash related to such Units or the subsequent sale of any shares acquired pursuant to such Units and receipt of any dividend equivalent payments (if any) and (ii) do not commit to structure the terms or any aspect of this grant of Units to reduce or eliminate the Participant’s liability for Tax-Related Items.

The Participant shall satisfy Tax-Related Items by having the Company or the Service Recipient deduct from shares of Stock otherwise deliverable to the Participant in settlement of the Award a number of whole shares having a Fair Market Value not in excess of the amount of such Tax-Related Items determined by the maximum applicable statutory withholding rates. Notwithstanding the foregoing, the Committee may instead, upon notice to the Participant, require the Participant to pay the Company or the Service Recipient in cash any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold as a result of the Participant’s participation in the Plan or the Participant’s receipt of Units (including, without limitation, by the Service Recipient withholding such amounts from the Participant’s wages, which the Participant hereby authorizes). If the obligation for Tax-Related Items is satisfied by withholding a number of shares as described herein, the Participant understands that he or she will be deemed to have been issued the full number of shares subject to the settled Units, notwithstanding that a number of shares are held back solely for the purpose of paying Tax-Related Items due as a result of the settlement of the Units. Further, if the Participant is subject to tax in more than one jurisdiction, the Participant acknowledges that the Company and/or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

In the event that the amount of the withholding is greater than the amount of Tax-Related Items, the Company or the Service Recipient may refund the amount of the over-withholding to the Participant (with no entitlement to any Stock equivalent), or alternatively, the Company or the Service Recipient may require the Participant to seek a refund from the applicable tax authorities. In the event that the amount of the withholding is less than the amount of Tax-Related Items, the Participant may be required to pay the under-withheld Tax-Related Items to the Company and/or the Service Recipient or directly to the applicable tax authorities.

 

7


The Company may refuse to deliver the shares if the Participant fails to comply with the Participant’s obligations in connection with Tax-Related Items.

The Participant acknowledges and understands that the Participant should consult a tax advisor regarding the Participant’s tax obligations prior to such settlement or disposition.

9. EFFECT OF CHANGE IN CONTROL.

9.1 Change in Control. Upon the occurrence of a Change in Control during the Performance Period where a Replacement Award (as defined below) is provided to the Participant at the time of the Change in Control in lieu of the Units, the number of Units that remain outstanding and unvested following the Change in Control and eligible to vest solely based on the passage of time will be determined as of the date of the Change in Control in accordance with Exhibit A to the Grant Notice (the “CIC Eligible Units”) and the date of the Change in Control will serve as the last day of the Performance Period for purposes of such determination. Subject to the Participant’s continuous Service, the CIC Eligible Units will vest on the last day of the Performance Period. Upon the occurrence of a Change in Control where a Replacement Award is not provided to the Participant in lieu of the Units, the CIC Eligible Units will vest. In either case, all Units in excess of the CIC Eligible Units shall immediately be forfeited and cancelled, and Participant shall not be entitled to any compensation or other amount with respect thereto.

9.2 Replacement Award. A “Replacement Award” is an Award that (i) is the same (i.e., the Award continues, other than with respect to performance conditions as set forth in Section 9.1) or is of the same type as the Award that is replaced or adjusted by a Replacement Award (the “Replaced Award”) (i.e., restricted stock units); (ii) has a value at least equal to the value of the Replaced Award at the time of the Change in Control; (iii) is subject to the same vesting schedule as the Replaced Award; (iv) relates to equity securities of the Company or its successor upon the Change in Control, or a parent entity of the Company or its successor upon the Change in Control, which securities are subject to an effective registration statement under the Securities Act; (v) if the Participant is subject to U.S. federal income tax under the Code, the tax consequences to the Participant under the Code of the Replacement Award are not less favorable to the Participant than the tax consequences of the Replaced Award; and (vi) its other terms and conditions are not less favorable to the Participant than the terms and conditions of the Replaced Award (including, but not limited to, the provisions that would apply in the event of a subsequent Change in Control). Without limiting the generality of the foregoing, the Replacement Award may take the form of a continuation of the Replaced Award if the requirements of the preceding sentence are satisfied. The determination of whether the requirements for a Replacement Award are satisfied will be made by the Committee, as constituted immediately before the Change in Control, in its good faith discretion (taking into account the requirements of Treasury Regulation 1.409A-3(i)(5)(iv)(B) and compliance of the Replaced Award or Replacement Award with Section 409A).

 

8


10. ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE.

Subject to any required action by the stockholders of the Company and the requirements of Section 409A, to the extent applicable, in the event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy) that has a material effect on the Fair Market Value of shares of Stock, or any other corporate transaction or event having an effect similar to any of the foregoing, appropriate and proportionate adjustments shall be made in the number of Units subject to the Award and/or the number and kind of shares or other property to be issued in settlement of the Award, in order to prevent dilution or enlargement of the Participant’s rights under the Award. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any and all new, substituted or additional securities or other property (other than regular, periodic cash dividends paid on Stock pursuant to the Company’s dividend policy, which shall be treated in accordance with Section 4.3) to which the Participant is entitled by reason of ownership of Units acquired pursuant to this Award will be immediately subject to the provisions of this Award on the same basis as all Units originally acquired hereunder. Any fractional Unit or share resulting from an adjustment pursuant to this Section shall be rounded down to the nearest whole number. Such adjustments shall be determined by the Committee, and its determination shall be final, binding and conclusive.

11. RIGHTS AS A STOCKHOLDER, DIRECTOR, EMPLOYEE OR CONSULTANT.

The Participant shall have no rights as a stockholder with respect to any shares which may be issued in settlement of this Award until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date the shares are issued, except as provided in Section 4.3 and Section 10. If the Participant is an Employee, the Participant understands and acknowledges that, except as otherwise provided in a separate, written employment contract between the Service Recipient and the Participant, the Participant’s employment is “at will” and is for no specified term unless otherwise required under applicable law. Nothing in this Agreement shall confer upon the Participant any right to continue in the Service of the Service Recipient or interfere in any way with any right of the applicable Service Recipient to terminate the Participant’s Service at any time.

12. LEGENDS.

The Company may at any time place legends referencing any applicable United States federal, state or non-U.S. securities law, including Local Law, restrictions on all certificates representing shares of stock issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to this Award in the possession of the Participant in order to carry out the provisions of this Section.

 

9


13. MISCELLANEOUS PROVISIONS.

13.1 Termination or Amendment. The Committee may terminate or amend the Plan or this Agreement at any time; provided, however, that except as set forth in Section 9 in connection with a Change in Control or in Section 10, no such termination or amendment may adversely affect the Participant’s rights under this Agreement without the consent of the Participant unless such termination or amendment is necessary to comply with applicable law or government regulation. No amendment or addition to this Agreement shall be effective unless in writing.

13.2 Nontransferability of the Award. Prior to the issuance of shares of Stock on the applicable Settlement Date, neither this Award nor any Units subject to this Award shall be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. All rights with respect to the Award shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s guardian or legal representative.

13.3 Further Instruments. The parties hereto agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

13.4 Binding Effect. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer set forth herein, be binding upon the Participant and the Participant’s heirs, executors, administrators, successors and assigns.

13.5 Delivery of Documents and Notices. Any document relating to participation in the Plan or any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery at the e-mail address, if any, provided for the Participant by a Participating Company, or upon deposit in the U.S. Post Office or non-U.S. postal service, by registered or certified mail, or with a nationally recognized overnight courier service, with postage and fees prepaid, addressed to the other party at the address of such party set forth in the Grant Notice or at such other address as such party may designate in writing from time to time to the other party.

(a) Description of Electronic Delivery. The Plan documents, which may include but do not necessarily include the Plan, the Grant Notice, this Agreement, the Plan Prospectus and any reports of the Company provided generally to the Company’s stockholders, may be delivered to the Participant electronically. In addition, if permitted by the Company, the Participant may deliver electronically the Grant Notice to the Company or to such third party involved in administering the Plan as the Company may designate from time to time. Such means of electronic delivery may include but do not necessarily include the delivery of a link to a Company intranet or the Internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other means of electronic delivery specified by the Company.

 

10


(b) Consent to Electronic Delivery. The Participant acknowledges that the Participant has read Section 13.5(a) of this Agreement and consents to the electronic delivery of the Plan documents and, if permitted by the Company, the delivery of the Grant Notice, as described in Section 13.5(a). The Participant acknowledges that he or she may receive from the Company a paper copy of any documents delivered electronically at no cost to the Participant by contacting the Company by telephone or in writing. The Participant further acknowledges that the Participant will be provided with a paper copy of any documents if the attempted electronic delivery of such documents fails. Similarly, the Participant understands that the Participant must provide the Company or any designated third party administrator with a paper copy of any documents if the attempted electronic delivery of such documents fails. The Participant may revoke his or her consent to the electronic delivery of documents described in Section 13.5(a) or may change the electronic mail address to which such documents are to be delivered (if the Participant has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised e-mail address by telephone, postal service or electronic mail. Finally, the Participant understands that he or she is not required to consent to electronic delivery of documents described in Section 13.5(a).

13.6 Integrated Agreement. The Grant Notice (including its exhibits), this Agreement and the Plan shall constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to the subject matter contained herein or therein and supersede any prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter. To the extent contemplated herein or therein, the provisions of the Grant Notice, this Agreement and the Plan shall survive any settlement of the Award and shall remain in full force and effect.

13.7 Country-Specific Terms and Conditions. Notwithstanding any other provision of this Agreement to the contrary, the Award shall be subject to the additional terms and conditions, if any, set forth in the Appendix to this Agreement which are applicable to the Participant’s country, the provisions of which are incorporated in and constitute part of this Agreement. Moreover, if the Participant relocates to one of the countries included in the Appendix, the additional terms and conditions applicable to such country will apply to the Award to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan or this Agreement.

13.8 Applicable Law. This Agreement shall be governed by the laws of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties as evidenced by this Agreement, the parties hereby submit to and consent to the jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of the County of Santa Clara, California, or the federal courts of the United States for the Northern District of California, and no other courts, where this Agreement is made and/or performed.

 

11


13.9 Language. The Participant acknowledges that the Participant is sufficiently proficient in the English language, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the provisions in this Agreement and the Plan. Further, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.10 Insider Trading / Market Abuse Restrictions. The Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including, but not limited to, the U.S. and the Participant’s country of residence, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of shares or rights to shares (e.g., Units) or rights linked to the value of shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by applicable laws). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s Securities Trading Policy. The Participant is responsible for ensuring compliance with any applicable restrictions.

13.11 Foreign Asset and Account Reporting and Exchange Control Requirements. Certain foreign asset and foreign account reporting requirements and exchange controls may affect the Participant’s ability to acquire or hold shares under the Plan or cash received from participating in the Plan in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country through a designated bank or broker or within a certain time after receipt. The Participant is responsible for complying with any applicable regulations and should consult the Participant’s personal legal and tax advisors.

13.12 Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement by the Participant shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant.

13.13 Counterparts. The Grant Notice may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

13.14 Clawback. The Award will be subject to recoupment in accordance with the Company’s Clawback Policy or any other clawback or recoupment policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.

 

12


APPENDIX

ADDITIONAL TERMS AND CONDITIONS OF

MAGNACHIP SEMICONDUCTOR CORPORATION

RESTRICTED STOCK UNITS AGREEMENT

Capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan, the Grant Notice and the Agreement.

TERMS AND CONDITIONS

This Appendix includes additional terms and conditions that govern the Units granted to the Participant under the Plan if the Participant resides and/or works in one of the countries listed below. If the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the Company shall, in its discretion, determine to what extent the additional terms and conditions contained herein shall apply to the Participant.

NOTIFICATIONS

This Appendix may also include information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of April 2022. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix as the only source of information relating to the consequences of the Participant’s participation in the Plan because such information may be out-of-date when the Participant’s Units vest and/or the Participant sells any shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation. As a result, the Company is not in a position to assure the Participant of any particular result. The Participant is therefore advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident (or is deemed to be a citizen or resident for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant relocates to another country after the grant of the Units, the notifications contained herein may not apply to the Participant in the same manner.

Below please find additional terms and conditions, as well as notifications, that apply to Korea and the United States.

KOREA

Terms and Conditions

 

13


There are no country-specific terms and conditions.

Notifications

If the Participant receives and owns Stocks at the time of delivery through a foreign financial account (i.e., financial account outside of Korea) and the total balance of all accounts of the Participant exceed KRW500 million on any last day of each month during a year, the Participant is required to file a Foreign Financial Account Report in accordance with the Korean tax law.

UNITED STATES

Terms and Conditions for Participants subject to Tax in the United States

1. The following paragraph is inserted as a new Section 13.15 to the Agreement:

Section 409A of the U.S. Internal Revenue Code. To the extent applicable, it is intended that this Agreement comply with the provisions of Section 409A, so that the income inclusion provisions of Section 409A(a)(1) do not apply. This Agreement shall be administered in a manner consistent with this intent. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall any Participating Company or any of their respective Subsidiary Corporations or Affiliates be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A or otherwise. For purposes of this Agreement, “Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and will also include any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.”

Notifications

There are no country-specific notifications.

 

14

EX-10.7 8 d306034dex107.htm EX-10.7 EX-10.7

Exhibit 10.7

EXECUTION VERSION

SECOND AMENDMENT TO TERMINATION AND SETTLEMENT AGREEMENT

This Second Amendment to Termination and Settlement Agreement (this “Amendment”) is entered into as of August 5, 2022, by and among South Dearborn Limited, an exempted company incorporated in the Cayman Islands with limited liability (“Parent”), Magnachip Semiconductor Corporation, a Delaware corporation (the “Company”), and Wise Road Capital LTD (“Wise Road”). Each of Parent, Wise Road and the Company are sometimes referred to herein as a “Party”.

RECITALS

WHEREAS, Parent, Company and Michigan Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (the “Merger Sub”), previously entered into that certain Agreement and Plan of Merger, dated as of March 25, 2021 (“Merger Agreement”), pursuant to which Merger Sub was to merge with and into the Company with the Company surviving as a wholly-owned subsidiary of Parent, subject to the terms and conditions of the Merger Agreement;

WHEREAS, Parent, Merger Sub, the Company and Wise Road have entered into that certain Termination and Settlement Agreement (the “Agreement”), dated as of December 13, 2021 and amended pursuant to the First Amendment to Termination and Settlement Agreement, dated as of April 4, 2022, pursuant to which, among other things, the Merger Agreement was terminated on December 20, 2021 upon the Company’s receipt of the Parent Initial Fee and the Amended Standby Letter of Credit; and

WHEREAS, pursuant to Section 16 of the Agreement, the Parties, with the exception of Merger Sub, which was dissolved effective March 21, 2022, desire to mutually amend the Agreement as set forth herein.

NOW, THEREFORE, in consideration of the mutual covenants, agreements and understandings herein contained, the receipt and sufficiency of which are acknowledged, on the terms and subject to the conditions set forth in this Amendment, the parties, intending to be legally bound, agree as follows:

1. Section 2 of the Agreement titled “Parent Fees” is hereby amended and restated as follows:

“Promptly following the execution of this Agreement, and in any event no later than 5:00 p.m. Eastern time on December 15, 2021 (the “Parent Initial Fee Deadline”), and in consideration for the agreements made by the Company under this Agreement, Parent shall (and Wise Road shall cause Parent to) pay or cause to be paid $51,000,000 (the “Parent Initial Fee”) in cash by wire transfer of immediately available funds to the account designated by the Company prior to the date hereof. Promptly following the execution of the first amendment to this Agreement, and in any event no later than 5:00 p.m. Eastern time on April 4, 2022 (the “Parent Second Fee Deadline”), and in consideration for the agreements made by the Company under this Agreement, Parent shall (and Wise Road shall cause Parent to) pay or cause to be paid $14,400,000 (the “Parent Second Fee”) in cash by wire transfer of immediately available funds to the account designated by the Company. Promptly following the execution of the second amendment to this Agreement, and in any event no later than 5:00 p.m. Eastern time on August 5, 2022 (the “Parent Third Fee Deadline”), and in consideration for the agreements made by the Company under this Agreement, Parent shall (and Wise Road shall cause Parent to) pay or cause to be paid $3,000,000 (the “Parent Third Fee”) in cash by wire transfer of immediately available funds to the account designated by the Company. By no later than 5:00 p.m. Eastern time on October 31, 2022 (the “End Date”), Parent shall (and Wise Road shall cause Parent to) pay or cause to be paid $1,800,000 (the “Remaining Parent Fee”) in cash by wire transfer of immediately available funds to the account designated by the Company. None of the Parent Initial Fee, the Parent Second Fee, the Parent Third Fee or the Remaining Parent Fee shall be repayable or refundable under any circumstances. The Parties acknowledge and agree that, effective as of, and from and after, the Termination Effective Time, neither the Company Termination Fee nor the Parent Termination Fee shall be payable in connection with this Agreement, the Merger Agreement, the Termination or otherwise.”


2. Section 3 of the Agreement titled “Amended Standby Letter of Credit” is hereby amended and restated as follows:

“Promptly following the execution of this Agreement, and in any event no later than 5:00 p.m. Eastern time on December 22, 2021 (the “SBLC Deadline”), (a) the Parties shall cause the Standby Letter of Credit to be amended to provide that, on or any time after April 1, 2022, if Parent has not paid the Parent Second Fee to the Company by the Parent Second Fee Deadline, the Company may deliver a draw notice to the Issuing Bank and demand immediate payment of the full amount of the Parent Second Fee (which, for the avoidance of doubt, will not require any consent, instruction or other approval or acknowledgment from Parent or any of its Affiliates) (the “Amended Standby Letter of Credit”), and (b) Parent and Wise Road shall cause an original fully executed version of the Amended Standby Letter of Credit to be delivered to the Company or its designee. Promptly following the execution of the first amendment to this Agreement, and in any event immediately prior to the payment of the Parent Second Fee (the “Second SBLC Deadline”), (a) the Parties shall cause the Amended Standby Letter of Credit, dated as of December 20, 2021, to be amended to provide that, on or any time after June 30, 2022, if Parent has not paid the Parent Third Fee to the Company by the Parent Third Fee Deadline, the Company may deliver a draw notice to the Issuing Bank and demand immediate payment of the full amount of the Parent Third Fee (which, for the avoidance of doubt, will not require any consent, instruction or other approval or acknowledgment from Parent or any of its Affiliates) (the “Second Amended Standby Letter of Credit”), and (b) Parent and Wise Road shall cause an original fully executed version of the Second Amended Standby Letter of Credit to be delivered to the Company or its designee. Promptly following the execution of the second amendment to this Agreement, and in any event immediately prior to the payment of the Parent Third Fee (the “Third SBLC Deadline”), (a) the Parties shall cause the Second Amended Standby Letter of Credit, dated as of April 4, 2022, to be amended to provide that, on or any time after October 31, 2022, if Parent has not paid the Remaining Parent Fee to the Company by the End Date, the Company may deliver a draw notice to the Issuing Bank and demand immediate payment of the full amount of the Remaining Parent Fee (which, for the avoidance of doubt, will not require any consent, instruction or other approval or acknowledgment from Parent or any of its Affiliates) (the “Third Amended Standby Letter of Credit”), and (b) Parent and Wise Road shall cause an original fully executed version of the Third Amended Standby Letter of Credit to be delivered to the Company or its designee.”

3. All references herein and in the Agreement to the “Agreement” shall mean and include the Agreement as amended by this Amendment. Except as amended hereby, the Agreement shall remain unchanged, and the Agreement, as so amended, shall continue in full force and effect in accordance with its terms.

4. The provisions of this Amendment may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing specifically designated as a subsequent amendment to the Agreement, signed on behalf of each of the Parties. No Party may assign either this Amendment or any of its rights, interests, or obligations hereunder without the prior written approval of the other Parties. Subject to the preceding sentence, this Amendment shall be binding upon and shall inure to the benefit of the Parties and their respective successors and permitted assigns. This Amendment and any dispute, claim, legal action, suit, proceeding or controversy arising out of or relating hereto, shall be governed by, and construed in accordance with, the Law of the State of Delaware, without regard to conflict of law principles (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware.

5. Each Party represents and warrants to the other Parties that: (i) such Party has all requisite power and authority to enter into this Amendment and to take the actions contemplated hereby; (ii) the execution and delivery of this Amendment and the actions contemplated hereby have been duly authorized by all necessary corporate or other action on the part of such Party; and (iii) this Amendment has been duly executed and delivered by such Party and, assuming the due authorization, execution and delivery by the other Parties, constitutes a legal, valid and binding obligation of such, enforceable against such Party in accordance with its terms, subject to the Enforceability Exceptions.

 

2


6. This Amendment may be executed in any number of counterparts, as if the signatures to each counterpart were upon a single instrument, and all such counterparts together shall be deemed an original of this Amendment. Facsimile signatures or signatures received as a pdf attachment to electronic mail shall be treated as original signatures for all purposes of this Amendment. This Amendment shall become effective when, and only when, each Party shall have received a counterpart signed by all of the other Parties.

7. Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed thereto in the Agreement.

[Remainder of page intentionally left blank.]

 

3


IN WITNESS WHEREOF, this Amendment has been duly executed and delivered by the duly authorized officers of the Parties as of the date first written above.

 

SOUTH DEARBORN LIMITED
By:  

/s/ Yuanjie Zhang

        Name: Yuanjie Zhang
        Title: Director
WISE ROAD CAPITAL LTD
By:  

/s/ Yuanjie Zhang

        Name: Yuanjie Zhang
        Title: Director


IN WITNESS WHEREOF, this Amendment has been duly executed and delivered by the duly authorized officers of the Parties as of the date first written above.

 

MAGNACHIP SEMICONDUCTOR CORPORATION
By:  

/s/ Theodore S. Kim

  Name: Theodore S. Kim
 

Title:   Chief Compliance Officer, General Counsel and Secretary

EX-10.8 9 d306034dex108.htm EX-10.8 EX-10.8

Exhibit 10.8

[***]

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

MagnaChip/Infineon Confidential    

PATENT CROSS-LICENSE AGREEMENT

This Patent Cross-License Agreement (“AGREEMENT”) is entered into on June 15, 2017 (“EFFECTIVE DATE”) by and between Infineon Technologies AG (“INFINEON”), a corporation duly incorporated under the laws of Germany having its principal offices at Am Campeon 1-12, 85579 Neubiberg, Germany, and MagnaChip Semiconductor, Ltd. (“MAGNACHIP”), a company duly organized under the laws of Korea, having its principal offices at 424, Teheran-ro, Gangnam-gu, Seoul 135-738, Republic of Korea (INFINEON and MAGNACHIP hereinafter collectively referred to as the “PARTIES” and individually as a “PARTY”).

Preamble

WHEREAS, each of the PARTIES desires to acquire for itself and its AFFILIATES (as “LICENSEE”) a non-exclusive license under patents of the other PARTY and its AFFILIATES (as “LICENSOR”);

WHEREAS, each of the PARTIES is engaged in semiconductor business;

WHEREAS, each of the PARTIES is willing to enhance its capability in research and development and other necessary functions as a semiconductor company; and

NOW THEREFORE, INFINEON and MAGNACHIP agree as follows:

 

1.

Definitions

 

1.1

“ACQUIRED ENTITY” shall have the meaning ascribed to it in Section 6.1.

 

1.2

“ACQUIRED PARTY” shall have the meaning ascribed to it in Section 6.2.

 

1.3

“ACQUIRING ENTITY” shall have the meaning ascribed to it in Section 6.2.

 

1.4

“ACQUIRING PARTY” shall have the meaning ascribed to it in Section 6.1.

 

1.5

“AFFILIATE” shall mean, with respect to any PERSON, any other PERSON that directly, or indirectly through one or more intermediaries, CONTROLS, is CONTROLLED by or is under common CONTROL with, such first PERSON, provided that such other PERSON shall be deemed to be an AFFILIATE only so long as such CONTROL exists. For these purposes, “CONTROL” shall mean that more than 50% of the controlled PERSON’s outstanding shares or ownership interests representing the right to make decisions for that PERSON are owned or controlled directly or indirectly by the controlling PERSON. Notwithstanding the foregoing, [***] shall not be regarded as an AFFILIATE of INFINEON.

 

Infineon – MagnaChip Confidential    Page 1 of 20


[***]

 

1.6

“AGREEMENT” shall have the meaning ascribed to it on page 1 of this AGREEMENT.

 

1.7

“BALANCING PAYMENTS” shall have the meaning ascribed to it in Section 4.1.1.

 

1.8

“COMPETITOR” shall mean, with respect to a PARTY, any PERSON that engages, as of the date of the closing of the transaction contemplated by Section 6.2 or 6.3, in a business that competes with the LICENSED PRODUCTS of such PARTY.

 

1.9

“DISCRETE POWER MOSFET PRODUCT” shall mean [***].

 

1.10

“EFFECTIVE DATE” shall have the meaning ascribed to it on page 1 of this AGREEMENT.

 

1.11

“IGBT DISCRETE PRODUCT” shall mean [***].

 

1.12

“INFINEON LICENSED PATENTS” shall mean:

 

  (a)

all classes or types of patents, utility models and design patents, including applications therefor, in all countries of the world, which are issued or published, or filed prior to (and including) December 31, 2020, including continuations, divisionals, reissues and other pre-grant and post-grant applications and issuances and foreign counterparts thereof; and

 

  (b)

under which patents, utility models or design patents (including applications therefor) INFINEON or any of its AFFILIATES has, during the TERM, the right to grant licenses of or within the scope granted herein without such grant or the exercise of rights thereunder resulting in the payment of royalties or other consideration by INFINEON or its AFFILIATES to THIRD PARTIES (except for payments among INFINEON and its AFFILIATES, and payments to employees of INFINEON or any of its AFFILIATES or to THIRD PARTIES for inventions made by said THIRD PARTIES while employed or otherwise engaged by INFINEON or any of its AFFILIATES).

 

1.13

“INFINEON LICENSED PRODUCTS” shall mean [***].

 

1.14

“LICENSED PATENTS” shall mean INFINEON LICENSED PATENTS or MAGNACHIP LICENSED PATENTS, as applicable.

 

1.15

“LICENSED PRODUCTS” shall mean INFINEON LICENSED PRODUCTS or MAGNACHIP LICENSED PRODUCTS, as applicable.

 

1.16

“LICENSEE” shall have the meaning ascribed to it on page 1 of this AGREEMENT.

 

1.17

“LICENSOR” shall have the meaning ascribed to it on page 1 of this AGREEMENT.

 

1.18

“MAGNACHIP LICENSED PATENTS” shall mean:

 

Infineon – MagnaChip Confidential    Page 2 of 20


[***]

 

  (a)

all classes or types of patents, utility models and design patents, including applications therefor, in all countries of the world, which are issued or published, or filed prior to (and including) December 31, 2020, including continuations, divisionals, reissues and other pre-grant and post-grant applications and issuances and foreign counterparts thereof; and

 

  (b)

under which patents, utility models or design patents (including applications therefor) MAGNACHIP or any of its AFFILIATES has, during the TERM, the right to grant licenses of or within the scope granted herein without such grant or the exercise of rights thereunder resulting in the payment of royalties or other consideration by MAGNACHIP or its AFFILIATES to THIRD PARTIES (except for payments among MAGNACHIP and its AFFILIATES, and payments to employees of MAGNACHIP or any of its AFFILIATES or to THIRD PARTIES for inventions made by said THIRD PARTIES while employed or otherwise engaged by MAGNACHIP or any of its AFFILIATES).

 

1.19

“MAGNACHIP LICENSED PRODUCTS” shall mean any DISCRETE POWER MOSFET PRODUCTS with identification numbers or codes assigned thereto and any individual IGBT DISCRETE PRODUCTS with identification numbers or codes assigned thereto, in each case first sold at production volume prior to (and including) December 31, 2020 which (i) are designed or developed by or for MAGNACHIP and/or any of its AFFILIATES (either solely or jointly with one or more THIRD PARTIES), or of which designs are licensed or acquired by MAGNACHIP and/or any of its AFFILIATES and (ii) if marketed, are marketed by MAGNACHIP and/or any of its AFFILIATES under its own name as its own product.

 

1.20

“MAGNACHIP POWER BUSINESS LINE” shall mean MAGNACHIP’s business line consisting of the design, marketing and sale of any and all power solutions products, where the term “power solutions” has the meaning generally understood in the global semiconductor industry. As of the EFFECTIVE DATE, the MAGNACHIP POWER BUSINESS LINE includes certain discrete and integrated circuit solutions for power management in consumer, communication and industrial applications — namely, power converters, discrete IGBTs, MOSFETs (low voltage, mid voltage, high voltage and superjunction) and power modules. Without limiting the foregoing, in the event that MAGNACHIP designs, markets and sells any other power solutions products now or anytime during the TERM, such products shall be deemed to be a part of the MAGNACHIP POWER BUSINESS LINE.

 

1.21

“MX” shall mean MagnaChip Semiconductor Corporation, a corporation duly incorporated under the laws of the State of Delaware, U.S.A.

 

1.22

“PERSON” shall mean an individual, corporation, partnership, limited liability company, limited liability partnership, syndicate, person, trust, association, organization or other entity, including any successor, by merger or otherwise, of any of the foregoing.

 

1.23

“PRIOR LICENSE AGREEMENT” shall have the meaning ascribed to it in Section 6.1.

 

Infineon – MagnaChip Confidential    Page 3 of 20


[***]

 

1.24

“RECIPIENT” shall have the meaning ascribed to it in Section 6.3.

 

1.25

“RECIPIENT LICENSED PATENTS” shall mean:

 

  (a)

all classes or types of patents, utility models and design patents, including applications therefor, in all countries of the world, which are issued or published, or filed prior to (and including) December 31, 2020, including continuations, divisionals, reissues and other pre-grant and post-grant applications and issuances and foreign counterparts thereof; and

 

  (b)

under which patents, utility models or design patents (including applications therefor) RECIPIENT or any of its AFFILIATES has, during the TERM, the right to grant licenses of or within the scope granted herein without such grant or the exercise of rights thereunder resulting in the payment of royalties or other consideration by RECIPIENT or its AFFILIATES to THIRD PARTIES (except for payments among RECIPIENT and its AFFILIATES, and payments to employees of RECIPIENT or any of its AFFILIATES or to THIRD PARTIES for inventions made by said THIRD PARTIES while employed or otherwise engaged by RECIPIENT or any of its AFFILIATES).

 

1.26

“SUBSIDIARY” of a PERSON shall mean a corporation, company or other entity:

 

  (a)

more than fifty percent (50%) of whose outstanding shares or securities (representing the right to vote for the election of directors or other managing authority) are, now or hereafter, owned or controlled, directly or indirectly, by such PERSON, but such corporation, company or other entity shall be deemed to be a SUBSIDIARY only so long as such ownership or control exists; or

 

  (b)

which does not have outstanding shares or securities, as may be the case in a partnership, joint venture or unincorporated association, but more than fifty percent (50%) of whose ownership interest representing the right to make the decisions for such corporation, company or other entity is now or hereafter, owned or controlled, directly or indirectly, by such PERSON, but such corporation, company or other entity shall be deemed to be a SUBSIDIARY only so long as such ownership or control exists.

Notwithstanding the foregoing, [***] shall not be regarded as a SUBSIDIARY of INFINEON.

 

1.27

“TERM” shall have the meaning ascribed to it in Section 5.1.

 

1.28

“THIRD PARTY” shall mean a PERSON other than a PARTY, a PARTY’S AFFILIATE or a PARTY’S SUBSIDIARY.

 

1.29

“THIRD PARTY MANUFACTURER” shall mean a manufacturer that is a THIRD PARTY, subject to the conditions set forth in Section 2.3.

 

1.30

“TRANSFERRING PARTY” shall have the meaning ascribed to it in Section 6.3.

 

Infineon – MagnaChip Confidential    Page 4 of 20


[***]

 

2.

License Grants

 

2.1

INFINEON, as LICENSOR, hereby grants and shall cause its AFFILIATES to grant to MAGNACHIP, as LICENSEE, a non-exclusive, non-transferable (except in accordance with Section 7.2), worldwide license, without the right to sublicense (except to its AFFILIATES in accordance with Section 2.5), under INFINEON LICENSED PATENTS:

 

  (a)

to make (including the right to use any apparatus and practice any method in making, including without limitation design, test, assemble etc.), use, import, offer for sale, lease, license, sell and/or otherwise dispose of MAGNACHIP LICENSED PRODUCTS; and

 

  (b)

to have MAGNACHIP LICENSED PRODUCTS made by a THIRD PARTY MANUFACTURER for the use, importation, offer for sale, lease, sale and/or other disposition of such LICENSED PRODUCTS by MAGNACHIP subject to the conditions set forth in Section 2.3.

 

2.2

MAGNACHIP, as LICENSOR, hereby grants and shall cause its AFFILIATES to grant to INFINEON, as LICENSEE, a non-exclusive, non-transferable (except in accordance with Section 7.2), worldwide license, without the right to sublicense (except to its AFFILIATES in accordance with Section 2.5), under MAGNACHIP LICENSED PATENTS:

 

  (a)

to make (including the right to use any apparatus and practice any method in making, including without limitation design, test, assemble etc.), use, import, offer for sale, lease, license, sell and/or otherwise dispose of INFINEON LICENSED PRODUCTS; and

 

  (b)

to have INFINEON LICENSED PRODUCTS made by THIRD PARTY MANUFACTURER for the use, importation, offer for sale, lease, sale and/or other disposition of such LICENSED PRODUCTS by INFINEON subject to the conditions set forth in Section 2.3.

 

2.3

The licenses granted in Section 2.1(b) and 2.2(b) to have LICENSED PRODUCTS made by a THIRD PARTY MANUFACTURER:

 

  (a)

shall only apply to such LICENSED PRODUCTS manufactured by such THIRD PARTY MANUFACTURER for LICENSEE after the EFFECTIVE DATE;

 

  (b)

shall only apply to LICENSED PRODUCTS or portions thereof for which the specifications were created by LICENSEE (either solely or jointly with one or more THIRD PARTIES) or for LICENSEE or by or for LICENSEE’S predecessor (including specifications licensed or acquired by LICENSEE or LICENSEE’S predecessor from THIRD PARTIES);

 

  (c)

shall only be granted under claims of LICENSED PATENTS, the infringement of which would be necessary in order to comply with such specifications;

 

Infineon – MagnaChip Confidential    Page 5 of 20


[***]

 

  (d)

shall not apply to any apparatus or methods when used or practiced by said THIRD PARTY MANUFACTURER for the manufacture of products other than LICENSED PRODUCTS;

 

  (e)

shall not include the right to resell LICENSED PRODUCTS to the THIRD PARTY MANUFACTURER for the purpose of further resale by the THIRD PARTY MANUFACTURER under its own name, trade mark or logo to THIRD PARTIES; and

 

  (f)

shall not apply to the manufacture or assembly by the THIRD PARTY MANUFACTURER of a standard, off-the shelf product of the THIRD PARTY MANUFACTURER, originally designed or developed by or for the THIRD PARTY MANUFACTURER and to which only minor revisions are made to conform to the specifications of the LICENSED PRODUCT.

For the avoidance of doubt, the licenses granted in Section 2.1(b) and 2.2(b) to have LICENSED PRODUCTS made by a THIRD PARTY MANUFACTURER shall not extend to the manufacturing process employed by the THIRD PARTY for manufacture of LICENSED PRODUCTS, except to the extent that the manufacturing process has been licensed or provided to the THIRD PARTY MANUFACTURER by LICENSEE.

Notwithstanding the foregoing, with respect to the manufacturing process employed by the THIRD PARTY MANUFACTURER, each PARTY agrees not to assert its rights under the LICENSED PATENTS against the other PARTY and/or its AFFILIATES and/or their customers to the extent the other PARTY would be licensed under this AGREEMENT if the manufacturing process had been provided by the other PARTY; provided, however, that each PARTY reserves the right to assert its rights against the THIRD PARTY MANUFACTURER or any other THIRD PARTY.

In response to a written request identifying a LICENSED PRODUCT and a THIRD PARTY MANUFACTURER, LICENSEE shall in a timely manner inform LICENSOR whether such LICENSED PRODUCT is manufactured by such THIRD PARTY MANUFACTURER pursuant to the license granted in Section 2.1(b) or 2.2(b).

 

2.4

It is the intent of the PARTIES that a PARTY is not subject to claims of indirect infringement (under 35 U.S.C. 271(b) and (c)) of any LICENSED PATENT of the other PARTY (“INDIRECT INFRINGEMENT”) arising from any activity that is authorized under the licenses granted to such PARTY under this AGREEMENT; provided that (a) nothing in this Section 2.4 will be deemed to constitute or give rise to any right of any THIRD PARTY by way of exhaustion or otherwise, and (b) an assertion of claims of infringement against any THIRD PARTY is not an assertion of INDIRECT INFRINGEMENT against the other PARTY for purposes of this Section 2.4. Each PARTY agrees that it will not in any event advocate or advise that this Section 2.4 constitutes or gives rise to any right of any THIRD PARTY by way of exhaustion or otherwise.

 

Infineon – MagnaChip Confidential    Page 6 of 20


[***]

 

The PARTIES agree that a PARTY has the right to sue a THIRD PARTY for patent infringement where such infringement arises from a combination of LICENSED PRODUCT with any other products or from the interaction/relationship between the LICENSED PRODUCT and such other products, but such PARTY shall not sue such THIRD PARTY for patent infringement solely based on the other PARTY’s LICENSED PRODUCT. By way of example and for the avoidance of any doubt regarding the effect of patent exhaustion, if MAGNACHIP’s customer (a THIRD PARTY) purchases a discrete power MOSFET product constituting a LICENSED PRODUCT from MAGNACHIP and incorporates such product into its TV device, which naturally includes many other semiconductor components and materials, then INFINEON shall have the right to sue such customer for patent infringement based on such other semiconductor components or materials or based on the interaction/relationship between the LICENSED PRODUCT and such other semiconductor components or materials, but not based solely on the LICENSED PRODUCT that the customer purchased from MAGNACHIP.

Nothing contained in this AGREEMENT shall be construed as conferring any rights by implication, estoppels or otherwise, under any non-patent intellectual property right, or any patents, patent applications, utility models or utility model applications, other than the LICENSED PATENTS. Neither PARTY is required hereunder to furnish or disclose to the other any technical or other information (including copies of LICENSED PATENTS) except as specifically provided herein.

In the event that neither a PARTY nor any of its AFFILIATES has the right to grant a license of the scope set forth in Section 2 under any particular LICENSED PATENT, then the license granted herein under said LICENSED PATENT shall be of the broadest scope which said PARTY or any of its AFFILIATES has the right to grant within the scope set forth above.

 

2.5

The licenses granted herein include the right of each PARTY to grant sublicenses to its AFFILIATES existing on or after the EFFECTIVE DATE, which sublicenses may include the right of the sublicensed AFFILIATES to grant sublicenses to other AFFILIATES. No sublicense shall be broader in any respect at any time during the TERM than the license held at that time by the PARTY that granted the sublicense.

Except as otherwise provided in Section 6, a sublicense granted to an AFFILIATE shall terminate on the earlier of:

 

  (a)

the date on which such AFFILIATE ceases to be an AFFILIATE of a PARTY hereto; and

 

  (b)

the date of termination or expiration of the license to the PARTY or AFFILIATE that granted the sublicense.

If an AFFILIATE ceases to be an AFFILIATE and holds any LICENSED PATENTS under which a PARTY hereto is licensed, such license shall continue for the TERM.

 

Infineon – MagnaChip Confidential    Page 7 of 20


[***]

 

3.

Releases and Non-Assertion Covenants

 

3.1

MAGNACHIP and its AFFILIATES hereby release, acquit and forever discharge INFINEON, its AFFILIATES, directors, officers, employees, successors, customers, THIRD PARTY MANUFACTURERS and end users in any country, for any time prior to the EFFECTIVE DATE, from any and all claims or liability for acts of infringement or alleged infringement of any of MAGNACHIP LICENSED PATENTS under which a license is herein granted by MAGNACHIP and which, if performed after the EFFECTIVE DATE, would have been licensed pursuant to the terms of this AGREEMENT.

 

3.2

Upon INFINEON’S receipt in full of BALANCING PAYMENT NO. 1 and BALANCING PAYMENT NO. 2, INFINEON and its AFFILIATES hereby, automatically and without further action being required, release, acquit and forever discharge MAGNACHIP, its AFFILIATES, directors, officers, employees, successors, customers, THIRD PARTY MANUFACTURERS and end users in any country, for any time prior to the EFFECTIVE DATE, from any and all claims or liability for acts of infringement or alleged infringement of any of INFINEON LICENSED PATENTS under which a license is herein granted by INFINEON and which, if performed after the EFFECTIVE DATE, would have been licensed pursuant to the terms of this AGREEMENT. Prior to INFINEON’S receipt in full of BALANCING PAYMENT NO. 1 and BALANCING PAYMENT NO. 2, no release will be understood to have been granted by INFINEON.

 

3.3

Subject to Section 5.4 and until the release set forth in Section 3.2 becomes effective, INFINEON and its AFFILIATES hereby covenant not to file against MAGNACHIP, its AFFILIATES, directors, officers, employees, successors, customers, THIRD PARTY MANUFACTURERS and/or end users any suit for infringement of any INFINEON LICENSED PATENTS under which a license is herein granted by INFINEON and which, if performed after the EFFECTIVE DATE, would have been licensed pursuant to the terms of this AGREEMENT.

 

3.4

The releases and non-assertion covenants contained herein shall not apply to any person other than the persons named in this Section 3 and shall not apply to the manufacture of any items by any person other than the PARTIES and their AFFILIATES and their respective THIRD PARTY MANUFACTURERS. The releases granted herein are effective immediately upon receipt of the payment due, if any, under Section 4.

 

4.

Payments

 

4.1

MAGNACHIP shall make the following payments to INFINEON in accordance with the following provisions:

 

4.1.1

Balancing Payments

In consideration for the license granted by each PARTY and its AFFILIATES pursuant to this AGREEMENT and the releases set forth in Section 3, MAGNACHIP shall pay to INFINEON in accordance with the agreed upon payment schedule as set forth in Annex 1 a sum of [***] (collectively, the “BALANCING PAYMENTS”).

 

Infineon – MagnaChip Confidential    Page 8 of 20


[***]

 

For each BALANCING PAYMENT installment as set forth in Annex 1, INFINEON will issue a corresponding invoice, and payments shall be made not later than (i) fifteen (15) calendar days following the receipt by MAGNACHIP of the respective invoice or (ii) the respective due date, whichever is later.

 

4.1.2

For the avoidance of doubt, no payment is to be made by INFINEON or its AFFILIATES to MAGNACHIP or its AFFILIATES with respect to the licenses and other rights granted by MAGNACHIP or its AFFILIATES to INFINEON and its AFFILIATES; provided that the foregoing shall not have any effect on any obligation that may arise under this AGREEMENT whereby INFINEON is required to make an adjustment payment or a refund payment to MAGNACHIP, including pursuant to Section 6.2.

 

4.2

MAGNACHIP shall be liable for interest on any overdue payment required to be made pursuant to this Section 4, commencing on the date such payment becomes due, at an annual rate of ten percent (10%). If such interest rate exceeds the maximum permissible legal rate in the jurisdiction where a claim therefor is being asserted, the interest rate shall be reduced to such maximum permissible legal rate.

 

4.3

Payments shall be made in US Dollars by electronic funds transfer and shall be deemed to be made on the date credited to the following account of INFINEON:

 

Bank    [***]
Account No.    [***]
Swift Code    [***]
IBAN    [***]

 

4.4

With the exception of value added tax (hereinafter “VAT”) and similar taxes (if any), all taxes, customs duties and other charges imposed by governmental authorities on INFINEON with respect to any payments to be made by MAGNACHIP under or in connection with this AGREEMENT (hereinafter “TAXES”) shall be the responsibility of INFINEON. All fees and charges hereunder shall include all TAXES.

All fees and charges (amounts) specified in accordance with this AGREEMENT shall be net of any VAT, sales tax, goods and service tax, business taxes or similar taxes thereon. Insofar as the license grants agreed upon under this AGREEMENT are subject to VAT or similar taxes, such VAT / similar taxes shall – to the extent they are not owed to the competent tax authority by the respective Licensee under a reverse charge mechanism/for an intra-community acquisition (or any similar provision under the applicable tax laws) – be paid by the respective Licensee in addition to the agreed amounts. The respective Licensor is obliged to render proper invoices within the meaning of the applicable tax law.

Notwithstanding the foregoing, the PARTIES acknowledge that for VAT purposes INFINEON supplies its service to a place of business of MAGNACHIP outside of Germany (that is, cross-border supply of services) and does not have to charge German VAT, MAGNACHIP will inform INFINEON in writing if a permanent establishment is to be established in Germany to which INFINEON’s service is to be rendered. In the event

 

Infineon – MagnaChip Confidential    Page 9 of 20


[***]

 

  that the PARTIES determine jointly that the place of supply (from INFINEON to MAGNACHIP) has changed to a German place of business and that INFINEON has to charge German VAT at statutory rates, then MAGNACHIP shall bear the cost of such German VAT, provided that INFINEON issues to MAGNACHIP on a timely basis an invoice that complies with the requirements of sec. 14, para. 4 of the German VAT Act (Umsatzsteuergesetz). The same applies in case the German tax authorities assess such German VAT on the grounds that MAGNACHIP has a permanent establishment in Germany. If MAGNACHIP fails to timely inform INFINEON about establishing a permanent establishment in Germany, MAGNACHIP holds INFINEON harmless of any damages, fines or penalties assessed against INFINEON as a result of MAGNACHIP having a permanent establishment in Germany.

All amounts due under this AGREEMENT shall be paid without deduction for income taxes. If withholdings of whatever nature are due on payments to be made by any LICENSEE or LICENSOR, then the PARTIES shall cooperate to achieve, if possible, a partial or complete exemption from the withholding obligation and to make the withholding at the lowest possible rate. Should a withholding obligation nevertheless exist, LICENSEE shall make the necessary gross-up payments to leave LICENSOR (after the deduction of the withholding tax) with an amount equal to the payment which would have been due had no withholding tax deduction been required. Gross-up payment for the tax to be withheld by LICENSEE shall not be made (i) if and to the extent LICENSOR may claim a credit in its own tax jurisdiction and (ii) if and to the extent LICENSOR may claim a refund of the tax withheld in the jurisdiction of the LICENSEE. In this event, LICENSEE shall promptly furnish receipts and other documents evidencing the payment of such withholding taxes.

Each PARTY shall be responsible for any and all taxes payable to any local, autonomous, state and/or national governments on its LICENSED PRODUCTS manufactured, imported, exported, distributed, marketed, promoted, advertised and/or sold, and the PARTIES shall reasonably cooperate with each other in obtaining exemption from withholding taxes where available under applicable law.

 

5.

Term and Termination

 

5.1

This AGREEMENT shall become effective as of the EFFECTIVE DATE and shall continue in effect until December 31, 2021 (the “TERM”). Unless this AGREEMENT is terminated before the end of TERM pursuant to Section 5.2, 5.3 or 5.4, at the request of a PARTY the PARTIES shall in good faith, commence discussing a renewal at least two (2) months prior to the end of TERM, including the consideration for renewal and the adjustment of the scope of LICENSED PRODUCTS under this AGREEMENT.

 

5.2

If, during the TERM, a PARTY or any of its AFFILIATES files any suit for infringement of any LICENSED PATENTS against the other PARTY or any of its AFFILIATES with regard to any product which is not a LICENSED PRODUCT (such PARTY hereinafter referred to as “ASSERTING PARTY”), the other PARTY shall have the right to terminate the ASSERTING PARTY’s and its AFFILIATES’ rights and licenses granted pursuant to this AGREEMENT with immediate effect. Should the other PARTY exercise this right: (i)

 

Infineon – MagnaChip Confidential    Page 10 of 20


[***]

 

  the other PARTY’s obligations (including without limitation any payment obligations) set forth in this AGREEMENT shall likewise terminate with immediate effect; and (ii) the licenses granted to the other PARTY under this AGREEMENT shall survive for the TERM, and the ASSERTING PARTY’s obligations (including without limitation any payment obligations) set forth in this AGREEMENT shall likewise survive for the TERM. The terms and conditions of this AGREEMENT shall be otherwise unaffected.

If MAGNACHIP is the ASSERTING PARTY and INFINEON terminates MAGNACHIP’s and its AFFILIATES’ rights and licenses granted pursuant to this AGREEMENT, all BALANCING PAYMENTS as set forth in Annex 1 shall automatically become due and payable in full on the effective date of such termination.

In the event of a PARTY being acquired by a THIRD PARTY pursuant to Section 6.2, the other PARTY shall have the right to terminate this Section 5.2 with immediate effect by giving written notice to the ACQUIRED PARTY within ninety (90) calendar days from receiving written notice of such acquisition.

 

5.3

Either PARTY may terminate this AGREEMENT with immediate effect by giving written notice to the other PARTY if such other PARTY: (a) becomes insolvent or makes an assignment for the benefit of creditors, or attempts to effect a composition with creditors; (b) suspends normal business operations; or (c) files a petition for bankruptcy, insolvency or reorganization, or for the appointment of a receiver, trustee or custodian for any creditor or its property (or any substantial portion thereof), or any similar petition or commencement of any similar action under applicable law, or has such a petition filed or proceeding commenced against it and such a petition filed or proceeding commenced against it is not dismissed within sixty (60) calendar days.

 

5.4

If any BALANCING PAYMENT is not made in full on or prior to the applicable due date, then INFINEON may terminate this AGREEMENT by providing written notice to MAGNACHIP; provided, however, that such written notice shall include sufficient details to inform MAGNACHIP as to the reason for the termination notice, including the amount due; and provided further that, MAGNACHIP shall have thirty (30) calendar days from receipt of such notice to cure its non-payment. If MAGNACHIP fails to make the required payment within such 30-day period, then INFINEON’s termination notice shall become effective immediately upon expiration of such 30-day period. In the event of termination by INFINEON pursuant to this Section 5.4, the licenses and rights granted hereunder to INFINEON shall remain unaffected for the duration of the TERM.

 

5.5

If INFINEON terminates this AGREEMENT pursuant to Section 5.3 or 5.4, BALANCING PAYMENT NO. 1, and BALANCING PAYMENT NO. 2, to the extent not already paid, and any other BALANCING PAYMENT that is due but unpaid, shall automatically become due and payable in full on the effective date of such termination.

 

5.6

The releases given to each PARTY pursuant to Section 3 of this AGREEMENT shall, once granted, be irrevocable and shall not be affected by the expiration or termination of this AGREEMENT. Sections 1, 3 and 7 shall survive the expiration or termination of this AGREEMENT.

 

Infineon – MagnaChip Confidential    Page 11 of 20


[***]

 

6.

Acquisition; Transfer; Spin-off

 

6.1

A PARTY acquiring a THIRD PARTY

If, after the EFFECTIVE DATE, a PARTY or any of its AFFILIATES (“ACQUIRING PARTY”) either acquires an entity or acquires substantially all of the assets from an entity (“ACQUIRED ENTITY”), the following shall apply:

 

  (a)

The license, release and other rights granted herein to the ACQUIRING PARTY with respect to the LICENSED PATENTS shall apply to products of the ACQUIRED ENTITY, to the extent that such products of the ACQUIRED ENTITY would be considered LICENSED PRODUCTS under this AGREEMENT if they were products of the ACQUIRING PARTY.

 

  (b)

In the event that, at the date of the acquisition, the ACQUIRED ENTITY is licensed by the other PARTY to this AGREEMENT through an existing license agreement covering the same LICENSED PRODUCTS and LICENSED PATENTS, or parts thereof, as licensed under this AGREEMENT (“PRIOR LICENSE AGREEMENT”), pursuant to which payments are to be made by the ACQUIRED ENTITY to the other PARTY, the following shall apply: In order to avoid double payment for the same license, the BALANCING PAYMENTS to be made under this AGREEMENT shall prevail over payments or royalties to be made under the PRIOR LICENSE AGREEMENT to the extent both agreements cover the same LICENSED PATENTS and LICENSED PRODUCTS. To the extent the PRIOR LICENSE AGREEMENT covers LICENSED PATENTS or LICENSED PRODUCTS not subject to this AGREEMENT, the royalties or other payments due for that scope of the PRIOR LICENSE AGREEMENT shall continue to be made by the ACQUIRING PARTY or ACQUIRED ENTITY to the other PARTY pursuant to the payment terms of the PRIOR LICENSE AGREEMENT.

 

  (c)

The other PARTY to this AGREEMENT shall have the right to terminate the application of the license in Section 6.1(a) to products of the ACQUIRED ENTITY based on a pending patent infringement suit or alleged patent infringement pursuant to a notice letter involving the ACQUIRED ENTITY or any of its SUBSIDIARIES and the other PARTY to this AGREEMENT or any of its SUBSIDIARIES whether or not related to any of the LICENSED PATENTS or LICENSED PRODUCTS.

 

6.2

A PARTY being acquired by a THIRD PARTY

If one PARTY (the “ACQUIRED PARTY”) is acquired by a THIRD PARTY (“ACQUIRING ENTITY”):

 

  (a)

the ACQUIRED PARTY shall promptly give notice of such acquisition to the other PARTY; and

 

Infineon – MagnaChip Confidential    Page 12 of 20


[***]

 

  (b)

the license granted to the ACQUIRED PARTY and all sublicenses (if any) granted to the ACQUIRED PARTY’S remaining AFFILIATES shall automatically become limited to apply to those LICENSED PRODUCTS, including error corrections and minor adaptations pursuant to customer requirements which are created by the ACQUIRED PARTY in the normal course of business, that have been marketed by said ACQUIRED PARTY (or, in the case of an AFFILIATE, by such AFFILIATE) within the licenses granted in this AGREEMENT (or within the sublicense in the case of an AFFILIATE) prior to such acquisition; and

 

  (c)

following such acquisition, the license granted to the ACQUIRED PARTY shall be limited in the twelve (12) months immediately following such acquisition to a volume of LICENSED PRODUCTS having an aggregate net selling price equal to no more than the aggregate net selling price of such LICENSED PRODUCTS in the twelve (12) months preceding such acquisition plus ten percent (10%) and shall be limited, in each of the successive twelve-month periods following such acquisition, to a volume of LICENSED PRODUCTS having an aggregate net selling price equal to no more than the aggregate net selling price of such LICENSED PRODUCTS for the immediately preceding twelve-month period plus ten percent (10%).

In the event the ACQUIRING ENTITY is a COMPETITOR or a supplier to a COMPETITOR of the other PARTY or any of its AFFILIATES at the time of the acquisition, then such other PARTY shall have the right to terminate this AGREEMENT with immediate effect by giving written notice to the ACQUIRED PARTY within ninety (90) calendar days from receiving written notice of the acquisition. In the event of a disagreement between the ACQUIRED ENTITY and such other PARTY regarding whether the ACQUIRING ENTITY is a COMPETITOR or a supplier to a COMPETITOR, the ACQUIRED PARTY shall have the burden of proof of establishing that the ACQUIRING ENTITY is neither a COMPETITOR nor a supplier to a COMPETITOR of such other PARTY.

If INFINEON terminates this AGREEMENT pursuant to the foregoing sentence, then BALANCING PAYMENT NO. 1, and BALANCING PAYMENT NO. 2, to the extent not already paid, and any other BALANCING PAYMENT that is due but unpaid, shall immediately become due and payable in full.

Notwithstanding the foregoing, except for BALANCING PAYMENT NO. 1, and BALANCING PAYMENT NO. 2, if INFINEON terminates this AGREEMENT pursuant to this Section 6.2, then any BALANCING PAYMENT, which had already been paid for the year during which such termination occurs, shall be subject to a pro rata refund. The amount of such refund shall be calculated by multiplying the amount of the applicable BALANCING PAYMENT by a fraction whose numerator is the number of calendar days remaining in the calendar year and whose denominator is 365. INFINEON shall pay such refund within thirty (30) calendar days after receipt of a proper invoice issued upon termination of this AGREEMENT pursuant to this Section 6.2. As an example, if this AGREEMENT is terminated after BALANCING PAYMENT NO. 4 is made and there are two hundred (200) calendar days remaining in the calendar year 2019, then INFINEON shall pay a refund of [***] to MAGNACHIP.

 

Infineon – MagnaChip Confidential    Page 13 of 20


[***]

 

In the event of a PRIOR LICENSE AGREEMENT between the ACQUIRING ENTITY and the other PARTY, pursuant to which royalties or other payments are to be made by the ACQUIRING ENTITY to the other PARTY, such royalties or other payments shall continue to be made by the ACQUIRING ENTITY to the other PARTY pursuant to the payment terms of the PRIOR LICENSE AGREEMENT.

 

6.3

If, subsequent to the EFFECTIVE DATE, a PARTY (the “TRANSFERRING PARTY”) either:

 

  (i)

transfers a business unit producing LICENSED PRODUCTS or a product line with LICENSED PRODUCTS to a THIRD PARTY without transferring the SUBSIDIARY to said THIRD PARTY; or

 

  (ii)

spins off a SUBSIDIARY producing LICENSED PRODUCTS (either by disposing of it to a THIRD PARTY or in any other manner reducing ownership or control so that the spun-off entity is no longer a SUBSIDIARY of the TRANSFERRING PARTY) (in each case of (i) and (ii) above, the THIRD PARTY transferee or spun-off ex-SUBSIDIARY hereinafter referred to as “RECIPIENT”), then the following shall apply:

After written request made jointly by the TRANSFERRING PARTY and the RECIPIENT to the other PARTY hereto, which is made within one hundred and twenty (120) calendar days following the effective date of such transfer or spin off (the “TRANSFER NOTICE”), the other PARTY hereto shall grant a license at no further cost (otherwise under the same terms as the license granted to the TRANSFERRING PARTY herein) to the RECIPIENT under its LICENSED PATENTS, provided that:

 

  (a)

the license shall be as broad as the scope of the license granted herein to the TRANSFERRING PARTY, but no broader than necessary to cover the particular LICENSED PRODUCTS, assets and/or business being transferred or spun off, of the ex-SUBSIDIARY, including derivatives thereof and extensions thereto created pursuant to the normal course of business; and

 

  (b)

the RECIPIENT shall grant to such other PARTY a royalty-free license (under the same terms as the license granted to such other PARTY herein) under all RECIPIENT LICENSED PATENTS for all LICENSED PRODUCTS of such other PARTY;

 

  (c)

this Section 6.3, Section 3, Section 4 and Section 5.2 shall be omitted from the license granted to the RECIPIENT; and

 

  (d)

the license granted to the RECIPIENT and granted by the RECIPIENT to the other PARTY shall terminate if the license granted to the TRANSFERRING PARTY terminates or is terminated for any reason.

 

Infineon – MagnaChip Confidential    Page 14 of 20


[***]

 

Any payments under this AGREEMENT shall continue to be made by the TRANSFERRING PARTY to the other PARTY, unless upon written request made jointly by the TRANSFERRING PARTY and the RECIPIENT, the other PARTY agrees in writing to receive a certain portion of any payments due hereunder directly from the RECIPIENT.

Notwithstanding the foregoing, if the RECIPIENT is a COMPETITOR or a supplier to a COMPETITOR of the other PARTY or any of its AFFILIATES at the time of the transfer or spin-off, as applicable, then such other PARTY shall have the right to contest its obligation under this Section 6.3 to grant a license to the RECIPIENT by providing written notice (the “CONTEST NOTICE”) to the TRANSFERRING PARTY within ninety (90) calendar days after delivery of the TRANSFER NOTICE. For a period of sixty (60) calendar days after delivery of the CONTEST NOTICE, such other PARTY, the TRANSFERRING PARTY and the RECIPIENT shall engage in good faith discussions to resolve the issue. In the event of a disagreement regarding whether the RECIPIENT is a COMPETITOR or a supplier to a COMPETITOR, the TRANSFERRING PARTY shall have the burden of proof of establishing that the RECIPIENT is neither a COMPETITOR nor a supplier to a COMPETITOR of such other PARTY. If the three parties are unable to resolve the issue within such sixty (60) day period, then such other PARTY shall not be obligated under this Section 6.3 to grant a license to the RECIPIENT.

In the event that the transfer of a business unit contemplated in this Section 6.3 consists of or includes all or substantially all of the MAGNACHIP POWER BUSINESS LINE, then INFINEON, MAGNACHIP and the RECIPIENT shall engage in good faith discussions for the purpose of assigning MAGNACHIP’s rights and obligations under this AGREEMENT to the RECIPIENT under substantially the same terms and conditions of this AGREEMENT; provided that, if the RECIPIENT is a COMPETITOR or a supplier to a COMPETITOR of INFINEON or any of its AFFILIATES at the time of the transfer or spin-off, as applicable, then the immediately preceding paragraph shall nevertheless apply.

 

7.

Miscellaneous

 

7.1

Either PARTY shall be free to assign or grant any right under any of its LICENSED PATENTS provided that the licenses and rights granted hereunder remain unaffected.

 

7.2

Without prejudice to Sections 6.2 and 6.3, neither PARTY shall assign any of its rights (other than the right to receive payments) or delegate any of its obligations under this AGREEMENT. Any attempt to do so shall be void. However, a PARTY which undergoes reorganization may assign such rights and delegate such obligations to its legal successor, provided that after the reorganization, the successor and its SUBSIDIARIES will have essentially the same assets as such PARTY and its SUBSIDIARIES had prior to the reorganization.

 

7.3

Notices and other communications shall be in writing and shall be deemed duly given (a) if by facsimile, on the date of written confirmation of receipt by facsimile, e-mail or otherwise, or (b) on the third (3rd) business day following the date of dispatch if delivered utilizing a express courier service by a recognized international courier. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the Party to receive such notice:

 

Infineon – MagnaChip Confidential    Page 15 of 20


[***]

 

For INFINEON:    For MAGNACHIP:
Vice President Intellectual Property    General Counsel
Infineon Technologies AG    MagnaChip Semiconductor, Ltd.
[***]    [***]
Fax: [***]    Fax: [***]
Email: [***]    Email: [***]

with a copy to

Infineon Technologies AG

Legal Department

[***]

Fax: [***]

E-mail: [***]

 

7.4

Each PARTY represents and warrants that it has the full right and power to grant the licenses and releases set forth in Sections 2 and 3. Neither PARTY makes any other representation or warranty, express or implied, nor shall either PARTY have any liability in respect of any infringement of patents or other rights of THIRD PARTIES due to the other PARTY’s operation under the license herein granted. In no event shall either PARTY be liable to the other PARTY by reason of this AGREEMENT or any breach or termination of this AGREEMENT for any loss of profits or revenue, business interruptions, cost of capital or any special, incidental or consequential damages. INFINEON represents and warrants that it has the proper power and authority to cause its AFFILIATES to comply with Section 2.1, and INFINEON hereby agrees to cause such AFFILIATES to comply with Section 2.1. MX represents and warrants that it has the proper power and authority to cause MAGNACHIP’s AFFILIATES to comply with Section 2.2, and MX hereby agrees to cause such AFFILIATES to comply with Section 2.2.

 

7.5

In particular, without limitation, nothing contained in this AGREEMENT shall be construed as:

 

  (a)

restricting the right of a PARTY to make, use, sell, lease of otherwise dispose of any particular product or products not herein licensed;

 

  (b)

an admission by a PARTY, or a warranty or representation of a PARTY, as to the validity and/or scope of the LICENSED PATENTS, or a limitation of a PARTY to contest, in any proceeding the validity and/or scope thereof;

 

  (c)

a warranty or representation by a PARTY that any manufacture, use, import, sale, lease or other disposition of LICENSED PRODUCTS will be free from infringement of any patent or other intellectual property rights, other than the LICENSED PATENTS; or

 

  (d)

an admission by a PARTY that it has infringed any patent or other intellectual property rights of the other PARTY.

 

Infineon – MagnaChip Confidential    Page 16 of 20


[***]

 

7.6

Neither PARTY shall have any obligation hereunder to institute any action or suit against THIRD PARTIES for infringement of any of its LICENSED PATENTS or to defend any action or suit brought by a third party which challenges or concerns the validity of any of its LICENSED PATENTS. Neither PARTY shall have any right to institute any action or suit against THIRD PARTIES for infringement of any of the other PARTY’S LICENSED PATENTS. Neither PARTY, nor any of its AFFILIATES, is required to file any patent application, or to secure any patent or patent rights, or to maintain any patent in force.

 

7.7

This AGREEMENT including the arbitration agreement in Section 7.8 shall be subject to the substantive law in force in the State of New York, USA, without reference to its conflicts of law provisions. The application of the United Nations Convention on Contracts for the International Sale of Goods of April 11, 1980 shall be excluded.

 

7.8

All disputes arising out of or in connection with this AGREEMENT, including any question regarding its existence, validity or termination, shall be settled finally by arbitration under the Rules of Arbitration of the International Chamber of Commerce, Paris (“ICC”) / (“Rules”) by three arbitrators without recourse to the courts of any jurisdiction. Each PARTY shall nominate one arbitrator and the two party nominated arbitrators shall nominate the chairman within thirty (30) calendar days. In case the two party nominated arbitrators are unable to nominate a chairman, he/she shall be nominated by the ICC in accordance with the Rules. Place of Arbitration shall be Zurich, Switzerland. The language to be used in the arbitration proceeding shall be English. The arbitration award shall be rendered in writing and shall be binding upon the PARTIES. Nothing in this AGREEMENT shall preclude either PARTY from seeking interim measures of protection in any court of competent jurisdiction. The courts at the place of arbitration shall not have exclusive jurisdiction to entertain such applications. Notwithstanding anything in this Section 7.8 to the contrary, a PARTY or any AFFILIATE of a PARTY shall be free to enforce this AGREEMENT, or any of the terms or conditions hereof, before any judicial, administrative or other body in which the other PARTY, any AFFILIATE of such other PARTY or any successor in interest to any of such other PARTY’s LICENSED PATENTS has asserted or claimed that such PARTY or any AFFILILATE of such PARTY is or may be infringing one or more of such other PARTY’s LICENSED PATENTS.

 

7.9

This AGREEMENT shall not be binding upon the PARTIES until it has been signed by or on behalf of each PARTY. No amendment or modification hereof shall be valid or binding upon the PARTIES unless made in writing and signed as aforesaid, except that either PARTY may amend its address in Section 7.3 by written notice to the other PARTY. The requirement of the written form itself can only be waived in writing.

 

7.10

Neither PARTY shall use or refer to this AGREEMENT or any of its provisions in any promotional activity, public announcement, press release or other communication with THIRD PARTIES. Notwithstanding the foregoing, each PARTY may disclose the existence of this AGREEMENT and what products are LICENSED PRODUCTS to THIRD PARTY customers and/or potential customers who have a reasonable need to know such information and who are bound to confidentiality obligations not less stringent than the obligations of this AGREEMENT.

 

Infineon – MagnaChip Confidential    Page 17 of 20


[***]

 

During the TERM, each PARTY agrees not to disclose any term or condition of this AGREEMENT, as well as any information provided hereunder by a PARTY in performance of its obligations hereunder, to any THIRD PARTY without the prior written consent of the other PARTY. This obligation is subject to the following exceptions:

 

  (a)

disclosure is permissible if required by government or court order, provided the PARTY required to disclose first gives the other PARTY prior written notice to enable it to seek a protective order;

 

  (b)

disclosure is permissible if otherwise required by law;

 

  (c)

disclosure is permissible if required to enforce rights under this AGREEMENT;

 

  (d)

each PARTY may use similar terms and conditions in other agreements;

 

  (e)

each PARTY may disclose, subject to a written confidentiality agreement or other legally binding confidentiality obligation (such as an attorney’s duty of confidentiality), this AGREEMENT to its accountants, attorneys and financial advisors, solely to the extent necessary for the performance of their services, and a redacted version of this AGREEMENT limited to the scope of the licenses and releases granted hereunder to its present or future providers of venture capital and/or potential investors in or acquirers of such PARTY, any of its AFFILIATES or product lines which qualify under Section 6.

 

7.11

If any provision of this AGREEMENT is held to be invalid, illegal or unenforceable under applicable law the remaining provisions shall continue to be in full force and effect. The PARTIES undertake to replace the invalid provision or parts thereof by a new provision which will meet as closely as possible the economic effect intended by the PARTIES at the time of execution of this AGREEMENT.

 

7.12

This AGREEMENT embodies the entire understanding of the PARTIES with respect to the LICENSED PATENTS, and replaces any prior oral or written communications between them.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK.]

 

Infineon – MagnaChip Confidential    Page 18 of 20


[***]

 

IN WITNESS WHEREOF, the PARTIES hereto have caused this AGREEMENT to be executed by their respective duly authorized representatives:

 

MagnaChip Semiconductor, Ltd.     Infineon Technologies AG
Date: May 31, 2017     Date: June 16, 2017
By:  

/s/ Theodore S. Kim

    By:  

/s/ [***]

Name: Theodore S. Kim     Name: [***]
Title: Executive Vice President & General Counsel     Title: Director & Corporate Legal Counsel
By:  

/s/ Woung Moo Lee

    By:  

/s/ [***]

Name: Woung Moo Lee     Name: [***]
Title: Executive Vice President & General Manager of SPG     Title: Senior Director
AGREED only with respect to Section 7.4 of this AGREEMENT:  
MagnaChip Semiconductor Corporation    
Date: May 31, 2017    
By:  

/s/ Theodore S. Kim

   
Name: Theodore S. Kim    
Title: Executive Vice President & General Counsel    
By:  

/s/ Woung Moo Lee

   
Name: Woung Moo Lee    
Title: Executive Vice President & General Manager of SPG    

 

Infineon – MagnaChip Confidential    Page 19 of 20


[***]

 

ANNEX 1

[***]

 

Infineon – MagnaChip Confidential    Page 20 of 20
EX-10.9 10 d306034dex109.htm EX-10.9 EX-10.9

Exhibit 10.9

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

FIRST AMENDMENT

TO THE

PATENT CROSS-LICENSE AGREEMENT

This Amendment to the Patent Cross-License Agreement (“FIRST AMENDMENT”) is entered into with effect as of January 1, 2022 by and between Infineon Technologies AG (“INFINEON”), a corporation duly incorporated under the laws of Germany having its principal offices at Am Campeon 1-15, 85579 Neubiberg, Germany, and Magnachip Semiconductor, Ltd. (“MAGNACHIP”), a company duly organized under the laws of Korea, having its principal offices at 15F, 76 Jikji-daero 436beon-gil (Jikji Smart Tower), Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28581, Republic of Korea (INFINEON and MAGNACHIP hereinafter collectively referred to as the “PARTIES” and individually as a “PARTY”).

Preamble

WHEREAS, INFINEON and MAGNACHIP have entered into a Patent Cross-License Agreement with effect as of June 15, 2017 (“AGREEMENT”);

WHEREAS, both INFINEON and MAGNACHIP desire to amend the AGREEMENT;

NOW THEREFORE, INFINEON and MAGNACHIP agree as follows:

 

1.

Section 1.9 (Definition of DISCRETE POWER MOSFET PRODUCT) of the AGREEMENT shall be replaced in its entirety by the following wording:

“1.9 “DISCRETE POWER MOSFET PRODUCT“ shall mean [***].

 

2.

In Section 1.12 (a) (Definition of INFINEON LICENSED PATENTS) of the AGREEMENT the words “December 31, 2020” shall be replaced by “December 31, 2026”. The new Section 1.12 (a) thus reads:

“(a) all classes or types of patents, utility models and design patents, including applications therefor, in all countries of the world, which are issued or published, or filed prior to (and including) December 31, 2026 including continuations, divisionals, reissues and other pre-grant and post-grant applications and issuances and foreign counterparts thereof; and”

 

1

MagnaChip/ Infineon Confidential


3.

In Section 1.13 (Definition of INFINEON LICENSED PRODUCTS) of the AGREEMENT the words [***] shall be deleted. The new Section 1.13 thus reads:

“1.13 “INFINEON LICENSED PRODUCTS” shall mean [***].

 

4.

Section 1.18 (a) (Definition of MAGNACHIP LICENSED PATENTS) of the AGREEMENT the words “December 31, 2020” shall be replaced by “December 31, 2026”. The new Section 1.18 (a) thus reads:

 

  “(a)

all classes or types of patents, utility models and design patents, including applications therefor, in all countries of the world, which are issued or published, or filed prior to (and including) December 31, 2026, including continuations, divisionals, reissues and other pre-grant and post-grant applications and issuances and foreign counterparts thereof; and”

 

5.

In Section 1.19 (Definition of MAGNACHIP LICENSED PRODUCTS) of the AGREEMENT the words “in each case first sold at production volume prior to (and including) December 31, 2020” shall be deleted. The new Section 1.19 thus reads:

“MAGNACHIP LICENSED PRODUCTS” shall mean any DISCRETE POWER MOSFET PRODUCTS with identification numbers or codes assigned thereto and any individual IGBT DISCRETE PRODUCTS with identification numbers or codes assigned thereto, which (i) are designed or developed by or for MAGNACHIP and/or any of its AFFILIATES (either solely or jointly with one or more THIRD PARTIES), or of which designs are licensed or acquired by MAGNACHIP and/or any of its AFFILIATES and (ii) if marketed, are marketed by MAGNACHIP and/or any of its AFFILIATES under its own name as its own product.”

 

6.

In Section 1.25 (a) (Definition of RECIPIENT LICENSED PATENTS) of the AGREEMENT the words “December 31, 2020” shall be replaced by “December 31, 2026”. The new Section 1.25 (a) thus reads:

“(a) all classes or types of patents, utility models and design patents, including applications therefor, in all countries of the world, which are issued or published, or filed prior to (and including) December 31, 2026, including continuations, divisionals, reissues and other pre-grant and post-grant applications and issuances and foreign counterparts thereof; and”

 

7.

Section 1.27 (Definition of TERM) of the AGREEMENT shall be replaced in its entirety by the following wording:

 

2

MagnaChip/ Infineon Confidential


“1.27“TERM” shall comprise the period from June 15, 2017 to December 31, 2021 (“FIRST TERM”) as well as the period from January 1, 2022 to December 31, 2026 (“SECOND TERM”) and shall have the meaning ascribed to it in Section 5.1.”

 

8.

Section 4.1.1 (Balancing Payments) of the AGREEMENT shall be replaced in its entirety by the following wording:

“4.1.1 Balancing Payments

In consideration for the license granted by each PARTY and its AFFILIATES pursuant to this AGREEMENT and the releases set forth in Section 3, MAGNACHIP has paid to INFINEON in accordance with the agreed upon payment schedule as set forth in Annex 1 a sum of [***] (collectively, the “BALANCING PAYMENTS”).

For each BALANCING PAYMENT installment as set forth in Annex 1 and Annex 2, INFINEON will issue a corresponding invoice, and payments shall be made not later than (i) fifteen (15) calendar days following the receipt by MAGNACHIP of the respective invoice or (ii) the respective due date, whichever is later.

 

9.

Within Section 4.3 of the AGREEMENT the bank account details shall be updated as follows:

 

Bank    [***]
Account No.    [***]
Swift Code    [***]
IBAN    [***]

 

10.

Section 5.1 (Term and Termination) of the AGREEMENT shall be replaced in its entirety by the following wording:

“5.1 This AGREEMENT has become effective as of the EFFECTIVE DATE and initially was in effect until December 31, 2021 (“FIRST TERM”). The PARTIES have agreed to extend the term of this AGREEMENT from January 1, 2022 to December 31, 2026 (the “SECOND TERM”). Unless this AGREEMENT is terminated before the end of TERM pursuant to Section 5.2, 5.3 or 5.4, at the request of a PARTY the PARTIES shall in good faith, commence discussing a renewal at least two (2) months prior to the end of TERM, including the consideration for renewal and the adjustment of the scope of LICENSED PRODUCTS under this AGREEMENT.”

 

11.

Within Section 6.2 (A PARTY being acquired by a THIRD PARTY) of the AGREEMENT the reference to BALANCING PAYMENT NO. 1 and BALANCING PAYMENT NO. 2 shall be deleted and the respective two paragraphs shall be amended as mentioned below:

(a) The paragraph:

 

3

MagnaChip/ Infineon Confidential


“If INFINEON terminates this AGREEMENT pursuant to the foregoing sentence, then BALANCING PAYMENT NO. 1, and BALANCING PAYMENT NO. 2, to the extent not already paid, and any other BALANCING PAYMENT that is due but unpaid, shall immediately become due and payable in full.”

shall be replaced by the following wording:

“If INFINEON terminates this AGREEMENT pursuant to the foregoing sentence, then any BALANCING PAYMENT that is due but unpaid, shall immediately become due and payable in full.”

(b) The paragraph:

“Notwithstanding the foregoing, except for BALANCING PAYMENT NO. 1, and BALANCING PAYMENT NO. 2, if INFINEON terminates this AGREEMENT pursuant to this Section 6.2, then any BALANCING PAYMENT, which had already been paid for the year during which such termination occurs, shall be subject to a pro rata refund. The amount of such refund shall be calculated by multiplying the amount of the applicable BALANCING PAYMENT by a fraction whose numerator is the number of calendar days remaining in the calendar year and whose denominator is 365. INFINEON shall pay such refund within thirty (30) calendar days after receipt of a proper invoice issued upon termination of this AGREEMENT pursuant to this Section 6.2. As an example, if this AGREEMENT is terminated after BALANCING PAYMENT NO. 4 is made and there are two hundred (200) calendar days remaining in the calendar year 2019, then INFINEON shall pay a refund of [***] to MAGNACHIP.”

shall be replaced by the following wording:

“Notwithstanding the foregoing, if INFINEON terminates this AGREEMENT pursuant to this Section 6.2, then any BALANCING PAYMENT, which had already been paid for the year during which such termination occurs, shall be subject to a pro rata refund. The amount of such refund shall be calculated by multiplying the amount of the applicable BALANCING PAYMENT by a fraction whose numerator is the number of calendar days remaining in the calendar year and whose denominator is 365. INFINEON shall pay such refund within thirty (30) calendar days after receipt of a proper invoice issued upon termination of this AGREEMENT pursuant to this Section 6.2. As an example, if this AGREEMENT is terminated after BALANCING PAYMENT NO. 4 is made and there are two hundred (200) calendar days remaining in the calendar year 2019, then INFINEON shall pay a refund of [***] to MAGNACHIP.”

 

12.

Within Section 7.3 of the AGREEMENT INFINEON´s and MAGNACHIP´s addresses shall be updated as follows:

 

4

MagnaChip/ Infineon Confidential


For INFINEON:

Senior Vice President Intellectual Property Infineon Technologies AG

[***]

Fax: [***]

Email: [***]

with a copy to

Infineon Technologies AG

Legal Department

[***]

Fax: [***]

E-mail: [***]

For MAGNACHIP:

General Counsel

Magnachip Semiconductor, Ltd.

[***]

Fax: [***]

Email: [***]

 

13.

Another Annex shall be added to the AGREEMENT as ANNEX 2 and shall be considered as a substantial part of the AGREEMENT.

ANNEX 2 shall have the following contents:

[***]

 

14.

Except as modified by this FIRST AMENDMENT, all other terms and conditions of the AGREEMENT shall remain in full force and effect.

 

15.

Unless otherwise defined herein, all capitalized terms set forth herein shall have the same meanings attributed to such terms in the AGREEMENT.

IN WITNESS WHEREOF, the PARTIES hereto have caused this FIRST AMENDMENT to be executed by their respective duly authorized representatives:

 

5

MagnaChip/ Infineon Confidential


Magnachip Semiconductor, Ltd.     Infineon Technologies AG
Date:   May 18, 2022     Date: May 20, 2022
By:  

/s/ Theodore S. Kim

    By:  

/s/ [***]

Name:   Theodore S. Kim     Name:   [***]
Title:   CCO & GC     Title:   SVP Intellectual Property
By:  

/s/ Chan Ho Park

    By:  

/s/ [***]

Name:   Chan Ho Park     Name:   [***]
Title:   GM of Power     Title:   Senior Director – Corporate Legal Counsel

 

6

MagnaChip/ Infineon Confidential

EX-31.1 11 d306034dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Young-Joon Kim, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Magnachip Semiconductor Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 8, 2022

/s/ Young-Joon Kim

Young-Joon Kim

Chief Executive Officer

(Principal Executive Officer)

EX-31.2 12 d306034dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Shin Young Park, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Magnachip Semiconductor Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 8, 2022

/s/ Shin Young Park

Shin Young Park

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

EX-32.1 13 d306034dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Magnachip Semiconductor Corporation (the “Company”) hereby certifies, to such officer’s knowledge, that:

(i) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

 

Dated: November 8, 2022     /s/ Young-Joon Kim
    Young-Joon Kim
    Chief Executive Officer
    (Principal Executive Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C § 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any registration statement of the Company filed under the Securities Act of 1933, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 14 d306034dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Magnachip Semiconductor Corporation (the “Company”) hereby certifies, to such officer’s knowledge, that:

(i) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

 

Dated: November 8, 2022     /s/ Shin Young Park
    Shin Young Park
   

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C § 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any registration statement of the Company filed under the Securities Act of 1933, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.SCH 15 mx-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Business, Basis of Presentation and Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Property, Plant and Equipment link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Derivative Financial Instruments link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Accrued Severance Benefits link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Foreign Currency Loss, Net link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Geographic and Other Information link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Stock Repurchases link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Merger Agreement link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Derivative Financial Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Accrued Severance Benefits (Tables) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Geographic and Other Information (Tables) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Inventories - Summary of Inventories (Detail) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Inventories - Changes in Inventory Reserve (Detail) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Property, Plant and Equipment - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Intangible Assets - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Intangible Assets - Summary of Intangible Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Leases - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Leases - Supplemental Balance Sheet (Detail) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Leases - Components of lease cost (Detail) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Leases - Other lease information (Detail) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Leases - Aggregate future lease payment (Detail) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Accrued Expenses - Summary of Accrued Expenses (Detail) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Derivative Financial Instruments - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Derivative Financial Instruments - Details of Derivative Contracts (Detail) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Derivative Financial Instruments - Fair Values of Outstanding Zero Cost Collar and Forward Contracts Recorded as Assets and Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Derivative Financial Instruments - Offsetting of Derivative Assets and Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 1053 - Disclosure - Derivative Financial Instruments - Impact of Derivative Instruments on Consolidated Statement of Operations (Detail) link:presentationLink link:definitionLink link:calculationLink 1054 - Disclosure - Derivative Financial Instruments - Cash deposits (Details) link:presentationLink link:definitionLink link:calculationLink 1055 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1056 - Disclosure - Accrued Severance Benefits - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1057 - Disclosure - Accrued Severance Benefits - Changes in Accrued Severance Benefits (Detail) link:presentationLink link:definitionLink link:calculationLink 1058 - Disclosure - Accrued Severance Benefits - Future Benefits Payments to Employees (Detail) link:presentationLink link:definitionLink link:calculationLink 1059 - Disclosure - Foreign Currency Loss, Net - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1060 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1061 - Disclosure - Geographic and Other Information - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1062 - Disclosure - Geographic and Other Information - Schedule of Operating Segment (Detail) link:presentationLink link:definitionLink link:calculationLink 1063 - Disclosure - Geographic and Other Information - Net Sales by Region, Based on Location of Products are Billed (Detail) link:presentationLink link:definitionLink link:calculationLink 1064 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Detail) link:presentationLink link:definitionLink link:calculationLink 1065 - Disclosure - Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Income Loss (Detail) link:presentationLink link:definitionLink link:calculationLink 1066 - Disclosure - Stock Repurchases - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1067 - Disclosure - Earnings (Loss) Per Share - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1068 - Disclosure - Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Loss Per Common Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1069 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from the Computation of Loss Per Common Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1070 - Disclosure - Merger Agreement - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1071 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 16 mx-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 17 mx-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 18 mx-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 19 mx-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 20 g306034g1103181052615.jpg GRAPHIC begin 644 g306034g1103181052615.jpg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end XML 21 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover Page - shares
9 Months Ended
Sep. 30, 2022
Oct. 31, 2022
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Entity Registrant Name Magnachip Semiconductor Corporation  
Entity Central Index Key 0001325702  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Incorporation, State or Country Code DE  
Entity Common Stock, Shares Outstanding   44,175,252
Entity File Number 001-34791  
Entity Tax Identification Number 83-0406195  
Entity Address, Address Line One c/o MagnaChip Semiconductor S.A. 1  
Entity Address, City or Town Allée Scheffer  
Entity Address, Postal Zip Code L-2520  
City Area Code 352  
Local Phone Number 45-62-62  
Document Quarterly Report true  
Document Transition Report false  
Entity Address, Country LU  
Common Stock [Member]    
Document Information [Line Items]    
Title of 12(b) Security Common Stock, par value $0.01 per share  
Trading Symbol MX  
Security Exchange Name NYSE  
Preferred Stock [Member]    
Document Information [Line Items]    
Title of 12(b) Security Preferred Stock Purchase Rights  
No Trading Symbol Flag true  
Security Exchange Name NYSE  
XML 22 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 250,831 $ 279,547
Accounts receivable, net 36,759 50,954
Inventories, net 37,298 39,370
Other receivables (Note 16) 8,248 25,895
Prepaid expenses 10,322 7,675
Hedge collateral (Note 7) 15,370 3,060
Other current assets (Note 17) 20,208 2,619
Total current assets 379,036 409,120
Property, plant and equipment, net 94,411 107,882
Operating lease right-of-use assets 4,928 4,275
Intangible assets, net 1,770 2,377
Long-term prepaid expenses 11,382 8,243
Deferred income taxes 34,299 41,095
Other non-current assets 10,382 10,662
Total assets 536,208 583,654
Current liabilities    
Accounts payable 26,545 37,593
Other accounts payable 14,809 6,289
Accrued expenses (Note 6) 15,800 20,071
Accrued income taxes 0 11,823
Operating lease liabilities 1,324 2,323
Other current liabilities (Notes 7 and 8) 15,881 7,382
Total current liabilities 74,359 85,481
Accrued severance benefits, net 28,036 33,064
Non-current operating lease liabilities 3,811 1,952
Other non-current liabilities 16,787 10,395
Total liabilities 122,993 130,892
Commitments and contingencies (Note 17)
Stockholders' equity    
Common stock, $0.01 par value, 150,000,000 shares authorized, 56,234,774 shares issued and 44,579,075 outstanding at September 30, 2022 and 55,905,320 shares issued and 45,659,304 outstanding at December 31, 2021 562 559
Additional paid-in capital 264,510 241,197
Retained earnings 332,535 343,542
Treasury stock, 11,655,699 shares at September 30, 2022 and 10,246,016 shares at December 31, 2021, respectively (152,161) (130,306)
Accumulated other comprehensive loss (32,231) (2,230)
Total stockholders' equity 413,215 452,762
Total liabilities and stockholders' equity $ 536,208 $ 583,654
XML 23 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 150,000,000 150,000,000
Common stock, shares issued 56,234,774 55,905,320
Common stock, shares outstanding 44,579,075 45,659,304
Treasury stock, shares 11,655,699 10,246,016
XML 24 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Net sales $ 71,199 $ 127,000 $ 276,668 $ 363,895
Cost of sales 53,974 80,413 191,502 248,956
Gross profit 17,225 46,587 85,166 114,939
Operating expenses:        
Selling, general and administrative expenses 11,411 12,550 38,310 39,185
Research and development expenses 13,321 12,270 38,685 39,015
Merger-related costs 0 1,552 0 13,842
Other charges, net 2,501 214 3,298 3,360
Total operating expenses 27,233 26,586 80,293 95,402
Operating income (loss) (10,008) 20,001 4,873 19,537
Interest expense (278) (113) (888) (1,239)
Foreign currency loss, net (12,809) (7,579) (20,511) (12,000)
Other income, net 1,958 1,608 4,163 2,839
Income (loss) before income tax expense (21,137) 13,917 (12,363) 9,137
Income tax expense (benefit) (3,942) 3,149 (1,356) 6,040
Net income (loss) $ (17,195) $ 10,768 $ (11,007) $ 3,097
Basic earnings (loss) per common share— $ (0.38) $ 0.23 $ (0.24) $ 0.07
Diluted earnings (loss) per common share— $ (0.38) $ 0.23 $ (0.24) $ 0.07
Weighted average number of shares—        
Basic 44,865,266 46,449,234 45,119,214 44,377,250
Diluted 44,865,266 47,808,457 45,119,214 45,811,792
Standard products business [Member]        
Net sales $ 62,771 $ 117,415 $ 248,069 $ 333,589
Cost of sales 45,497 71,641 165,197 221,297
Gross profit 17,274 45,773 82,872 112,291
Fab Three Foundry Services [Member]        
Net sales 8,428 9,585 28,599 30,306
Cost of sales 8,477 8,772 26,305 27,659
Gross profit $ (49) $ 814 $ 2,294 $ 2,648
XML 25 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ (17,195) $ 10,768 $ (11,007) $ 3,097
Other comprehensive income (loss)        
Foreign currency translation adjustments (5,974) (860) (15,881) (2,809)
Derivative adjustments        
Fair valuation of derivatives (11,757) (3,271) (19,498) (4,964)
Reclassification adjustment for loss (gain) on derivatives included in net income (loss) 2,820 653 5,378 (333)
Total other comprehensive loss (14,911) (3,478) (30,001) (8,106)
Total comprehensive income (loss) $ (32,106) $ 7,290 $ (41,008) $ (5,009)
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Balance beginning at Dec. 31, 2020 $ 345,600 $ 450 $ 163,010 $ 286,834 $ (108,397) $ 3,703
Balance, Shares beginning at Dec. 31, 2020   35,783,347        
Stock-based compensation $ 6,056   6,056      
Exchange of exchangeable senior notes into common stock 83,740,000 10,144,131        
Exchange of exchangeable senior notes $ 83,740 $ 101 83,639      
Exercise of stock options 3,920 $ 3 3,917      
Exercise of stock options, Shares   289,704        
Settlement of restricted stock units   $ 3 (3)      
Settlement of restricted stock units, Shares   299,162        
Acquisition of treasury stock (1,010)       (1,010)  
Acquisition of treasury stock, Shares   (51,455)        
Other comprehensive loss, net (8,106)         (8,106)
Net income (loss) 3,097     3,097    
Balance ending at Sep. 30, 2021 433,297 $ 557 256,619 289,931 (109,407) (4,403)
Balance, Shares ending at Sep. 30, 2021   46,464,889        
Balance beginning at Dec. 31, 2020 345,600 $ 450 163,010 286,834 (108,397) 3,703
Balance, Shares beginning at Dec. 31, 2020   35,783,347        
Accelerated stock repurchase     17,427      
Balance ending at Dec. 31, 2021 $ 452,762 $ 559 241,197 343,542 (130,306) (2,230)
Balance, Shares ending at Dec. 31, 2021 45,659,304 45,659,304        
Balance beginning at Jun. 30, 2021 $ 422,631 $ 556 253,244 279,163 (109,407) (925)
Balance, Shares beginning at Jun. 30, 2021   46,350,945        
Stock-based compensation 2,005   2,005      
Exercise of stock options 1,371 $ 1 1,370      
Exercise of stock options, Shares   112,944        
Settlement of restricted stock units   $ 0 0      
Settlement of restricted stock units, Shares   1,000        
Other comprehensive loss, net (3,478)         (3,478)
Net income (loss) 10,768     10,768    
Balance ending at Sep. 30, 2021 433,297 $ 557 256,619 289,931 (109,407) (4,403)
Balance, Shares ending at Sep. 30, 2021   46,464,889        
Balance beginning at Dec. 31, 2021 $ 452,762 $ 559 241,197 343,542 (130,306) (2,230)
Balance, Shares beginning at Dec. 31, 2021 45,659,304 45,659,304        
Stock-based compensation $ 4,487   4,487      
Exercise of stock options 1,786 $ 1 1,785      
Exercise of stock options, Shares   152,326        
Settlement of restricted stock units (174) $ 2 (176)      
Settlement of restricted stock units, Shares   177,128        
Acquisition of treasury stock (4,638)       (4,638)  
Acquisition of treasury stock, Shares   (378,107)        
Accelerated stock repurchase     17,217   (17,217)  
Accelerated stock repurchase, Shares   (1,031,576)        
Other comprehensive loss, net (30,001)         (30,001)
Net income (loss) (11,007)     (11,007)    
Balance ending at Sep. 30, 2022 $ 413,215 $ 562 264,510 332,535 (152,161) (32,231)
Balance, Shares ending at Sep. 30, 2022 44,579,075 44,579,075        
Balance beginning at Jun. 30, 2022 $ 448,147 $ 562 263,698 349,730 (148,523) (17,320)
Balance, Shares beginning at Jun. 30, 2022   44,903,718        
Stock-based compensation 861   861      
Settlement of restricted stock units (49)   (49)      
Acquisition of treasury stock (3,638)       (3,638)  
Acquisition of treasury stock, Shares   (324,643)        
Other comprehensive loss, net (14,911)         (14,911)
Net income (loss) (17,195)     (17,195)    
Balance ending at Sep. 30, 2022 $ 413,215 $ 562 $ 264,510 $ 332,535 $ (152,161) $ (32,231)
Balance, Shares ending at Sep. 30, 2022 44,579,075 44,579,075        
XML 27 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
shares in Thousands, $ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net income (loss) $ (11,007) $ 3,097
Adjustments to reconcile net income (loss) to net cash provided by operating activities    
Depreciation and amortization 11,225 10,576
Provision for severance benefits 5,163 5,514
Amortization of debt issuance costs and original issue discount   261
Loss on foreign currency, net 66,335 32,607
Provision for inventory reserves 7,730 1,484
Stock-based compensation 4,487 6,056
Other, net 631 442
Changes in operating assets and liabilities    
Accounts receivable, net 7,805 6,696
Inventories (13,208) (4,561)
Other receivables 17,115 (5,287)
Other current assets (14,117) 7,933
Accounts payable (14,792) (16,192)
Other accounts payable (6,215) (3,729)
Accrued expenses 5,866 (1,641)
Accrued income taxes (11,483) (8,308)
Other current liabilities (1,583) 555
Other non-current liabilities 523 (666)
Payment of severance benefits (4,181) (4,772)
Other, net (50) (49)
Net cash provided by operating activities 50,244 30,016
Cash flows from investing activities    
Proceeds from settlement of hedge collateral 2,805 3,995
Payment of hedge collateral (15,282) (2,744)
Purchase of property, plant and equipment (11,812) (13,368)
Payment for intellectual property registration (301) (455)
Collection of guarantee deposits   3,192
Payment of guarantee deposits (2,075) (4,960)
Other, net 792 (103)
Net cash used in investing activities (25,873) (14,443)
Cash flows from financing activities    
Proceeds from exercise of stock options 1,786 3,920
Acquisition of treasury stock (5,065) (1,653)
Repayment of financing related to water treatment facility arrangement (381) (427)
Repayment of principal portion of finance lease liabilities (50) (49)
Net cash provided by (used in) financing activities (3,710) 1,791
Effect of exchange rates on cash and cash equivalents (49,377) (21,003)
Net decrease in cash and cash equivalents (28,716) (3,639)
Beginning of the period 279,547 279,940
End of the period 250,831 276,301
Supplemental cash flow information    
Cash paid for interest   2,094
Cash paid for income taxes 17,856 12,609
Non-cash investing activities    
Property, plant and equipment additions in other accounts payable 3,957 $ 11,513
Exchange of exchangeable senior notes into common stock   83,740
Unsettled common stock repurchases $ (399)  
XML 28 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business, Basis of Presentation and Significant Accounting Policies
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Business, Basis of Presentation and Significant Accounting Policies
1. Business, Basis of Presentation and Significant Accounting Policies
Business
Magnachip Semiconductor Corporation (together with its subsidiaries, the “Company”) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, Internet of Things (“IoT”) applications, consumer, computing, industrial and automotive applications.
The Company’s standard products business includes its Display Solutions and Power Solutions business lines. The Company’s Display Solutions products provide panel display solutions to major suppliers of large and small rigid and flexible panel displays, and mobile, automotive applications and home appliances. The Company’s Power Solutions products include discrete and integrated circuit solutions for power management in communications, consumer, computing, servers, automotive, and industrial applications.
On September 1, 2020, the Company completed the sale of the Company’s Foundry Services Group business and its fabrication facility located in Cheongju, Korea, known as “Fab 4”. Following the consummation of the sale, and for up to three years, the Company is expected to provide transitional foundry services associated with its fabrication facility located in Gumi, Korea, known as “Fab 3”, at an agreed upon cost plus
mark-up
(the “Transitional Fab 3 Foundry Services”).
Basis of Presentation
The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). These interim consolidated financial statements include normal recurring adjustments and the elimination of all intercompany accounts and transactions which are, in the opinion of management, necessary to provide a fair statement of the Company’s financial condition and results of operations for the periods presented. These interim consolidated financial statements are presented in accordance with Accounting Standards Codification (“ASC”) 270, “Interim Reporting” and, accordingly, do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, except for the changes below. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for a full year or for any other periods.
The December 31, 2021 balance sheet data was derived from the Company’s audited financial statements, but does not include all disclosures required by U.S. GAAP. The interim consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the fiscal year ended December 31, 2021.
There have been no material changes to the Company’s significant accounting policies as of and for the nine months ended September 30, 2022 as compared to the significant accounting policies described in the Company’s Annual Report on Form
10-K
for the fiscal year ended December 31, 2021.
Recently Adopted Accounting Pronouncements
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
No. 2020-06,
“Debt—Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40)”
(“ASU
2020-06”),
which updates various codification topics to simplify the accounting guidance for certain financial instruments with characteristics of liabilities and equity, with a specific focus on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and amends the diluted EPS computation for these instruments. The Company adopted ASU
2020-06
as of January 1, 2022, and the adoption of ASU
2020-06
did not have an impact on the Company’s consolidated financial statements.
In May 2021, the FASB issued ASU
No. 2021-04,
“Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic
470-50)”,
Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
815-40):
Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU
2021-04”),
ASU
2021-04
clarifies the accounting for modifications or exchanges of freestanding equity-classified written call options so that the transaction should be treated as an exchange of the original instrument for a new instrument. The Company adopted ASU
2021-04
as of January 1, 2022, and the adoption of ASU
2021-04
did not have an impact on the Company’s consolidated financial statements.
 
XML 29 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories
9 Months Ended
Sep. 30, 2022
Inventory Disclosure [Abstract]  
Inventories
2. Inventories
Inventories as of September 30, 2022 and December 31, 2021 consist of the following (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Finished goods
   $ 6,828      $ 9,594  
Semi-finished goods and
work-in-process
     32,431        25,968  
Raw materials
     9,282        9,443  
Materials
in-transit
     295        95  
Less: inventory reserve
     (11,538      (5,730
    
 
 
    
 
 
 
Inventories, net
   $ 37,298      $  39,370  
    
 
 
    
 
 
 
Changes in inventory reserve for the three and nine months ended September 30, 2022 and 2021 are as follows (in thousands):

 
 
  
Three Months
Ended
 
  
Nine Months
Ended
 
  
Three Months
Ended
 
  
Nine Months
Ended
 
  
September 30, 2022
 
  
September 30, 2021
 
Beginning balance
   $  (10,206    $  (5,730    $  (8,101    $  (5,901
Change in reserve
                                   
Inventory reserve charged to costs of sales
     (3,199      (10,899      (242      (5,592
Sale of previously reserved inventory
     672        2,996        2,099        4,076  
    
 
 
    
 
 
    
 
 
    
 
 
 
       (2,527      (7,903      1,857        (1,516
Write off
     16        311        180        1,110  
Translation adjustments
     1,179        1,784        328        571  
    
 
 
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (11,538    $  (11,538    $  (5,736    $  (5,736
    
 
 
    
 
 
    
 
 
    
 
 
 
Inventory reserve represents the Company’s best estimate in value lost due to excessive inventory level, physical deterioration, obsolescence, changes in price levels, or other causes based on individual facts and circumstances. Inventory reserve relates to inventory items including finished goods, semi-finished goods,
work-in-process
and raw materials. Write off of this reserve is recognized only when the related inventory has been disposed or scrapped.
 
XML 30 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Plant and Equipment
9 Months Ended
Sep. 30, 2022
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
3. Property, Plant and Equipment
Property, plant and equipment as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Buildings and related structures
   $ 21,484      $ 24,273  
Machinery and equipment
     94,152        105,300  
Finance lease
right-of-use
assets
     340        316  
Others
     29,233        32,396  
    
 
 
    
 
 
 
       145,209        162,285  
Less: accumulated depreciation
     (86,281      (94,119
Land
     11,513        13,898  
Construction in progress
     23,970        25,818  
    
 
 
    
 
 
 
Property, plant and equipment, net
   $ 94,411      $  107,882  
    
 
 
    
 
 
 
Aggregate depreciation expenses totaled $10,699 thousand and $10,018 thousand for the nine months ended September 30, 2022 and 2021, respectively.
XML 31 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible Assets
9 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets
4. Intangible Assets
Intangible assets as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):

 
  
September 30, 2022
 
  
Gross
amount
 
  
Accumulated
amortization
 
  
Net
amount
 
Intellectual property assets
   $ 8,040      $ (6,270    $ 1,770  
    
 
 
    
 
 
    
 
 
 
Intangible assets
   $ 8,040      $ (6,270    $ 1,770  
    
 
 
    
 
 
    
 
 
 

 
  
December 31, 2021
 
  
Gross
amount
 
  
Accumulated
amortization
 
  
Net
amount
 
Intellectual property assets
   $ 9,312      $ (6,935    $ 2,377  
    
 
 
    
 
 
    
 
 
 
Intangible assets
   $ 9,312      $ (6,935    $ 2,377  
    
 
 
    
 
 
    
 
 
 
Aggregate amortization expenses for intangible assets totaled $526 thousand and $558 thousand for the nine months ended September 30, 2022 and 2021, respectively.
 
XML 32 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases
9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
Leases
5. Leases
The Company has operating and finance leases for buildings and other assets such as vehicles and office equipment. The Company’s leases have remaining lease terms ranging from 1 year to 5 years.
The tables below present financial information related to the Company’s leases.
Supplemental balance sheets information related to leases as of September 30, 2022 and December 31, 2021 are as follows (in thousands):

Leases
  
Classification
 
  
September 30,
2022
 
  
December 31,
2021
 
Assets
  
 
 
 
             
Operating lease
  
 
Operating lease right-of-use assets
 
   $  4,928      $  4,275  
Finance lease
  
 
Property, plant and equipment, net
 
     141        126  
    
 
 
 
  
 
 
    
 
 
 
Total lease assets
  
 
 
 
   $ 5,069      $ 4,401  
    
 
 
 
  
 
 
    
 
 
 
Liabilities
  
 
 
 
                 
Current
  
 
 
 
                 
Operating
  
 
Operating lease liabilities
 
   $ 1,324      $ 2,323  
Finance
  
 
Other current liabilities
 
     78        68  
Non-current
  
 
 
 
                 
Operating
  
 
Non-current operating lease liabilities
 
     3,811        1,952  
Finance
  
 
Other
non-current
liabilities
 
     73        73  
    
 
 
 
  
 
 
    
 
 
 
Total lease liabilities
  
 
 
 
   $ 5,286      $ 4,416  
    
 
 
 
  
 
 
    
 
 
 
The following table presents the weighted average remaining lease term and discount rate:

 
 
  
September 30,
2022
 
 
December 31,
2021
 
Weighted average remaining lease term
                
Operating leases
     3.9 years       2.4 years  
Finance leases
     2.5 years       2.0 years  
Weighted average discount rate
                
Operating leases
     6.58     4.20
Finance leases
     7.63     7.75
The components of lease cost included in the Company’s consolidated statements of operations, are as follows (in thousands):

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Operating lease cost
   $  557      $  691      $  1,738      $  2,098  
Finance lease cost
                                   
Amortization of
right-of-use
assets
     18        17        48        50  
Interest on lease liabilities
     2        4        7        11  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total lease cost
   $ 577      $ 712      $ 1,793      $ 2,159  
    
 
 
    
 
 
    
 
 
    
 
 
 
The above table does not include an immaterial cost of short-term leases for the nine months ended September 30, 2022 and 2021.
 
Other lease information is as follows (in thousands):


 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Cash paid for amounts included in the measurement of lease liabilities
                                   
Operating cash flows from operating leases
   $  561      $  691      $  1,742      $  2,098  
Operating cash flows from finance leases
     2        4        7        11  
Financing cash flows from finance leases
     18        16        50        49  
The aggregate future lease payments for operating and finance leases as of September 30, 2022 are as follows (in thousands):

 
 
  
Operating
Leases
 
  
Finance
Leases
 
Remainder of 2022
   $ 508      $ 22  
2023
     1,449        86  
2024
     1,330        24  
2025
     1,218        23  
2026
     846        11  
2027
     585        —    
    
 
 
    
 
 
 
Total future lease payments
     5,936        166  
Less: Imputed interest
     (801      (15
    
 
 
    
 
 
 
Present value of future payments
   $  5,135      $  151  
    
 
 
    
 
 
 
XML 33 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Expenses
9 Months Ended
Sep. 30, 2022
Payables and Accruals [Abstract]  
Accrued Expenses
6. Accrued Expenses
Accrued expenses as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):
 
    
September 30,

2022
    
December 31,

2021
 
Payroll, benefits and related taxes, excluding severance benefits
   $  10,552      $ 9,548  
Withholding tax attributable to intercompany interest income
     3,345        1,950  
Outside service fees
     1,608        1,088  
Merger-related costs
     —          7,035  
Others
     295        450  
    
 
 
    
 
 
 
Accrued expenses
   $ 15,800      $  20,071  
    
 
 
    
 
 
 
 
XML 34 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments
9 Months Ended
Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
7. Derivative Financial Instruments
The Company’s Korean subsidiary from time to time has entered into zero cost collar contracts to hedge the risk of changes in the functional-currency-equivalent cash flows attributable to currency rate changes on U.S. dollar denominated revenues.
Details of the zero cost collar contracts as of September 30, 2022 are as follows (in thousands):
 
Date of transaction
  
Total notional amount
    
Month of settlement
August 13, 2021
   $ 15,000     
October 202
2 to December 2022
January 04, 2022
   $ 39,000      October 2022 to June 2023
March 07, 2022
   $ 24,000      July 2023 to December 2023
April 27, 2022
   $ 51,000      October 2022 to December 2023
Details of the zero cost collar contracts as of December 31, 2021 are as follows (in thousands):
 
Date of transaction
  
Total notional amount
    
Month of settlement
May 13, 2021
   $ 39,000      January 2022 to September 2022
August 13, 2021
   $ 48,000      January 2022 to December 2022
The zero cost collar contracts qualify as cash flow hedges under ASC 815, “Derivatives and Hedging,” since at both the inception of the contracts and on an ongoing basis, the hedging relationship was and is expected to be highly effective in achieving offsetting cash flows attributable to the hedged risk during the term of the contracts.
The fair values of the Company’s outstanding zero cost collar contracts recorded as liabilities as of September 30, 2022 and December 31, 2021 are as follows (in thousands):

Derivatives designated as hedging instruments:
  
 
 
  
September 30,
2022
 
  
December 31,
2021
 
Liability Derivatives:
                          
Zero cost collars
     Other current liabilities      $ 12,744      $ 2,020  
Zero cost collars
    
Other non-current liabilities
     $ 2,318      $ —    
Offsetting of derivative liabilities as of September 30, 2022 is as follows (in thousands):

 
As of September 30, 2022
  
Gross amounts of
recognized
liabilities
 
  
Gross amounts
offset in the
balance sheets
 
  
Net amounts of
liabilities
presented in the
balance sheets
 
  
Gross amounts not offset
in the balance sheets
 
 
Net amount
 
  
Financial
instruments
 
  
Cash collateral
pledged
 
Liability Derivatives:
                                                    
Zero cost collars
   $ 15,062      $ —        $ 15,062      $ —        $ (14,370   $ 692  
Offsetting of derivative liabilities as of December 31, 2021 is as follows (in thousands):

As of December 31, 2021
  
Gross amounts of
recognized
liabilities
 
  
Gross amounts
offset in the
balance sheets
 
  
Net amounts of
liabilities
presented in the
balance sheets
 
  
Gross amounts not offset
in the balance sheets
 
 
Net amount
 
  
Financial
instruments
 
  
Cash collateral
pledged
 
Liability Derivatives:
                                                    
Zero cost collars
   $ 2,020      $ —        $ 2,020      $ —        $ (2,060   $ (40

For derivative instruments that are designated and qualify as cash flow hedges, gains or losses on the derivative aside from components excluded from the assessment of effectiveness are reported as a component of accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative, representing hedge components excluded from the assessment of effectiveness, are recognized in current earnings.
The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the three months ended September 30, 2022 and 2021 (in thousands):
 
Derivatives in ASC
815 Cash Flow Hedging
Relationships
  
Amount of Loss
Recognized in
AOCI on
Derivatives
 
 
Location/Amount of Loss
Reclassified from AOCI
Into Statement of Operations
 
 
Location/Amount of Gain
Recognized in
Statement of Operations on Derivatives
 
 
  
Three Months Ended
September 30,
 
 
 
 
  
Three Months Ended
September 30,
 
 
 
 
  
Three Months Ended
September 30,
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
  
2021
 
Zero cost collars
   $ (11,757   $ (3,271     Net sales      $ (2,820)     $   (653)     Other income, net      $ 146      $ 237  
The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the nine months ended September 30, 2022 and 2021 (in thousands).
 
Derivatives in ASC
815 Cash Flow Hedging
Relationships
  
Amount of Loss
Recognized in
AOCI on
Derivatives
 
 
Location/Amount of Gain (Loss)
Reclassified from AOCI
Into Statement of Operations
 
  
Location/Amount of Gain
Recognized in
Statement of Operations on Derivatives
 
 
  
Nine Months Ended
September 30,
 
 
 
 
  
Nine Months Ended
September 30,
 
  
 
 
  
Nine Months Ended
September 30,
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
 
2021
 
  
 
 
  
2022
 
  
2021
 
Zero cost collars
   $ (19,498   $ (4,964     Net sales      $ (5,378)     $ 333        Other income, net      $ 201      $ 94  
As of September 30, 2022, the amount expected to be reclassified from accumulated other comprehensive loss into loss within the next 12 months is $13,262 thousand.
The Company set aside cash deposits to the counterparties, Nomura Financial Investment (Korea) Co., Ltd. (“NFIK”) and Standard Chartered Bank Korea Limited (“SC”), as required for the zero cost collar contracts. These cash deposits are recorded as hedge collateral on the consolidated balance sheets. Cash deposits as of September 30, 2022 and December 31, 2021 are as follows (in
thousands):
 
Counterparties
  
September 30,
2022
 
  
December 31,
2021
 
SC
   $ 1,000      $ 1,000  
The Company is required to deposit additional cash collateral with NFIK and SC for any exposure in excess of $500 thousand. As of September 30, 2022, $11,670 thousand and $2,700 thousand of additional cash collateral was required by NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance sheet. As of December 31, 2021, $760 thousand and $1,300 thousand of additional cash collateral was required by NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance sheet.
These zero cost collar contracts may be terminated by the counterparties if the Company’s total cash and cash equivalents is less than $30,000 thousand at the end of a fiscal quarter, unless a waiver is obtained.
 
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements
8. Fair Value Measurements
Fair Value of Financial Instruments
As of September 30, 2022, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in thousands):

 
 
  
Carrying Value
September 30, 2022
 
  
Fair Value
Measurement
September 30, 2022
 
  
Quoted Prices in
Active Markets
for Identical
Liability (Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Unobservable
Inputs
(Level 3)
 
Liabilities:
                                            
Derivative liabilities (other current liabilities)
   $ 12,744      $ 12,744        —        $ 12,744        —    
Derivative liabilities (other
non-current
liabilities)
   $ 2,318      $ 2,318        —        $ 2,318        —    
As of December 31, 2021, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in
thousands):
 
 
  
Carrying Value
December 31, 2021
 
  
Fair Value
Measurement
December 31, 2021
 
  
Quoted Prices in
Active Markets
for Identical
Liability (Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Unobservable
Inputs
(Level 3)
 
Liabilities:
                                            
Derivative liabilities (other current liabilities)
   $ 2,020      $ 2,020        —        $ 2,020        —    
Items not reflected in the table above include cash equivalents, accounts receivable, other receivables, accounts payable, and other accounts payable, fair value of which approximate carrying values due to the short-term nature of these instruments. The fair value of assets and liabilities whose carrying value approximates fair value is determined using Level 2 inputs.
 
XML 36 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Severance Benefits
9 Months Ended
Sep. 30, 2022
Postemployment Benefits [Abstract]  
Accrued Severance Benefits
9. Accrued Severance Benefits
The majority of accrued severance benefits are for employees in the Company’s Korean subsidiary. Pursuant to the Employee Retirement Benefit Security Act of Korea, eligible employees and executive officers with one or more years of service are entitled to severance benefits upon the termination of their employment based on their length of service and rate of pay. As of September 30, 2022, 97% of all employees of the Company were eligible for severance benefits.
Changes in accrued severance benefits are as follows (in thousands):
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
September 30, 2022
 
 
September 30, 2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
Beginning balance
  
$ 47,586     $ 51,567      $ 53,105      $ 54,452  
Provisions
  
  1,923       5,163        2,007        5,514  
Severance payments
  
  (1,247     (4,181      (1,936      (4,772
Translation adjustments
  
  (4,730     (9,017      (2,441      (4,459
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
  
  43,532       43,532        50,735        50,735  
Less: Cumulative contributions to
severance insurance deposit
accounts

  
  (15,292     (15,292      (12,739      (12,739
The National Pension Fund

  
  (40     (40      (55      (55
Group severance insurance plan

  
  (164     (164      (200      (200
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Accrued severance benefits,
 
net
  
$ 28,036     $ 28,036      $ 37,741      $ 37,741  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The severance benefits funded through the Company’s National Pension Fund and group severance insurance plan will be used exclusively for payment of severance benefits to eligible employees. These amounts have been deducted from the accrued severance benefit balance.
Beginning in July 2018, the Company contributes to certain severance insurance deposit accounts a certain percentage of severance benefits that are accrued for eligible employees for their services from January 1, 2018. These accounts consist of time deposits and other guaranteed principal and interest, and are maintained at insurance companies, banks or security companies for the benefit of employees. The Company deducts the contributions made to these severance insurance deposit accounts from its accrued severance benefits.
The Company is liable to pay the following future benefits to its
non-executive
employees upon their normal retirement age (in thousands):
 
 
  
Severance benefit
 
Remainder of 2022
   $ 212  
2023
     534  
2024
     769  
2025
     1,273  
2026
     1,772  
2027
     1,463  
2028 – 2032
     17,223  
The above amounts were determined based on the
non-executive
employees’ current salary rates and the number of service years that will be accumulated upon their retirement dates. These amounts do not include amounts that might be paid to
non-executive
employees that will cease working with the Company before their normal retirement ages.
Korea’s mandatory retirement age is 60 years of age or older under the Employment Promotion for the Aged Act. The Company sets the retirement age of employees at 60.
 
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Foreign Currency Loss, Net
9 Months Ended
Sep. 30, 2022
Foreign Currency [Abstract]  
Foreign Currency Loss, Net
10. Foreign Currency Loss, Net
Net foreign currency gain or loss includes
non-cash
translation gain or loss associated with intercompany balances. A substantial portion of the Company’s net foreign currency gain or loss is
non-cash
translation gain or loss associated with intercompany long-term loans to the Company’s Korean subsidiary. The loans are denominated in U.S. dollars and are affected by changes in the exchange rate between the Korean won and the U.S. dollar. As of September 30, 2022 and December 31, 2021, the outstanding intercompany loan balances including accrued interest between the Korean subsidiary and the Dutch subsidiary were $356,746 thousand and $344,411 thousand, respectively. The Korean won to U.S. dollar exchange rates were 1,434.8:1 and 1,185.5:1 using the first base rate as of September 30, 2022 and December 31, 2021, respectively, as quoted by the KEB Hana Bank.
XML 38 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes
9 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
Income Taxes
11. Income Taxes
The Company and its subsidiaries file income tax returns in Korea, the U.S. and in various other jurisdictions. The Company is subject to income or
non-income
tax examinations by tax authorities of these jurisdictions for all open tax years.
For the three and nine months ended September 30, 2022, the Company recorded an income tax benefit of $3,942 thousand and $1,356 
thousand, respectively, primarily attributable to a decrease in its Korean subsidiary’s
pre-tax
income for the respective period due to the foreign currency translation loss recorded in its Korean subsidiary in connection with intercompany loans.
For the three and nine months ended September 30, 2021, the Company recorded an income tax expense of $3,149 thousand and $6,040 
thousand, respectively, primarily attributable to the Company’s Korean subsidiary based on its estimated taxable income for the respective period, combined with its ability to utilize net operating loss carryforwards
up to 60%, and interest on intercompany loan balances.
XML 39 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Geographic and Other Information
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Geographic and Other Information
12. Geographic and Other Information
The following sets forth information relating to the single operating segment (in thousands):


 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Revenues
                                   
Standard products business
                                   
Display Solutions
   $ 6,355      $ 58,528      $ 63,876      $  164,024  
Power Solutions
     56,416        58,887        184,193        169,565  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total standard products business
     62,771        117,415        248,069        333,589  
Transitional Fab 3 foundry services
     8,428        9,585        28,599        30,306  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenues
   $  71,199      $  127,000      $  276,668      $ 363,895  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Gross Profit
                                   
Standard products business
   $  17,274      $  45,773      $  82,872      $  112,291  
Transitional Fab 3 foundry services
     (49      814        2,294        2,648  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total gross profit
   $ 17,225      $ 46,587      $ 85,166      $ 114,939  
    
 
 
    
 
 
    
 
 
    
 
 
 
The following is a summary of net sales—standard products business (which does not include the Transitional Fab 3 Foundry Services) by geographic region, based on the location to which the products are billed (in thousands):

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Korea
   $  23,867      $ 29,664      $ 86,065      $ 86,966  
Asia Pacific (other than Korea)
     34,612        84,220        148,940        237,312  
United States
     2,718        1,756        8,074        4,393  
Europe
     1,574        1,398        4,990        3,847  
Others
            377               1,071  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 62,771      $  117,415      $  248,069      $  333,589  
    
 
 
    
 
 
    
 
 
    
 
 
 
For the three months ended September 30, 2022 and 2021, of the Company’s net sales – standard products business in Asia Pacific (other than Korea), net sales – standard products business in China and Hong Kong represented 74.2% and 72.0%, respectively, and net sales—standard products business in Vietnam represented 2.4% and 19.6%, respectively. For the nine months ended September 30, 2022 and 2021, of the Company’s net sales – standard products business in Asia Pacific (other than Korea), net sales – standard products business in China and Hong Kong represented 66.4% and 63.4%, respectively, and net sales—standard products business in Vietnam represented 16.2% and 29.5%, respectively.
Net sales from the Company’s top ten largest customers in the standard products business (which does not include the Transitional Fab 3 Foundry Services) accounted for 64% and 81% for the three months ended September 30, 2022 and 2021, respectively, and 70% and 81% for the nine months ended September 30, 2022 and 2021, respectively.
For the three months ended September 30, 2022, the Company had one customer that represented 16.2% of its net sales – standard products business. For the nine months ended September 30, 2022, the Company had two customers that represented 20.6% and 13.9% of its net sales – standard products business. For the three months ended September 30, 2021, the Company had two customers that represented 44.7% and 10.1% of its net sales – standard products business. For the nine months ended September 30, 2021, the Company had two customers that represented 44.6% and 10.6% of its net sales – standard products business.
As of September 30, 2022, two customers of the Company’s standard products business accounted for 24.1% and 11.8% of its accounts receivable – standard products business (which does not include the Transitional Fab 3 Foundry Services), respectively. As of December 31, 2021, two customers of the Company’s standard products business accounted for 31.5% and 16.1% of its accounts receivable – standard products business (which does not include the Transitional Fab 3 Foundry Services), respectively.
 
XML 40 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accumulated Other Comprehensive Loss
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Accumulated Other Comprehensive Loss
13. Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss consists of the following as of September 30, 2022 and December 31, 2021, respectively (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Foreign currency translation adjustments
   $  (16,651    $ (770
Derivative adjustments
     (15,580      (1,460
    
 
 
    
 
 
 
Total
   $  (32,231    $  (2,230
    
 
 
    
 
 
 
Changes in accumulated other comprehensive loss for the three months ended September 30, 2022 and 2021 are as follows (in
thousands):
 
Three Months Ended September 30, 2022
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $  (10,677    $  (6,643    $  (17,320
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (5,974      (11,757      (17,731
Amounts reclassified from accumulated other comprehensive loss
     —          2,820        2,820  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (5,974      (8,937      (14,911
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (16,651    $  (15,580    $  (32,231
    
 
 
    
 
 
    
 
 
 
 
Three Months Ended September 30, 2021
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ 120      $  (1,045    $ (925
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (860      (3,271      (4,131
Amounts reclassified from accumulated other comprehensive loss
            653        653  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (860      (2,618      (3,478
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (740    $  (3,663    $  (4,403
    
 
 
    
 
 
    
 
 
 
Changes in accumulated other comprehensive loss for the nine months ended September 30, 2022 and 2021 are as follows (in
thousands):
 
Nine Months Ended September 30, 2022
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ (770    $  (1,460    $  (2,230
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (15,881      (19,498      (35,379
Amounts reclassified from accumulated other comprehensive loss
     —          5,378        5,378  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (15,881      (14,120      (30,001
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (16,651    $  (15,580    $  (32,231
    
 
 
    
 
 
    
 
 
 
 
Nine Months Ended September 30, 2021
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ 2,069      $ 1,634      $ 3,703  
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (2,809      (4,964      (7,773
Amounts reclassified from accumulated other comprehensive income
     —          (333      (333
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (2,809      (5,297      (8,106
    
 
 
    
 
 
    
 
 
 
Ending balance
   $ (740    $  (3,663    $  (4,403
    
 
 
    
 
 
    
 
 
 
 
XML 41 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Repurchases
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Stock Repurchases
14. Stock Repurchases
On December 21, 2021, the Board of Directors authorized the Company to repurchase up to $75,000 thousand of the Company’s outstanding common stock and the Company entered into an accelerated stock repurchase agreement (the “ASR Agreement”) with JPMorgan Chase Bank, National Association (“JPM”) to repurchase an aggregate of $37,500 thousand of the Company’s common stock.
Pursuant to the terms of the ASR Agreement dated December 21, 2021, the Company paid to JPM $37,500 thousand in cash and received an initial delivery of 994,695 shares of its common stock in the open market for an aggregate purchase price of $20,073 thousand and a price per share of $20.18 on December 22, 2021.
As of December 31, 2021, the Company accounted for the remaining portion of the ASR Agreement as a forward contract indexed to its own common stock and recorded $17,427 thousand in additional
paid-in
capital in stockholders’ equity in its consolidated balance sheets.
In March 2022, the previously announced repurchase of $37,500 thousand of the Company’s common stock was completed pursuant to the ASR Agreement, and as a result, the Company additionally received 1,031,576 shares of its common stock for an aggregate purchase price of $ 17,217 thousand at a price per share of $16.69, which was reclassified as treasury stock from additional
paid-in
capital in stockholder’s equity in the Company’s consolidated balance sheets.
On August 31, 2022, the Board of Directors has authorized an expansion of the Company’s previously announced stock repurchase program from $75,000 thousand to $87,500 thousand of the Company’s common stock.
In September 2022, the Company repurchased
 
324,643
shares of its common stock in the open market for an aggregate purchase price of $
3,638 
thousand and a price per share of $
11.21
under the stock repurchase program.
 
XML 42 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share
15. Earnings (Loss) Per Share
The following table illustrates the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2022 and
2021:
 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(In thousands of U.S. dollars, except share data)
 
Basic earnings (loss) per share
                                   
Net income (loss)
   $ (17,195    $ 10,768      $ (11,007    $ 3,097  
Basic weighted average common stock outstanding
     44,865,266        46,449,234        45,119,214        44,377,250  
Basic earnings (loss) per common share
   $ (0.38    $ 0.23      $ (0.24    $ 0.07  
Diluted earnings (loss) per share
                                   
Net income (loss)
   $ (17,195    $ 10,768      $ (11,007    $ 3,097  
Basic weighted average common stock outstanding
     44,865,266        46,449,234        45,119,214        44,377,250  
Net effect of dilutive equity awards
     —          1,359,223        —          1,434,542  
    
 
 
    
 
 
    
 
 
    
 
 
 
Diluted weighted average common stock outstanding
     44,865,266        47,808,457        45,119,214        45,811,792  
Diluted earnings (loss) per share
   $ (0.38    $ 0.23      $ (0.24    $ 0.07  
The following outstanding instruments were excluded from the computation of diluted earnings (loss) per share, as they have an anti-dilutive effect on the calculation:

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
Options
     1,141,551        50,000        1,141,551        50,000  
Restricted Stock Units
     1,014,124        —          1,014,124        —    
For the nine months ended September 30, 2021, 1,906,786 shares, of potential common stock from the assumed conversion of Exchangeable Notes were also excluded from the computation of diluted loss per share as the effect were anti-dilutive for the period.
Rights Plan
The Company entered into a Rights Agreement, dated as of December 13, 2021, between the Company and American Stock Transfer & Trust Company, LLC, as rights agent (the “Rights Agreement”), and the Board of Directors of the Company authorized and declared a dividend of one preferred stock purchase right (a “Right” and collectively, the “Rights”) for each share of the Company’s common stock, par value $0.01 per share, outstanding at the close of business on December 23, 2021. Each Right, once exercisable, will entitle the registered holder to purchase from the Company one
one-thousandth
of a share of Series
A-1
Junior Participating Preferred Stock, par value $0.01 per share, at a purchase price of $80, subject to adjustment (the “Purchase Price”). The Rights are not presently exercisable and remain attached to the shares of common stock unless and until the occurrence of the earlier of the following (the “Distribution Date”): (i) the tenth day after the public announcement or disclosure by the Company or any person or group of affiliated or associated persons that any person or group of affiliated or associated persons has become an “Acquiring Person” by obtaining beneficial ownership of 12.5% (or 20% in the case of a “passive institutional investor,” which is defined generally as any person who has reported beneficial ownership of shares of common stock on Schedule 13G under the Securities Exchange Act of 1934) or more of the Company’s outstanding common stock, subject to certain exceptions; or (ii) the tenth business day (or such later date as the Company’s Board of Directors may designate before a person or group of affiliated or associated persons becomes an Acquiring Person) after (and not including) the commencement of, or first public announcement of the intent of any person to commence, a tender or exchange offer by any person or group of affiliated or associated persons, which would, if consummated, result in such person or group becoming an Acquiring Person. The Board of Directors may redeem all of the Rights for $0.001 per Right at any time before any person or group of affiliated or associated persons becomes an Acquiring Person. In addition, at any time on or after any person or group of affiliated or associated persons becomes an Acquiring Person (but before any person or group of affiliated or associated persons becomes the owner of 50% or more of the Company’s outstanding common stock), the Board of Directors may exchange all or part of the Rights (other than the Rights beneficially owned by the Acquiring Person and certain affiliated persons) for shares of common stock at an exchange ratio of one share of common stock per Right. The Rights will expire at the close of business on December 12, 2022, unless redeemed or exchanged prior to that time.
If any person or group of affiliated or associated persons becomes an Acquiring Person, then, after the Distribution Date, each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons or transferees thereof) will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock having a market value of twice the Purchase Price. Alternatively, if, after any person or group of affiliated or associated persons becomes an Acquiring Person, (1) the Company is involved in a merger or other business combination in which the Company is not the surviving corporation or its common stock is changed into or exchanged for other securities or assets; or (2) the Company or one or more of its subsidiaries sell or otherwise transfer assets or earning power aggregating more than 50% of
the
assets or earning power of the Company and its subsidiaries, taken as a whole, then each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons) will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock of the other party to such business combination or sale (or in certain circumstances, an affiliate) having a market value of twice the Purchase Price.
XML 43 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Merger Agreement
9 Months Ended
Sep. 30, 2022
Business Combinations [Abstract]  
Merger Agreement
16. Merger Agreement
On March 25, 2021, the Company, South Dearborn Limited, an exempted company incorporated in the Cayman Islands with limited liability (“Holdco”), formed by an affiliate of Wise Road Capital LTD (“Wise Road”), and Michigan Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Holdco (“Merger Sub”), entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”), providing for, among other things and subject to the terms and conditions thereof, the merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Holdco.
The closing of the Merger was subject to certain conditions, including clearance by the Committee on Foreign Investment in the United States (“CFIUS”) under the Defense Production Act of 1950, as amended. The Company and Holdco were advised that CFIUS clearance of the Merger would not be forthcoming and received permission from CFIUS to withdraw their joint filing. In connection therewith, the Company and Holdco entered into a Termination and Settlement Agreement, dated December 13, 2021 (the “Termination Agreement”), pursuant to which Holdco agreed to pay
$70,200 thousand (the “Termination Fee”) to the Company on the terms specified in the Termination Agreement in satisfaction of Holdco’s obligation
to
 
pay a termination fee in connection with the termination of the Merger Agreement. On December 20, 2021, the Merger Agreement was terminated pursuant to the Termination Agreement after the Company’s receipt of a fee of $51,000 thousand from Holdco and a standby letter of credit, which
secures a deferred fee of $19,200 thousand from Holdco due on or before March 31, 2022. As of December 31, 2021, of the Termination Fee, $19,200 thousand deferred fee was recorded as other receivables. In connection therewith, the Company, Holdco and Wise Road entered into a First Amendment to the Termination Agreement, dated April 4, 2022, pursuant to which Holdco paid $14,400 thousand on April 4, 2022, with

$4,800 thousand remaining outstanding. The Company, Holdco and Wise Road entered into a Second Amendment to the Termination Agreement, dated August 5, 2022 pursuant to which Holdco paid $3,000 thousand on August 5, 2022, of the deferred fee and payment of the remaining $1,800 thousand is
due on or before October 31, 2022.
 The Company, Holdco and Wise Road entered into a Letter Agreement, dated October 28, 2022 pursuant to which
the parties agreed to defer the remaining $1,800 thousand due on or before December 23,
2022. As of September 30, 2022, the remaining fee of $1,800 thousand was recorded as other receivables. Other than in respect of this receivable, the Company has no further relationship with Holdco.
For the three and nine months ended September 30, 2021, the Company incurred $1,552 thousand and $13,842 thousand, respectively, of professional fees and certain transaction related-expenses incurred in connection with the Merger, which were recognized in merger-related costs in the consolidated statements of operations.
XML 44 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
17. Commitments and Contingencies
Advances to Suppliers
The Company, from time to time, may make advances in form of prepayments or deposits to suppliers, including external foundries, to meet its planned production. The Company recorded advances of $9,532 thousand and $1,708 thousand as other current assets as of September 30, 2022 and December 31, 2021, respectively.
COVID-19
Pandemic
In December 2019, a strain of coronavirus causing a disease known as
COVID-19
surfaced in Wuhan, China, resulting in significant disruptions among Chinese manufacturing and other facilities and travel throughout China. In March 2020, the World Health Organization declared the
COVID-19
outbreak a pandemic. Governmental authorities throughout the world have implemented numerous containment measures, including travel bans and restrictions, quarantines,
shelter-in-place
orders, and business restrictions and shutdowns, resulting in rapidly changing market and economic conditions. Although some of these restrictions and other containment measures have since been lifted or scaled back, ongoing surges of
COVID-19
have in some cases resulted in the
re-imposition
of certain restrictions and containment measures, and may continue to lead to other restrictions being
re-implemented
in the foreseeable future in response to efforts to reduce the rapid spread of
COVID-19.
The Company experienced some minor disruption in its Power Solutions business from assembly and test subcontractors located in China in the first quarter of 2020 as a result of the
COVID-19
pandemic. To date, its external Display Solutions business contractors and
sub-contractors
have not been materially impacted by the
COVID-19
pandemic. The Company is, however, unable to accurately predict the full impact that the
COVID-19
pandemic will have on its future results of operations due to numerous uncertainties. The extent to which the
COVID-19
pandemic impacts the Company’s business, results of operations and financial condition will depend on future developments, which, despite progress in vaccination efforts, are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information that may emerge concerning the severity of the
COVID-19
pandemic, such as new strains of the virus, including the Delta and Omicron variants and any future variants that may emerge, which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines and the extent and effectiveness of actions to contain the
COVID-19
pandemic or treat its impact, including vaccination campaigns and lockdown measures, among others. In addition, recurrences or additional waves of
COVID-19
cases could cause other widespread or more severe impacts depending on where infection rates are highest. The Company cannot presently predict the scope and severity of any potential business shutdowns or disruptions, but if the Company or any of its customers and suppliers were to experience prolonged business shutdowns or other disruptions, its ability to conduct its business could be materially and negatively affected, which could have a material adverse impact on its business, results of operations and financial condition.
The Company continues to closely monitor and evaluate the nature and scope of the impact of the
COVID-19
pandemic to its business, consolidated results of operations, and financial condition, and may take further actions altering its business operations and managing its costs and liquidity that the Company deems necessary or appropriate to respond to this ongoing and uncertain global health crisis and the resulting global economic consequences.
XML 45 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Business
Business
Magnachip Semiconductor Corporation (together with its subsidiaries, the “Company”) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, Internet of Things (“IoT”) applications, consumer, computing, industrial and automotive applications.
The Company’s standard products business includes its Display Solutions and Power Solutions business lines. The Company’s Display Solutions products provide panel display solutions to major suppliers of large and small rigid and flexible panel displays, and mobile, automotive applications and home appliances. The Company’s Power Solutions products include discrete and integrated circuit solutions for power management in communications, consumer, computing, servers, automotive, and industrial applications.
On September 1, 2020, the Company completed the sale of the Company’s Foundry Services Group business and its fabrication facility located in Cheongju, Korea, known as “Fab 4”. Following the consummation of the sale, and for up to three years, the Company is expected to provide transitional foundry services associated with its fabrication facility located in Gumi, Korea, known as “Fab 3”, at an agreed upon cost plus
mark-up
(the “Transitional Fab 3 Foundry Services”).
Basis of Presentation
Basis of Presentation
The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). These interim consolidated financial statements include normal recurring adjustments and the elimination of all intercompany accounts and transactions which are, in the opinion of management, necessary to provide a fair statement of the Company’s financial condition and results of operations for the periods presented. These interim consolidated financial statements are presented in accordance with Accounting Standards Codification (“ASC”) 270, “Interim Reporting” and, accordingly, do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, except for the changes below. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for a full year or for any other periods.
The December 31, 2021 balance sheet data was derived from the Company’s audited financial statements, but does not include all disclosures required by U.S. GAAP. The interim consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the fiscal year ended December 31, 2021.
There have been no material changes to the Company’s significant accounting policies as of and for the nine months ended September 30, 2022 as compared to the significant accounting policies described in the Company’s Annual Report on Form
10-K
for the fiscal year ended December 31, 2021.
Recently Adopted Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
No. 2020-06,
“Debt—Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40)”
(“ASU
2020-06”),
which updates various codification topics to simplify the accounting guidance for certain financial instruments with characteristics of liabilities and equity, with a specific focus on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and amends the diluted EPS computation for these instruments. The Company adopted ASU
2020-06
as of January 1, 2022, and the adoption of ASU
2020-06
did not have an impact on the Company’s consolidated financial statements.
In May 2021, the FASB issued ASU
No. 2021-04,
“Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic
470-50)”,
Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
815-40):
Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU
2021-04”),
ASU
2021-04
clarifies the accounting for modifications or exchanges of freestanding equity-classified written call options so that the transaction should be treated as an exchange of the original instrument for a new instrument. The Company adopted ASU
2021-04
as of January 1, 2022, and the adoption of ASU
2021-04
did not have an impact on the Company’s consolidated financial statements.
XML 46 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories (Tables)
9 Months Ended
Sep. 30, 2022
Inventory Disclosure [Abstract]  
Summary of Inventories
Inventories as of September 30, 2022 and December 31, 2021 consist of the following (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Finished goods
   $ 6,828      $ 9,594  
Semi-finished goods and
work-in-process
     32,431        25,968  
Raw materials
     9,282        9,443  
Materials
in-transit
     295        95  
Less: inventory reserve
     (11,538      (5,730
    
 
 
    
 
 
 
Inventories, net
   $ 37,298      $  39,370  
    
 
 
    
 
 
 
Changes in Inventory Reserve
Changes in inventory reserve for the three and nine months ended September 30, 2022 and 2021 are as follows (in thousands):

 
 
  
Three Months
Ended
 
  
Nine Months
Ended
 
  
Three Months
Ended
 
  
Nine Months
Ended
 
  
September 30, 2022
 
  
September 30, 2021
 
Beginning balance
   $  (10,206    $  (5,730    $  (8,101    $  (5,901
Change in reserve
                                   
Inventory reserve charged to costs of sales
     (3,199      (10,899      (242      (5,592
Sale of previously reserved inventory
     672        2,996        2,099        4,076  
    
 
 
    
 
 
    
 
 
    
 
 
 
       (2,527      (7,903      1,857        (1,516
Write off
     16        311        180        1,110  
Translation adjustments
     1,179        1,784        328        571  
    
 
 
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (11,538    $  (11,538    $  (5,736    $  (5,736
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 47 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Plant and Equipment (Tables)
9 Months Ended
Sep. 30, 2022
Property, Plant and Equipment [Abstract]  
Summary of Property, Plant and Equipment
Property, plant and equipment as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Buildings and related structures
   $ 21,484      $ 24,273  
Machinery and equipment
     94,152        105,300  
Finance lease
right-of-use
assets
     340        316  
Others
     29,233        32,396  
    
 
 
    
 
 
 
       145,209        162,285  
Less: accumulated depreciation
     (86,281      (94,119
Land
     11,513        13,898  
Construction in progress
     23,970        25,818  
    
 
 
    
 
 
 
Property, plant and equipment, net
   $ 94,411      $  107,882  
    
 
 
    
 
 
 
XML 48 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible Assets (Tables)
9 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Intangible Assets
Intangible assets as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):

 
  
September 30, 2022
 
  
Gross
amount
 
  
Accumulated
amortization
 
  
Net
amount
 
Intellectual property assets
   $ 8,040      $ (6,270    $ 1,770  
    
 
 
    
 
 
    
 
 
 
Intangible assets
   $ 8,040      $ (6,270    $ 1,770  
    
 
 
    
 
 
    
 
 
 

 
  
December 31, 2021
 
  
Gross
amount
 
  
Accumulated
amortization
 
  
Net
amount
 
Intellectual property assets
   $ 9,312      $ (6,935    $ 2,377  
    
 
 
    
 
 
    
 
 
 
Intangible assets
   $ 9,312      $ (6,935    $ 2,377  
    
 
 
    
 
 
    
 
 
 
XML 49 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases (Tables)
9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
Supplemental Balance Sheet Information Related To Leases
Supplemental balance sheets information related to leases as of September 30, 2022 and December 31, 2021 are as follows (in thousands):

Leases
  
Classification
 
  
September 30,
2022
 
  
December 31,
2021
 
Assets
  
 
 
 
             
Operating lease
  
 
Operating lease right-of-use assets
 
   $  4,928      $  4,275  
Finance lease
  
 
Property, plant and equipment, net
 
     141        126  
    
 
 
 
  
 
 
    
 
 
 
Total lease assets
  
 
 
 
   $ 5,069      $ 4,401  
    
 
 
 
  
 
 
    
 
 
 
Liabilities
  
 
 
 
                 
Current
  
 
 
 
                 
Operating
  
 
Operating lease liabilities
 
   $ 1,324      $ 2,323  
Finance
  
 
Other current liabilities
 
     78        68  
Non-current
  
 
 
 
                 
Operating
  
 
Non-current operating lease liabilities
 
     3,811        1,952  
Finance
  
 
Other
non-current
liabilities
 
     73        73  
    
 
 
 
  
 
 
    
 
 
 
Total lease liabilities
  
 
 
 
   $ 5,286      $ 4,416  
    
 
 
 
  
 
 
    
 
 
 
Lease, Cost
The following table presents the weighted average remaining lease term and discount rate:

 
 
  
September 30,
2022
 
 
December 31,
2021
 
Weighted average remaining lease term
                
Operating leases
     3.9 years       2.4 years  
Finance leases
     2.5 years       2.0 years  
Weighted average discount rate
                
Operating leases
     6.58     4.20
Finance leases
     7.63     7.75
Other Lease Information
The components of lease cost included in the Company’s consolidated statements of operations, are as follows (in thousands):

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Operating lease cost
   $  557      $  691      $  1,738      $  2,098  
Finance lease cost
                                   
Amortization of
right-of-use
assets
     18        17        48        50  
Interest on lease liabilities
     2        4        7        11  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total lease cost
   $ 577      $ 712      $ 1,793      $ 2,159  
    
 
 
    
 
 
    
 
 
    
 
 
 
The above table does not include an immaterial cost of short-term leases for the nine months ended September 30, 2022 and 2021.
 
Other lease information is as follows (in thousands):


 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Cash paid for amounts included in the measurement of lease liabilities
                                   
Operating cash flows from operating leases
   $  561      $  691      $  1,742      $  2,098  
Operating cash flows from finance leases
     2        4        7        11  
Financing cash flows from finance leases
     18        16        50        49  
Schedule Of Future Lease Payments
The aggregate future lease payments for operating and finance leases as of September 30, 2022 are as follows (in thousands):

 
 
  
Operating
Leases
 
  
Finance
Leases
 
Remainder of 2022
   $ 508      $ 22  
2023
     1,449        86  
2024
     1,330        24  
2025
     1,218        23  
2026
     846        11  
2027
     585        —    
    
 
 
    
 
 
 
Total future lease payments
     5,936        166  
Less: Imputed interest
     (801      (15
    
 
 
    
 
 
 
Present value of future payments
   $  5,135      $  151  
    
 
 
    
 
 
 
XML 50 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Expenses (Tables)
9 Months Ended
Sep. 30, 2022
Payables and Accruals [Abstract]  
Summary of Accrued Expenses
Accrued expenses as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands):
 
    
September 30,

2022
    
December 31,

2021
 
Payroll, benefits and related taxes, excluding severance benefits
   $  10,552      $ 9,548  
Withholding tax attributable to intercompany interest income
     3,345        1,950  
Outside service fees
     1,608        1,088  
Merger-related costs
     —          7,035  
Others
     295        450  
    
 
 
    
 
 
 
Accrued expenses
   $ 15,800      $  20,071  
    
 
 
    
 
 
 
XML 51 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Details of Derivative Contracts
Details of the zero cost collar contracts as of September 30, 2022 are as follows (in thousands):
 
Date of transaction
  
Total notional amount
    
Month of settlement
August 13, 2021
   $ 15,000     
October 202
2 to December 2022
January 04, 2022
   $ 39,000      October 2022 to June 2023
March 07, 2022
   $ 24,000      July 2023 to December 2023
April 27, 2022
   $ 51,000      October 2022 to December 2023
Details of the zero cost collar contracts as of December 31, 2021 are as follows (in thousands):
 
Date of transaction
  
Total notional amount
    
Month of settlement
May 13, 2021
   $ 39,000      January 2022 to September 2022
August 13, 2021
   $ 48,000      January 2022 to December 2022
Fair Values of Outstanding Zero Cost Collar and Forward Contracts Recorded as Assets and Liabilities
The fair values of the Company’s outstanding zero cost collar contracts recorded as liabilities as of September 30, 2022 and December 31, 2021 are as follows (in thousands):

Derivatives designated as hedging instruments:
  
 
 
  
September 30,
2022
 
  
December 31,
2021
 
Liability Derivatives:
                          
Zero cost collars
     Other current liabilities      $ 12,744      $ 2,020  
Zero cost collars
    
Other non-current liabilities
     $ 2,318      $ —    
Offsetting of Derivative Liabilities
Offsetting of derivative liabilities as of September 30, 2022 is as follows (in thousands):

 
As of September 30, 2022
  
Gross amounts of
recognized
liabilities
 
  
Gross amounts
offset in the
balance sheets
 
  
Net amounts of
liabilities
presented in the
balance sheets
 
  
Gross amounts not offset
in the balance sheets
 
 
Net amount
 
  
Financial
instruments
 
  
Cash collateral
pledged
 
Liability Derivatives:
                                                    
Zero cost collars
   $ 15,062      $ —        $ 15,062      $ —        $ (14,370   $ 692  
Offsetting of derivative liabilities as of December 31, 2021 is as follows (in thousands):

As of December 31, 2021
  
Gross amounts of
recognized
liabilities
 
  
Gross amounts
offset in the
balance sheets
 
  
Net amounts of
liabilities
presented in the
balance sheets
 
  
Gross amounts not offset
in the balance sheets
 
 
Net amount
 
  
Financial
instruments
 
  
Cash collateral
pledged
 
Liability Derivatives:
                                                    
Zero cost collars
   $ 2,020      $ —        $ 2,020      $ —        $ (2,060   $ (40

Impact of Derivative Instruments on Consolidated Statement of Operations
The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the three months ended September 30, 2022 and 2021 (in thousands):
 
Derivatives in ASC
815 Cash Flow Hedging
Relationships
  
Amount of Loss
Recognized in
AOCI on
Derivatives
 
 
Location/Amount of Loss
Reclassified from AOCI
Into Statement of Operations
 
 
Location/Amount of Gain
Recognized in
Statement of Operations on Derivatives
 
 
  
Three Months Ended
September 30,
 
 
 
 
  
Three Months Ended
September 30,
 
 
 
 
  
Three Months Ended
September 30,
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
  
2021
 
Zero cost collars
   $ (11,757   $ (3,271     Net sales      $ (2,820)     $   (653)     Other income, net      $ 146      $ 237  
The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the nine months ended September 30, 2022 and 2021 (in thousands).
 
Derivatives in ASC
815 Cash Flow Hedging
Relationships
  
Amount of Loss
Recognized in
AOCI on
Derivatives
 
 
Location/Amount of Gain (Loss)
Reclassified from AOCI
Into Statement of Operations
 
  
Location/Amount of Gain
Recognized in
Statement of Operations on Derivatives
 
 
  
Nine Months Ended
September 30,
 
 
 
 
  
Nine Months Ended
September 30,
 
  
 
 
  
Nine Months Ended
September 30,
 
 
  
2022
 
 
2021
 
 
 
 
  
2022
 
 
2021
 
  
 
 
  
2022
 
  
2021
 
Zero cost collars
   $ (19,498   $ (4,964     Net sales      $ (5,378)     $ 333        Other income, net      $ 201      $ 94  
Summary Of Cash Deposits These cash deposits are recorded as hedge collateral on the consolidated balance sheets. Cash deposits as of September 30, 2022 and December 31, 2021 are as follows (in
 
Counterparties
  
September 30,
2022
 
  
December 31,
2021
 
SC
   $ 1,000      $ 1,000  
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
As of September 30, 2022, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in thousands):

 
 
  
Carrying Value
September 30, 2022
 
  
Fair Value
Measurement
September 30, 2022
 
  
Quoted Prices in
Active Markets
for Identical
Liability (Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Unobservable
Inputs
(Level 3)
 
Liabilities:
                                            
Derivative liabilities (other current liabilities)
   $ 12,744      $ 12,744        —        $ 12,744        —    
Derivative liabilities (other
non-current
liabilities)
   $ 2,318      $ 2,318        —        $ 2,318        —    
As of December 31, 2021, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in
thousands):
 
 
  
Carrying Value
December 31, 2021
 
  
Fair Value
Measurement
December 31, 2021
 
  
Quoted Prices in
Active Markets
for Identical
Liability (Level 1)
 
  
Significant
Other
Observable
Inputs
(Level 2)
 
  
Significant
Unobservable
Inputs
(Level 3)
 
Liabilities:
                                            
Derivative liabilities (other current liabilities)
   $ 2,020      $ 2,020        —        $ 2,020        —    
XML 53 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Severance Benefits (Tables)
9 Months Ended
Sep. 30, 2022
Postemployment Benefits [Abstract]  
Changes in Accrued Severance Benefits
Changes in accrued severance benefits are as follows (in thousands):
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
September 30, 2022
 
 
September 30, 2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
Beginning balance
  
$ 47,586     $ 51,567      $ 53,105      $ 54,452  
Provisions
  
  1,923       5,163        2,007        5,514  
Severance payments
  
  (1,247     (4,181      (1,936      (4,772
Translation adjustments
  
  (4,730     (9,017      (2,441      (4,459
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
  
  43,532       43,532        50,735        50,735  
Less: Cumulative contributions to
severance insurance deposit
accounts

  
  (15,292     (15,292      (12,739      (12,739
The National Pension Fund

  
  (40     (40      (55      (55
Group severance insurance plan

  
  (164     (164      (200      (200
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Accrued severance benefits,
 
net
  
$ 28,036     $ 28,036      $ 37,741      $ 37,741  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future Benefits Payments to Employees
The Company is liable to pay the following future benefits to its
non-executive
employees upon their normal retirement age (in thousands):
 
 
  
Severance benefit
 
Remainder of 2022
   $ 212  
2023
     534  
2024
     769  
2025
     1,273  
2026
     1,772  
2027
     1,463  
2028 – 2032
     17,223  
XML 54 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Geographic and Other Information (Tables)
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Schedule of Operating Segments
The following sets forth information relating to the single operating segment (in thousands):


 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Revenues
                                   
Standard products business
                                   
Display Solutions
   $ 6,355      $ 58,528      $ 63,876      $  164,024  
Power Solutions
     56,416        58,887        184,193        169,565  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total standard products business
     62,771        117,415        248,069        333,589  
Transitional Fab 3 foundry services
     8,428        9,585        28,599        30,306  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenues
   $  71,199      $  127,000      $  276,668      $ 363,895  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Gross Profit
                                   
Standard products business
   $  17,274      $  45,773      $  82,872      $  112,291  
Transitional Fab 3 foundry services
     (49      814        2,294        2,648  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total gross profit
   $ 17,225      $ 46,587      $ 85,166      $ 114,939  
    
 
 
    
 
 
    
 
 
    
 
 
 
Net Sales by Region, Based on Location of Products are Billed
The following is a summary of net sales—standard products business (which does not include the Transitional Fab 3 Foundry Services) by geographic region, based on the location to which the products are billed (in thousands):

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
Korea
   $  23,867      $ 29,664      $ 86,065      $ 86,966  
Asia Pacific (other than Korea)
     34,612        84,220        148,940        237,312  
United States
     2,718        1,756        8,074        4,393  
Europe
     1,574        1,398        4,990        3,847  
Others
            377               1,071  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 62,771      $  117,415      $  248,069      $  333,589  
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 55 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accumulated Other Comprehensive Loss (Tables)
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss consists of the following as of September 30, 2022 and December 31, 2021, respectively (in thousands):

 
 
  
September 30,
2022
 
  
December 31,
2021
 
Foreign currency translation adjustments
   $  (16,651    $ (770
Derivative adjustments
     (15,580      (1,460
    
 
 
    
 
 
 
Total
   $  (32,231    $  (2,230
    
 
 
    
 
 
 
Changes in Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss for the three months ended September 30, 2022 and 2021 are as follows (in
thousands):
 
Three Months Ended September 30, 2022
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $  (10,677    $  (6,643    $  (17,320
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (5,974      (11,757      (17,731
Amounts reclassified from accumulated other comprehensive loss
     —          2,820        2,820  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (5,974      (8,937      (14,911
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (16,651    $  (15,580    $  (32,231
    
 
 
    
 
 
    
 
 
 
 
Three Months Ended September 30, 2021
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ 120      $  (1,045    $ (925
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (860      (3,271      (4,131
Amounts reclassified from accumulated other comprehensive loss
            653        653  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (860      (2,618      (3,478
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (740    $  (3,663    $  (4,403
    
 
 
    
 
 
    
 
 
 
Changes in accumulated other comprehensive loss for the nine months ended September 30, 2022 and 2021 are as follows (in
thousands):
 
Nine Months Ended September 30, 2022
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ (770    $  (1,460    $  (2,230
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (15,881      (19,498      (35,379
Amounts reclassified from accumulated other comprehensive loss
     —          5,378        5,378  
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (15,881      (14,120      (30,001
    
 
 
    
 
 
    
 
 
 
Ending balance
   $  (16,651    $  (15,580    $  (32,231
    
 
 
    
 
 
    
 
 
 
 
Nine Months Ended September 30, 2021
  
Foreign
currency
translation
adjustments
 
  
Derivative
adjustments
 
  
Total
 
Beginning balance
   $ 2,069      $ 1,634      $ 3,703  
    
 
 
    
 
 
    
 
 
 
Other comprehensive loss before reclassifications
     (2,809      (4,964      (7,773
Amounts reclassified from accumulated other comprehensive income
     —          (333      (333
    
 
 
    
 
 
    
 
 
 
Net current-period other comprehensive loss
     (2,809      (5,297      (8,106
    
 
 
    
 
 
    
 
 
 
Ending balance
   $ (740    $  (3,663    $  (4,403
    
 
 
    
 
 
    
 
 
 
 
XML 56 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Loss Per Common Share
The following table illustrates the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2022 and
2021:
 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(In thousands of U.S. dollars, except share data)
 
Basic earnings (loss) per share
                                   
Net income (loss)
   $ (17,195    $ 10,768      $ (11,007    $ 3,097  
Basic weighted average common stock outstanding
     44,865,266        46,449,234        45,119,214        44,377,250  
Basic earnings (loss) per common share
   $ (0.38    $ 0.23      $ (0.24    $ 0.07  
Diluted earnings (loss) per share
                                   
Net income (loss)
   $ (17,195    $ 10,768      $ (11,007    $ 3,097  
Basic weighted average common stock outstanding
     44,865,266        46,449,234        45,119,214        44,377,250  
Net effect of dilutive equity awards
     —          1,359,223        —          1,434,542  
    
 
 
    
 
 
    
 
 
    
 
 
 
Diluted weighted average common stock outstanding
     44,865,266        47,808,457        45,119,214        45,811,792  
Diluted earnings (loss) per share
   $ (0.38    $ 0.23      $ (0.24    $ 0.07  
Schedule of Antidilutive Securities Excluded from the Computation of Loss Per Common Share
The following outstanding instruments were excluded from the computation of diluted earnings (loss) per share, as they have an anti-dilutive effect on the calculation:

 
 
  
Three Months Ended
 
  
Nine Months Ended
 
 
  
September 30,
2022
 
  
September 30,
2021
 
  
September 30,
2022
 
  
September 30,
2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
Options
     1,141,551        50,000        1,141,551        50,000  
Restricted Stock Units
     1,014,124        —          1,014,124        —    
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories - Summary of Inventories (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]            
Finished goods $ 6,828   $ 9,594      
Semi-finished goods and work-in-process 32,431   25,968      
Raw materials 9,282   9,443      
Materials in-transit 295   95      
Less: inventory reserve (11,538) $ (10,206) (5,730) $ (5,736) $ (8,101) $ (5,901)
Inventories, net $ 37,298   $ 39,370      
XML 58 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories - Changes in Inventory Reserve (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Inventory Disclosure [Abstract]        
Beginning balance $ (10,206) $ (8,101) $ (5,730) $ (5,901)
Change in reserve        
Inventory reserve charged to costs of sales (3,199) (242) (10,899) (5,592)
Sale of previously reserved inventory 672 2,099 2,996 4,076
Change in reserve (2,527) 1,857 (7,903) (1,516)
Write off 16 180 311 1,110
Translation adjustments 1,179 328 1,784 571
Ending balance $ (11,538) $ (5,736) $ (11,538) $ (5,736)
XML 59 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Plant and Equipment - Additional Information (Detail) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Property, Plant and Equipment [Line Items]    
Depreciation expenses $ 10,699 $ 10,018
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 145,209 $ 162,285
Less: accumulated depreciation (86,281) (94,119)
Land 11,513 13,898
Construction in progress 23,970 25,818
Property, plant and equipment, net 94,411 107,882
Buildings and Related Structures [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 21,484 24,273
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 94,152 105,300
Finance Lease Right Of Use Assets [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 340 316
Others [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 29,233 $ 32,396
XML 61 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible Assets - Additional Information (Detail) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense for intangible assets $ 526 $ 558
XML 62 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible Assets - Summary of Intangible Assets (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Intangible asset, Gross amount $ 8,040 $ 9,312
Accumulated amortization (6,270) (6,935)
Intangible asset, Net amount 1,770 2,377
Intellectual Property Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible asset, Gross amount 8,040 9,312
Accumulated amortization (6,270) (6,935)
Intangible asset, Net amount $ 1,770 $ 2,377
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Additional Information (Detail)
9 Months Ended
Sep. 30, 2022
Maximum [Member]  
Lease Agreements Remaining Term of Lease 5 years
Minimum [Member]  
Lease Agreements Remaining Term of Lease 1 year
XML 64 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Supplemental Balance Sheet (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Assets    
Operating lease $ 4,928 $ 4,275
Total lease assets 5,069 4,401
Current    
Operating 1,324 2,323
Non-current    
Operating 3,811 1,952
Total lease liabilities 5,286 4,416
Operating Lease Right Of Use Assets [Member]    
Assets    
Operating lease 4,928 4,275
Property, Plant and Equipment, Net [Member]    
Assets    
Finance lease 141 126
Current Operating Lease Liabilities [Member]    
Current    
Operating 1,324 2,323
Other Current Liabilities [Member]    
Current    
Finance $ 78 $ 68
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current Other Liabilities, Current
Non Current Operating Lease Liabilities [Member]    
Non-current    
Operating $ 3,811 $ 1,952
Other Noncurrent Liabilities [Member]    
Non-current    
Finance $ 73 $ 73
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Noncurrent Other Liabilities, Noncurrent
XML 65 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Components of lease cost (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Leases [Abstract]        
Operating lease cost $ 557 $ 691 $ 1,738 $ 2,098
Finance lease cost [Abstract]        
Amortization of right-of-use assets 18 17 48 50
Interest on lease liabilities 2 4 7 11
Total lease cost $ 577 $ 712 $ 1,793 $ 2,159
XML 66 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Other lease information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash paid for amounts included in the measurement of lease liabilities          
Operating cash flows from operating leases $ 561 $ 691 $ 1,742 $ 2,098  
Operating cash flows from finance leases 2 4 7 11  
Financing cash flows from finance leases $ 18 $ 16 $ 50 $ 49  
Weighted average remaining lease term          
Operating leases 3 years 10 months 24 days   3 years 10 months 24 days   2 years 4 months 24 days
Finance leases 2 years 6 months   2 years 6 months   2 years
Weighted average discount rate          
Operating leases 6.58%   6.58%   4.20%
Finance leases 7.63%   7.63%   7.75%
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Aggregate future lease payment (Detail)
$ in Thousands
Sep. 30, 2022
USD ($)
Leases [Abstract]  
Operating Leases, Remainder of 2022 $ 508
Operating Leases, 2023 1,449
Operating Leases, 2024 1,330
Operating Leases, 2025 1,218
Operating Leases, 2026 846
Operating Leases, 2027 585
Operating Leases, Total future lease payments 5,936
Less: Present value adjustment (801)
Present value of future payments 5,135
Finance Leases [Abstract]  
Finance Leases, Remainder of 2022 22
Finance Leases, 2023 86
Finance Leases, 2024 24
Finance Leases, 2025 23
Finance Leases, 2026 11
Finance Leases, 2027 0
Finance Leases, Total future lease payments 166
Less: Present value adjustment (15)
Present value of future payments $ 151
XML 68 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Expenses - Summary of Accrued Expenses (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Payroll, benefits and related taxes, excluding severance benefits $ 10,552 $ 9,548
Withholding tax attributable to intercompany interest income 3,345 1,950
Outside service fees 1,608 1,088
Merger-related costs 0 7,035
Others 295 450
Accrued expenses $ 15,800 $ 20,071
XML 69 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments - Additional Information (Detail) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Derivative [Line Items]    
Estimated amount reclassified from accumulated other comprehensive income into income $ 13,262  
Nomura Financial Investment (Korea) Co., Ltd. [Member]    
Derivative [Line Items]    
Threshold amount of cash collateral   $ 760
Standard Chartered Bank Korea Limited [Member]    
Derivative [Line Items]    
Threshold amount of cash collateral   $ 1,300
Zero Cost Collar and Forward Contracts [Member] | Nomura Financial Investment (Korea) Co., Ltd. [Member]    
Derivative [Line Items]    
Threshold amount of cash collateral 500  
Cash collateral for credit exposure in derivatives 11,670  
Termination provisions for cash and cash equivalents 30,000  
Zero Cost Collar and Forward Contracts [Member] | Standard Chartered Bank Korea Limited [Member]    
Derivative [Line Items]    
Cash collateral for credit exposure in derivatives $ 2,700  
XML 70 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments - Details of Derivative Contracts (Detail) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Zero Cost Collar One [Member]    
Derivative [Line Items]    
Date of transaction Aug. 13, 2021 May 13, 2021
Total notional amount $ 15,000 $ 39,000
Month of settlement, start 2022-10 2022-01
Month of settlement, end 2022-12 2022-09
Zero Cost Collar Two [Member]    
Derivative [Line Items]    
Date of transaction Jan. 04, 2022 Aug. 13, 2021
Total notional amount $ 39,000 $ 48,000
Month of settlement, start 2022-10 2022-01
Month of settlement, end 2023-06 2022-12
Zero Cost Collar Three [Member]    
Derivative [Line Items]    
Date of transaction Mar. 07, 2022  
Total notional amount $ 24,000  
Month of settlement, start 2023-07  
Month of settlement, end 2023-12  
Zero Cost Collar Four [Member]    
Derivative [Line Items]    
Date of transaction Apr. 27, 2022  
Total notional amount $ 51,000  
Month of settlement, start 2022-10  
Month of settlement, end 2023-12  
XML 71 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments - Fair Values of Outstanding Zero Cost Collar and Forward Contracts Recorded as Assets and Liabilities (Detail) - Zero Cost Collars [Member] - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Liability Derivatives:    
Other non current liabilities $ 15,062 $ 2,020
Other Current Liabilities [Member]    
Liability Derivatives:    
Other non current liabilities 12,744 2,020
Other Noncurrent Liabilities [Member]    
Liability Derivatives:    
Other non current liabilities $ 2,318 $ 0
XML 72 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments - Offsetting of Derivative Assets and Liabilities (Details) - Zero Cost Collars [Member] - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Liability Derivatives:    
Liability Derivatives, Gross amounts of recognized liabilities $ 15,062 $ 2,020
Liability Derivatives, Gross amounts offset in the balance sheets 0 0
Liability Derivatives, Net amounts of liabilities presented in the balance sheets 15,062 2,020
Liability Derivatives, Gross amounts not offset in the balance sheets, Financial instruments 0 0
Liability Derivatives, Gross amounts not offset in the balance sheets, Cash collateral pledged (14,370) (2,060)
Liability Derivatives, Net amount after master netting $ 692 $ (40)
XML 73 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments - Impact of Derivative Instruments on Consolidated Statement of Operations (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Derivative [Line Items]        
Amount of Gain (Loss) Reclassified from AOCI into Statement of Operations (Effective Portion) $ 2,820 $ 653 $ 5,378 $ (333)
Zero Cost Collars [Member] | Cash Flow Hedging [Member]        
Derivative [Line Items]        
Amount of Loss Recognized in AOCI on Derivatives (Effective Portion) (11,757) (3,271) (19,498) (4,964)
Zero Cost Collars [Member] | Cash Flow Hedging [Member] | Other income, net [Member]        
Derivative [Line Items]        
Amount of Gain Recognized in Statement of Operations on Derivatives (Ineffective Portion) 146 237 201 94
Zero Cost Collars [Member] | Cash Flow Hedging [Member] | Net Sales [Member]        
Derivative [Line Items]        
Amount of Gain (Loss) Reclassified from AOCI into Statement of Operations (Effective Portion) $ (2,820) $ (653) $ (5,378) $ 333
XML 74 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments - Cash deposits (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Zero Cost Collar And Forward Contracts [Member] | SC    
Deposit Assets [Line Items]    
Margin Deposit Assets $ 1,000 $ 1,000
XML 75 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Measurements, Recurring [Member] - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Carrying Value [Member] | Other Current Liabilities [Member]    
Liabilities:    
Derivative liabilities $ 12,744 $ 2,020
Carrying Value [Member] | Other Noncurrent Liabilities [Member]    
Liabilities:    
Derivative liabilities 2,318  
Estimate of Fair Value Measurement [Member] | Other Current Liabilities [Member]    
Liabilities:    
Derivative liabilities 12,744 2,020
Estimate of Fair Value Measurement [Member] | Other Noncurrent Liabilities [Member]    
Liabilities:    
Derivative liabilities 2,318  
Significant Other Observable Inputs (Level 2) [Member] | Other Current Liabilities [Member]    
Liabilities:    
Derivative liabilities 12,744 $ 2,020
Significant Other Observable Inputs (Level 2) [Member] | Other Noncurrent Liabilities [Member]    
Liabilities:    
Derivative liabilities $ 2,318  
XML 76 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Severance Benefits - Additional Information (Detail)
9 Months Ended
Sep. 30, 2022
Percentage of employees eligible for severance benefits 97.00%
Retirement age of employees 60 years
Korea [Member] | Minimum [Member]  
Korea's mandatory retirement age 60 years
XML 77 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Severance Benefits - Changes in Accrued Severance Benefits (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Postemployment Benefits [Abstract]          
Beginning balance $ 47,586 $ 53,105 $ 51,567 $ 54,452  
Provisions 1,923 2,007 5,163 5,514  
Severance payments (1,247) (1,936) (4,181) (4,772)  
Translation adjustments (4,730) (2,441) (9,017) (4,459)  
Ending balance 43,532 50,735 43,532 50,735  
Less: Cumulative contributions to severance insurance deposit accounts (15,292) (12,739) (15,292) (12,739)  
The National Pension Fund (40) (55) (40) (55)  
Group severance insurance plan (164) (200) (164) (200)  
Accrued severance benefits, net $ 28,036 $ 37,741 $ 28,036 $ 37,741 $ 33,064
XML 78 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accrued Severance Benefits - Future Benefits Payments to Employees (Detail)
$ in Thousands
Sep. 30, 2022
USD ($)
Postemployment Benefits [Abstract]  
Remainder of 2022 $ 212
2023 534
2024 769
2025 1,273
2026 1,772
2027 1,463
2028 – 2032 $ 17,223
XML 79 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
Foreign Currency Loss, Net - Additional Information (Detail)
$ in Thousands
Sep. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
Foreign Currency Transaction [Abstract]    
Exchange rates using first base rate 1,434.8 1,185.5
Intercompany loan balances $ 356,746 $ 344,411
XML 80 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Tax Contingency [Line Items]        
Income tax expenses (benefits) $ (3,942) $ 3,149 $ (1,356) $ 6,040
Korean Subsidiary [Member]        
Income Tax Contingency [Line Items]        
The net operating income carry forwards of the taxable income   60.00%   60.00%
XML 81 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
Geographic and Other Information - Additional Information (Detail)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Customer Concentration Risk [Member] | Net Sales [Member] | Top Ten Customers [Member] | Standard products business [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Concentration risk, percentage 64.00% 81.00% 70.00% 81.00%  
Customer Concentration Risk [Member] | Net Sales [Member] | Top Customer One [Member] | Standard products business [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Concentration risk, percentage 16.20% 44.70% 20.60% 44.60%  
Customer Concentration Risk [Member] | Net Sales [Member] | Top Customer Two [Member] | Standard products business [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Concentration risk, percentage   10.10% 13.90% 10.60%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Top Customer One [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Concentration risk, percentage     24.10%   31.50%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Top Customer Two [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Concentration risk, percentage     11.80%   16.10%
Geographic Concentration Risk [Member] | Net Sales [Member] | Asia Pacific Other Than Korea [Member] | Standard products business [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Concentration risk, percentage 74.20%   66.40%    
Geographic Concentration Risk [Member] | Net Sales [Member] | CHINA, HONG KONG | Standard products business [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Concentration risk, percentage   72.00%   63.40%  
Geographic Concentration Risk [Member] | Net Sales [Member] | VIET NAM | Standard products business [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Concentration risk, percentage 2.40% 19.60% 16.20% 29.50%  
XML 82 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Geographic and Other Information - Schedule of Operating Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Segment Reporting Information [Line Items]        
Total revenues $ 71,199 $ 127,000 $ 276,668 $ 363,895
Total gross profit 17,225 46,587 85,166 114,939
Standard products business [Member]        
Segment Reporting Information [Line Items]        
Total revenues 62,771 117,415 248,069 333,589
Total gross profit 17,274 45,773 82,872 112,291
Fab Three Foundry Services [Member]        
Segment Reporting Information [Line Items]        
Total revenues 8,428 9,585 28,599 30,306
Total gross profit (49) 814 2,294 2,648
Operating Segments [Member] | Standard products business [Member]        
Segment Reporting Information [Line Items]        
Total revenues 62,771 117,415 248,069 333,589
Operating Segments [Member] | Standard products business [Member] | Display Solutions [Member]        
Segment Reporting Information [Line Items]        
Total revenues 6,355 58,528 63,876 164,024
Operating Segments [Member] | Standard products business [Member] | Power Solutions [Member]        
Segment Reporting Information [Line Items]        
Total revenues $ 56,416 $ 58,887 $ 184,193 $ 169,565
XML 83 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2
Geographic and Other Information - Net Sales by Region, Based on Location of Products are Billed (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]        
Total revenues $ 71,199 $ 127,000 $ 276,668 $ 363,895
Standard products business [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Total revenues 62,771 117,415 248,069 333,589
Standard products business [Member] | Korea [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Total revenues 23,867 29,664 86,065 86,966
Standard products business [Member] | Asia Pacific (Other Than Korea) [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Total revenues 34,612 84,220 148,940 237,312
Standard products business [Member] | United States [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Total revenues 2,718 1,756 8,074 4,393
Standard products business [Member] | Europe [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Total revenues 1,574 1,398 4,990 3,847
Standard products business [Member] | Others [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Total revenues $ 0 $ 377 $ 0 $ 1,071
XML 84 R64.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Equity [Abstract]    
Foreign currency translation adjustments $ (16,651) $ (770)
Derivative adjustments (15,580) (1,460)
Total $ (32,231) $ (2,230)
XML 85 R65.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Income Loss (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Balance beginning $ 448,147 $ 422,631 $ 452,762 $ 345,600
Total other comprehensive loss (14,911) (3,478) (30,001) (8,106)
Balance ending 413,215 433,297 413,215 433,297
Foreign Currency Translation Adjustments [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Balance beginning (10,677) 120 (770) 2,069
Other comprehensive loss before reclassifications (5,974) (860) (15,881) (2,809)
Total other comprehensive loss (5,974) (860) (15,881) (2,809)
Balance ending (16,651) (740) (16,651) (740)
Derivative Adjustments [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Balance beginning (6,643) (1,045) (1,460) 1,634
Other comprehensive loss before reclassifications (11,757) (3,271) (19,498) (4,964)
Amounts reclassified from accumulated other comprehensive loss (income) 2,820 653 5,378 (333)
Total other comprehensive loss (8,937) (2,618) (14,120) (5,297)
Balance ending (15,580) (3,663) (15,580) (3,663)
Accumulated Other Comprehensive Income (Loss) [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Balance beginning (17,320) (925) (2,230) 3,703
Other comprehensive loss before reclassifications (17,731) (4,131) (35,379) (7,773)
Amounts reclassified from accumulated other comprehensive loss (income) 2,820 653 5,378 (333)
Total other comprehensive loss (14,911) (3,478) (30,001) (8,106)
Balance ending $ (32,231) $ (4,403) $ (32,231) $ (4,403)
XML 86 R66.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Repurchases - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 21, 2021
Sep. 30, 2022
Sep. 30, 2022
Dec. 31, 2021
Aug. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Accelerated Share Repurchases, Settlement (Payment) or Receipt $ 37,500 $ 37,500        
Accelerated share repurchase program adjustment shares   994,695        
Aggregate purchase price of shares   $ 20,073        
Additional Paid-In Capital [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Accelerated stock repurchase       $ 17,217 $ 17,427  
Treasury Stock [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Accelerated stock repurchase       $ (17,217)    
Treasury Stock [Member] | Reclassified As A Treasury Stock From Additional Paid In Capital [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Accelerated share repurchase program adjustment shares       1,031,576    
Aggregate purchase price of shares $ 17,217          
Sale of stock issue price per share $ 16.69          
Accelerated Stock Repurchase Program [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Stock Repurchase Program, Authorized Amount   75,000        
Accelerated stock repurchase   $ 37,500        
Stock Repurchase Program [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Stock Repurchase Program, Authorized Amount           $ 87,500
Stock repurchased during period, Shares     324,643      
Aggregate purchase price     $ 3,638      
Sale of aggregate purchase price per share     $ 11.21      
Stock Repurchase Program [Member] | Previously Reported [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Stock Repurchase Program, Authorized Amount           $ 75,000
XML 87 R67.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share - Additional Information (Detail)
9 Months Ended
Sep. 30, 2022
BusinessLines
$ / shares
Sep. 30, 2021
shares
Dec. 31, 2021
$ / shares
Conversion Of Exchangeable Notes | shares   1,906,786  
Common stock, par value $ 0.01   $ 0.01
Redemption of rights per right | BusinessLines 0.001    
Common Stock, Voting Rights 50    
Percentage of assets or earning power of the Company 50.00%    
Acquiring Person [Member]      
Business Acquisition, Percentage of Voting Interests Acquired 12.50%    
Passive Institutional Investor [Member]      
Business Acquisition, Percentage of Voting Interests Acquired 20.00%    
Series A1 [Member]      
Common stock, par value $ 0.01    
Sale of stock issue price per share $ 80    
XML 88 R68.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Loss Per Common Share (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Basic Earnings (Loss) per Share        
Net income (loss) $ (17,195) $ 10,768 $ (11,007) $ 3,097
Basic weighted average common stock outstanding 44,865,266 46,449,234 45,119,214 44,377,250
Basic earnings (loss) per common share $ (0.38) $ 0.23 $ (0.24) $ 0.07
Diluted earnings (loss) per share        
Basic weighted average common stock outstanding 44,865,266 46,449,234 45,119,214 44,377,250
Net effect of dilutive equity awards 0 1,359,223 0 1,434,542
Diluted weighted average common stock outstanding 44,865,266 47,808,457 45,119,214 45,811,792
Diluted earnings (loss) per share $ (0.38) $ 0.23 $ (0.24) $ 0.07
XML 89 R69.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from the Computation of Loss Per Common Share (Detail) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Outstanding units and warrants excluded from computation of diluted loss per share/unit       1,906,786
Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Outstanding units and warrants excluded from computation of diluted loss per share/unit 1,141,551 50,000 1,141,551 50,000
Restricted Stock Units [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Outstanding units and warrants excluded from computation of diluted loss per share/unit 1,014,124 0 1,014,124 0
XML 90 R70.htm IDEA: XBRL DOCUMENT v3.22.2.2
Merger Agreement - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 20, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Oct. 31, 2022
Oct. 28, 2022
Aug. 05, 2022
Apr. 04, 2022
Business Acquisition [Line Items]                    
Merger Related Costs Income Net   $ 0 $ 1,552 $ 0 $ 13,842          
Merger Termination Fee           $ 70,200        
Proceed from termination cost $ 51,000                  
Secures Deferred Merger Termination Fee $ 19,200                  
Termination Agreement [Member]                    
Business Acquisition [Line Items]                    
Termination agreement outstanding amount                   $ 4,800
Termination agreement amount Paid                 $ 3,000 $ 14,400
Letter agreement outstanding amount   $ 1,800   $ 1,800            
Termination Agreement [Member] | Subsequent Event [Member]                    
Business Acquisition [Line Items]                    
Termination agreement outstanding amount             $ 1,800      
Letter Agreement [Member] | Subsequent Event [Member] | Due on or Before December 23, 2022 [Member]                    
Business Acquisition [Line Items]                    
Letter agreement outstanding amount               $ 1,800    
Other Receivable [Member]                    
Business Acquisition [Line Items]                    
Deferred Merger Termination Fee As Other Receivable           $ 19,200        
XML 91 R71.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies - Additional Information (Detail) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Other Current Assets [Member]    
Loss Contingencies [Line Items]    
Prepayments to suppliers $ 9,532 $ 1,708
XML 92 d306034d10q_htm.xml IDEA: XBRL DOCUMENT 0001325702 2022-09-30 0001325702 2021-12-31 0001325702 2022-07-01 2022-09-30 0001325702 2021-07-01 2021-09-30 0001325702 2022-01-01 2022-09-30 0001325702 2021-01-01 2021-09-30 0001325702 2021-09-30 0001325702 2022-10-31 0001325702 2021-01-01 2021-12-31 0001325702 2022-03-31 0001325702 2021-12-21 0001325702 2021-12-21 2021-12-21 0001325702 2021-12-20 2021-12-20 0001325702 2021-12-20 0001325702 2022-06-30 0001325702 2021-06-30 0001325702 2020-12-31 0001325702 us-gaap:OtherCurrentLiabilitiesMember mx:ZeroCostCollarsMember 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember mx:ZeroCostCollarsMember 2022-09-30 0001325702 mx:NomuraFinancialInvestmentCoLtdMember mx:ZeroCostCollarAndForwardContractsMember 2022-09-30 0001325702 us-gaap:IntellectualPropertyMember 2022-09-30 0001325702 us-gaap:BuildingAndBuildingImprovementsMember 2022-09-30 0001325702 us-gaap:MachineryAndEquipmentMember 2022-09-30 0001325702 mx:FinanceLeaseRightOfUseAssetsMember 2022-09-30 0001325702 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2022-09-30 0001325702 mx:StandardCharteredBankKoreaLimitedMember mx:ZeroCostCollarAndForwardContractsMember 2022-09-30 0001325702 mx:ZeroCostCollarOneMember 2022-09-30 0001325702 mx:ZeroCostCollarTwoMember 2022-09-30 0001325702 mx:ZeroCostCollarThreeMember 2022-09-30 0001325702 mx:ZeroCostCollarFourMember 2022-09-30 0001325702 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 us-gaap:OtherCurrentLiabilitiesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001325702 mx:OperatingLeaseRightOfUseAssetsMember 2022-09-30 0001325702 us-gaap:PropertyPlantAndEquipmentMember 2022-09-30 0001325702 mx:CurrentOperatingLeaseLiabilitiesMember 2022-09-30 0001325702 us-gaap:OtherCurrentLiabilitiesMember 2022-09-30 0001325702 mx:NonCurrentoperatingLeaseLiabilitiesMember 2022-09-30 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember 2022-09-30 0001325702 mx:ZeroCostCollarsMember 2022-09-30 0001325702 mx:SeriesA1Member 2022-09-30 0001325702 mx:PassiveInstitutionalInvestorMember 2022-09-30 0001325702 mx:AcquiringPersonMember 2022-09-30 0001325702 mx:TerminationAgreementMember 2022-09-30 0001325702 us-gaap:OtherCurrentLiabilitiesMember mx:ZeroCostCollarsMember 2021-12-31 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember mx:ZeroCostCollarsMember 2021-12-31 0001325702 mx:NomuraFinancialInvestmentCoLtdMember 2021-12-31 0001325702 mx:StandardCharteredBankKoreaLimitedMember 2021-12-31 0001325702 us-gaap:IntellectualPropertyMember 2021-12-31 0001325702 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0001325702 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001325702 mx:FinanceLeaseRightOfUseAssetsMember 2021-12-31 0001325702 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2021-12-31 0001325702 mx:ZeroCostCollarOneMember 2021-12-31 0001325702 mx:ZeroCostCollarTwoMember 2021-12-31 0001325702 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001325702 us-gaap:OtherCurrentLiabilitiesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001325702 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001325702 mx:OperatingLeaseRightOfUseAssetsMember 2021-12-31 0001325702 us-gaap:PropertyPlantAndEquipmentMember 2021-12-31 0001325702 mx:CurrentOperatingLeaseLiabilitiesMember 2021-12-31 0001325702 us-gaap:OtherCurrentLiabilitiesMember 2021-12-31 0001325702 mx:NonCurrentoperatingLeaseLiabilitiesMember 2021-12-31 0001325702 us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001325702 mx:ZeroCostCollarsMember 2021-12-31 0001325702 mx:StandardCharteredBankKoreaLimitedMember mx:ZeroCostCollarAndForwardContractsMember 2021-12-31 0001325702 mx:OtherReceivableMember 2021-12-31 0001325702 us-gaap:OperatingSegmentsMember mx:DisplaySolutionsMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:PowerSolutionsMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:FabThreeFoundryServicesMember 2022-07-01 2022-09-30 0001325702 country:KR mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 country:US mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 srt:EuropeMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:OtherCountriesMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:EmployeeAndNonEmployeeStockOptionMember 2022-07-01 2022-09-30 0001325702 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 country:VN us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:TopTenCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:TopCustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2022-07-01 2022-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember 2022-07-01 2022-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2022-07-01 2022-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2022-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001325702 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0001325702 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001325702 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001325702 mx:StockRepurchaseProgramMember 2022-07-01 2022-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:DisplaySolutionsMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:PowerSolutionsMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:FabThreeFoundryServicesMember 2021-01-01 2021-09-30 0001325702 country:KR mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 country:US mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 srt:EuropeMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:OtherCountriesMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:EmployeeAndNonEmployeeStockOptionMember 2021-01-01 2021-09-30 0001325702 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001325702 mx:ChinaAndHongKongMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 country:VN us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:TopTenCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:TopCustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:TopCustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2021-01-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember 2021-01-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2021-01-01 2021-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001325702 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001325702 us-gaap:TreasuryStockMember 2021-01-01 2021-09-30 0001325702 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:DisplaySolutionsMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:PowerSolutionsMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:FabThreeFoundryServicesMember 2021-07-01 2021-09-30 0001325702 country:KR mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 country:US mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 srt:EuropeMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:OtherCountriesMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:EmployeeAndNonEmployeeStockOptionMember 2021-07-01 2021-09-30 0001325702 us-gaap:RestrictedStockUnitsRSUMember 2021-07-01 2021-09-30 0001325702 mx:ChinaAndHongKongMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 country:VN us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:TopTenCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:TopCustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:TopCustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2021-07-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember 2021-07-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2021-07-01 2021-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-07-01 2021-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-07-01 2021-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001325702 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001325702 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:DisplaySolutionsMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:PowerSolutionsMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 us-gaap:OperatingSegmentsMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:FabThreeFoundryServicesMember 2022-01-01 2022-09-30 0001325702 country:KR mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 country:US mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 srt:EuropeMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:OtherCountriesMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:EmployeeAndNonEmployeeStockOptionMember 2022-01-01 2022-09-30 0001325702 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001325702 srt:MinimumMember country:KR 2022-01-01 2022-09-30 0001325702 mx:AsiaPacificOtherThanKoreaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 country:VN us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:TopTenCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:TopCustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:TopCustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mx:StandardProductsBusinessMember 2022-01-01 2022-09-30 0001325702 mx:TopCustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001325702 mx:TopCustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarOneMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarTwoMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarThreeMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarFourMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2022-01-01 2022-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001325702 mx:ZeroCostCollarsMember us-gaap:CashFlowHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001325702 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001325702 us-gaap:TreasuryStockMember 2022-01-01 2022-09-30 0001325702 srt:MinimumMember 2022-01-01 2022-09-30 0001325702 srt:MaximumMember 2022-01-01 2022-09-30 0001325702 us-gaap:OtherCurrentAssetsMember 2022-01-01 2022-09-30 0001325702 us-gaap:PreferredStockMember 2022-01-01 2022-09-30 0001325702 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001325702 mx:ReclassifiedAsATreasuryStockFromAdditionalPaidInCapitalMember us-gaap:TreasuryStockMember 2022-01-01 2022-09-30 0001325702 srt:SubsidiariesMember 2021-09-30 0001325702 mx:TopCustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001325702 mx:TopCustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001325702 mx:ZeroCostCollarOneMember 2021-01-01 2021-12-31 0001325702 mx:ZeroCostCollarTwoMember 2021-01-01 2021-12-31 0001325702 us-gaap:OtherCurrentAssetsMember 2021-01-01 2021-12-31 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001325702 mx:AcceleratedStockRepurchaseProgramMember 2021-12-21 2021-12-21 0001325702 mx:AcceleratedStockRepurchaseProgramMember 2021-12-21 0001325702 mx:ReclassifiedAsATreasuryStockFromAdditionalPaidInCapitalMember us-gaap:TreasuryStockMember 2022-03-31 2022-03-31 0001325702 mx:ReclassifiedAsATreasuryStockFromAdditionalPaidInCapitalMember us-gaap:TreasuryStockMember 2022-03-31 0001325702 mx:TerminationAgreementMember 2022-04-04 0001325702 mx:TerminationAgreementMember 2022-08-05 0001325702 us-gaap:SubsequentEventMember mx:TerminationAgreementMember 2022-10-31 0001325702 mx:StockRepurchaseProgramMember 2022-08-31 0001325702 srt:ScenarioPreviouslyReportedMember mx:StockRepurchaseProgramMember 2022-08-31 0001325702 us-gaap:SubsequentEventMember mx:LetterAgreementMember mx:DueOnOrBeforeDecember232022Member 2022-10-28 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001325702 us-gaap:CommonStockMember 2022-06-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001325702 us-gaap:RetainedEarningsMember 2022-06-30 0001325702 us-gaap:TreasuryStockMember 2022-06-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001325702 us-gaap:CommonStockMember 2022-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001325702 us-gaap:RetainedEarningsMember 2022-09-30 0001325702 us-gaap:TreasuryStockMember 2022-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001325702 us-gaap:CommonStockMember 2020-12-31 0001325702 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001325702 us-gaap:RetainedEarningsMember 2020-12-31 0001325702 us-gaap:TreasuryStockMember 2020-12-31 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-09-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001325702 us-gaap:CommonStockMember 2021-09-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001325702 us-gaap:RetainedEarningsMember 2021-09-30 0001325702 us-gaap:TreasuryStockMember 2021-09-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-06-30 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001325702 us-gaap:CommonStockMember 2021-06-30 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001325702 us-gaap:RetainedEarningsMember 2021-06-30 0001325702 us-gaap:TreasuryStockMember 2021-06-30 0001325702 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001325702 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001325702 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001325702 us-gaap:CommonStockMember 2021-12-31 0001325702 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001325702 us-gaap:RetainedEarningsMember 2021-12-31 0001325702 us-gaap:TreasuryStockMember 2021-12-31 iso4217:USD shares pure utr:Year iso4217:USD shares mx:BusinessLines false Q3 0001325702 --12-31 true c/o MagnaChip Semiconductor S.A. 1 10-Q true 2022-09-30 2022 false 001-34791 Magnachip Semiconductor Corporation DE 83-0406195 Allée Scheffer L-2520 LU 352 45-62-62 Common Stock, par value $0.01 per share Preferred Stock Purchase Rights MX NYSE NYSE Yes Yes Large Accelerated Filer false false false 44175252 http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent 250831000 279547000 36759000 50954000 37298000 39370000 8248000 25895000 10322000 7675000 15370000 3060000 20208000 2619000 379036000 409120000 94411000 107882000 4928000 4275000 1770000 2377000 11382000 8243000 34299000 41095000 10382000 10662000 536208000 583654000 26545000 37593000 14809000 6289000 15800000 20071000 0 11823000 1324000 2323000 15881000 7382000 74359000 85481000 28036000 33064000 3811000 1952000 16787000 10395000 122993000 130892000 0.01 0.01 150000000 150000000 56234774 44579075 55905320 45659304 562000 559000 264510000 241197000 332535000 343542000 11655699 10246016 152161000 130306000 -32231000 -2230000 413215000 452762000 536208000 583654000 62771000 117415000 248069000 333589000 8428000 9585000 28599000 30306000 71199000 127000000 276668000 363895000 45497000 71641000 165197000 221297000 8477000 8772000 26305000 27659000 53974000 80413000 191502000 248956000 17225000 46587000 85166000 114939000 11411000 12550000 38310000 39185000 13321000 12270000 38685000 39015000 0 1552000 0 13842000 2501000 214000 3298000 3360000 27233000 26586000 80293000 95402000 -10008000 20001000 4873000 19537000 -278000 -113000 -888000 -1239000 -12809000 -7579000 -20511000 -12000000 1958000 1608000 4163000 2839000 -21137000 13917000 -12363000 9137000 -3942000 3149000 -1356000 6040000 -17195000 10768000 -11007000 3097000 -0.38 0.23 -0.24 0.07 -0.38 0.23 -0.24 0.07 44865266 46449234 45119214 44377250 44865266 47808457 45119214 45811792 -17195000 10768000 -11007000 3097000 -5974000 -860000 -15881000 -2809000 -11757000 -3271000 -19498000 -4964000 2820000 653000 5378000 -333000 -14911000 -3478000 -30001000 -8106000 -32106000 7290000 -41008000 -5009000 44903718 562000 263698000 349730000 -148523000 -17320000 448147000 861000 861000 -49000 -49000 324643 3638000 3638000 -14911000 -14911000 -17195000 -17195000 44579075 562000 264510000 332535000 -152161000 -32231000 413215000 46350945 556000 253244000 279163000 -109407000 -925000 422631000 2005000 2005000 112944 1000 1370000 1371000 1000 0 0 -3478000 -3478000 10768000 10768000 46464889 557000 256619000 289931000 -109407000 -4403000 433297000 45659304 559000 241197000 343542000 -130306000 -2230000 452762000 4487000 4487000 152326 1000 1785000 1786000 177128 2000 -176000 -174000 378107 4638000 4638000 -1031576 17217000 -17217000 -30001000 -30001000 -11007000 -11007000 44579075 562000 264510000 332535000 -152161000 -32231000 413215000 35783347 450000 163010000 286834000 -108397000 3703000 345600000 6056000 6056000 10144131 101000 83639000 83740000 289704 3000 3917000 3920000 299162 3000 -3000 51455 1010000 1010000 -8106000 -8106000 3097000 3097000 46464889 557000 256619000 289931000 -109407000 -4403000 433297000 -11007000 3097000 11225000 10576000 5163000 5514000 261000 -66335000 -32607000 7730000 1484000 4487000 6056000 -631000 -442000 -7805000 -6696000 13208000 4561000 -17115000 5287000 14117000 -7933000 -14792000 -16192000 -6215000 -3729000 5866000 -1641000 -11483000 -8308000 -1583000 555000 523000 -666000 -4181000 -4772000 50000 49000 50244000 30016000 2805000 3995000 15282000 2744000 11812000 13368000 301000 455000 3192000 2075000 4960000 -792000 103000 -25873000 -14443000 1786000 3920000 5065000 1653000 381000 427000 50000 49000 -3710000 1791000 -49377000 -21003000 -28716000 -3639000 279547000 279940000 250831000 276301000 2094000 17856000 12609000 3957000 11513000 83740000 -399000 <div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1. Business, Basis of Presentation and Significant Accounting Policies </div></div></div></div> <div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Magnachip Semiconductor Corporation (together with its subsidiaries, the “Company”) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, Internet of Things (“IoT”) applications, consumer, computing, industrial and automotive applications. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s standard products business includes its Display Solutions and Power Solutions business lines. The Company’s Display Solutions products provide panel display solutions to major suppliers of large and small rigid and flexible panel displays, and mobile, automotive applications and home appliances. The Company’s Power Solutions products include discrete and integrated circuit solutions for power management in communications, consumer, computing, servers, automotive, and industrial applications. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">On September 1, 2020, the Company completed the sale of the Company’s Foundry Services Group business and its fabrication facility located in Cheongju, Korea, known as “Fab 4”. Following the consummation of the sale, and for up to three years, the Company is expected to provide transitional foundry services associated with its fabrication facility located in Gumi, Korea, known as “Fab 3”, at an agreed upon cost plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mark-up</div> (the “Transitional Fab 3 Foundry Services”). </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). These interim consolidated financial statements include normal recurring adjustments and the elimination of all intercompany accounts and transactions which are, in the opinion of management, necessary to provide a fair statement of the Company’s financial condition and results of operations for the periods presented. These interim consolidated financial statements are presented in accordance with Accounting Standards Codification (“ASC”) 270, “Interim Reporting” and, accordingly, do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, except for the changes below. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for a full year or for any other periods. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The December 31, 2021 balance sheet data was derived from the Company’s audited financial statements, but does not include all disclosures required by U.S. GAAP. The interim consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the fiscal year ended December 31, 2021. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">There have been no material changes to the Company’s significant accounting policies as of and for the nine months ended September 30, 2022 as compared to the significant accounting policies described in the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the fiscal year ended December 31, 2021. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Pronouncements </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-06,</div> “Debt—Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)”</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06”),</div> which updates various codification topics to simplify the accounting guidance for certain financial instruments with characteristics of liabilities and equity, with a specific focus on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and amends the diluted EPS computation for these instruments. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> as of January 1, 2022, and the adoption of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> did not have an impact on the Company’s consolidated financial statements. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In May 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2021-04,</div> “Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-50)”,</div> Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04”),</div> ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04</div> clarifies the accounting for modifications or exchanges of freestanding equity-classified written call options so that the transaction should be treated as an exchange of the original instrument for a new instrument. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04</div> as of January 1, 2022, and the adoption of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04</div> did not have an impact on the Company’s consolidated financial statements. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Magnachip Semiconductor Corporation (together with its subsidiaries, the “Company”) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, Internet of Things (“IoT”) applications, consumer, computing, industrial and automotive applications. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s standard products business includes its Display Solutions and Power Solutions business lines. The Company’s Display Solutions products provide panel display solutions to major suppliers of large and small rigid and flexible panel displays, and mobile, automotive applications and home appliances. The Company’s Power Solutions products include discrete and integrated circuit solutions for power management in communications, consumer, computing, servers, automotive, and industrial applications. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">On September 1, 2020, the Company completed the sale of the Company’s Foundry Services Group business and its fabrication facility located in Cheongju, Korea, known as “Fab 4”. Following the consummation of the sale, and for up to three years, the Company is expected to provide transitional foundry services associated with its fabrication facility located in Gumi, Korea, known as “Fab 3”, at an agreed upon cost plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mark-up</div> (the “Transitional Fab 3 Foundry Services”). </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). These interim consolidated financial statements include normal recurring adjustments and the elimination of all intercompany accounts and transactions which are, in the opinion of management, necessary to provide a fair statement of the Company’s financial condition and results of operations for the periods presented. These interim consolidated financial statements are presented in accordance with Accounting Standards Codification (“ASC”) 270, “Interim Reporting” and, accordingly, do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, except for the changes below. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for a full year or for any other periods. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The December 31, 2021 balance sheet data was derived from the Company’s audited financial statements, but does not include all disclosures required by U.S. GAAP. The interim consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the fiscal year ended December 31, 2021. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">There have been no material changes to the Company’s significant accounting policies as of and for the nine months ended September 30, 2022 as compared to the significant accounting policies described in the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the fiscal year ended December 31, 2021. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Pronouncements </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-06,</div> “Debt—Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)”</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06”),</div> which updates various codification topics to simplify the accounting guidance for certain financial instruments with characteristics of liabilities and equity, with a specific focus on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and amends the diluted EPS computation for these instruments. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> as of January 1, 2022, and the adoption of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> did not have an impact on the Company’s consolidated financial statements. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In May 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2021-04,</div> “Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-50)”,</div> Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04”),</div> ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04</div> clarifies the accounting for modifications or exchanges of freestanding equity-classified written call options so that the transaction should be treated as an exchange of the original instrument for a new instrument. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04</div> as of January 1, 2022, and the adoption of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04</div> did not have an impact on the Company’s consolidated financial statements. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2. Inventories </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories as of September 30, 2022 and December 31, 2021 consist of the following (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finished goods</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,828</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,594</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Semi-finished goods and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">work-in-process</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,431</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,968</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,282</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,443</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Materials <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-transit</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">295</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">95</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: inventory reserve</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,538</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,730</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories, net</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,298</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 39,370</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in inventory reserve for the three and nine months ended September 30, 2022 and 2021 are as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/>Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/>Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/>Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/>Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (10,206</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (5,730</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (8,101</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (5,901</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in reserve</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventory reserve charged to costs of sales</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,199</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,899</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(242</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,592</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sale of previously reserved inventory</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">672</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,996</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,099</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,076</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,527</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,903</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,857</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,516</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Write off</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">311</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,110</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Translation adjustments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,179</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,784</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">328</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">571</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (11,538</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (11,538</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (5,736</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (5,736</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Inventory reserve represents the Company’s best estimate in value lost due to excessive inventory level, physical deterioration, obsolescence, changes in price levels, or other causes based on individual facts and circumstances. Inventory reserve relates to inventory items including finished goods, semi-finished goods, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">work-in-process</div></div> and raw materials. Write off of this reserve is recognized only when the related inventory has been disposed or scrapped. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories as of September 30, 2022 and December 31, 2021 consist of the following (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finished goods</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,828</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,594</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Semi-finished goods and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">work-in-process</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,431</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,968</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,282</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,443</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Materials <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-transit</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">295</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">95</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: inventory reserve</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,538</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,730</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories, net</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,298</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 39,370</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 6828000 9594000 32431000 25968000 9282000 9443000 295000 95000 11538000 5730000 37298000 39370000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in inventory reserve for the three and nine months ended September 30, 2022 and 2021 are as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/>Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/>Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/>Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/>Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (10,206</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (5,730</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (8,101</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (5,901</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in reserve</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventory reserve charged to costs of sales</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,199</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,899</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(242</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,592</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sale of previously reserved inventory</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">672</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,996</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,099</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,076</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,527</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,903</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,857</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,516</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Write off</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">311</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,110</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Translation adjustments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,179</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,784</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">328</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">571</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (11,538</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (11,538</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (5,736</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (5,736</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 10206000 5730000 8101000 5901000 3199000 10899000 242000 5592000 672000 2996000 2099000 4076000 2527000 7903000 -1857000 1516000 16000 311000 180000 1110000 -1179000 -1784000 -328000 -571000 11538000 11538000 5736000 5736000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3. Property, Plant and Equipment </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property, plant and equipment as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Buildings and related structures</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,484</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,273</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">94,152</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">105,300</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Finance lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">340</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">316</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Others</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,233</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,396</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">145,209</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">162,285</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated depreciation</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(86,281</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(94,119</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Land</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,513</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,898</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Construction in progress</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,970</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,818</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property, plant and equipment, net</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">94,411</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 107,882</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Aggregate depreciation expenses totaled $10,699 thousand and $10,018 thousand for the nine months ended September 30, 2022 and 2021, respectively. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property, plant and equipment as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Buildings and related structures</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,484</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,273</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">94,152</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">105,300</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Finance lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">340</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">316</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Others</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,233</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,396</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">145,209</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">162,285</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated depreciation</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(86,281</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(94,119</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Land</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,513</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,898</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Construction in progress</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,970</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,818</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property, plant and equipment, net</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">94,411</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 107,882</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 21484000 24273000 94152000 105300000 340000 316000 29233000 32396000 145209000 162285000 86281000 94119000 11513000 13898000 23970000 25818000 94411000 107882000 10699000 10018000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4. Intangible Assets </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands): </div></div> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>amortization</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intellectual property assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,040</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,270</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,770</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 80%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 80%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,040</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,270</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,770</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 80%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>amortization</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intellectual property assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,312</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,935</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,377</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 80%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 80%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,312</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,935</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,377</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 80%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Aggregate amortization expenses for intangible assets totaled $526 thousand and $558 thousand for the nine months ended September 30, 2022 and 2021, respectively. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands): </div></div> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>amortization</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intellectual property assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,040</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,270</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,770</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 80%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 80%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,040</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,270</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,770</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 80%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>amortization</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intellectual property assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,312</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,935</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,377</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 80%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 80%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,312</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,935</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,377</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 80%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 8040000 6270000 1770000 8040000 6270000 1770000 9312000 6935000 2377000 9312000 6935000 2377000 526000 558000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5. Leases </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has operating and finance leases for buildings and other assets such as vehicles and office equipment. The Company’s leases have remaining lease terms ranging from 1 year to 5 years. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The tables below present financial information related to the Company’s leases. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental balance sheets information related to leases as of September 30, 2022 and December 31, 2021 are as follows (in thousands): </div></div> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="text-align: center;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 39%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Leases</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Classification</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease right-of-use assets</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;"> 4,928</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;"> 4,275</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance lease</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">Property, plant and equipment, net</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">141</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">126</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease assets</div></div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">5,069</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">4,401</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities</div></div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">Operating lease liabilities</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">1,324</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">2,323</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"><span style="-sec-ix-hidden:hidden59180399">Other </span><span style="-sec-ix-hidden:hidden59180398">current</span> liabilities</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">78</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">68</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-current</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-current operating lease liabilities</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">3,811</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">1,952</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><span style="-sec-ix-hidden:hidden59180397">Other</span> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden59180396">non</span>-current</div> liabilities</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">73</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">73</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease liabilities</div></div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">5,286</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">4,416</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the weighted average remaining lease term and discount rate: </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining lease term</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.9 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.4 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.5 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.0 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average discount rate</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.58</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.20</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.63</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.75</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of lease cost included in the Company’s consolidated statements of operations, are as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 54%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 557</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 691</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,738</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 2,098</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance lease cost</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Amortization of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">48</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest on lease liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease cost</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">577</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">712</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,793</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,159</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The above table does not include an immaterial cost of short-term leases for the nine months ended September 30, 2022 and 2021. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other lease information is as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 54%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash paid for amounts included in the measurement of lease liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from operating leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 561</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 691</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,742</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 2,098</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from finance leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financing cash flows from finance leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The aggregate future lease payments for operating and finance leases as of September 30, 2022 are as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Operating<br/>Leases</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Finance<br/>Leases</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remainder of 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">508</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,449</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,330</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,218</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">846</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">585</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total future lease payments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,936</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Imputed interest</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(801</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Present value of future payments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 5,135</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 151</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> P1Y P5Y <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental balance sheets information related to leases as of September 30, 2022 and December 31, 2021 are as follows (in thousands): </div></div> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="text-align: center;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 39%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Leases</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Classification</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease right-of-use assets</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;"> 4,928</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;"> 4,275</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance lease</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">Property, plant and equipment, net</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">141</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">126</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease assets</div></div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">5,069</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">4,401</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities</div></div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">Operating lease liabilities</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">1,324</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">2,323</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"><span style="-sec-ix-hidden:hidden59180399">Other </span><span style="-sec-ix-hidden:hidden59180398">current</span> liabilities</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">78</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">68</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-current</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-current operating lease liabilities</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">3,811</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">1,952</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><span style="-sec-ix-hidden:hidden59180397">Other</span> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden59180396">non</span>-current</div> liabilities</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">73</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">73</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease liabilities</div></div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">5,286</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">4,416</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> </table> 4928000 4275000 141000 126000 5069000 4401000 1324000 2323000 78000 68000 3811000 1952000 73000 73000 5286000 4416000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the weighted average remaining lease term and discount rate: </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining lease term</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.9 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.4 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.5 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.0 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average discount rate</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.58</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.20</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.63</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.75</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> </table> P3Y10M24D P2Y4M24D P2Y6M P2Y 0.0658 0.042 0.0763 0.0775 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of lease cost included in the Company’s consolidated statements of operations, are as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 54%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 557</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 691</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,738</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 2,098</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance lease cost</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Amortization of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">48</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest on lease liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease cost</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">577</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">712</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,793</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,159</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The above table does not include an immaterial cost of short-term leases for the nine months ended September 30, 2022 and 2021. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other lease information is as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 54%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash paid for amounts included in the measurement of lease liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from operating leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 561</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 691</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,742</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 2,098</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from finance leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financing cash flows from finance leases</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 557000 691000 1738000 2098000 18000 17000 48000 50000 2000 4000 7000 11000 577000 712000 1793000 2159000 561000 691000 1742000 2098000 2000 4000 7000 11000 18000 16000 50000 49000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The aggregate future lease payments for operating and finance leases as of September 30, 2022 are as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Operating<br/>Leases</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Finance<br/>Leases</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remainder of 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">508</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,449</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,330</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,218</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">846</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">585</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total future lease payments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,936</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Imputed interest</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(801</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Present value of future payments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 5,135</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 151</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 508000 22000 1449000 86000 1330000 24000 1218000 23000 846000 11000 585000 0 5936000 166000 801000 15000 5135000 151000 <div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6. Accrued Expenses</div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Payroll, benefits and related taxes, excluding severance benefits</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 10,552</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,548</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Withholding tax attributable to intercompany interest income</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,345</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,950</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outside service fees</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,608</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,088</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger-related costs</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,035</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Others</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">295</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,800</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 20,071</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses as of September 30, 2022 and December 31, 2021 are comprised of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Payroll, benefits and related taxes, excluding severance benefits</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 10,552</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,548</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Withholding tax attributable to intercompany interest income</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,345</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,950</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outside service fees</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,608</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,088</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger-related costs</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,035</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Others</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">295</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,800</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 20,071</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 10552000 9548000 3345000 1950000 1608000 1088000 0 -7035000 295000 450000 15800000 20071000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7. Derivative Financial Instruments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Korean subsidiary from time to time has entered into zero cost collar contracts to hedge the risk of changes in the functional-currency-equivalent cash flows attributable to currency rate changes on U.S. dollar denominated revenues. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Details of the zero cost collar contracts as of September 30, 2022 are as follows (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 41%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 37%; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Date of transaction</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total notional amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Month of settlement</div></div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">August 13, 2021</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">October 202</div>2 to December 2022</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">January 04, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">October 2022 to June 2023</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">March 07, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">July 2023 to December 2023</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">April 27, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">October 2022 to December 2023</td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Details of the zero cost collar contracts as of December 31, 2021 are as follows (in thousands): </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 41%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Date of transaction</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total notional amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Month of settlement</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 41%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">May 13, 2021</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">January 2022 to September 2022</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 41%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">August 13, 2021</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">48,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">January 2022 to December 2022</td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The zero cost collar contracts qualify as cash flow hedges under ASC 815, “Derivatives and Hedging,” since at both the inception of the contracts and on an ongoing basis, the hedging relationship was and is expected to be highly effective in achieving offsetting cash flows attributable to the hedged risk during the term of the contracts. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair values of the Company’s outstanding zero cost collar contracts recorded as liabilities as of September 30, 2022 and December 31, 2021 are as follows (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 50%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivatives designated as hedging instruments:</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liability Derivatives:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">Other current liabilities</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,744</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Other non-current liabilities</div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offsetting of derivative liabilities as of September 30, 2022 is as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 39%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022</div></div></div></div> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts of<br/>recognized<br/>liabilities</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts<br/>offset in the<br/>balance sheets</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net amounts of<br/>liabilities<br/>presented in the<br/>balance sheets</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts not offset<br/>in the balance sheets</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net amount</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial<br/>instruments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash collateral<br/>pledged</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liability Derivatives:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,062</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,062</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,370</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">692</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offsetting of derivative liabilities as of December 31, 2021 is as follows (in thousands): </div></div> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 42%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021</div></div></div></div> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts of<br/>recognized<br/>liabilities</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts<br/>offset in the<br/>balance sheets</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net amounts of<br/>liabilities<br/>presented in the<br/>balance sheets</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts not offset<br/>in the balance sheets</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net amount</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial<br/>instruments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash collateral<br/>pledged</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liability Derivatives:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,060</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(40</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For derivative instruments that are designated and qualify as cash flow hedges, gains or losses on the derivative aside from components excluded from the assessment of effectiveness are reported as a component of accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative, representing hedge components excluded from the assessment of effectiveness, are recognized in current earnings. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the three months ended September 30, 2022 and 2021 (in thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 43%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivatives in ASC</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">815 Cash Flow Hedging</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Relationships</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount of Loss<br/>Recognized in<br/>AOCI on<br/>Derivatives</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Location/Amount of Loss<br/>Reclassified from AOCI<br/>Into Statement of Operations</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Location/Amount of Gain<br/>Recognized in<br/>Statement of Operations on Derivatives</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 43%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 43%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,757</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,271</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">Net sales</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,820)</td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;;text-align:right;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(653)</td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">Other income, net</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">146</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">237</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the nine months ended September 30, 2022 and 2021 (in thousands). </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 43%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td style="width: 2%;"/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivatives in ASC</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">815 Cash Flow Hedging</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Relationships</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount of Loss<br/>Recognized in<br/>AOCI on<br/>Derivatives</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Location/Amount of Gain (Loss)<br/>Reclassified from AOCI<br/>Into Statement of Operations</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Location/Amount of Gain<br/>Recognized in<br/>Statement of Operations on Derivatives</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt; border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 43%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td style="width: 2%;"/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 43%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(19,498</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,964</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 2%;;text-align:right;">Net sales</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,378)</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">Other income, net</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">201</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">94</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022, the amount expected to be reclassified from accumulated other comprehensive loss into loss within the next 12 months is $13,262 thousand. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company set aside cash deposits to the counterparties, Nomura Financial Investment (Korea) Co., Ltd. (“NFIK”) and Standard Chartered Bank Korea Limited (“SC”), as required for the zero cost collar contracts. These cash deposits are recorded as hedge collateral on the consolidated balance sheets. Cash deposits as of September 30, 2022 and December 31, 2021 are as follows (in </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Counterparties</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SC</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is required to deposit additional cash collateral with NFIK and SC for any exposure in excess of $500 thousand. As of September 30, 2022, $11,670 thousand and $2,700 thousand of additional cash collateral was required by NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance sheet. As of December 31, 2021, $760 thousand and $1,300 thousand of additional cash collateral was required by NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance sheet. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These zero cost collar contracts may be terminated by the counterparties if the Company’s total cash and cash equivalents is less than $30,000 thousand at the end of a fiscal quarter, unless a waiver is obtained. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Details of the zero cost collar contracts as of September 30, 2022 are as follows (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 41%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 37%; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Date of transaction</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total notional amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Month of settlement</div></div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">August 13, 2021</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">October 202</div>2 to December 2022</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">January 04, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">October 2022 to June 2023</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">March 07, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">July 2023 to December 2023</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">April 27, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">October 2022 to December 2023</td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Details of the zero cost collar contracts as of December 31, 2021 are as follows (in thousands): </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 41%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Date of transaction</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total notional amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Month of settlement</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 41%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">May 13, 2021</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">January 2022 to September 2022</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 41%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">August 13, 2021</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">48,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">January 2022 to December 2022</td> </tr> </table> 2021-08-13 15000000 2022-10 2022-12 2022-01-04 39000000 2022-10 2023-06 2022-03-07 24000000 2023-07 2023-12 2022-04-27 51000000 2022-10 2023-12 2021-05-13 39000000 2022-01 2022-09 2021-08-13 48000000 2022-01 2022-12 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair values of the Company’s outstanding zero cost collar contracts recorded as liabilities as of September 30, 2022 and December 31, 2021 are as follows (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 50%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivatives designated as hedging instruments:</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liability Derivatives:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">Other current liabilities</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,744</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Other non-current liabilities</div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> </table> 12744000 2020000 2318000 0 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offsetting of derivative liabilities as of September 30, 2022 is as follows (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 39%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022</div></div></div></div> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts of<br/>recognized<br/>liabilities</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts<br/>offset in the<br/>balance sheets</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net amounts of<br/>liabilities<br/>presented in the<br/>balance sheets</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts not offset<br/>in the balance sheets</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net amount</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial<br/>instruments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash collateral<br/>pledged</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liability Derivatives:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,062</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,062</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,370</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">692</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offsetting of derivative liabilities as of December 31, 2021 is as follows (in thousands): </div></div> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 42%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021</div></div></div></div> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts of<br/>recognized<br/>liabilities</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts<br/>offset in the<br/>balance sheets</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net amounts of<br/>liabilities<br/>presented in the<br/>balance sheets</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross amounts not offset<br/>in the balance sheets</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net amount</div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial<br/>instruments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash collateral<br/>pledged</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liability Derivatives:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,060</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(40</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> 15062000 0 15062000 0 14370000 692000 2020000 0 2020000 0 2060000 -40000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the three months ended September 30, 2022 and 2021 (in thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 43%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivatives in ASC</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">815 Cash Flow Hedging</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Relationships</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount of Loss<br/>Recognized in<br/>AOCI on<br/>Derivatives</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Location/Amount of Loss<br/>Reclassified from AOCI<br/>Into Statement of Operations</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Location/Amount of Gain<br/>Recognized in<br/>Statement of Operations on Derivatives</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 43%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 43%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,757</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,271</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">Net sales</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,820)</td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;;text-align:right;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(653)</td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">Other income, net</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">146</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">237</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the nine months ended September 30, 2022 and 2021 (in thousands). </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 43%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td style="width: 2%;"/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivatives in ASC</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">815 Cash Flow Hedging</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Relationships</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount of Loss<br/>Recognized in<br/>AOCI on<br/>Derivatives</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Location/Amount of Gain (Loss)<br/>Reclassified from AOCI<br/>Into Statement of Operations</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Location/Amount of Gain<br/>Recognized in<br/>Statement of Operations on Derivatives</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/>September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt; border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 43%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td style="width: 2%;"/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 43%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Zero cost collars</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(19,498</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,964</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 2%;;text-align:right;">Net sales</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,378)</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">Other income, net</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">201</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">94</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> -11757000 -3271000 -2820000 -653000 146000 237000 -19498000 -4964000 -5378000 333000 201000 94000 13262000 These cash deposits are recorded as hedge collateral on the consolidated balance sheets. Cash deposits as of September 30, 2022 and December 31, 2021 are as follows (in <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Counterparties</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SC</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 1000000 1000000 500000 11670000 2700000 760000 1300000 30000000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8. Fair Value Measurements </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value<br/>September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>Measurement<br/>September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/>Active Markets<br/>for Identical<br/>Liability (Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities (other current liabilities)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,744</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,744</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,744</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Derivative liabilities (other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities)</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 47%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>Measurement<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/>Active Markets<br/>for Identical<br/>Liability (Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities (other current liabilities)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Items not reflected in the table above include cash equivalents, accounts receivable, other receivables, accounts payable, and other accounts payable, fair value of which approximate carrying values due to the short-term nature of these instruments. The fair value of assets and liabilities whose carrying value approximates fair value is determined using Level 2 inputs. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value<br/>September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>Measurement<br/>September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/>Active Markets<br/>for Identical<br/>Liability (Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities (other current liabilities)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,744</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,744</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,744</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Derivative liabilities (other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities)</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 47%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>Measurement<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/>Active Markets<br/>for Identical<br/>Liability (Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative liabilities (other current liabilities)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,020</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 12744000 12744000 12744000 2318000 2318000 2318000 2020000 2020000 2020000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9. Accrued Severance Benefits </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The majority of accrued severance benefits are for employees in the Company’s Korean subsidiary. Pursuant to the Employee Retirement Benefit Security Act of Korea, eligible employees and executive officers with one or more years of service are entitled to severance benefits upon the termination of their employment based on their length of service and rate of pay. As of September 30, 2022, 97% of all employees of the Company were eligible for severance benefits. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in accrued severance benefits are as follows (in thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,586</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,567</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53,105</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,452</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Provisions</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,923</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,163</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,007</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,514</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Severance payments</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,247</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,181</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,936</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,772</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Translation adjustments</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,730</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(9,017</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,441</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,459</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 44%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width:6%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 44%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,532</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,532</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,735</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,735</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; white-space: nowrap; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Less: Cumulative contributions to<br/> severance insurance deposit<br/> accounts</div><br/></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,292</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,292</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,739</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,739</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The National Pension Fund</div><br/></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(40</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(40</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(55</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(55</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%; font-size: 10pt; white-space: nowrap;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Group severance insurance plan</div><br/></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(164</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(164</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(200</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(200</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 44%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width:6%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; white-space: nowrap; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued severance benefits,<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>net</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,036</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,036</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr> <td style="vertical-align: top; white-space: nowrap; width: 44%; font-size: 0pt; line-height: 0pt; padding-bottom: 1.25pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px 0px 1.25pt; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;;width:6%;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 8%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 8%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 8%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The severance benefits funded through the Company’s National Pension Fund and group severance insurance plan will be used exclusively for payment of severance benefits to eligible employees. These amounts have been deducted from the accrued severance benefit balance. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning in July 2018, the Company contributes to certain severance insurance deposit accounts a certain percentage of severance benefits that are accrued for eligible employees for their services from January 1, 2018. These accounts consist of time deposits and other guaranteed principal and interest, and are maintained at insurance companies, banks or security companies for the benefit of employees. The Company deducts the contributions made to these severance insurance deposit accounts from its accrued severance benefits. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company is liable to pay the following future benefits to its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-executive</div> employees upon their normal retirement age (in thousands): <br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 81%;"/> <td style="width: 15%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Severance benefit</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remainder of 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">212</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">534</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">769</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,273</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,772</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,463</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2028 – 2032</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,223</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The above amounts were determined based on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-executive</div> employees’ current salary rates and the number of service years that will be accumulated upon their retirement dates. These amounts do not include amounts that might be paid to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-executive</div> employees that will cease working with the Company before their normal retirement ages. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Korea’s mandatory retirement age is 60 years of age or older under the Employment Promotion for the Aged Act. The Company sets the retirement age of employees at 60. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> 0.97 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in accrued severance benefits are as follows (in thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,586</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,567</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53,105</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,452</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Provisions</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,923</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,163</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,007</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,514</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Severance payments</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,247</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,181</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,936</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,772</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Translation adjustments</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,730</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(9,017</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,441</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,459</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 44%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width:6%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 44%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,532</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,532</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,735</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,735</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; white-space: nowrap; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Less: Cumulative contributions to<br/> severance insurance deposit<br/> accounts</div><br/></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,292</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,292</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,739</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,739</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The National Pension Fund</div><br/></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(40</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(40</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(55</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(55</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%; font-size: 10pt; white-space: nowrap;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Group severance insurance plan</div><br/></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(164</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;">) </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(164</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(200</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(200</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 44%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width:6%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; white-space: nowrap; width: 44%; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued severance benefits,<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>net</div></div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,036</td> <td style="vertical-align: bottom; white-space: nowrap;;width:6%;"> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,036</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr> <td style="vertical-align: top; white-space: nowrap; width: 44%; font-size: 0pt; line-height: 0pt; padding-bottom: 1.25pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 8%; padding: 0px 0px 1.25pt; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;;width:6%;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 8%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 8%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 8%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> 47586000 51567000 53105000 54452000 1923000 5163000 2007000 5514000 -1247000 -4181000 -1936000 -4772000 -4730000 -9017000 -2441000 -4459000 43532000 43532000 50735000 50735000 -15292000 -15292000 -12739000 -12739000 40000 40000 55000 55000 164000 164000 200000 200000 28036000 28036000 37741000 37741000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company is liable to pay the following future benefits to its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-executive</div> employees upon their normal retirement age (in thousands): <br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 81%;"/> <td style="width: 15%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Severance benefit</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remainder of 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">212</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">534</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">769</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,273</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,772</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,463</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2028 – 2032</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,223</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 212000 534000 769000 1273000 1772000 1463000 17223000 P60Y P60Y <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">10. Foreign Currency Loss, Net </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Net foreign currency gain or loss includes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> translation gain or loss associated with intercompany balances. A substantial portion of the Company’s net foreign currency gain or loss is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> translation gain or loss associated with intercompany long-term loans to the Company’s Korean subsidiary. The loans are denominated in U.S. dollars and are affected by changes in the exchange rate between the Korean won and the U.S. dollar. As of September 30, 2022 and December 31, 2021, the outstanding intercompany loan balances including accrued interest between the Korean subsidiary and the Dutch subsidiary were $356,746 thousand and $344,411 thousand, respectively. The Korean won to U.S. dollar exchange rates were 1,434.8:1 and 1,185.5:1 using the first base rate as of September 30, 2022 and December 31, 2021, respectively, as quoted by the KEB Hana Bank. </div> 356746000 344411000 1434.8 1185.5 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11. Income Taxes</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-style: normal; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company and its subsidiaries file income tax returns in Korea, the U.S. and in various other jurisdictions. The Company is subject to income or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-income</div> tax examinations by tax authorities of these jurisdictions for all open tax years. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">For the three and nine months ended September 30, 2022, the Company recorded an income tax benefit of $3,942 thousand and $1,356 <div style="letter-spacing: 0px; top: 0px;;display:inline;">thousand, respectively, primarily attributable to a decrease in its Korean subsidiary’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-tax</div> income for the respective period due to the foreign currency translation loss recorded in its Korean subsidiary in connection with intercompany loans. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three and nine months ended September 30, 2021, the Company recorded an income tax expense of $3,149 thousand and $6,040 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousand, respectively, primarily attributable to the Company’s Korean subsidiary based on its estimated taxable income for the respective period, combined with its ability to utilize net operating loss carryforwards </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> up to 60%, and interest on intercompany loan balances. </div></div> -3942000 -1356000 3149000 6040000 0.60 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">12. Geographic and Other Information </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following sets forth information relating to the single operating segment (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenues</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Standard products business</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Display Solutions</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,355</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,528</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">63,876</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 164,024</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Power Solutions</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,416</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,887</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">184,193</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">169,565</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total standard products business</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,771</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">117,415</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">248,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">333,589</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transitional Fab 3 foundry services</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,428</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,585</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,599</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,306</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenues</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 71,199</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 127,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 276,668</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">363,895</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross Profit</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Standard products business</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 17,274</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 45,773</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 82,872</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 112,291</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transitional Fab 3 foundry services</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(49</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">814</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,294</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,648</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gross profit</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,225</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,587</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,166</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">114,939</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following is a summary of net sales—standard products business (which does not include the Transitional Fab 3 Foundry Services) by geographic region, based on the location to which the products are billed (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Korea</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 23,867</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,664</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,065</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,966</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asia Pacific (other than Korea)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,612</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">84,220</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">148,940</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">237,312</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,718</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,756</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,074</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,393</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Europe</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,574</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,398</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,990</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,847</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Others</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">377</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,071</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,771</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 117,415</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 248,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 333,589</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended September 30, 2022 and 2021, of the Company’s net sales – standard products business in Asia Pacific (other than Korea), net sales – standard products business in China and Hong Kong represented 74.2% and 72.0%, respectively, and net sales—standard products business in Vietnam represented 2.4% and 19.6%, respectively. For the nine months ended September 30, 2022 and 2021, of the Company’s net sales – standard products business in Asia Pacific (other than Korea), net sales – standard products business in China and Hong Kong represented 66.4% and 63.4%, respectively, and net sales—standard products business in Vietnam represented 16.2% and 29.5%, respectively. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net sales from the Company’s top ten largest customers in the standard products business (which does not include the Transitional Fab 3 Foundry Services) accounted for 64% and 81% for the three months ended September 30, 2022 and 2021, respectively, and 70% and 81% for the nine months ended September 30, 2022 and 2021, respectively. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended September 30, 2022, the Company had one customer that represented 16.2% of its net sales – standard products business. For the nine months ended September 30, 2022, the Company had two customers that represented 20.6% and 13.9% of its net sales – standard products business. For the three months ended September 30, 2021, the Company had two customers that represented 44.7% and 10.1% of its net sales – standard products business. For the nine months ended September 30, 2021, the Company had two customers that represented 44.6% and 10.6% of its net sales – standard products business. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022, two customers of the Company’s standard products business accounted for 24.1% and 11.8% of its accounts receivable – standard products business (which does not include the Transitional Fab 3 Foundry Services), respectively. As of December 31, 2021, two customers of the Company’s standard products business accounted for 31.5% and 16.1% of its accounts receivable – standard products business (which does not include the Transitional Fab 3 Foundry Services), respectively. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following sets forth information relating to the single operating segment (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenues</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Standard products business</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Display Solutions</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,355</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,528</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">63,876</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 164,024</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Power Solutions</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,416</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,887</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">184,193</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">169,565</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total standard products business</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,771</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">117,415</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">248,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">333,589</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transitional Fab 3 foundry services</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,428</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,585</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,599</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,306</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenues</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 71,199</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 127,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 276,668</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">363,895</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross Profit</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Standard products business</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 17,274</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 45,773</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 82,872</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 112,291</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transitional Fab 3 foundry services</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(49</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">814</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,294</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,648</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gross profit</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,225</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,587</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,166</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">114,939</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 6355000 58528000 63876000 164024000 56416000 58887000 184193000 169565000 62771000 117415000 248069000 333589000 8428000 9585000 28599000 30306000 71199000 127000000 276668000 363895000 17274000 45773000 82872000 112291000 -49000 814000 2294000 2648000 17225000 46587000 85166000 114939000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following is a summary of net sales—standard products business (which does not include the Transitional Fab 3 Foundry Services) by geographic region, based on the location to which the products are billed (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Korea</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 23,867</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,664</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,065</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,966</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asia Pacific (other than Korea)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,612</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">84,220</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">148,940</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">237,312</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,718</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,756</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,074</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,393</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Europe</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,574</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,398</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,990</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,847</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Others</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">377</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,071</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,771</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 117,415</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 248,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 333,589</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 23867000 29664000 86065000 86966000 34612000 84220000 148940000 237312000 2718000 1756000 8074000 4393000 1574000 1398000 4990000 3847000 0 377000 0 1071000 62771000 117415000 248069000 333589000 0.742 0.72 0.024 0.196 0.664 0.634 0.162 0.295 0.64 0.81 0.70 0.81 0.162 0.206 0.139 0.447 0.101 0.446 0.106 0.241 0.118 0.315 0.161 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13. Accumulated Other Comprehensive Loss </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accumulated other comprehensive loss consists of the following as of September 30, 2022 and December 31, 2021, respectively (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency translation adjustments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (16,651</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(770</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative adjustments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,580</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,460</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (32,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (2,230</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in accumulated other comprehensive loss for the three months ended September 30, 2022 and 2021 are as follows (in </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Three Months Ended September 30, 2022</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign<br/>currency<br/>translation<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (10,677</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (6,643</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (17,320</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive loss before reclassifications</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,974</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,757</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,731</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amounts reclassified from accumulated other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,820</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,820</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net current-period other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,974</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,937</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,911</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (16,651</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (15,580</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (32,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 68%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Three Months Ended September 30, 2021</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign<br/>currency<br/>translation<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">120</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (1,045</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(925</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive loss before reclassifications</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(860</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,271</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,131</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amounts reclassified from accumulated other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">653</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">653</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net current-period other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(860</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,618</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,478</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (740</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (3,663</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (4,403</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in accumulated other comprehensive loss for the nine months ended September 30, 2022 and 2021 are as follows (in </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Nine Months Ended September 30, 2022</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign<br/>currency<br/>translation<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(770</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (1,460</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (2,230</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive loss before reclassifications</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,881</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(19,498</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(35,379</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amounts reclassified from accumulated other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,378</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,378</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net current-period other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,881</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,120</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(30,001</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (16,651</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (15,580</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (32,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"/> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Nine Months Ended September 30, 2021</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign<br/>currency<br/>translation<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,634</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive loss before reclassifications</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,809</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,964</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,773</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amounts reclassified from accumulated other comprehensive income</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(333</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(333</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net current-period other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,809</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,297</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,106</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(740</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (3,663</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (4,403</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accumulated other comprehensive loss consists of the following as of September 30, 2022 and December 31, 2021, respectively (in thousands): </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency translation adjustments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (16,651</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(770</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative adjustments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,580</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,460</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (32,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (2,230</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> -16651000 -770000 -15580000 -1460000 -32231000 -2230000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in accumulated other comprehensive loss for the three months ended September 30, 2022 and 2021 are as follows (in </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Three Months Ended September 30, 2022</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign<br/>currency<br/>translation<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (10,677</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (6,643</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (17,320</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive loss before reclassifications</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,974</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,757</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,731</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amounts reclassified from accumulated other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,820</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,820</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net current-period other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,974</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,937</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,911</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (16,651</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (15,580</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (32,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 68%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Three Months Ended September 30, 2021</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign<br/>currency<br/>translation<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">120</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (1,045</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(925</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive loss before reclassifications</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(860</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,271</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,131</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amounts reclassified from accumulated other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">653</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">653</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net current-period other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(860</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,618</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,478</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (740</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (3,663</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (4,403</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in accumulated other comprehensive loss for the nine months ended September 30, 2022 and 2021 are as follows (in </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Nine Months Ended September 30, 2022</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign<br/>currency<br/>translation<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(770</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (1,460</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (2,230</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive loss before reclassifications</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,881</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(19,498</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(35,379</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amounts reclassified from accumulated other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,378</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,378</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net current-period other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,881</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,120</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(30,001</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (16,651</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (15,580</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (32,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"/> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Nine Months Ended September 30, 2021</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign<br/>currency<br/>translation<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative<br/>adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,634</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive loss before reclassifications</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,809</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,964</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,773</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amounts reclassified from accumulated other comprehensive income</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(333</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(333</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net current-period other comprehensive loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,809</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,297</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,106</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending balance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(740</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (3,663</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> (4,403</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> -10677000 -6643000 -17320000 -5974000 -11757000 -17731000 -2820000 -2820000 -5974000 -8937000 -14911000 -16651000 -15580000 -32231000 120000 -1045000 -925000 -860000 -3271000 -4131000 -653000 -653000 -860000 -2618000 -3478000 -740000 -3663000 -4403000 -770000 -1460000 -2230000 -15881000 -19498000 -35379000 -5378000 -5378000 -15881000 -14120000 -30001000 -16651000 -15580000 -32231000 2069000 1634000 3703000 -2809000 -4964000 -7773000 333000 333000 -2809000 -5297000 -8106000 -740000 -3663000 -4403000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">14. Stock Repurchases </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 21, 2021, the Board of Directors authorized the Company to repurchase up to $75,000 thousand of the Company’s outstanding common stock and the Company entered into an accelerated stock repurchase agreement (the “ASR Agreement”) with JPMorgan Chase Bank, National Association (“JPM”) to repurchase an aggregate of $37,500 thousand of the Company’s common stock. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the terms of the ASR Agreement dated December 21, 2021, the Company paid to JPM $37,500 thousand in cash and received an initial delivery of 994,695 shares of its common stock in the open market for an aggregate purchase price of $20,073 thousand and a price per share of $20.18 on December 22, 2021. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of December 31, 2021, the Company accounted for the remaining portion of the ASR Agreement as a forward contract indexed to its own common stock and recorded $17,427 thousand in additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital in stockholders’ equity in its consolidated balance sheets. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In March 2022, the previously announced repurchase of $37,500 thousand of the Company’s common stock was completed pursuant to the ASR Agreement, and as a result, the Company additionally received 1,031,576 shares of its common stock for an aggregate purchase price of $ 17,217 thousand at a price per share of $16.69, which was reclassified as treasury stock from additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital in stockholder’s equity in the Company’s consolidated balance sheets. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On August 31, 2022, the Board of Directors has authorized an expansion of the Company’s previously announced stock repurchase program from $75,000 thousand to $87,500 thousand of the Company’s common stock. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In September 2022, the Company repurchased<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div>324,643 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">shares of its common stock in the open market for an aggregate purchase price of $</div>3,638 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thousand and a price per share of $</div>11.21 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">under the stock repurchase program.</div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> 75000000 37500000 37500000 994695 20073000 17427000 37500000 1031576 17217000 16.69 75000000 87500000 324643 3638000 11.21 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15. Earnings (Loss) Per Share </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table illustrates the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2022 and </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="14" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(In thousands of U.S. dollars, except share data)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic earnings (loss) per share</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,195</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,768</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,007</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,097</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic weighted average common stock outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,865,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,449,234</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,119,214</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,377,250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic earnings (loss) per common share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.38</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.23</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.24</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.07</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Diluted earnings (loss) per share</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,195</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,768</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,007</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,097</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic weighted average common stock outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,865,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,449,234</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,119,214</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,377,250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net effect of dilutive equity awards</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,359,223</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,434,542</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Diluted weighted average common stock outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,865,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,808,457</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,119,214</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,811,792</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Diluted earnings (loss) per share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.38</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.23</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.24</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.07</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following outstanding instruments were excluded from the computation of diluted earnings (loss) per share, as they have an anti-dilutive effect on the calculation: </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 54%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,141,551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,141,551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted Stock Units</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,014,124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,014,124</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the nine months ended September 30, 2021, 1,906,786 shares, of potential common stock from the assumed conversion of Exchangeable Notes were also excluded from the computation of diluted loss per share as the effect were anti-dilutive for the period. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Rights Plan </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company entered into a Rights Agreement, dated as of December 13, 2021, between the Company and American Stock Transfer &amp; Trust Company, LLC, as rights agent (the “Rights Agreement”), and the Board of Directors of the Company authorized and declared a dividend of one preferred stock purchase right (a “Right” and collectively, the “Rights”) for each share of the Company’s common stock, par value $0.01 per share, outstanding at the close of business on December 23, 2021. Each Right, once exercisable, will entitle the registered holder to purchase from the Company one <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-thousandth</div> of a share of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Junior Participating Preferred Stock, par value $0.01 per share, at a purchase price of $80, subject to adjustment (the “Purchase Price”). The Rights are not presently exercisable and remain attached to the shares of common stock unless and until the occurrence of the earlier of the following (the “Distribution Date”): (i) the tenth day after the public announcement or disclosure by the Company or any person or group of affiliated or associated persons that any person or group of affiliated or associated persons has become an “Acquiring Person” by obtaining beneficial ownership of 12.5% (or 20% in the case of a “passive institutional investor,” which is defined generally as any person who has reported beneficial ownership of shares of common stock on Schedule 13G under the Securities Exchange Act of 1934) or more of the Company’s outstanding common stock, subject to certain exceptions; or (ii) the tenth business day (or such later date as the Company’s Board of Directors may designate before a person or group of affiliated or associated persons becomes an Acquiring Person) after (and not including) the commencement of, or first public announcement of the intent of any person to commence, a tender or exchange offer by any person or group of affiliated or associated persons, which would, if consummated, result in such person or group becoming an Acquiring Person. The Board of Directors may redeem all of the Rights for $0.001 per Right at any time before any person or group of affiliated or associated persons becomes an Acquiring Person. In addition, at any time on or after any person or group of affiliated or associated persons becomes an Acquiring Person (but before any person or group of affiliated or associated persons becomes the owner of 50% or more of the Company’s outstanding common stock), the Board of Directors may exchange all or part of the Rights (other than the Rights beneficially owned by the Acquiring Person and certain affiliated persons) for shares of common stock at an exchange ratio of one share of common stock per Right. The Rights will expire at the close of business on December 12, 2022, unless redeemed or exchanged prior to that time. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If any person or group of affiliated or associated persons becomes an Acquiring Person, then, after the Distribution Date, each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons or transferees thereof) will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock having a market value of twice the Purchase Price. Alternatively, if, after any person or group of affiliated or associated persons becomes an Acquiring Person, (1) the Company is involved in a merger or other business combination in which the Company is not the surviving corporation or its common stock is changed into or exchanged for other securities or assets; or (2) the Company or one or more of its subsidiaries sell or otherwise transfer assets or earning power aggregating more than 50% of <div style="letter-spacing: 0px; top: 0px;;display:inline;">the</div> assets or earning power of the Company and its subsidiaries, taken as a whole, then each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons) will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock of the other party to such business combination or sale (or in certain circumstances, an affiliate) having a market value of twice the Purchase Price. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table illustrates the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2022 and </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="14" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(In thousands of U.S. dollars, except share data)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic earnings (loss) per share</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,195</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,768</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,007</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,097</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic weighted average common stock outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,865,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,449,234</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,119,214</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,377,250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic earnings (loss) per common share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.38</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.23</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.24</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.07</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Diluted earnings (loss) per share</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,195</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,768</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,007</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,097</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic weighted average common stock outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,865,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,449,234</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,119,214</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,377,250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net effect of dilutive equity awards</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,359,223</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,434,542</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Diluted weighted average common stock outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,865,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,808,457</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,119,214</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,811,792</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Diluted earnings (loss) per share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.38</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.23</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.24</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.07</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> -17195000 10768000 -11007000 3097000 44865266 46449234 45119214 44377250 -0.38 0.23 -0.24 0.07 -17195000 10768000 -11007000 3097000 44865266 46449234 45119214 44377250 0 1359223 0 1434542 44865266 47808457 45119214 45811792 -0.38 0.23 -0.24 0.07 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following outstanding instruments were excluded from the computation of diluted earnings (loss) per share, as they have an anti-dilutive effect on the calculation: </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 54%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/>2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 1pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,141,551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,141,551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted Stock Units</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,014,124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,014,124</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> 1141551 50000 1141551 50000 1014124 0 1014124 0 1906786 0.01 0.01 80 0.125 0.20 0.001 50 0.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">16. Merger Agreement </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March 25, 2021, the Company, South Dearborn Limited, an exempted company incorporated in the Cayman Islands with limited liability (“Holdco”), formed by an affiliate of Wise Road Capital LTD (“Wise Road”), and Michigan Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Holdco (“Merger Sub”), entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”), providing for, among other things and subject to the terms and conditions thereof, the merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Holdco. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The closing of the Merger was subject to certain conditions, including clearance by the Committee on Foreign Investment in the United States (“CFIUS”) under the Defense Production Act of 1950, as amended. The Company and Holdco were advised that CFIUS clearance of the Merger would not be forthcoming and received permission from CFIUS to withdraw their joint filing. In connection therewith, the Company and Holdco entered into a Termination and Settlement Agreement, dated December 13, 2021 (the “Termination Agreement”), pursuant to which Holdco agreed to pay </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/>$70,200 thousand (the “Termination Fee”) to the Company on the terms specified in the Termination Agreement in satisfaction of Holdco’s obligation <br/>to<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>pay a termination fee in connection with the termination of the Merger Agreement. On December 20, 2021, the Merger Agreement was terminated pursuant to the Termination Agreement after the Company’s receipt of a fee of $51,000 thousand from Holdco and a standby letter of credit, which <br/>secures a deferred fee of $19,200 thousand from Holdco due on or before March 31, 2022. As of December 31, 2021, of the Termination Fee, $19,200 thousand deferred fee was recorded as other receivables. In connection therewith, the Company, Holdco and Wise Road entered into a First Amendment to the Termination Agreement, dated April 4, 2022, pursuant to which Holdco paid $14,400 thousand on April 4, 2022, with<div style="letter-spacing: 0px; top: 0px;;display:inline;"><br/></div>$4,800 thousand remaining outstanding. The Company, Holdco and Wise Road entered into a Second Amendment to the Termination Agreement, dated August 5, 2022 pursuant to which Holdco paid $3,000 thousand on August 5, 2022, of the deferred fee and payment of the remaining $1,800 thousand is <br/>due on or before October 31, 2022.</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> The Company, Holdco and Wise Road entered into a Letter Agreement, dated October 28, 2022 pursuant to which <br/>the parties agreed to defer the remaining $1,800 thousand due on or before December 23, </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022. As of September 30, 2022, the remaining fee of $1,800 thousand was recorded as other receivables. Other than in respect of this receivable, the Company has no further relationship with Holdco. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three and nine months ended September 30, 2021, the Company incurred $1,552 thousand and $13,842 thousand, respectively, of professional fees and certain transaction related-expenses incurred in connection with the Merger, which were recognized in merger-related costs in the consolidated statements of operations. </div></div> 70200000 51000000 19200000 19200000 14400000 4800000 3000000 1800000 1800000 1800000 1552000 13842000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">17. Commitments and Contingencies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Advances to Suppliers </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company, from time to time, may make advances in form of prepayments or deposits to suppliers, including external foundries, to meet its planned production. The Company recorded advances of $9,532 thousand and $1,708 thousand as other current assets as of September 30, 2022 and December 31, 2021, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> Pandemic </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In December 2019, a strain of coronavirus causing a disease known as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> surfaced in Wuhan, China, resulting in significant disruptions among Chinese manufacturing and other facilities and travel throughout China. In March 2020, the World Health Organization declared the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreak a pandemic. Governmental authorities throughout the world have implemented numerous containment measures, including travel bans and restrictions, quarantines, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">shelter-in-place</div></div> orders, and business restrictions and shutdowns, resulting in rapidly changing market and economic conditions. Although some of these restrictions and other containment measures have since been lifted or scaled back, ongoing surges of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> have in some cases resulted in the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-imposition</div> of certain restrictions and containment measures, and may continue to lead to other restrictions being <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-implemented</div> in the foreseeable future in response to efforts to reduce the rapid spread of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19.</div> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company experienced some minor disruption in its Power Solutions business from assembly and test subcontractors located in China in the first quarter of 2020 as a result of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. To date, its external Display Solutions business contractors and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-contractors</div> have not been materially impacted by the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. The Company is, however, unable to accurately predict the full impact that the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic will have on its future results of operations due to numerous uncertainties. The extent to which the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic impacts the Company’s business, results of operations and financial condition will depend on future developments, which, despite progress in vaccination efforts, are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information that may emerge concerning the severity of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, such as new strains of the virus, including the Delta and Omicron variants and any future variants that may emerge, which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines and the extent and effectiveness of actions to contain the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic or treat its impact, including vaccination campaigns and lockdown measures, among others. In addition, recurrences or additional waves of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> cases could cause other widespread or more severe impacts depending on where infection rates are highest. The Company cannot presently predict the scope and severity of any potential business shutdowns or disruptions, but if the Company or any of its customers and suppliers were to experience prolonged business shutdowns or other disruptions, its ability to conduct its business could be materially and negatively affected, which could have a material adverse impact on its business, results of operations and financial condition. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company continues to closely monitor and evaluate the nature and scope of the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic to its business, consolidated results of operations, and financial condition, and may take further actions altering its business operations and managing its costs and liquidity that the Company deems necessary or appropriate to respond to this ongoing and uncertain global health crisis and the resulting global economic consequences. </div> 9532000 1708000 EXCEL 93 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

1Y+;KKM8#' M/@4B2"P<4!K8I;Y-=4[42;!2VW7QQ:QD*@.DGH\W;A$^"NN0%_H,C/K\VI3M M.W11")[F12*-="/9J9EVA 0EK99%_=2=7:!7.SY1E#PLZT[XO;9+^:+J/D4C MYW26IZV.R3?HD@$52?2VXD01*0!X+8,K3IS=BBVFE+0@PXK+>(ZQ-I5)=-<\ MP$ DX!MT-KU\\=W;]*A\\#?D@UU#%*>8;-<8GT$'/3EHC4FG@HR4/,>9.LMV M"XS6&(A'^/4"@+)4RRQY*)8L;U2Q8EPD^)2NHR>[2/^E3;9Z>^7*"K_Y::R^ MW\H.ULTW&0?0)\,0XZH&!%7>LU^F.L3))JO;[6B*5?':8DQF914<) MZR_N$3@O'8Q955R#*U+E&+62<+ A*3D[EVM9R+U&[4X^?V[00W#X=\3A4S"2 M-D#-X0EO=WM(J%T,!D(P49/F(.3R#W5'_>P2N\@#QO.;N$D'6DZRM%^;VYDN M[[^YRN]86:Z*#1AE3UP<:'GC[0^^,'IH72[[6;&VUN8UR@FXAL@KXL_WL\NM MS&A:JTN>%C(44TVE+D"N0P4G>Z" @B$E!_->T$\G>_7AG]8ZJI H09:PI+3! M*M)M1=12\JE.Z$.6Z7/.07H:JPLE%II=5*.D)QO\H$K=NC/LPF'W+0\CL/2" M6[IB(I>LY)).D%L6FKD-%E_7B@YEA@OK;W2QL=>'4Q72XT58W;DX'9XO M"&!*C0;("<"9\6[/#Z5,[I'':42PTZ7=)!'A="% M :H62KKD3:Y97%_6;G"=K!# "ZL,<->I';[;++'ZE:9%,X#C1@]K' MRR5CO:3^1$^3D$OK G63IJ$+D26/*^]+8]PI2LY/T?VT]6TK^T$V1Y52@E!I M[7@N[-P/*DCAH1DQM^"?Q=E'TS9X4Y7*X=O,0 A_W$*90,LGAHWL'\CKEQV& M);=M-87!.HY!'75T9P;3DTF?8?N>/+8V%=<<>$4M8H%63T78F&5+&$# M+DOPNFWO/'_1W2T;[S3F(U7[']M^=;H9O"&><2+=Z72#=723><&DARR'13^OS^4 ]B#90$^R%& M3_"NVF<B4-RL <=\U>%!M5B] MFOL21%XC5&+]1O+%BWSM#P3#F3JD3:/U"L?0\PQ4$J!=JF4/[U$MK^20.F^2 MELX9,C]'K9=G^' 7S6"5J>191_EB\?RX0"'X 8EU4@''0VT.=785""@WV,CU MO,@K6>72G5O##^J5JM\L';_Z3L>/!DS98.O\O#\\&OP5J8*RATC%S]Q&]^AH M,!V,AMW3"&!W-HFZPZ.H-QKRIY-H=!S=L;,O!)^S[KMAMW#WK1_!.\<]?Z,+G D<=1]-^[3,-F[MO4H5_FV MI_ILR9)Y,,O0$E=^&>4JT*X_%?PC#X3E6"O]0&$XR5.K)K4X4=,I?WN,4V*M M8P@M%8COU^CDGC7+-MAD6+&T(HB@RH7B=B0!.0RBO>URN$8X.[5F3@>CGB75 M)$BWW4U>?"1S-!@ E;)M)M+\IK'C1#2'W?Y;9"S$R0_'; M>V/"C2J L\^9GMK'9QR[9HL4TVAL/@12NF W.+U+.DS4H)/G.F-LL^]K:W(VFLY M6:?HJC3V4TE[.IX)*MD.]=<64OQT2.X;;# MR;M.R'PLPAJ.IH/C0:_K4E0#.7\!DM+.$95H;+E"+2>H[\,BV$KO U\T5=E; M^0>^V4L]EA&?,>P8R@JZWP@,-?[1;!A.-HM+85I7:8VSXQV!3J"G5W)/4O;) MR5?(K6$2C2'LF [871=)&KUZ\>J5S/.F%7@(-/9U(;^*^,1 XKU4&+2VJ6LMEFM1&-:)N>^I;K;CP.%NKB13G$*9I;YIN"B7O>F3<&8 M3(9A!\)?WL-TF[?H=:JSO3#_,--H]\OJ"QY)2#J >7 M78E&/Z&9"VZW^7,05:2$X/[8*%=*/,R#Y]8L<\K!G8R"KX.KHJ1MUNR21,9 M>0NO&O15(F623<*>0SGPBV8C6"VO,%#+S3#0U;C@KCPD?ZYD@!906USCFHK* M[W#!$D?<#J=VRX+. [R9]T(!G1P;$+B?KT5$]U0BV.O]?UF+H'1G/0G6HY&[ M2$%A"/G^N.G 5Z#S0U04L3,!2"]L+KBX.\40L/P&HZUR2KD^-5V2#R*\C\(#.&2\4T&0'X#&Z$F+Z6JQ^8F M(4M32&&"E"H,CNU0,YI-JP+(>\F!..@$OE"195B0.-.^9DU5CG4BLSC5@\]3 M_;-@%Q;L)P"\[,_QAY]?O)!34I,TE6YHFGP>@Y:WB"EDA_&B=FL%T+E2>2-Q M="OBPB\[J;G+ETF*TE,E%ASK,[F)!0V.?3YF1C%0XWS^LE8EH!;ZP\@YUIWV M)\@D#9E_0?QJ(G+4,BP(.\U_ICSVS9-.N.4O+WE?LO*YS#&C#Y$"4W% MUA? M(1HD8 85E8K(9O"S>JW0RY]U)KIRR;W>MNLF,,N/D/O?OYN:GLTL=T=<)-U/&'A[;?[T7[^^]W%>ETZ3UX(V&$Z--F;/JR2K; M2E&"6%FI+F1\)&[2L\M\4V/ KVB>=Y;72X[, ?7P8"01V3_'*NP+=D:S(1J MG\P8P\%UU^:\N)UPZ9(*)1(R)(7MZ9AL9JBL8[E#S\R4H)R8[A(884**^8S' M;^/0-#5[6ZXI6_$K4P^8'OI>U@+PC-TPU*>5>BFJX)SXA--81"VI+2/[81%L M3&6--]]AJB#V0S&Y:_9LRAZ)KV!HKP<%*Z\Y=YD3L( M71;"![;#]!HD5?SRY>^__<+#*E=$D(P+7"5C>_4X@="D\SC!9/(HI-'E)F') MA5TM-^EEK).E)7Y@V@0[=%0_=GDYQ$Z.,(FQLHO,IM@.:U/H28C>*60;734 MX(L+QB:%Z\NZ6[>HGJ[E]@V;8S]M-\< TT='?\.')].ST[?_#U!+ P04 M" "1@&A5 _BUU8$P$ $0 &0S,#8P,S1D97@Q,#8N:'1M[7UK<]K( MFO!WJO@/JFSMEEU%/)/,/9.3*HQ)S(X-7L#)S'X3(&R="(FCBQWFU^]SZ:NZ M!=AQ[)/WS=;9FAA$J_OIYWY]?3H]/WOS^K3?/7G3;KV>#J9G_3?]/Y^_^/[H MY]??\9_P^7?B@>#U\>CDK^#X76]T-AK_X]F'T\&T_PR_"-HM>*X7I664OWE] M,G@?3*9_G?7_\>PV7I37KWX]^BE.GP5A$E^E_WB61,N2?O7Z0CZV"O.K.'U> M9NM7WZ_+WP/Q]RPKRVS%'RVSM'Q>Q']'KU[HOY?A*DXVKZ;Q*BJ"870;C+-5 M"&_JG@W>#?_Q+(^OKN%5KX_?]#]=Q[.X#/!DP>OOCM^\_NX"C^;;P&\^V[8[9T.X)W]\T%O-#RY[$U'XZ W&E^,QMWI8#3M/^";QSU/LCN!P.II.@^V[<[Y_WA],GVM;!=#(.+OKCMZ/Q>7?8ZQ_N MVL>+EPT;*:-/Y?,X7<#:KW[\S[MM[,UY>)6&\^MX'4RB53S/TD4U+[,\Z&7Y M.LO#,L[2X*"\CH+_^H\7/_[R.VS\]>!-+UNMPW3S^KO!&]PT?O7K[X?!=5@$ M5WD(1UP$91;@KR["O(SG,3Q=!FFX@B_BE+X89O!Y%&3+X!W^ O\! &FWQE%1 MYO$QW/K^%%<1$TK-B]RJ-H M!3##M>$Q\WSJN_H)X;FP+ %>L%B8!MW;,%\$ +0B+LHXO<)3-+RNJ&;_C.:E MA M@P0K62A?M%L(\1CC#0U$)MY67UQ)*YBGQ:3Z1VMY1,(6'PO4Z@B4^Z:U= M1WD$+W+NK2N>K!^+5S9V%1B;@@W5KQ)_]_/O!3Q5I66^,?9=XJMA\V$>P1GF M HE@2[--D$=+^#*=XS=EUF[YSF+B2W$=)DDPBP+X-BX31JJ3^"8&3%\$_7]5 M\4V8X 6.D1,6P6T,&\BC8FW F6[H*$"R\G/D+T-54_EJHHE9%*62,-JM=947 M%9X/MHB@YF,BS. _8OOX&S_*&!<#R(:?[T/!+[]_^3U!K-S0.P!;!,L]600D@H)W"?SNTKW6>W<2%V&F[ MQ13IX(7 %Q,]CH)C0"F0IDA1=2KHU''Q57 0'OY7.BO6OX?SCVEV"XAR!;>1 M1_,H7A-CP1/GT1I@"XA0MZ&/"2;C8.<\8JWRY,Y!6[0O#A M[T,\/%UD5;1;BH#P:]C%&H! ?!#N*H5G$/+J+7ET!;Q$7)OZ=!+-JQRN/6+J M['^:7X?I%=W>*BX0R!(; )O@G' "P+%9 K=@8)LB"/\=!Q=JT\YU'\R 2\SG MT9K@)Y"7/X M/6!A!8B>[]X_7W2[A?O?QG1^_A(\Y\41W>CEFY/7D_/NV=F;_ML!:#J@>$U> M?\>?!.*;[O!$?=03G\%CTS'H;/"\_.[H]7>7A #!YZHEO]W],"_P-"<17"8C MT!'I1Y=I$A5P=RAG;N,B@BN&)Q0? 5P(UW$)NOC?*"X($9F_7H> '7B!JRA$ MQ@)W6R"/8:E25*@MT.,>R=MN&13\V<+DQ0]W!08P.(M8?3*0M R;;.FH0;A@ M"@22:%!-YL".8OS0X!7MUH0Y$Y/?CT<_/,6Y9_:Y&\^(=]-PN S,).0'R4:I MIGZ6*'A/N]4(72^@] HD$^'PUUIQ"1?_K(K2)R*M)2Q0@Q'WN9"^![6]!.H^ M!KT^!2!6M!NFMUZX%IP0P8-:&*D@96@0'0EU%'+PQ4V4QJ3B96FR,=2;- .6 MO5R2L-!$Z+)E%M<;K3PPF[8511!_* )NKT&MTIP I<%4["QGY$3] 0^,1R,- M">X8U=A/0DIU0)X0&S-V&,N44+=.I$;B4R9O8XGR<[I,J94U\ V4+L";"M!_.^T6RZ4.&%6H4N66K O) M4"!I)9:,F!9(F]RR?^ GZ)-:-_@W') &)@Q_79?/WC!W:N9,7\)-\D+N'/UT M)X/W@"#"#0>'H?_!B8IRDT0VFD0K9ROXT3J\BI[/0,O_^'P6 <.*7H7);;@I MT%_W^G0<3 ;_"V?ZX9E(YI,HOT%O0D^IYHS?8'.Q:BVM+H&<==RVC"Q2\@U*>/4TRE$7 M)$;*3I)UE,?9 EZ3+D@6L.:N:,$01\"12\ %? @$MP2+--: 5-<9<_E%A#P^ M5N;H343.'M *EQI0OVOCQ?63D*L6B9Z,TAMMI:7H.@&ARM;#TE1'EB5:'/1B M)1G%)CM!3%*RPXQF1O*TJ'(M^O#LM)[]^X;MA7-R!4@0X$$4!R.Y)<38#"7Z MIMW:#]1'P<1V8"#%764(125I31>!TK [TBY;TQD!2.1 R\":7<0%*&%XG(ZX M27DY$:H#R"F;#BE/AX:^!$NDU+X@(N4$P2!AIVP" < C9$)/H &##8+\O"A# M,G?Q"D A0ES,E *1A_G&9[D0IC0 ) )QD6VDW5H(\,06=!B=P*"5/R?N(*[& M]+/:/")'?,DUS ],)Z3\< S&^3KV.%GQM%E5!KVP0@+,/6= /QGP479.OLL M"\= 8@5 (0HA"W-0_@M*V&.GR4,>H->\#\5\.)E#*><&E1R .B!"[1;=4L2 M02.M30'JK5 EOT11):50=$F.*SCSK'U@).51PH$B#]@O,/B"./-&FLR7CP("X*P3].MG(=Y<9W&:05JL97(.U>X8@L_2J- @- M>1K"$B&X6H'Q!R=*-OK&ZBR"."08>^&<6=3!)^&^PG?!FR/8;D8O9[J)V030 M>Z+K7P%J7!?!@:0#!$&>5;2I0[_"28P4632B59Q66:6);U'E$@0NS#LLP@\V MQD:!5V5THKVW*LB!/G+?<11TX7,&-2(J:*R%8OC.)5($@;X,2W$S\+!Q+0VX M;%\0R%EZ&#V^9(\*:\YX:!:1:W89Q5(.S''%!%2;CD^8VZJ#&9/ "YJ;?G1% M[>$*(R2UR 1'9XZ"P1(Y$3MRX5 ]Y @9J/SS.9@)[(V$A30!.=B&F[2XQU;R M(O8A"-Q+Q(H,@KM1 5&^T+ 945)*# >?0R M.$P.=S>+ /C([%-QG>3XMF0.\'L08EE1/C=Y/1W;E3ZL4AG,)%38JO0J[Y$] MF"E#\UT)*$]$;]>RM".4&Q'N!)])0CCZ(MQLX:4H&(4.6Y"F2M@C#\4*#47< M4!3Z(5-3,PG>)@(0AN+K"6,YLM=X"/NHJ:$X>.!8L.AXT0UWGH(@2 MDT+4Z"-3R,G"I5\"9BQ/X<><'R*QU_E)G!*A;]%&.A3%8.HT^&$S?3+1@4GF M4IU-:Q9H?CL4,$8&ON&+%E?;I P3A^Q(QA_=X"4HR63]J%G5$HS.XB,V*B%C M=="C4Q-$XN@$I7;+0[[")DI@EQ2C$MJ%H57 ]R!@KZ[OL/NOUZGR\IM3Y2%I M>W%(;%0X!6PCGJEJ'J$M@MR2]8HTDSDA]#61FY+R'1;0^QGNIM."M$0R@H3N M >28(JNTU/NZ>*7 +OP:6-11\+;*\9?,=11/,?-GQ>7?$ M]TLA:1!, !-0+^("TVQNL@1V&N8Q:I,;TVL!REU)]J+R5P@#':ZTREGP@U:P M"ED-764+8C =F5/1 >Y3K-GKDN6N1:Y,HY#- \ZZJ.K!46462'M5QM7K$97' M!^N2P-IN7^%F4@G'/)DH21Y7Y-/TFBRWG62HB!79,LR1WZ]QW=+KD'V"ZXJ=ZS+I&SGGV@*0 M<6U/LM]_\GYU3@!0CO#AL=->TTI(C!S=XWD(1E_,/+Z,5JP):S:%4?6XK,JH M)O(803[&*9MK\K[Y\W:+OF!7JA::7G1BX:L<-6@>Q#)F/<_6T185XJ[^2GG\ M)[F+T5=GIA_] E9'3G#; 6C"!.\(JDM"5NQ(V+\I'S-@*1P MU21>Q9S&C"E%R;Q*&.!T,07(@YR]D>R'%B:191^M0_:M&^(D%3YYN$X@35@ M+N[UV]%PJI3::WCI\V(=SJ-7:7:;A^MG;W8^ CR/%L^%Q?U^CM\_HWXC]P% M8.TL2X%3P#^2++V23P>AD' ()P$E9/6YRF>[C1+@*R"HE7Q$0 )T,)="KOX4 M"D0"-K77^C19C:)!H0DI&JNGI]O4I'01J9^8X3"5L,)$B38DL8$[$A*#.N%D M1,S>50+$NZDGH;<5TYO0&&["I%*LA&0+.]=5RBE\B+'A5%H& F!K3)LB@J0C MSJ,G&:F6LZ,L/$YX%PTTKJ1]:%JF<$ $7JRH+=?$UA:BT=F]Z]1;$YJ-FM,H*+ M!Q>A.W0L@%"#M90:<^@W->,\CV[@F1GE4"5XUX5M*L&/>#%ZB5\OHU/@/\C[ MP_= G 7QB:",6(N79 =E+;]VI[X"YI-C (?C0_.L8I%%MUD"3-NM?U:P-E() MA4 R-C'H?<3C0)[,S)QX3^ZYKW!B@4\L+-#(M6]#,(@:$Q9J:$=Y2Q&?*.0S M?;W^KQ^^^;\>DKEEA_!GK#(O)"&EJ-!6,^!X,>I<"B63F*(SDO(18+!W# JR MGQ>K0MJM95*A+<\QU:B\C:+&@'M"?$%XC3>*-:#7BE*!8;TB.,D2U%M4 M5)<)DCN . 9YHHI@4;D* P9=:]E\33Q29!05 (WH7Q5^#8JH\F\SNVVWFOCM MXV<#OSSZ@7+O,2I[D<#0<])WUW[!QY!)L=UY_#VE7G1=MS?YLOB E:?.U [Z(_GHR&W;/Z MYR?=:=CX;L] M[OZ\?WX,I[Q;+G4=GM.!\2Z5IWT.@/Y+G_2=^'P\NKSPW.D>>^W_V3N[G S> M.U]<7(XO1BZFNH<8G%^<4?VUL6&%0]V3\\%P, $I.'!!YP'Q>7?8?>=YU-AY MNW5OU-.P'3E$Y)*5[W;.NF91U9.RT.//9Z&7PQ/ TRG<@\OD3KO.XULO80]\ M#;:AZ^GHS-U%KU:OL(.'#(94A.^[WN[QZ'+;@;9 JZ,XRF (Q'+BP_-C=_'A MR/GH;' ^F+J\2PN4SMUVMAW=0;;UG85/1^>N]#DY&?1UP]3U8R/%@/#UU?CL9]0;N'4_ZO%WD:#C?IGG7'?SD?#VD-, &F[G?_/3IV0(H-3%S&.71..#GMPC7M M/N')8-S'EAV3T\&%>ZFG_;,MPM.'?WYBUE?;[H_]D?]P83SS?O^Y.IY^/+H?W% M%F2]G!)[]DC$K7=V?QGYMOO>V(:4-5*;?=\_,Q! ).9AMQ-*SI/URH8F)Y/R MQ#?X'#5'47^*;#T%F_VTEIIRHI7;)]=.O)I"\%#2V=!M#?'L@;O>L4,XQPXT MI:DQWB::MI B*-ICYY>D;'FH:S(!@-\=G^O7V?6:5O)"QWX=H.%&^SZ+8#]M MW;AE0W9[52=7EP8V/;@8^$Q,X]K4T=U[.QN!N-IF"CVD-M$;70ZG8Y<-NSSX M;-+_@,:Y1Z:Y^&7 RD#N9E!]UF8]U'#:=4V?D\%;H 8/3OALU(OQX'VWYZQ[ MUOVPK5N#.NO%>#1E/X%/!7^,FWPR.Z;W:(:+BT\>Q\C$8\B[^#+N_\\E"&_G M:IW['[@/?1AH+7>+<$.]?6NG#\7L2&WWJ(2NZC5T^ @41\YXYISX]/+ARW'.A..Y?P'-Z$374"C[O8T7V7=U(C]\#S_U^=7,;-U5P?6_1!Y)&#R<"U_)O01\-;<^/+WNDVE-+Z MY+U47MKB?OJNL]AX],>='0U>55G3*MR9LVF?M/AP.CK?YP:;&9$'.D2"NP%Q MT@=:&;B<;9>C0KN3>GZ87UZXB#KI3VMV_'XRR-N1Y,',+Z^.X4%.=>0/@S-' MO+K(Z'/)C(:>")9'SGD(TGG*#8,,06I,)EU70W:O77&^+6S/O>HF2^M+"/L' M=NO?#5N,4.*#J:2:CK9II/H>]J')Z<#C#'X_Z'_82V[7M%Y]SR?<-^AA7?'R M^-/1V(,R'MP"(PKQV2.=#&ZQZWR#L>=5KMK<2#J@M0]/SG=H;5LDF7O_X_Y; M3ZS8?0XEQUZ1B1CSVP*U>U]TE[LESS;W1Q&4D=[$.W U] M& ]VF!'W5Z8L.T+!ZNG," ^3,2(['_KOC2B%WU=HHI:/7AJ1ZPM9:@(A]U!3 MNF_?^O24A[CF[O'@S!-29*'L6KW]_8] M&! '=C[T(.N72?D@9'/IR 5O S)XG#42*]U5W2/45KUCC/6NZN"#R7=U5L$, MO\3-?#G^IIR*7V-FZ8_?,DL?K@?E#[('I;3-O#&:AVL;>><-8I6E[A2=+>N= M3+$K=90W-C%O:!\N4D\Y1YUJ2S!/U.PPS5\MLGFUHM1Q+CQQ2X-%)5VXP-9U MJJ6XT6=-)J::M>K>S@FJ139W\G$[B13.DT:].';?['7^HV&,BCY1)P.J\WV@ZK\CK+ ML1*6NK932Y%9!,\L:V7$3H4R?K8* >9YA^MT02G-9L")5-U+E,A^;F9S*EP" MBVQT 2X6L,DG8',9]P>6/8O$ZV7K<%4MKTK)Y,FP9Z H+M>GJN^:R,+>=N#? M]>,W]/U1,E./^?!OUHWW1^[&JZ;"4/L)W8+7O+391I;RN]GYG?KX#$^OJ1K_ MG5*#N*'9(*[=$MTOM@UFL5[%+;]YFD%A-6"H-U0GXG-:?T\:YL28@S]V[&;+ M4(4.5T#AH%GPANUUG"%<=<3GU( U7T)>NKD/J#;&;]H :H;2!D3$FZOL>%%\P0 6S>B3>']J DT@M'@!!Y<^2 VVRIR#9)H M;R.NQS[<.HP7*'L#FT90U.%K"PN7)C9\MV"Q]N/@XP@)LXJXIDH\&S M1Z&3;H[ PI5$/A?[1A('%]R[4/8*:AQW\#/\*,EN18\]=4JJ=SR8&8=\&\9Y M:K69 M5NX!FLG9H4JJX$ JR:0:$6)&FYJ<*112-H/(PB#&IDU M%D1J]&F&M%JW)I6*<-7 Y'6CD5GDAZE@_K0$T%Q*S9-0X2V-I7'6A.B7YPS$ MJ.V%K[6NUJA&?1NC[XW$EJ^W"O2G;[;ZPZF7/TGU\KW0)?O>7$W#QW8IPR(# M'51X0EN>24.58-H,SU)E)$E2R]'W9H>TFKI7UXN.]N .N&B[9:_ZZ,3\>%;) MST4._P67LJ M@-7,M]:5^0#[,F'[Q$Q06A*6TK@"G1!6??'3Z\FE@K:&W"\_ 2!OL"\]X/AS M$I&OX!*>O2FOX=(N ?.4)@X,>0%4M@%5KW8H^[M8'HV.HZ>!4#O;PXZ'S,A$ M\VG6=?Y,UCDM:PB![>;SQ&\..J-%3$DC:--T6["F3!/4R%N5JI%$5CM1V=?$ M>!8G%HE.EMHT;M3W":EJC9DSJW6$9IAJYN4T#\G.NLC C-Y('WG!*O\M*+[4 M0.FJ O&:@'%&9K(PL.64$N-+LX6G8+_'&4I+9TK;$]C-O[!WXIBZ;)$Z# M( '#^[3&4!ZDVMTKW .U&MUSJD.;Q$ <(6",S9+/\:"UZR@A IAEV4<40-SS M;<6#MK) 'LDX&FWA$MI$N597<4"W[^0(.'94 M*3]6Q_R-:H]_'<6Y'N6C%WA\)]\O['X::S9%0TK>N=UF:1RR$)K4*)])3'L M/1UJ>4:P%K1UE]S6EED^5T!]=AOI9MII*-@J]=J3O%PWMUE&V%4LZ0!#1%Q( M0!G$#6K5T!NI*!1[/0(+I=VJGT%P="%.=(Q*#..QCF\0TFU6)0NSY648W,19 M8G6\-$ZV]229H=]V=.@,#TC-\ZZJ1,[RS44 R(:3EA*JOQ!%]\B)5&P ^U>6 MKD*:N#H]]MWBED4%64>(#*"UZ^B22< 5FY=IUN(B0UFP'YFV6(C@VEVJR\S M4*9;BXKSQ"NI:,E7+FAN1I%U9&\O.^BKFB)%5]@4"9A/$26"*Z81,DUT43-3 M;K< D,LJL:Y2=R3R&Y2,O,#/XDB$^20 Q(^QOQ,#"$ A<4X._@CC!!L)PHJL M$9F($Q;:0!4J!EPF\&DSDJC5%VV^,MCQ@KJ."]TK>]HMHWN@W#Y>N$ ?AV4B MR0"B%K?.8]5W47-'\GT W6UE& ML$&%;E1H$0Z$;*H>E>2VZ8%2T-HM/".KEO6.Y5^K)^_G;YZ\AY2;/Z+0P!D9'W%: M5*+5\3K]A<7Y(UONO^0/)-;<3-&_H$@.3*2A(QS<12*>YX7F,XBWC2:,:(;H&; M*-]H11[,@)PCLP))E=*L@O#EKH:._F""L0A?YSR*UPI<*@X8Q2XU>00/<*Z'&<&A1]K/@A2=S[ MIC_;-+PS$ZT[1T2*@-3P[H^S,Z7B[\6.%Q&E"9"Y4#>^S)G?A)VA&'KG\(4M M$X2-C .6XNWR*0^"JFW6U9,7;1=MF M=F@D0IC 8;%6X2:2J8Y[[K/9K15%'XF^Z"2*T];R5:7_C7S%=[^H@ Q6]Y+ M=/Z\6S(/XZ$:*;6)G?)](-?Z#&F<[4_R-&P#B+Q,I+_5@"K(H#I8OU;OVR_? MO&\/:YK8#NEE540[P''2P%RJ>M%'A5:^ZIU4@K[G]%5MTIJ3F ME%A'HW*CHBINA9I&R'QO<1,7[(DWO!P>4.+#)CC52&,1:=/Z"G*%@L+/3U(' M])OT>/:%>]-;'&_D/>@91KX M4C>O#MF_19U>/C=.%HG0!QTR6Q^'Y"JOT1C%^L/DNSV$&6A M+C)S=0*!EY2!LFW(O)PGIU3?^DCL.TP,MQ.=_'/;@?=?A04F M!*J!IT5XQ1O' Z"E0H47AM$?*I?"]HGWGC*C_J?K>!8#<"7@K)JC _S$]!KC MW.Z^W#:!H^8.K@VD;]H)V5NHLZO$VR0$ "Q"%0#V(,42M35C$KVG8M8I]/)P M%9P4%Z=55JGD4:'T.6?C;9ISVW?O\DY$T(SFL35?C],\/4ZJ!I3==A12-<5D MH7E86$FICHO*LY!(O5N!G8PAV&2S< 5.[,6: 74$MSM=, M'AQO$%=,?$0%!T2M+26D'\1'T5&'+YR?%3B+3ADC;; >XO5[K$1WSI^4CC8,:"7U ^= MQTX,@//0T.16G3#894$2S@C=.7AU>-1N?3 ]URJ>R&6F!M;6(@_N!5$:&493 MQ=/L-'ACQI1N:,]4L=8-C0%$II_19RU)(&VN? M?>BEG=O2]>QMCD%>3)WUMZC)W64F_$\>*A;9QU=9)EIWF!TU#CC2C.TG,N7Z M] %FBM4)5;[!;&B1-K6'?^G%T8_?_]9]_@-(MX.?#I$%'AP?2FN6<5.E:OGO M"6#G H[DG5WO#Z\Y_'J]/+]^\_(\G!&.;1YJK8W^^W(R]?: -!M26[:XVR?7 M8XUW+P93HU&7+'B:CB][9I'=@U7/W1D4DWH%BO#>BK0FP65(MS*J_BT%1-IQ M=8;@D%]'BB/8,/7%<)/9M81 )5^Q*M(.V"=/ZH1H(H "PHA_VO.=[>S*CL%] M\ZRZN@Y647Z%H2K\59;$"Q$>S:,LOPK3^&_U-ZH38$GRLJ1SSL-U7 +ZZF?F M8.X5*B6U(Y11F4XB_R[@O!3GO@$X1O:'.SDE/?>\6G9>? '*9 MOP#V.Q,BC'+SV?79,=*Y=?*]'DMOWYP EY$88^N(&7$=CB!:3!XB M,.KF4>)-\GYDUJ&C1!D9T^RWQ3_!&L0\4LP#5[UUC(8*LO.7SP/F36$WPC;B M>7P3:!D+&YOXC+B#*.F^ MS KLR%,8IH#(D7T+2YB^I1H(@9\@>1O5%OQ)29X1QY#SI_-2(A_[Z]@HOB_? M.Q+N!+,76QK==B@50>F*9*"K)AKF'IU;V$TSP<.0C+(N)9Y)F'A\D_7.3H=6 MJ7TMC[/=4MZDV4;4U%*K,K/,;V<_ J%F\M9,77N/KE>LMQK-0V9A$9/W13O8 MC,8":A>J!H@;JQ@9WERE*KNQF!U7J!0&:%EWQ7+.(J#GMEY9 $CVZK_BX0I; MFABRK\_LYA/:[]_:(^_Q8S8O7DAU<2PUO7>GKJ;H]N_ONHK?J/<'9K.;0REE M:W$Q_5%_(4-$YQ=GH[_ZGJ%YKF8Z&DXNSZ9&&]FGTRSK,4&C.6&:2>9*\M"0 MWM[D>)D\Q01ME\5YY("B,+!4X\0),335S6&X2!8(*9PUY*&H8Q5DBY6M#@O/ M9AK.=J6X,E:/I91& MMQ>(!"%SN4B5[@0P'E$Z)C\.\CS1156?A@O#B,VSQF'7HU'B[34[8@)O1QPX M(J*8!+?A1A<%\-(R5UGO MVU,!DP6J]4JCXB5_%O+&=1^ 1ZQ,>O%2\OPSV:3D7=]H(?Z$-4C36HZ* :: M_&!8RD+J5Q[AE:5S6;:_?]GO'IZ[-$N?H]M=6HJ&UIA@M; N!3%*B/-:.3@A MKBZC+W1A)7E7E?%3F)TUFIM#N8T7B#8Z,I8C:B\=^Q,XR6I=)IMV2[S=S333 MZO/._>[2&@7=@0$!%D1A>*!K(5MEQ,S#'"5/539IE!.SK>W7Z-[\[9M[\P%Y ME^K)> M,($;5;!&D8D6*FC*KB*CXRZGYMH->37'_%UI$9W@.KM%SUR'5 ZP$I7*L24F M[JV3\^1OL(>KIBUU2"] ';2TSQO*\S*#7Y"_$'5*=N,T:"0UAX5U9.DV('\< M1A^U'FJLU&X)M63[IC#EQ.QE8"8[NF7T5YB-G=(/=44]*[UJ1<,!L:7EGQ%, M%OO$3E Y!0B?H%,0(*MH9)Q*#;_6FT)551^_N3"5[VVM2V1/"E.-LCIS =:( MI!PM4]JM5#@&/7XW)7B/>I6QNZ0(D3/1VKUI/O$P!4$U=<-3NRLU]O'< ;H3,RG15YJY MC#AO),7HJUM-W'S(JPHS79EM<1,1LP9XA_OCB^$Y]?(1U3W!($5//OE[-#^F MVC6L;10-+Y!X*8'E$^B%I>@TLA0KQ'H%V5J#@O360\*;S:TST#Q2S>_JO51L M_0AM%=,7H)7#Q\X \!1,X=CX>X3^-R2?T MM_\$3X/1/U%S=*/R_$3,<^&]<5JKP&]TMLIQ+Z*5&-<4;2W8Q-L0Y:[*M,?0 M@6P@VF[IGDZ*QUS!?E)#K-E=J$71H1*#0 O\@P.AK-@!5I%H;R&:4'?8+:$6 M2LD7@(\_2>*YK^H7EM4>A7/1\ M%<:)ROU8+ !M"]V127E[EB[SY*S""WT; #@SN$@;EEWGQ#51RMA%!M8@#QD) M]JE"K1N]L")%-F5V, 445%-IZ.=B/[WX?LO*>^K_/L*B5?(2E+ MY$^99R!C=,$B5_/R&Z^X"?T2FV6 <, P2T="3&>VB\A-B&$;627&SZ@;Y2^W MCK,@5!:]^L3D'+%(6)B+H*8*> 443>Y&A<$X**C6U=&SP<]FSB]^N"L3. @/ M \XU/:&"X+7,T^IK-)8, K?'&:A32>&2(:CJ9RYV1Z='1$ERBPRULE*)JCC1 MWTL^T7' O64RU46>D7I2"?;)?:C@WAPAH&A%#69HB+F9@?..=*T+VO672&@: MQV4I15QJ[DBK[99ND%S/P*@OQ1C#957VLBX2UOPQ1G$/@"M?"!R,TYLLN1$> M82%\(JVH(1!#J_5F#6L]_4S?;G82@*J8?2?,V M$A90/D=*21R@GP'_IE9L]*.[G;GCO);^E@+M)@YW,SZ;.6.DD:8\, 5O!8_V M>_^_TN_LQ???O%4/R8=GD@_WA&,"R&$W#][5&,!.%[_F]MGU@!7H@2@&'%M! MQIQY.I/4JCS8+0U82R*P$@Z*RW9>6%_$%@-6HPK'=\0;=_S=GMB9T;N"*UII MO)0N-5>& ^#AFG**UJJ7I#Z1E@DU3AUB-CC\J/ 54I&Q#W>/IERM*P\"!)9: M7V/G _:.*4]._7ZU1;CSGF5&AI* 0MG:=C:1Z8V#XU;KTCJBW9N*BLC4SZC6 M%P0$YU3Y9A_M+'I=5872R.ORC?8H)=/"9/F8S6$85E_^B/7[8#RZR!@FLV!*Q6(WC] LZ9_D7ZC0F(\6W-N6TT34OHI.8.VZL*.XG5HOW*)C M=,.EDK!5AD;@0QR-TW6LLP%SLEP>>%3,S* +=D[K5"IY)>_NVRTJH+<;!E=C M]S?,9)'=FJD$'%M35SP21DQIC)1#\-$=D[]0<3Y6\^2;YQ/6T>?!5-6$]51- M&%-'O>^;3D)6X)1J5+NE@2<0DO-ON$'X**Q];NAS4/&S&]TFRZ*+ M/.(AN2322#<2TU%H1TA0PI9,318G#LN[$!7M6 *3N5-1R3B5Y MXD@EU8F(WR"]*2J4Z&S%"B-2!/!&1%>LY 7/KTAR70W_,TSK:HP%H#.8G(':>I !+4K3*D5.(YA'(5Q3Y":F W"H M(8J@5NQ[4HDQGZ!/Y#$^IEHDD0JN_E+607UP1FF$>MR$2==Q98:%9I0<+;JD M&@:61#"K+W_]F#UL^9[E:1QJLR8]X+>4]$;&_\TUI%U1#'RZ27EP=B# MQN*;6LVA2'%A_8TN-G3ZWB-JRO(SHQLN9\/S!0%,J=4,.0$X,=YNYR:52:-? M%\5SK40R;!WZS:+C?D "8\,BW"Z _YFQT2:O$8?3T#&E)<)*F8$@B[H%FA\(3"[ MHB7$F"*1TJO1E^7!,O]Q;!2',X'C #V:UB26#-62ZA,UO$TLK6HD=)Z&JD,6 M/*ZX*XUQ9]:,QQ5*U->W+>T',8Q 2 E"I;7EN3"3/Z@>A6?4A3SQ:A:F'_68 MCJHLI,.WF8$0_MC.;4^+58:-Z-?-ZQ<=AB6/2=!UP2J.0&0T0-5G6'[ MGARV'"9%YME76'+=%(UF %D]CZ*%4;&$#6\-P6NWF7;\1;M;I.\TY@-9^1^: M?G6Z&;PA'BDHW.ET@W.!H3SU>8F>-)$1LQ=ML^&*N.&G:#T\C7-\L%\.^P\0 M!DWGEUDWG!M(8W3%5%P8\&RR AG8Q!S#B6FB;>+=S0XLDQC-E,/&ZV+Q$[= M;3P1C_Y!.?6B'"FE:/!L"T8BTD M.(::5"7SSJ,]5.!76<9(O% M\[+B_[P9/!G(&N7[L-_/W,;W9.3P70P&G;/ H#=^23H#D^"WFC(GTZ" MT=M@Q\Z^$'S.N^^&W=[I %[9/Q_@CBZQTP#L;7PQ&G=Q=T^TLW%_,AT/>M/^ M";QSU/LCN!P.I@"X=^-^']MQ[=I64^WOG01!3[9S$K79H/^CR2<= -(F53XF M&64B4]?PX!1N1,J?XZEDX)X!B5\?XI185>?#2@GANQ57W[%BV02;B%\51J@* M)*R>[R1-B'9J'=X8V># M8 Z[_3M*68:3PX?GS:#73@T)FD7^)WF>H8YKR?C-H>Q3*9Q)VH.HMT@AC:8N M-P%WE"XINQS>)2QS>6AR<67YS@ADF*H0!;V1S2#\B365V^PH;?8S4LTEC:GV M.-)>A TY;0ZUP=IPCT G45'+N2\[.'_$*L37,UM"$S6WPN^L\3H*7W[]\*=*\:860 M^M-A_Q RX*-/#"1^ZS)GRP\SW[O:8]&Q;=@"LZ.N1%W':A4UYO]QDE6BNLI8 M4*B+&^%]I5AFD54YEX_:-ZU+DT36A=-F^$X^E5DT#]$]3^XE\TW"@-RCJF=G MGEM688_"Y]B/1B2[J8FTUU&C0XI% 37<-]K)68@:)83@[CQ06TK'G^%@4"[;P+L JPUK A$'$>B(,4VLSKY/[,R&)0.5J+>NHZMDU.V6 MR/8CGY>2/]F$3N\7N7#; M\EL,ZX6%?>2.<)/*\_T!)!0JN\%*.GD M_Y4Z?G[XYOCY')V79N#0I /)2IX7,G751U^/01J7F!IK\"J%GU].^?=8HB*. MQ@#(;C'X3>U$BOH8$Y6QKZ-A,MZ*;3?3.38FEI%*'K/B^4*&,&%!XDQZFE.9 M84'"+$QD?Q,RSD1DTI?CCI7KP,O^&'_XZ?OOF2CAU(GP0J.F88Y2HL#$"H!S M+?,3PF 3A7G',3SJWO)EC*-7 AG!?JO.9$>P?>UE<Y^M()]SSEY>\+UCYU+/4,.<#=(OU M-:)!#&907LK07PH_JQ>EO/A)I3Q+E]RK^_29%1\A,[Q[WRXU_DCLCJ[Z^(WX MC^ZCK]0ES$3BZN 0,RQN(NSJB -K>,2471EA==LO&2SP!8T,<_M$8"#:FF!9 MRX+W-/O#B4E=.D]>"-^M.B=96S[/TI&AA1 M)E)1RGY7?"1N![//X'IMP*_"CU%!;6KMVA9]0-&>GDE$=&HQ*LB\/;A,B'K@ M)U*3<"+QC3XO;L=?(R,CB80,<6YZ.B;5#)5US*OOZ=D%E'S170(CC$DQGV&P MD*?AT@0:SBXCVXY;ODM3#Y@>^E[6$> 9NV&H'RAU4I2QN>@3#F2+:ME3*=D/ M"V\+))W@D^TQ+AH[;^@D*>4B\,+22I+S-6RW-,-9TW8L62R:.0!%=5 MS)(+>UI6R56HLG(%?F!\GATZLN^WN!QB)R>8+5>:U4QJKH_5CL XA6C7*CO- M/X)=X%>XOJR[=9OJ:5EN7W%8^L?MU@E@^NCD+_CP='I^]N;_ %!+ P04 M" "1@&A5&XVZ5F / ##1P $0 &0S,#8P,S1D97@Q,#QN.548@^V\;$(5ADG,O1A<0)+=O74_##,"M)D'=T9CPO[ZV]W2 MS&@ OQ-[4^6M30QBD/IQ^G2WI+AQ-C[O-1MG5JO3+)<:X^ZX9S6MW_?JM>J; MQKYZ"^/[^@'6.!UT_F"G']N#WF#X?N?+67=L[> 'K%R"Y]H\D#QJ-CK=SVPT M_J-GO=]9"E?.C]]67XE@A]F>F 7O=SP^E?2MQD7ZF&]',Q'LR7!Q7%O($Z;? M3T(I0U\-3<- [L7B;WY! M+448,!L^''$I/4Z?MF815Z]V)7R]7/KM1?WHS4GC4S.;H;'_J8FC;T]>,EB MK,-=)@*8V8Y9.&6M9);$\K=@$B].7E780>W@H,(F*UK+]L-@QD9A(N>LP^UH M$D8!ZPE?2.Y6X G&OW%_ 6^8$_H+.UC!Q$X8+<+(EK0*DW/.VO8*5&3=V(,Y M8[84,)NG)H&?]D1X0J[8;B;\A1T5):^P&4;G4UJN! M=4 @$-*SE_!UYN3C:!S.LMG;2M+"]*CK%Q%S<(;M@KP+(6V/]<8=0ZKL<^.; M56:!5&A%)7/%F 7G).VU95"J./2Y),]'?,HC] 3X80XN 5.!.VQF&D$:0E;9 M8T6P$4%#J]T=MWJC)PD(6/_+F36T6B->AYZWVPF4 +HB322Q<84>KW)-KH,FG+^!F$?%+$2:Q MMRI&EIS;DCD\DC;X-8]27/L"@@"743-6F$N1HD+QW(Z5(KKMA:1 M\-2B1VF6V,!<16>,$):-8&U 3ES9ZFR$9+DDM1BP"@A25.V@IE5+%F%@>@'- M\OH$*=3A8B%3..FX[0: ,B#O#YQG%-S2AAE)&('4U@-M01CX8AM<)P E^.23 MH\\T)U0"Z!SMY=>IDH9SM,Y2<#!Q%KG\F\,7Y-:,8Q2,%2<@$;@BCD/O$NS! MIU-J]AQJS M/_BB# FOQVC8#X.AI48@'(& @*^X3@/*GN624@P^O.0!F!Y,::=Z*=Y*0!X( M'WB)8$YS-4R&,8Y5$-HBA2)^(4ZF4^$('CA$C,KNF(5LYVL0+CWNSO!K&M,Y M0:XQI\&7N7&IH((R+HMEM?PBA0&0$"=!<98)9QZ?D=%,@\G 9 M'S_43>_NZJ9Z-84V.]@ -9,"6,C5:5<'- 1RK)@0"UBT_V2541T:+N+@'DU4 M!;VN".;75^BEA[!=N[M>6N0(*$J"P94S0@7D'==J;%'UL=2,8100 &MOTF5=%PSK&64++4(E[WH WHT2>"-* M '6D@!$3ONUR; _,M$@QLJ&87CF> P39;C%UJD''3N*,N&7X$H ,,1/I<07A MA2U<]LNK>J56J^&?M<*LJ%ZY!/H56A[0R([G*/"2J"RR@WBJN%_X/I _6!II M[=(6GCWQ.)LFV*/H(+0=!R)'$A'.5)Y:4QVR(MI(/8[YDA :3JOL=EB !2D[ MVV9VO@=$RJ6M&-G,VMOMIQO/GQ(=Y=(O]:/*T77PR-5[3'#<'@.QDN^N("B7 M;D446SK\[68:ST7T;C7CD/M0\2"$\\3\HTT)'8)IRWX8\*O+_8HYGD=\83A' MN(;M-JVTR298UX&92%9X/.(H,+U3:$9<.R)R$A_K0X?'59@_*\K->D^U9U1] M88M8R2MOU5VIV)H"6^"+2MP;0 '-3LW*OH7U1X4%7.A&*P\T\WG4)="* MI@98^SA3-554!7B@:S3=5Q2C=EL_MRDLK$MMX!*06-4%G*[*]CO=S\W&OMX_ M+Y<8_=]8L%BN/%ZL0KF_4:SAT,*>\;U)Q.VO>Q,.',2/;6]IKV+<:&^<#=FH M^R=4?8<[Z92TA7_\XAW]M\.^=#OCL_<[]5KMUVSCJVWUQ];PL?;W'U1%'^15 M].$-5?1-O>]Z:0W@NTUMO5W9G[2T+I>NKZVQ%\YJZYP11Z>]]O9,N6N_-/OS M @?C^%7.T$2<>@#>+:+P$I*MI@T55J@/"4HT8=9X6>U.7BIGZH6NSN:XD1P)""P0%DVVTM$ JX$O8J.^U$*4 M2S< 3[M10<_T,6B+:JKDS/F/[6[,:J'07ZW!9 LFBO&I/L P+9?N%:^Z MK=ET_[)RKZ#^5Q)P70C6;A_4>7FC+(;G8]MB>K/0?[J0SF6Y;T2S;0%=+OVH MB#8/:9\ZL(NR/$%\WZMSO6. &P@I.$*-/R"\;^G)FP]"[A/A6[N]:X-\6Z\" M'=+6Y)VVB4\0UUM;JN\:V[0!\$-B6T'J'Q':6T4IEQX:V48G]IC[_H=5U@(C MT+4'CKUR=NLAR.Z)&!V,SEZZA4G'M>S*GCZWTV\[7N+RS4.I-!XI),Q3DRJS MZ)C,?$AU/Y6U6=12$2$:NGX'VH:9NOJR=@A6H5.P,)VNDCH=;"*"A-IJ"A7 MOZ.V ]06 !&CXX21"@;JM\%?ZF@T?O QVIW]=*3V,(B_XORTWK0>L0B&:4YY M%>:'KI@*/,>-6)PL%NHPF6?$#Y,'N*6QG'.*VPE&=A+%%/_Z/D\>UKAG4-%G MF>HND@Y_6A^F7$9"(L/$"^[ N@Z= X"@PZ@)YP M<-H4)>+Z6H^1/7#[B5XK&K5C_![+=F *%BK2#=V)TZ=SV%##2ZQ-)IZ8T58) M>!O1IS:5$ %A(E4ZI-R(NDH>&%2GY%($F$DW*IX?+O!,DHX"D3XQY"KK4F9[ M/Q.A#@WII)W.(ND3 &Z4988)#_A4R#6CI($@<'L,G4&[4W'B0(3'8:0^7^"N MD%1N0:/1/AE>5\M%H?TQL)@KXD6"6*EF]#A2C7< MP 0T@UF ._&*%6 6AQ.2D_;LH-_'(32P#"NYSC/\3D#L4$DOJ"#"-&2+(:EH MH0?I,JV[<%=$U?SJCE$E M1#RO]%TZ%6$1!_S&V2$\R!3AZ7P*Q@+TR1S';%?H' SH2Z?!$DH1.!04L<#R M)5S2SBW +0%_17CS$":EG;[T#L\F-''8_JKM[*A3>00>]Q<>\8W*'B<@1"I% ML5I6I12EZ-461DW3R35SJ]M&$PY$X":XC:[$_UOE-U0RX!AT>!\KNX)I[&IH MQP?9A0$4(S?5B=IX!OES!0HBHBGSU;.BQ5!,26)8WZ8[!U!1^FG[X$(F3 77 M=S:OL)$N8PN.KJ@8%1)61GXG7O<\2"5_WI]_.)F]5AENK6::\#QN=%D4)+AAI&J@!+7!R(RIF!2ZP::2 M!A(QDE^Y1(6)\2P#.N,Z<3-,?G2$DY9**K,A.1#4S35@MIG*0%E*=+$B<@LM MR@955=D'VXD%J%T0#:N^_!U=A[I,R["%"QE(2A \+<"X![$4A8%PP"["RR60 M )BTT]8BE$O&Q-@]XJ.+! @NYEN*TPW#IW,[(73>^;$;I-] 62<,@,_46YXG M(/4UXMQ7&-)5]JR<@X[+;K\9L=.)":<M3B=]KSU\A X^'0P[UI"&M51J M9 ]0T6M=C*SC],6U=E]W$CI=(7<\;.H7G73A-[_N ,3'G?R#SUH5I6R.P?3! MXO??':3C\-?06"E5P8@ 09>:CFE?DMU1A37AP#%@RP&:MH_QTQP-/HW/6,=J M#<%F?=;KGG?'5B<7K"B4,;LQ^9G5_7@V!E5?%U4UQO,U#TRU'TOEYNGJV)1L MS5<9*#>?H&_?.O3K.#2!2IU'^= W%H?8!KRHT7]WY(+]>)_]D=C!7X*S/W&/ MCT+GT2U8 (TRU^W_[ML^/U[7XJ?28(SW5HY91T#%)1CH4NU2E,5O.RY\GVN?)\KWY^F\CUO M?>RWVF==<*AUWL7?Q_"I/1X,X9GAQ6!(OX;A.1G^HY+A>,Y#%QB1C:KLW\)_ MFG38?( !53;<4.-G4L' "N"@-UXO?JP6J,49V:(O73P;K^1A)+R;R_>UM\= MG<"/@UI=_3@X:<\%G](5$T_0>0!CVP//DN"F'OZ'Y<[$9=VM"J" MZ9:YO;&/OX4'!NF7]_P?4$L#!!0 ( )& :%6%]Z@POT, %DJ @ 1 M9#,P-C S-&1E>#$P."YH=&WM?6ESVTB2]G=&\#\@O#$;T@8L6_)]M"-HB;:Y M(TM:D>Z>WHWW T@4);1!@(-#LOK7OWE5H7"0HBQ:IFU,3+A%$J@S*RO/)U]_ M&'T\?//Z0[]W\*;;>3T:C [[;_K_NK_[<.?YZP?\$;Y_( \XK]\>'_SIO'V_ M?WQX?/K;O3\^#$;]>_B#T^W <_LJRE3RYO7!X'=G./KSL/_;O[Q>>I-PO"JY>C8*92YTA=.J?QS(.>>H>#]T>_W4N"LW/HZO7;-_TO MY\$XR!R MX,C9/SYZ-SCH'XT&O4-GB3Z?]]X/A MZ+1W!!]/^[W1T('>3DX'OT,;SO%I>0[+-NWY.E8.MNFC=Q9Y^^?!_,$@F@:1 MBB-G/X:_?"#NP MY*O5_KR.JO<=K)*H)'30:[@FL$ZS=_NGQ<'C_<+#?/X*- MZ;T_[?=Q-^^$W$;G0=KMG'@9C,K93^(TO7\8P!!3Y?3.$J5F^/W6?_['[N-G MK\S(\./S5]M.D#HT&>4[093%#BSW?^>1XD7=?>(Z>P]WG^FW^^_>]?='@]_[ MS@%,6S,XF3>9QX60!O^GEX!2/27\'P\LA7B9.=*R?T+E,GGG8[[U4"*W#EG'L7 M073F!%GJS!-X*9A[(3PPA55('2]S>C-GWYO-<42OW\'1,]SQ/,C4_73N3=3+ M*+Y,O/F]-[OW=_?N'_7V/PQ.2O.=S7'X--3[>>^S"FI^KQ(ON)S$,UXM@?+/[9[D+ XSS<(7Y/WIR_]FCYV8)3M4\ M'X?!Q(P#.(IL'2V"F9@#W:H@\J9 33"U,%23++A0,+5$356"% ;TY:4T,UZ4 MD][I:- ?\I)0:T'D!Q>!GWLAO ?/>MU.\>B?LG8[SI(CM2X^]/K3FQ.8[6P< M*NCNTYOE)_GI.GK]XT,?6/#0=90W.>]V8,%QJ621'%^E00(OX")._IW#W]!: M@M2@PBDO'M!_[]V[P>$ 3N?0V8+UX\43OF1.K'<]&41Q=%]]F81Y"GNH:2$4 MML(4.B>.0P2*XXSAGX1&^^WQZT#^]#Z+V8>]DV'^I_U@ZD^JT[SG]@X/!T7OS>7C2 MV]>?_Q@/- O/_G'/>=WD5)@WD9B89D?V-KN#C.RT8%^TWZB]*Z]LDYY+9W;;ODK MISXTX+@'"@2'@(@2>:X1GVB\\,\I_H.[5#J+1;]/?\U=?[QTUW=W=C=OOT4< MW?^?3X-34&E0P=#WNY.>P_6/THXB)CA3(!@!Y_/220)B&(D1H$H"NQLJ8F"\ MGT]W=EDP:(GE5L2RM_'$8LF"7TTK>RVMK(%6'FTVKSM-2R#FIYO/G4 ML@[6TEY#ZR"6)QM++%JG+9$)4H<+2EIVCDK8'"B"%/7HRCGIGPZ/CUSZ6W1D M^@:(RLL<'_3X219>N0[J\I'^V.UDYTF>)_,XA1EI:X\\6EMA'A*M!?P5.4\>_D.KRJ"Z9@E:G7P9 M)[[\]%7JQ'F69J!(XMF%EM"$ AW'EY%*4C3,&!^$[M19#)]<=@G(@D1QA@L/OWD);!EI\:5-F!I%>A%'1*;TG\4"O,NL#!:&/.+YB\\\6+ M^L$*'WNNOZ>5%6XHDUG "YV;3>9-96#$^(R-'>C\R<-73F&)MMTE]H K\WIC MNT^:GK.YLKC13F ^SBY2UM[#1FI"4]'!X'?X2IR1M*K8\)QOB++Q2,UJ3!J_ MLI9MK)#Z7WKAI7>5XCZ^_@"K._A?6-Q']W23Y ]]^1\OZ'\5"I,)[(,F?I';I+M:,235MK.9M"V3^_S/!T8V6&LMMM1=$2#O?<'+CL/$@+QV(K8JZ! M7)YM*KF\[1WVCO99'_D3MWMX*Y7D,:@DNSMLQ6_@VBW%K$PQSS>58O://Y[T M1X.1]JHMUTI8S74M]83%6?:#@6+A&:^>[V5*_NYV)F&<(KW);UGB1:E'A$;" MK)K-0W+5@X!;-:"@"/QTYY&+Q.D9OQIWB[XFE:F4!XHMB\/RP#DY/3[XM#\: M8I>D1-#(%XJS+2FO3,HO-I64#P;#_=,^Z"\GQW_T3YV/Q\-W_9$FA+I&2-)2 M>QVNPTOT<%-)HBGN: TR5'LCKH%H-M:W.'C_=N04S*3E']^<%#;6-D2PDJ$\*9N-EHI F7+V]X\(L'-GX1>FK)I.+N:*Y)_)<#-=?*, M(ZQFL:_"5(*KTN L*AX)HDF8D\76F\_#8.)Q9!7:S=&"Q7)O&((,'>=1AN9[ M+45?QDGH@Y!^'F#<%EKYTS1G4S)%7J;GRB?OP#1 F_(\"7",L;/%\9+2[;9S MH"9J-E8)[\RC70S=W7MHCPQE]"#*>6BN@Y&6:,_V0OB0*.HVM2+%KHT1G"?J M_AGH )F.#Z2@6'JKVUGV7IQFE1?M-:-YP6 PQHT_H0D05YO63B5S+\ED:>,I MQXVV%_FW/+3C#3RT[-KB4[/HH,)!*9]39^N:<[I=Q!["R^2RFW+ M17*>N[A MZEHP[-H7H;1/1@.HGGBI^",\V1T_1[G(O+C5M@ M%YFCOJAD$J2DB5,?,F)>!%#M\Y"<5M+ZW+NBJ$]\.K[RX#=Q>M&Y!C: 9"*! M]J"KVU.N1.UF<;V31$*P.1,/3@ G-:9QZ",FUCR) M$=(&&[J(PWRF;BIV"&/>"@1&#^2:;H=Y,9\]P=GA,X?"3]&6'XZ,^R/RT?6@-RQ\8&\!:4 MPGSE[:?AX*@_' );.JKG43LEL#S,X37Y B'\AR_]-+,R$?@ N)H\228"0DZ] MD,0,I$OB0=#!/+[D Y?S-2OTEZ+:HA(VC&*6M8"551Z7L9X+C)VVH)ZI"&00 MQ*PC8D^S./:U ',6QF-@>&5X+>"$>9HE5SM.SVA/Y2AG%L*6+ISP+@42W40E MF0<=^D$Z 9:H!$PO4V<,GC@)DDD>9-:\2>2AR<&V ?V1D!50(D<*7!+4/$P; MSR/-A06=#T<=P'1*(B<:C'9?T='&3'9N%AJZ@%'!:KC%L)#MPV>^5T"&#>-+ M9,L9#,!U9B#HF _G(!KJ3[R9^5PE?PEFV3;CDLD$8 =#E>XX?XC0&0:S(&O( MGI8=42AC<>I)L;["0UUA>*RMI2HD)5EG[B\B'@?T01'V,C@0=8&:Q&#S]((, M>@>U04T-2W>^]1>O@UUN;.CZQW\U\,1FI%%GOP!-O2F&JH&8'&:2Y76@X'NX MYUWGT\YPI]=>RFN@LHV-BB]@,JIZ@"6HNS9%N<2A!#C#938+5!4&&H)24"/- M3]U.\5OIU?0*>H#K R@-N'J*36<)W"T8S9#&DT"Z$U!<)F>C]*-VD%V5#)7 MH8'%(K(E&BA!-H4;[ P>M55C5XL"0O7F8FB]FNN@\XT-ZCLY'1R?.C5L[ENC M/"V\@UL7:.L"O:D+]%'K FU=H)O)V#TOS\X&=R>E3]J!8!UT,G&AM\: M.FGS/[^[_[4-FFB#)MJ@B1_LT/Y*01/%9?'K!$V4YGR;H(FBH1L'32Q8]SL/ MFK#'T09-?$-Q<6-S;(:?W@X'!X/>J08"1[-A&?R8[:1ETZBNYE4Q4[82Y2\H M418(U=-@BK9OX-Y4A>_)PW]L<]Q&C,R\$9HZ51.X6HAE;RV&I+Z(,RX 1LA\ M*F25%MMFG.DXL3@^N7CITLOAAH'&K[8=6N[\JTF#$@<5JY1@T%1$=X[!@\1O"4)5<5160Y*&'D"/,.%)='):=JR6.%)V#5TU^# MH+\.@9Y#76P4^M4/6Y#>_K!W.]_YM#OEP[Z*WF7P7L;V6$FPB4&YN%B^KAK4S43]J:,NLAD8W-O"U4U3\; C*T\L'\ ME&Z6 L.Y>.OIJZ%=_B.I_-;M%+RFU6#70$T;&_9O49/SL7?TZ5UO?_3IM%_' M!@<*@5;RJ3=!X4:*V@1X+5E-8/3B^"_!#I?"-3X7Z02!0)$A"*/V*TQK;[%? MK:6R&Y38V]B@[M%I[VCXKG^ZML)IC]J0FC:D9GTA-8_;D)HVI&8#>?KKMV_V M-KH*]R%[K9SWZ(%J"W&O;>/W-K$0M[8XD#5,XT6Y9"0:7[$34G)AZ%:?>#E: MR:H^0O%6PA\F;\5JL-]'/66%R( HCNZK+Y,P3X,+Y>KH@&L#$? U*D8S50EB MX.D7M:<2C7J329SX&%+ J94ET>/9SMZVRX$8P%M-#J5K'+(E4UR*41E\0G0' M)-&4EJ3>)4R\+!X_@3[9?[L01'(ARE)[YGY:WY$V]EJA"B7RP_-'"8WSN9=X M6:;;DM(&C,S9D$FB4*EM M*,^OZ;P!HB9E<0EIF,".DF6B9-S0SE";7G4:D2;:;J=$M90?;!.K$&J@7:GD M@*@/II3[OM XXK2VD6\L3FU@:EV3^',K>:I!/FO%J>7BU&(8RU:>:N6IGTR> M6@PW2NB@!Z'2E? MW_Y=.(3$Z4 >Q#\U^:^H0W0[-N&W L*O)R"P($ZQ9Y@3M23WRUW132376/@%+]XB00EN4:0I#G:E+**YFAB@ MQ-2Y1 "S":RF /1IXNMVOAIH4 ,:&CJ&OPN80[L<"48?S>%<*$9AL>7MRC 7 M013:?2QK>9K$L\HP%QVBUCNUIE,TV>Q3-"YRZ=@&, F]8$:)9?726WAR@FB* MZ7M*I\GQF;J,\]#'QB*B-2]!_"P@1VBQVX$SBK'-^LP0[R]3]D)6WH:OM.$K M-PU?>=*&K[3A*S_%O[#V!V1=&V"H;_%#T(1-?BB"P$5H]&']!C(!^0TIQ ML\$$$6B-BD 8$AKSTXK=;K#4M2K MR1*M=%$*2B^9:LTIH'![W6E0&QCUUKN MYGDB)N)N9YHG1'W0*%KI@)B7-E$'[$9T1C2>P!I\QH,1QF=Q+1>_M3=_>TJ> M;C0E&_9*8=\V(TRT%^3J6NJC;'M*I_,2WUW%S1E/I_>A2>VF3,]5:!BO1ME9 MU!TBZP2P&@3>?1VJ_])Q(_'#U%F1(*5D%D0Q'KH+2=A$^.(!DW:0.),\A=7#HB/5 M;2XW9>P%9E_U>.RJJ4XPK:]+MU,0A\_$80A"5LCJ"23$3V_T[QB1[>(7Y_$E M<*F$/Q,)6BN'$D1RH=*R7%%?07N9%C/EQ$+!MYZJYRE_:WH<1$1N,<:+X'R< MRR3(8'/@VW_GF$,OU6.N*.6H=H"Y#L22Z\ 8(9FO$!X 8OHC/_>B" 4CXMR: M.1^?HL[ QM4FIP&FT]W,;0"2&X*?F>.DHV.N8:BP1UECI%:ZJAV$SP2U.!QP<'0Q.^T#P@Z-WF!)H@6PCV S(0' @R71/ MRC<0\ 7"0IB44T:F^;ML:BIX4>ZYI2D3!FB96PM\_:-O@IJ4BGI;59A*V.F%O>ZECS( AY'#Q(5LFT" MS]9899>HL)35+DO 9N"F4LL67!1/L-#;$,(P]4J.CZC6F M2\;532=OK0O" V54:6SANCT#%X9L&@+6I!5?-9TJMBG)UA17C8M:7JUPG58D M00RQ9[>-%^T$J !CHOJ:%Q>C(NCD7Y(%BQS)2[0:&B_*N5J"WRRM%1[#/>4 M@^M'OZ.)"^0K#3T-Q))S#3M=5@[U%DT@Y?)UZ >/(Z53&6;0#U:%2\D$%%D! MG64DB!*Y,W*87I^%VVWVV:*IA8,A XZ,A2)5;")9"SFOU#73.L%]T0!TU,V" M+K3QJ-LQRZ')PZ_L[ODX&:. *8OCVCA0C1M7N5TZ@\8T,1]971MY<$E1?D M!WS8 XUJDH=>4EU%87=-1AI!].9FR'5.L#:I MV&[4[2 5ZDCF6L5:H5FK-817;1P&D:5YT&_,?JP,BSE=\2!PU5+VH#E0?)(2 M;8;0W@F/#2=-!5H+UJT;.U=Y$S M9AA[#7@+LTFM=;1L;5YDU3V0!<;BR*A9*"W/*"\) ZRU.'W96IY_\EP)0B"6 MO=>G'?XI:&2B/#FN".X;V7B4TT+]!?Z4QAGS9Y7H:.7?&F?)+0 M :!O4JXUCNG(]JTHI9],Q0"Z]429;*W?K?7[IM;O9ZWU^X>S?O\TE^%R;,5' M&XVM>*I"YO]%K;PEEJVC.+K?TRY=;=S:!^4]TLB,>-@603.V@OBJ9/-H$Y$9 M*R;]BM&'\802)? +E$>9F6J)%XR_,#F'(2D+0ZA:DLW4"G)!M9].06: /XO" M;"1,<-8E_&VBXMR%P4L41^=@%&:>8OB!O((;8IWE<^-!T C2<4Q4P^-8TQ[37J?.V=]@[VF?T]3_)$W-TO./L$B4V M_[;G%KXY82KEPI;$55P,QHK1F\ N :)L@>[2J23L1P.Z13.:]F6X*_(C"R1M M,4-ROAT_TE5X-XHA+02!O0D[*NUN S?J=KXE.SK1Z_>UQ,O<9PD%BWL&"]=I M6C-A>[1,0!&Q;S(*:!ZR/&3 +==7:D6FVW#.#80,&A81L)4"2H^)IN#0!R$[ M(H1X%OL X6H ^IG$V"/'?2"(8NF$=3O-4ME$)'2=MH"5NTWPYATS/TQJ*/@? M\IH4&3/7S:TSHA6Y4&%?^BHV]!V$HO9DKWZR-S >?E2TFZGXCO&7$7#]9Q@!K,,O RCF'*4 M3O6%+D9Z76_?M\6PT<3W>:!/7B91X;PN'K&O+ M'V^V>4KJR>D*M=,X#.-+2OT42K!5@B;TZ,I;&*A &=,O5W#?M:1S'>EL(O$ MFWCKA4 !N.$5AO&]*_H.(@IDA0473[3VF58#9."JMC.5ZT;:LLA:BIF5R[J0 M:6Q%I)*;]LAUJH<-3M8JAXI2#WR^LO4=G4[.E9^C0E*!U>U%D?IB-'!0$V9X MO;,G:FL24SPM" -8"AK;YJR_FI8^E)2_UKG<.I>_TKG\O'4N_W#.Y;M+K4( M$F*[=0,AVE> .W(ZU!+N9EEQR'@8I)1_A6;AA,$%?,X4AK,TD5Q=(\N8,%/" M)D'%+O0RK:1M!9+1.PVFF5+"P+=VGVP[$R]4B&GC^$!HEKC#MP"K4R6'DNA6 MEC(G W((757W5'D&5# *KI)H7+*\8W@0CK$-^?X*Z6D#'43+,'BBV-ST@8XR MTR@ZANKK\"=VY3[YN>09:L)Y,<'9>#[84B%9/HT.TL9.J^XHZ^<:YDF!LF, M:"SS"ID,*>UO8T0ZI4HVH@=(>J6]5O"SR=71M40PT][_ M*T\S6F>]WE1Q/5'3O& 7E8J(16:.+1I6RB#OM2;,VY_;#3RU51F>8(.POI(8 MXX%!8_J/IEM@W,C+-2'9-*B/=%6_J.@-CUU,4(2W)YR]X9C 6TX)E9:UDX., M=Q[#2$019LXE)D@W0H/DA)!#=A_^ X3[P52G(,NPZ5G,*5-^*A;.+\$,=(@Y M1OBF:8 3#=69;E92D_[*X2SZ 7N3.;798\\J_IPH6II4_,QLSD4_L\GGU%UW M.V9189'RB845LGP@[6&[_6';0$_@2;.X!E3W:>@<@/#E)61K5ZC5)G$43!SD MVZFC"Y]9QOL2)(QNR3I.(#<"S069@7*SI#O4RG-VK^D;Y48U1G;W;DARI&^4 MY?T;J\XOGGY#S9EUG69E^<6JNO)>LZ[\_$5)5RYZN@-]^:T7?;ZM-LRJV7=0 M]GM,ICRZHWCGAYW(\!(4+V<_]M4/.X7!V][1N@>/9A/F,FP^:6^WU6^W#?2& M_Z$-O)S$+^E2%UZ(9@R?L,^\+\X6^W(YUH+-M;_W"D@VO-\"Z,Y+\&GH;XL] MM]LNA;?1=Z[&I$#Q, M*NAX'\Z54'BYE9>\,I=8(+UZ0K@31C=ZR AIKJB2# M,12>(DMA+41F5M9(3D;K?*1$8N2%*)G6&Z8]ZOVKKPW3Q:6N+2=H[)?X/>N: MW@']%YZ;*IFTGFZ!UZ 1(CF]&?^F?C8@_[=QX%O>#'E\NJT!'SAPH>XW0$6B M =TC4B9*",B(*_ZE2"8N['OL2U5;E2"H#'\]SM,@0HA3IB^L&5@B.)+PXPBT MB2B-IQZ"1-<=+6G)B]&(K^H1()()_8+1U?KBM#CZZ4%E%#Q!MG)3E9=+ACYW<./7(-W7(K"F7R.XLM0^6<"[X4;B!1F4!2MRI8X-626J)+H,X+P MM?/08_N=.2SEY(0XS_#JPF_?@P*+F[\EF)F@WB=QFL+<$V)'.0488:E-[B!E M)N_' J#,.$RQ)CQNCL]RP6C9(,[@Y+9[$6%VR2B.:=QS>I4 L&"A8,?3\[+% MT7S-/$:/W."CEP.$BR71#2 ^#A*/\I$Y6( PK5.Q=2I^E5/Q1>M4_.&BDC2D7&4TNM4M"\0P4/$'K*EL\9!]^5$IYX\ M1CRXQ)./C[5D8DVW!T+FUJ=9ZF5_IYG*%);$;)7$B123QKU8<@N;"Y?L],5K4R\(N:0!KU?U MFO?&F.)E&F.\R>M[<;%^@QD: 5A85)/,0I%J"%73F\&I =$%[P%2">8J\D)K M*5#.E%2)8F IRD;"=STO&BE 5E6N.3T''-HDMQ:8)#[''#YNWK3%XA2H< M8$JP5J)Q:>><79>T2(K!W<2R(5%<;=7J%I\L<"9WKL^8>"\3U,D2>@PZ_A&; M9[*A3A$AS:[:6[CB-6&9:!@R+!G=671KLVCHDF>7G^>P)P6/K:X_AKV6O(2$ MG!\L:]JJS6&W+:YYV0YLU\RCR1LISQ65=P:2Y4&:2(UBX-X"P@:NJC$\):C' M-IGY\21GTE%XQ[%CUMYN?2=6=A4/^ETKPA;.O^5:%6N9.*WM=%@VIL!$6']G MNUX83[R0\XFC&,@<[3 9<@W)3&/D)R#[PG)(QD+<_,9R4$4A%9<,C^P.5E_T M7SX60M T^"JP+4PFPMVJ\+?:1FHG]P7M1DRZ]K^)YN8Y#!JENU(>BMRZSQ=[J^2"FL%(!CT-N T$MU& MFJ'F"\!-WQV&3M;>]MXA.!+^0^/: ;+=<[9)"5$ M!VLZ=B@>*Z35A _3J=P+5KQ?"42ZJ4A@HVS?HK6LX91O8%C?8.I6X81=0_$+ M0;L1$F"%=/QJ%O[BZDT+>Q)W*Y:Q,-Y6*0;!RH6N'E4O3+!EE>NPG:H@2*M$ M8A&!?3&CZ0V'?3C:%(XO=3B Y[BU@2ZJ"5'@"N/7IC60_NRR'O4P8?[%5#.$ MWVMXV$ORL&AU3'JS<%>C0E;'#L)=,N$*5H$44'R)6LXBCV_KJ&@=%3=U5.P^ M;#T5K:?BA_%4-!9?*FQMJ5V.1-LSPV 69-K(=U48/XJWMLO)6XU6TC#XK C9 MOK@Y&KGYJXK%R$Y=*7 O2E56%I>7E+[3/+E X=V&4RYL" U7X=VO2M,0.7*# MD'- DL#8($QULVJ.-QNCBR(".4@ N*9D3_S.J-J%%T JI5:6G;:C<(1I(DDM M;\4WDBHX@*Z>&MV,8J4M. CBV[8AB-#I1+&,ALSDXO&:?']>\D-)'F8MYY510W3O-TKM") M'6&)LM *=)N+P06>QI3FBATY:-37D M3 !F/L8007)OHN^!\TLQG'6Z;4K,F2A-/1%VA)*)R];R]7,"JMKD$< VNQWT M^S/+L!8'5LLG1WH28_8=UWWC3@I7NF"Q?O7+8B3P@Q1SZ)2O&6 :?,FN),O] MZ<-*EGMK\EH#@]O ](,!DVT# -3B4ZUTX(*T9=EB+5(NX KR$J50X%M@G:Q MB&^.=9W"9B9IY+M:"CE%&)W'EQ@ P)\ILH9]KN5VRM']:8Z G &!W*E,Q]%( M (T% I[J.;+GL/"=6W5NN(.J"5JB &!!7K%L7HV%@L^"OFQ"H^K 0"(/!<2K M'ETGEA.,&4&FMV+A35)3=G300'/ D0FG,&G,)L!!^ B.@3L$D6UQ MEX\>WHCMU=#@,BWT,(R^U?4=0;FU&*RM/UMB3]@>X. M++2<1_S>M]>B6U'F5D?BZ>8="1L$%[4N13E/%JS?PM/P:)'%#$1U=&$+5W8I MFR5($G41L\A31@7&(G":)4M6EGW[).4*>76T:QE3BF>/$8>?56R4-VZR=6:U MSJQU.;-V6V=6Z\S:P,OH]=LW3S]K514X5#I>S72H;@*8\=9=4^[@V3FI+@HO(^U(-+G(46]K% MI40V;;S+,C(+ZV_10&Z,M5C.B@L0D_GS46&!,;7.%J-?2BF-D@.Q\$XW(6I:*0]2=<N]EVR@ M;+:6&'%3!1YY<2'PN(TD:A4YUYJR[0DU&)@%96;G29R?48X=9?DAO];8,@1I M0A9HK EDPG#X5+=8_&SN M&-OJP%&Z)ND0LSG+R9L9YAU75ZON*UYZ4-!,H5)"C$D,"(B(BB)!@":NYE#"5@ MY6=0UH95U+7I&?MD>-H%&:HL$S2L\$+?.M5!E-6AX:>WP\'!H'=JE7Z[[NI; MTL+EN:)W,?TV1F#IT), 6'G#ED27,K'637A[H\(&9C3U5HS7W 3C IQ4)<.Q MDA[+P9K:6H#8, LG4S,TE+3^EVWEC)]=MV\(\JT .Z![<$GL;H-P](K=X:U# MK76HK@P?PFQ+<"K-"H/ M-I@BS%FEQ:TX<76SA)Y'4?+%NKGT(EZ^YJMM&U2XEJA53Y7#*'[KC6)?E_6[ M700Q5Z_^Y?=\*S3^M+8,RYI:(8E2N.XU_,6J!\6G7J@PNU0A0G-O[>YMV] F MI8#EQ4-@N\-%'.:S!3@E&CXQ BC= E>2SY!*#\* MB:.N[U.'$JJ=+EE(]XY7$B:^XE)JJ[Q-$&;]FJ:Y8 4WH&8!>XFZ'>TFLNW1 MA0?(<_://Y[TX>/Q*1?<$VAU]ER4?IVN#I(B_BC$15WDCY(1>O:CF7EV?>UJ99#U7P<-TK\)/-E9 3P(&6C58FMPR>WD8=(8Z%Y-C M:5>[G:_95G5V$.*KB6UZNR_ M0]KUC:/[V1]H2FFB3A9-="K6DAA^#O-?]L2>6ZVDL>XP?YOC+0_RW[@:$ERT MAWCW+1<98R^NW_/KDHMT>GW4G-4GE80)<%;O( GRA%&L;Z KQ/86'"Q^OII" MX<2328[9Q.:FMOR?'AY5Q._5,*T,52%)G3N%R4T]?M$/,NUUUA\'2I MHK,T : .;%$O4-OC6+LO'J(ZNQP"M 13D(>WA)0?XPODBQ;_EL!6(\K?.2P# MFNRW]AXV3]XL/R:&-ZS_WL/=%]7\TF*Q;5Q@-O[8&:0[;<61UE3[E:;:1ZVI M]HP"U?^'P;+PLF:@PIJW?5%%+&5]62MF\0 M=;2.&",-_5X+,FJM<*O')&P@I@ZF$6 8/X(*%W2P*)W QC\^[1T-W_5/%R4/ MO&S-MM_6;!MLH-E6%_E&PX.!(\)JBQ(>AJ)\W=A&-@"-G1MB-2:RY]0?)'W& M"B[I=C3&G^[8Q!N;R"SB>^0.L5XD7*26/+\I>6XB?:;S@! 942JP*&09<6Z) MV0IN53]($96+ZVH&68TF(:;SW$Y#U*E5!!#DA'%T1A8V:VX:?:3&KK<1*Y,-^=HK9^K*:&!/K%QU M(>'H]D3U<6.8KQ7@9:K#OG:>ZLO]8A+ZK6NQLD_[^X.3@1WPG^DR2TLRR[YS M_2J:CC8C:W1_DN1T43J1Z.I[:*14,_$F*0^7+8O= I:<&A<#",;Y:4L .5M! M)H[0(K*[MP#ER"QDM@3A0PB$Z@7/L1LX*)?>7J_A0%&7T6MU:X.$KPYK6&]94A>*,PB&)0M?R/*2>[-*E% M=>?GJY:H?[E0J"9/T2.W@IE5^?R8&& -H;L GI^AM.D7I4*;Z+ITFEJ6^NVI MS]](ZEL8;%W,B%4U1C33-2 M; N[UKH>U^=Z?-RZ'EO7XV)33E%>)ET&T+#$:]?$ZV+FCB7_8,X5)RGJ9%VV MH[KYA8(4L[)C9&WSV0HF84:F,UHVZ"I%3-9-8VR1-A75)K +*]G4 M7)5%\:VJ::XF(C0ARW<[$C1K&0;W80;]X:AL%UPB"*Q6+X9-QKX*L43%5=4F M+IWM.._8$\4!W:A^81$&!^LOK-YH>0)N;>%=/LPKV7)YCU1TAG=/J:2K*>1* MAA(\DU2X@V/6,2#MVJCCYB#BKR1X=]'VE*D,DY=6C" N#61MH<,#.5[GJ/"3 M>4QQE$8>Z>KJM94L(>E7RW( (93!\IO/&5$Z*5Y\HLHH1E]SH&K!%W>31F"! M3548U;3J\NUVB)7,YAQ'JI/%:I,E8+24@4/(@4:%(5*&$TR2QD:%?BA"LE;[S"IQ9A>H M:Q0+%C@7RG.O6J2N*3-7J]'A,$38[:\V$^R)I7-6SOM8_YV6+4S0@:,-G,Z; MGVM <*Q+ H^3S$2>O[K$89V&Y[^L[6(YLN^SC4;V_0AG586A!ZIAGK;XO.O: M]V>;B,];*@5GS)IDQZ=X &3+R&CD&D5K$ FX8I(O>%;-'M_$-%E 7ZU$3*T@ M3 OF='L*W$ PIS\D\@PNG;]R7Y(*3=&(ISM[1"9DJM?BJTVM0J(6)0I%<02# M8Q)8Z6M*^M)ZMU:OMY' 0?W@]%:KI>O$C1T'#152>!"'[<<8A&2.$>[0CO.! MJWD5P9\L-IR 7S*BKJB8)0 M/KX"G6-")2L5' "IH*2CJK2-;X(6[F1F4LQTN;G2VRN$9]R'6RK4PK7.+L"X M*4+?-35&9128)><[6X\2?[M0\E#W+0>#Z<%BH*278:S95-M'4./-@C#XF['T MU1?@FVE*L1NH9:0JN4 >BBG;5$PT!K7J;U(;XL#CP,"XR@]M2''W M6BNM.]65$7T?^U-VG>BQ@J$SV+ 56&(I\%BC,\DUWDM*'(X:1R:GE5J]TV)G M/?$PG=#BUE81P$71AJTKJG5%W=P5]:1U1?UXKBB<9KF;&Q_9%[O?\,3R$M_- M(2VZNH.#"O(D6O>UZ0IERI>W/9:Z46/Z*UJ]6R[T.UZ=)W#!$<-Q!G"DPA!4 M$03%.9$*V[>>['L5J00:W(]ST(+#[\EL1VIR'L5A?(;F^][[6T^MX-I#-0O0 MJ JW/J*E'6;^SG>8*+&>6\^J:.5N1__.^_+26<\4*DW=[3SZ*"*O:R:UQH0% MZDN;[^OFRVUW;P6'SHN;.G0HQ\X#D7I.\NH2!_PJL1(W[G[185[BU_HFXSA$ MTT.WT3L>@"UGW%FGQ<'B--T[[/I:W;1/NNE+K9PVKD]K0+G&@/)X M\PPH_:+X;Z)0_6>,!,3B\1*THZ<"386@IAQN3[6DV7)/ %3Q)7LD):B_9I37 M!8=3Q/IC+1]4=&.599OLHQT8I&V1G7F?J0$-F65&9PK[R@"O7&.X0$_U##VD MODN1".)#MILE6R.V&@;>. @I33,REA07X(&94^*E(P$0K MI)^K4F@MEC8SP+CP_%PEY1#THPZ/J(8UC76< M;0/>D80\(3&C3>6:^L@F;C>,TU0B1*:!%"["P>7*-<8G1"2"UI)\3COK9@NX%(XQ-Z.@).9@>!6(806Q^%AFB(W6H;I MO;;5'>?CO]8ZJ5JTP\ICV>,9PGBJ25,PJ$*H*=39*MAC#!L"A3#@L# M_^3"U14,VRR^7R\U%0&L_5E H80,BBG1P!1MI^5+EG7*TN>T>-9+M0AVX86! MCS>RI&_;6>4&JJM<4=.S>&>%["7FV]7H)4"\$Z5,7'QS9Y*UW1+SKY>2NI1@ M"^*6H T@*&@DGWJ3+$\T>P7E"=0S8+,>^JN%S6J=1X!VA%)M>M:YT13,H2.^ M*)^DJD@Q;R:(9--N8!O&YV(8%PW+=2J!-]5#U&)&_9()L L8=TEKTK3GWYCJ M2IE"HL*W&:MMF,#ZP@2>MF$"/UR8P$]S$RPU.CS=/&9_U!"I:\RX5C9D$7*& M :Q1F@59+C&X@G1/F4MP/7AG'OY>,=Y.445LDE@61:5SL*FOIDJ*.U2Z&2=Q MCNHL75 G2#0.VIW@3!3TE8KUV M&HWB6SV+5LJ^73ZHF>:(J=[O\ M983'A.T' 9FB[&>Q6D:<3-1.:W2Z/<]XMGD\8U0IT& @SBCN-!D'F3ABBMS; MPB?%&_ALYWEC\0Z.:I<<0#AIH7=)I1B(GG1-C&$F4;1(CDH1>T.0;YYYP5#MU'!SS/*O0X84#?/3/XO$FBDI& ,>GS*)GV[+">R6<*\P&>+C':@ M\FY'?0E2J;M4W'$E'Z1=,4=E68C80?!3R*@9]M$M?*BG>:B8AJV?Y9"4J7[_ MW--5;?;CV0RKPKD8'@YSD9KH@_U]#7#P0']'[>MO*:8<+1QZ+'&26N=:@ ^% M4> G.M.'B5[LHY^J9;SW3J=COGZD%Z;B%O%BU);#ZL-UDX)Y,X M\3WDB$)>LJT[SDGH<0TW>W=-@_\+2SHY=YTAO/:W2D)/5U."O\YRU+88SR5/ MBU*3-A599E739C\Z0^P#8;SV;7$)Q%P\!QS& >,9,*%B# 5 M@<4KD(W$3[;(.X9YT\ARRVY_LJJE2GWF5X&T@YDS4UX*LI#VSV=R3$7B(1(D M+WP\FRN2?LID."KH5#+$YWK%O=J*D^>$\K7P1J#ZDG9KE!-':B%)7%Q;LKBY M4IIW">,%AEA>B-HE;(X27FC)59'[)N*DD2-M WHM_51%?$%7^58ADQ+)[? YAOEB" ,<:Q\(&IA:0KBIA8%I'/L46L*R?D5D=NL#KV%4 MZ& )DT 71+SC" 2#^;0\ZNI[VO=?TU;0)H;Y=$G&\+&3T LP\XEL9E9Z76E5 M#^W120WDE'QIDG(< MQ#8D1]?A.$P)^2PNPU)2+@MX)6M372S(RM!OQ6&G(X4(0&$L8JK1*1K"%[D: MI:=+W4CYK\8B-G8IC4F>PFY0R1SVKL_C3.(2S4_=SN5Y+,8V";F)V93]7 MFWOKL6H]5NOS6#UK/58_G,?J[C!6#W)3XPL6_&.)7TLH,?(Q])9HSHTW"VI; M)66KSL50PTJ=2T7H+#HXWW!3C49B^7ZL: $054)/2VW0Q6(Q;SF:HW*O@5, M'3.*OT9L$0OP(55%L>6*B!:40#J#M&H]+O 96&[$H;Q< GWVZXI?/U6LJY ^ M>JV )N9H\DS3@&JW3POO%]#O&1:+B;0J(_:;A*BTCL"C3/:.<9]U.^:438,D MS0C7)*UEB91)NE Z%,LQ7$L-;4U<"#"3DE(TDC; \->+EEU*OT4HMDW)H7>Y MB%):5O<3QZ*NQNHLJZP$WC4!H[4$] L&>%;T?4I!0Q@M+VD&VL5BAHQ&K?WY M:4LWWYANU.;3C9:#7%L$]\JX;9;=I0@&,98K D%$&RJ;B@D_>X&MQMEB=Q<2 M)P(YQDFDKK37P\\YFJOR.E77K*).DZEX G)?A#$FJ6L:8[)'=WB$WB?'\R^" M-$[@B30.$6Q9% RJUY=9%0@-2G99'8*O @/SEG(.*-JR? \Q4AV00E,=[5\9 M)66M%$AN3?43*]G?=5!6F:GD*>"23W-,1M!:74)&+0QIP2]U#G'-(!=$(-R2 M/SJ@H#9O0M<+OUWXK=P%E1[BI%3E.A6'W;]SV)_I5;?#8ZT I+?2[^V-YQL( M8#R8:H,WF\ ;#,H!&@U"7X(*@/;0E^0Z021"#6E1@FUL4-(IMHOR MP1B3F(#1"Y-[8RD:#"Y#S 46E:@@)\$8LSNH\%GYZ'7_+ 43V(=/:.P\2'M: M"<5U%$4^R6@2*2OJ3(X!I?3,E,J0K1$K1;Q_.+2QR'/$;F"\\2R8R+#(2QWY M18B''B%'%P O$0!Z]45-\F:S3WO"UG#"-A"@N>(55K-Q[ =BFT!^GLB),7X@ MN5,T"9'K2*-UR.533ZRD&!PY JD<:;1UQ D?T>+^+V'%CE5VJ;B$P6P% EP% M#.IK+,+:?_%_I_V/O<$1D)1S_ XF][[O#(YPAH/CH][AX9_.8?_=R'E[V#OZ MYXZ8CEO73NO:N;%KYWGKVOFY73LW@X [@O4>4/S[T3_O'[]P2!Y;ZW^3W M)FP8OT&#H8AQO-R-$! DFFVC#1G1MKL=@;!!1&D[71G$^9>+H<6(U7[=;;\1 MK&P9F.NCVS*O6S=PW?M-+ZUOU*_O&H'6@3T$BCA"YK,"X.A2SKL09?+K7RT- M;RG0:L-E94W?FOV'_N#]AQ'LQ=-RZ_80&I_96^&9Q]_CZBQ-X\#+U$NX/*4< MW*-=%VZVW6???_=X8/\-RJ&DV#RU1O8UN[>>'5OW,WN'.KGR) M[N)78_)[%E]]09L;3.,_'M+_;GC+/D@?H/(>^Q@L/=QQ_AG,C+YQUW3Z@R^C MH/>>?&_6<^3-X(37-O5[,QX>UG>":RZ-9!1D(0RESU8?D ++".FBOWBS^2NG M"=;\NZZBC/V JB7'B3W6_3B9QPDF/A%J\750["UC_^D9^Q] 6?.QS@&BE M M6_\9V'IE2[\W._JAF?I'+X*Q40[N\&2%.A%WQ-N'*D(;L6;Q:U"KGFR^R@1# M),/- 6<*57CKZG[>#&M/9+*.";NBH_@-;=,J]?BWE]/_UX4P_I]U0R-W5- M?AS-_AC7D;4/GQP9_PY8?1Q\,W_Q]02P,$% @ MD8!H55TCT%H)$@ WWX !$ !D,S V,#,T9&5X,3 Y+FAT;>T]:W/:R++? MJ>(_3'DKI^PMC TVCN,0JC#(MG9MH$!)3NZM^V&0!IA$2#IZA'!^_>V>D83$ MT]@8XRRNQ$:OF>Z>?G>/*-]I#_>5\IU2K5>RF;*F:O=*1?GW<>$T_Z%\(@_A M_$EX RE?-^O?R/5MK7G?;'\Z^'JG:LH!7B#9#-Q78Y;/W$JYKGXA'>W;O?+I M8,0-?W!UF2]QZX!0D_>M3P;?G''O\ONRI,CGMTR,WQE<:'S",--B)M>TAAINJ]>MOX=.#R_@"F*E]7 ME%\#WN4^02Z4CYI(6KS("@4-P!"I::TM:K:(+5FXT:M*PU-K=X3M7'3 M;#]4-;4I+N -2AW.$NU.[9!ZL_;Y >[,D8=J^V^X;W#M=,%,8O%NU'9'(U4@31W)LY7UFP.&UA3$BF:?3X.7FKP%2]'0LIE: MN]GI'-^K-:4!JU^];2M*BB8O"%5%&W"/5(?,,N"_3WR;^ -&6M3'HYIK>][Q M/0>8/4:J?9/+RXQ&! 06.S"#<@@%'W!\0UNLQW2?4 M(W8OF_F+6@%UQY)_"SE2/"T627=,J&60+O-'C%F@F"JJU>,6LRVB,7U@V:;= MYP!]]590)@0"Q \$KMD(9\\12G3;=6R7^AR>- )S#&!$IP"FP#*8*[ TZ0C! M(;?,!5J,R8#^Y%:?<-\CC@O/<(>:<+T'^'N$^D F4J-#!P$JWX"DQPIQP'UV M[#E49U>6/7*IC?#YV447*'/%]Y&6BO5I2.>/Y,7]A!AC&&&P"&V#>=QE@GM0_0I!C6'= I"- MYE>T?6T%W!=EX>)0I#G2N >\;X^\JVDNG%"1BR0&0?>T>GVO M1$-=-]MUI7T,GNA]M=51KJ(/2Q&9QOJ R&$^'9P>D)IR?]^JUNMJXS8^[K2J MM>CXJUK7[CX=%$Y/WQU(>-K$\\<@')_(@4/[[+@+TO+CF%L>-]@5_6ES([RQ M'CU\_NZ ? F-.^ =&WKI$A?RX'37HT>2EU(/)2E*TD0DSUWJCV0*I@[J,-L* MQ06QU?RJM,E#LW.C:. [-NN?:]H1WI'B5>(- M0*^!W0:5Z)B@DU&*T;ID,R"KP./^&&T[/B.9"(W/R'8-^"O929 (?K7Q%W+$ M C6X2!V%IQ"[J_-W:\J!U!)(!OEI*?;REA#C(:.6=.;S,^*Z%XNE8E'<0;%0 M+3(E&84B.:1'T^(1:\K08Z\3ZY%O4%8K=::S(;B!Y1.U H?A M'SGGF72&3_%DZ#_,2A<(TSJ#74P&RQ,- +* !/,Q]0>!!_-0PULDF&LZ"AN0 M3(0+*:";U//@!AM\VK'#A-5WA)O@Y4C@)WZ@%"PV=SS E@' M@$1XD=Z &3D\ZG$33H-/C3#:0%'A^H73'I%HK=*KDP ,_'Z?0V0D(,L1]!D] M^$A-. O%&>5N-D(]6J?V''9<=^EEA\YQ"+:6/F4[?FIQ[*9%,4$5@ +M?00 M'" ?0UH+TC'7 7<_)*S=$PYPR,JA>B-E9T&2:(:#2))E+J<4Y8OGFJ)8O;#, M&]N(CRSBOQK$?R!:2#C-W=?4+B&.8F -JBG] 4J&ATXXB M&\Z AJ<2*KR+O \JW!S1L8<9O/)=FW34_P$=(>6FCSI&L7V*YL!U/,$"OX!D" M7.EO\/()7N&>P]]-D)KPX\7%1@6$DU%] -))/0:"YGH^\6S3P)*1X]I8L<*I?MIF,&2K M17!=0[?2>_RPD^F+)62?=1JQBK* MEQE2_K'$8!D0Q5OC1"6*J+?76F*V9TT0J>9#'C8EH(Z6ZE]J:8/]9*;M2#\% M]33\3U09+.,$3B" P(E8F*S>W*CW*GA0'7+(N%"UP&M,%#C)=YM;/GP4H-H6 MPW-#4'_8K_";@K(7LD2,C2ASS" ME?>047X@=^;$Z-'1&B/*8BV>M$= ;SH419?H.!2O?$*%[UVN1VOLBS>AL8NE M>7%%6ZFI+14U\F\45X2H[J*Z_MVSS=MV=6$%U\XW;]+3W?NUC]62[W=02T[K MC??3ZE%3V@]K5*3)PH(T"-R*BO0;K%L4]W6+%Z];K+68&TE'%]_+3\C[*:N- M?8 NA]@,.=MA8!A 5[KV<%YSE&]G,W,M1"'=W3F9Y @=TA&#>62W6WJ&>0V= M8)06E#S#*3I*K=FHI^< _2ZQ$6UA. ]&1L*0>KK+N[+ACOLHT2GU4,H7]O[Q MDS3_Y:YK_G-86N#+:VJ"$X"LT*)C[ /TMJ3ZM^V$2GS+GRNS&&/3YE.T^K.@ M4M'7$NP5=E5C]"X:B\/.3.&]R5@!4T0B O\F/;=TF.L$+GIR8:,YMI['"T?# M'DB7F8RBZ^TQ'R?";(25S:08XBR7ZA_UP#)PH1?B"AVZU[H.ZXINHTP4X."B MG=$@@6.CKRY(2CP=/.K % %W_)A!^W)5] TQ[#>?YL?@ZE2ZT?0GU ? F1 MO4\Y1/DQ!P>.(3:2))JBT;U]=%5%M&^OPS3"%TUO?YOPT?3R3B]_N&(?+MZE MN&2C[%=!SUFR4M3*$[/*!^ R09CX0L0#$MD8PF)T8_KYRW@ 0=G)3!$*"UB6 MK(G"%'""0:^!#Y(@34$>+M%LK35QN;!AYUCM0R,K3>C*[Y1QBHPND.6JCI8)8<:LP="C<*/W!+N-Z_ M:<2#^&KI> #=^B[3[2$+=WJAGT;C/+ER+1]720"5 O]):9%)&#&;&LF3 MSY;)/&]Z(CCP0_[ "$SDQ01@""!6/W&,5. UQ6G@V)?0$W+ASWD.J_G2.?Y/ MP#P?,:-A/.-[X/DBW@D9R--MA^'!3%T^WCF;I'-^7U1XBJ;=Q?UO\V*!BWR1'%9#1N\R MP;F)O@"::"WXMJ#R*C8$"_8'CHU#[FPFBKD;S3R1 ?5L/ [7)!S%F8:71&(D M#E=1?!SJ@CZBSB 1FHB=I#(T058'[(1* *V_"Q56K*VB3HTAOWJS.T+.]I65 MWZZRHB8V.L06=<;>M;&:)E!=R*_5 +K9[O\16 M>$R941.[)<8BVRE'$,U$HCH_.Y8_ (L+L&-NJQN@&R2?"TTWF&J# X;@+H5N M%MX89NTHOB =&0O,,U%59675A=S6U&6["+>?K/(9CE&+.::RYC-/&T=M^C@ M'W;G:OWMKU;#]K$.X/G4BCW'>"UR(&2ER0 Z-?7 E.'(.)L9!J;/ M'7,G M85DA!4$V(U\;$]4I1"@%!'6PN! 6)<+F+E&02JW*3$"YDEORI(K]4<#(=.B8 M3+#ATEA10K>$E<_Q 5&P"7U0B"RQ(PW=SP&0 9WCP^+I-/+9S&/H7SPM? @9 M? ZQ(X:;5-P [;C*\TJJ;+5%FLJL;#V/LD+'+5%,ZW#:/+T4QSEO13&13>DE M[-5\6XJ)/%LOK67&=D8Q/8K\*_02II;65DS[+-'R+-$NO@YF7I;H_;R*1L)O5^K=^C_?1\GR39K22)SW[Y(*9(G*=U M$T6LOC2$>Y$438=96 OX@K:I!7(D5A@6'>)>;,/"_6PM8<' ZBUY;>AV@9;V M87VA>U[7%_UU128S;Q-?!0RKF9Q\B_ZO:/'#9C1GC!9YVZ@OY;DMKOX]ZU-1 MZ\1=,:+N;U).192$>UM6BF9+R(=Y<]"?\=>"997EX6H M+T*J6V9!@ 3<68- RV/FMN=?]9+EO7%X+>.PCX^6QT>[^.*PJB4+3[([?%*" M-@S9(I,.DB@8PT9#^3M&[)HC4WV74Q>"><=35@8;B7R#?F-]"P] MRQ6.,)G:J#2I2^'.6NQ[7^HGO\C7"JP0KWT_X%SYVL77CBFR'H6M'+;!>SS* M-G./3'WQ0D[L))?2B%DTF8% ^\;E%NH%+8,R$29VUV!]$'.SNLRHR<:Y1TC: M7G$O9ZQ=?%E0V$8H^&7$19H98QS7Q:R1\EW<#GQG9#!B#.+GO14G7)^KSS;S[7FW ^FD-I=,AXEW]S9M< MJKLQ?&N.P$VG@2=>=#,K>&CFNMBAP3#'%U6#N&@_3&PMPN]\"/R![0IJNLR! MJZ"N*5[VWFX/5&F?WMO>6W$?N\\-P!5CT_[Z'- M0;WUW4D$UA XHH$LN3RT7;WS9.&>DZ<_F@)O479LT5:\Z3Z[NU#4-UZK.K9ZS; QV3PJ7< ]\;E'VM<:O@ZD3N;M*C[8V]9_GF6);W^ M>[.R1;-R^X!YYA9^R^M;-2BRQZC.78;!,^[$+H$ U:+O#B:BN8*$U>MY;V)X MBVF\BQU/XY5/\!OJX:3X8OO_!U!+ P04 " "1@&A5T4!&69<' #4' M$0 &0S,#8P,S1D97@S,3$N:'1M[5EK;^)(%OV.Q'\H,9I1(D& ]$,C0I!X MN#O>I0-+W#W='PN[#*78+H_+AC"_?LXMFT<(>= SG5WM;G](XW(][CWGWG-O M0?O*^33LM*^L[J!3+K4=VQE:'>MK[4WSK-FNYX\8KQ<36+LW&GQCO8_]T7 T MN:S\=F4[5H5>L'()\_HB2D72:0_L+^S&^3:T+BM+Z:7SUJ]G[V1483R0L^BR M$@@_-:O:X_6TD"I2E,5YD.^BM*:EG^(5G/[[/-0!JN6 M(T.AV;58LHD*.4[J#NV/UY>51,[F.*K=ZUAWZ[3K8W+MD 7- M\[_1!-=@8FSH6Q/'_F#WNXX]NF:C#VP\L:_[]K@[9-97J__9L;]8&,8,:_*< MC7\G2CLFCC]/;CYWKQWFC#86_'B:=@RXL?H&G3>-\W()$#E7UK_)D.ZDU[VV M;FJCKT/K&^OV'6+LO-$X?Y7PZ=A5]DUET:SV#Z4B]D\95IDKDE3Z*Y;.>=IB MCR/R_I'S4W&7UF3DP#!$:O9[QA. %JQ8 M(F*5I SF?E!)R-H?1@BDM0[,92IJ.N:N:$5JF? 86S9J_VK7:5:'*9]]XK.( MNW,9LQL12E=%7N:F*F%]E6!?GDH573SA]:.P_R6WS\]8CVOXJJ)R*5RQ6Q@? M"&\FJKGWA<^>PK)(I0QFIUQ&C$3DQP6 BW) ^9S%T,) M4R%T*57YO <3(N$*K7FRHBDAOQ4X=V=/C3$/QN#(@,2.SJ )KDS<+,2T",MA MB2<2!@[<.=,9_=FN7XI$%)N0 Z'4@>">C&9L*=,YL:UCX1H+:>,8MBD/?BZP MSF/3U2X.K\_/FRT_;)\>P7P9 0#"=H8Y'(] M9WZ@EGI-82)F4J<)QT&H( H- MKS7?G8C3M4K1&<^O>N?EJ^XMDU19HCP:R&!&";03)#EIY-RSAH/3%UKN?Y?E M_M9R8F(_%K$3U8'OJ4#%$#6 QT?7"3\MEP9"HX<$,D;&GH^#*BFLRS/]\B6D M=%,!"HJ3#W2J&3U-!$Z$I6"^\I_3\QW \/67W*"8Q?F'B M/*#ZY2GW8L81)0OI$9%XEG\I IBM2]$/'4MP9 M3@S<><@HOUPZ5+9R4;PK/(HS]$0:V%$),8"B@4V$Q$J2P#:\4;$%% T M!=U(3BT"3\:0D=<* 4?M:E!WSYA I1Z07":1RW2PA5+9B1,WE_JZATBF6TDT,>VD7&Q4W M#'9RV X?["+L]R879J.M$J;OII8\RC9FG>9&S;G>*#S>('21U^=7[IW??6>[1M5_G2.$U2:N*25AOHC"+7-.GG[:>:JE_5,_#NKAB4&&2X( :,.H-72F 62%[ MF]9C*?@MZ5A>%XR2F9)F;IGKZP9!\/+4S9L$] *4JP>2@7M8J<4F%QZCK2B$ M6 'P4:ZJN9AJ**G.0F $0(PSA0 =O)EMT^15.4!/TH4>^@EBK0I$A$D/8&KN MRP7XU5Q09+10P4*0JD1\5ES[DR*C1!@':B7P=CE7>1KQ>]2"BL<%]X@$.MO7 MDAV'24KVOCY[@%BE\TLTU?&%V86^&.[VAA;K6\/AS;C;MZ\_7E8:%?,\[@X& MZ^??[(%S=5EYV_BYPGJCR<":F.'"A'RDUA\-A]WQC=5:?W@2_7VJZ&OC.M*$X]DOQ MK2%@K.R"S>[#RYX-R>99HR'"^VI>6P\>%:L#:JU:[!J!$4Y%DK/X:Y6=-\[/ MB!V3EDQ\$KR_YXY0#8]Y5'5_XX2/<"IS=RG-$GV'?'S$V)_=0P__Y3 MH*_K^MXWMD\!_E\?B?^'8@-%?RZ%SZP[X69TTV"CO)OZG\;D9)S?0U&U'@!S M>A\9NAF9 F3#@3) :XQ#N[\[&QV]"*[6;=-H3]]?=4VX!#2 *SF]S5G0\9 MW.Y'U3E5IZJA>6M_';2:MU:[URH6FG;?'E@MZX_*A_K%9;.:/F*\FDU@S#238256BT9M$5^Q['FJXE@%Z9"GPKBBY5^B M4=\]>SR0_KIART!H-A0K-E$!QTGM0?_+\+H4R=D<1S4[+>MA+JGJ:< 7=6UZ#SH799+ B^];Z M'QG2GG3:0^NN,OIC8'UG[:Y-C%W6:N\3/JU^F=W-9QJ.@%=T0C5*N(+[!EK?*?9I5F MM9CRV%<^"[DSEPMV)P+IJ-!-G%A%K*LB[,MCJ<*K%[Q^%O>_Y?;E!>MP#5]5 M6"P$:W8/XWWASD0Y]3[SV558%JJ8P>R8@S<>KED2QE$BF(YY+ *<3DYR6 BT M)/>9QQT,14P%$*98I?.>3 B%([3FT9JF!/Q>X-SA_?GY\..'[9/CV"># $ 8;ESN QN,!VOH]Q[&7J(61-D MQ8(,'3]QL2E0S7E7!B.2 GT!3(A/XMGW=X1E4.F]LRF4)>U4!B)F=1QQ'$0I\'4<)A9SA&A-\8\L3;EXE21^EMD?+Q@ M]B/#?_FI_O'SE<[0SO2+0DMYGL2C\:C/>"0,=L!"3GU!/C(!QJ:^U'.:3M," MI!6E%CV[4CN^T@G64<)%RD]!7$3*$2Z&=;%P!M!< 1929*P'9\[#F6!MQ/(D M\6'YZP+U@5?JG\[$^4:EZ(S75WURTU6/EDDJ+6$:#60PHP3*!4E*&CGWJN'@ M]$C+O1^RW-M93DSLQR)VHCKP(Q4H&Z(.\/3H.N/GQ4)/:#210,;(V.MQ4":% M=7BBCU]"2C<5H" [*15/E438 $FWE-JD,F:)T.Q#]7@G CDE 6P^-YQFXKF# MD12;1(9>2@@";-'*ERZ/C:%3+5W)(TD.2!!.^FS$+:2M$DVZ:Y)*&Y4VF:^T M@$4QE(96+5"5I9/XG 0+?ADK=OJ-%6DYR%4+U\2EW-..(DJ5TB4BN523Z4OXS4I M^J%C*>X,)P;N-&245RP<*ENI*#YD'BT2]$0:V%$)<64ON)R;(R7'A>:B7<@F+M3:NQP?KQQ%) MFSX>+H6&2BQ$PNFTX$Y5$A^TP P>(RM\.UM0.^&]WARQZ:91,=$I4B1,5XO- MZ9[]OFRX2+74T:> 4?N:E1WSYA I)Z07":1RG"0B5'9B1,WE_JZ!TC&6TE4, M>VD'&V4W#'9VV X/["+L]R9G9J.M$J;OII8\3+9FG:=&S;G>*CNQ+FF3W. MP#)25I,DX'^JVQOU%G\F$M:;*$Q"Q_3IYXV76NJWZGE8&U<,*DP2'% #1KVA M(P4PRV1OVWJL!+\G'4OK@E$R4]+,+7-SW2 (CD_=M$E +T"Y>B 9N(N56FQS MX3G:LD*(%0 ?Y:JBA%R'6RD!$ MF/0 IN:^G(%?3@5%ADOE+P6I2LAGV;4_RC)*! M?K07>KN8J32/^B%I0\;S@ MGI! %_M:DG.8I&3O^[,GB)5:OX13O;@RN] WP^W.P&)=:S"X&[>[_>&7ZU*M M9)['[5YO\_Q[OV??7I<^UGXNL#07M\9S4V'UY$?Y\J M^MZX6# F35K9A][FX'H-)[>:5;M'?R:YJ1L;%J"D,D4@WT,TT6*+!E\JZ;(3 M;+/1ZO1QE/95I_W0 M4W\[2\_&Z>T0M61K*1OEFK_=^_;N2IE-.'],,5UH3-TPO%1[_6\8SWXB3'6Y M2C\G8M#\"OE?4$L#!!0 ( )& :%75Z%5Q0P4 /(1 1 9#,P-C S M-&1E>#,R,2YH=&WE6&M3VSH0_9Z9_(>==-J!&?*$4IJ$S#B)@?2F<9H86CXJ MMAQK:DNNI?"XO_ZN9#N$ 'U-X7XHPP"6Y-VSYZRD0[IG[L=QKWMF6\->N=1U M1^[8[ME?JONM6K-;SQYQO)XO@&[?&5Y"_W3@C)W9<>7SVCNWCRC7S5=@^JKUEO (D8DM^7(EHH,Q;W6FQ+";IDO&J$DF[ MD:@.Y,\+H92(LZ% <%65[%_:;MX]!R1FT6W;93&5,*'7,!,QP4S6>'0Z.:ZD M;!EBJFZ_9]^$;,$4Z,J@6^_WNO6I+NTQ!,W6'X3@&4X,AH$] MP7EM7AO4RJ6Y/3 D-???-O;^'S36'*RA,W7M(3S&S,MJ4_#QOG&H&\<]LV%N MS?K6Q)Y7G2]C^Q*L@:MG6HU&Z[?[6]$;567_!KHW7:5R1;@")6"M M)+QYU3Q\U\EU)!*(+Q)%?4@V5L^IIYC@;_A")AU=H0A A13F)%T03F75N8GH M+5B>TC.ZPCTSOT*DJ<0C!>.)(& >3?%WN?21+#GQ0I9@Y)AY@OLK3XD4!B)- M1$IT+MC1 1#=]BN9J-<^K0B*?9+= LSBG4B61Q.1!I# M]\3!WBT.Y) I6I4)\6@;D:JG;EVOZA7%+DRAF M4FI-\%NO](FBAGZ$NQ MYOX.V06L[/[HVQU_-VO2!*-Y9!&AID4OWL%?0\\;LOE^_R![+3:D=$R!+[[_ M=EC6", XBA9G;8[-KPC3&X1EY.:M$1!FM$RIU SMZ6D210@*168D0OYD@N3( M;*<%C!/NZ7&]FY@)K8O$5:LH(UA@7YB!UK9WTP8EFL6MD_IJV)HAV.U1_;,+#'X_G4&HPFI\>51L4\3ZWA ML'C^/!JZ9\>59J/QN@)]9S:T9V8\QY"-5-$$C:WIW&X7?WQ7H&TUM0%""Z0Q MS7KY'\,B\\&[UWCLU]WAW&W,[TFXLH<*W"4'2B;:+??*Q1^>L5W MYHK2*8E<4G,Q4_'U$[$Q3AE=+@G?+ S9V-P\C M_*4/[R>LU?/$%O>QJ91(65 \'JY0S&>+5A?N\ M:83-!2A#?=]RH3 *^!2=BE\N99X);>>V!<.0B9#T$2MS]!L.94]['V0]]\-9 MRI0&Z+FX1XT7X'I@R:3*_;)4N$Z[J0<&T4 V5GP;QEWV_,&M_S.EQ[7E1VH3UH M[KWN"UHN&0.T[IH\PL\89%0-W19B#0)8)3BBP5*IUI36AZ,+W##Y!S'9_5W7 M']K@H/FLYS]02P,$% @ D8!H54<'C*=6!0 XA$ !$ !D,S V,#,T M9&5X,S(R+FAT;>58;4_;.A3^7JG_X:C3)I#H*PQ86RJE33HJ=4W79B]\=!.G ML9;&F>T.N+_^'CM)6PIL8QK<#QY]A^:/?2^S#N=2\=R^Z52UUO MY(V=GO.U>MRJM;KU[!''Z_D"Z/9=^PKZ[P?NV)U=5+Y@7,)U YHH M*GI=>_09YM[5V+FH7+- 1>WSVEN65(#$;)E<5&(:*O-6=UHL6Q&Q9$E5\;3= M2%4'\N<%5XJOLJ&0)ZHJV3^TW=P^AV3%XMNVQU94PH1>PXRO"&:RQJ/WDXN* M8,L(4W7[/>>NT'P_!+M &B> MPZ?:O#:HE4MS9V!(:AZ_;1S]-VBL.5BV._4<&QYBYF6U*?AXUSC5C>-=.C"W M9GUKXLRK[M>Q=LGKY\&NC=="[DFB0+%8:,D MO'G5/#WKY#H2"23@J:(!I#NKY]17C"=ODH5,.[I"'H***,R)6)"$RJI[$]-; ML'RE9W2%1V9^C4B%Q",%X_$P9#X5^+M<^D"6"?$CEF+D%?-Y$JQ]Q04,N$BY M(#H7'.@ ".[DK*-W)E^E)+G5O.FQ\\XA1%30Q2U@3,5"1N611BK7?E2DT@M/ M.Q*^)?PZIL&2:E!$M>'Q3CU]#MX/V*%FHUSZN"8"^R6^A1G%.I&L!(9E6K9= M/'\9V=[E1:79:+RN0-^=V<[,C.<8LI$JFJ"Q-9T[[>*/GPJTKZ8V0&B!-*99 M+__#+C*?G+W&8[_NV=N9S_FED-6VQ5@LW OPJ_$_[#'"MPGATHNVCWWRL4?GS%3^:* MTG*9JWW7\]P/[69Z Y+'6-NKAOGZC31[[?%XI+JLPSS"/K_BZV0)4R*^;5E_ M2<:?C=7?>/M_3\#SF=G>(&(TA.'FT'8SQ_(D"]U\(5='=^G*G:#BY]Y](1+3JN#X5 M_ ?3CA_ M8S"VLN\TLI1=MNQ&R9YL(2:F2%E3MBS#B%!#2$4;QIIH[$/$V$D+,K:2?:>8 MP3 &,S_]GN7WS_/'\WN>.&D ? M!XP!%F9F"#,3"P0"865E8>/@.\;!SLXAS,/+R2V:7L4?]R@0 P MZ+_L?^3B/N)B8&0$,T+^><'>3Z75Y)M?LL?.>?Y%6U ML4JIVQ/Y/8*^LPE(:\S(D/ZB_9/L?P<6]W\B^V^P?W']!#C H*/@@;D!&+"[ M*IL?RZ:034(DUVXP_QA'^,:="]"?Y5ENV.P5-]^>P_GZ-!:E5GF)+^;>XQ^N M2(H[+>6 M\;:VYO)<$9*9U2'=7&))JJ3B$M&L.SNJ?=*M& ._3##J[A7=?9*V Z>* -1& M]&*3PEPVN-L)?_-I.%96.&/2N.X"'8BE W9N2@"?GI3^D5"]B/ M0=KP$B0PLT;.?U>HSW<,PY0?[W@[E%U!LL6OJ;Y^8L!:OCSFY9J10$FQF:1E MWIS7C>OIGX,X!W.-F/CLCN1H8&97->@_WS2DG%]7G^)5^+P2LK>-X50ZS(?- MGZ^E Q7#-%-\-'$T.;2?=8H=>X)J?CPFO.89RN-MO'O57(NH*_+RT'ND\,SV MWHT/O^IK,DJ_\FTC;(+=+6:A''[N LUG([M2,C=RGS_\#&NL-S82KT ;:E%> M=^H&N<#]"9)RCUZ-90^>.""#QYRMB58=KF;)^J@!6RN [I^A.C^Q$.V2ZI%4TWVCIMW&C.\DWNK])(K.'YFN8&PGI!0_6'#/:' M?4[FXWY@*EP3B6FXEM7H->\R@N )5^]T M;4DZ.'>3ZO:[CN:_G"$!4X@SDD#O!^* B/KN0]-=*TJ4S+>$H1$"^XO8C-/R M=W/MW+6('V>5L=?GROB&AYWJ"[%2.V8(1U&?XV*W+\1>^5X3J9;(?>Z^D< L/ ML>F'9E]'ZI#.D +O;Q^:O-!LM3DU?7Q0!;(U3=-LI0W@9?>/W_>968;R(K1> M:T.>B.1 9E'/@?#,O+D-WLE502W$>!9I;U#]M\48$^,V _[3P,3\@,:*M,?Z MR/<:]5#IDD6\ 2DK@0[,"!$.]#/>P3^.J^ N<3HJ]K!3.)P'J70@!7O 25SO M<8XZOHO4 ;/*6(9+CNAS6DSNJ9(+VD-Z\;+QOX M1ENY4O*(/P?] CPB%FH:'^6CI[\LLKQ)%4:47!]ECC7,SF]RF(:A<=D1H4NC MFG[)M77<:J))?6U;\[2XAEQ^Y!6267*3^4_!N"8*9M+S,0;:_%H'S&_EUS?6 M/JHLGZGL3/UQ-+!$MH*)TCMG?:_CA &!UV98&?N[4TZQCE3'3[L=9-##?]X' M+X>TX?&--*Y[69 )N_G09@$"GBJ#QCP#;5OS;^XDD=B[$9SZ3J]L'BU^R!EV M<0I7%HVX?'JCP+F!LM0CX,Y!;!B>\M\X*S B\ZH(D[->-^ZE>M;X4*HQ7B3[^0"AXH MVY$:&( 0GCFCD6PD)UQY3[EA?>DO-VQCGL.=/1:=WO+@;IA@D\EL0/AR#"NO M&?.6B 7#HD]_":Q=%KQ\M.!^VO$#CP$L']61])9UZ\-*>N7])MZN)BM^M4T$7NZW9R&<>\JE!T_3=;U!E>U;K-H M0RT!ZJ6FC[/U'096/?6OD#M: W"E]_XI,I W;W;*/:?I0)<2W'8T*1%IIF>C M&)L<,2^4KDLV)4]#/Q=3MF:Q41V-J:FO#,M";U2W+YHD[*Q+D#5 :[03A,)! M?=C;E1K=ILP!1?\O ^FZ(]D1*#3YFVO_] U='.Z Y,O\4T!+?DI'.F5KPQV> MCS2E),RZ*8]W1(K^^N4+GUC"?U*IS&&>:[_?KP$B\_-O'; MZ?J5N;T%;^6FB?@&K^V*BQ0+TKD#/[Y7-TNKBK$!0M&]K=FZ CTE&V0,2]-= M4HL9<<[*LQ#T;M72LDX;+:D[OVO8C@\G::5H3@E.OG[LOK<(+$A"N+L-LHJB MS\W9/)@4)\5I?&.I&K*Q*@L%GSXL6O9;4A%&:I $XQ9N-M>ICRW--\4*&)-I M*]0!1MBQP#^U_0\;919^KS$U.2S,!\=BXD=)%14X<2U+TJFL>01\?,KELYK6 M]6?[\8.*; M8F\:J>HE/I0.A'X\/!;^?.'Y2&[(3GWF)KQ?N*-'\OFUF$1\'=&YJX(SO%6: M(;#2]T*PGQ[H QVHG!#=&^E''[!C*)^'NLI<%"PAZ^M2>UXV%$%4'H83/9=A M[N7B$6;!M^!RB<6PNSFX#2J."^#]7$UBJ"OR .RT+ J@B%FH:Q^IOBT@JIWF MM9B#+?4IZZ.,_GV"LZCH+1X6::YS$$9;R"_JJ88B2L&%9#M",?RU7!LXB'KG MQP@G&F_3>+?+Z "H93[3%37:.47EKKB(X4Q6 MT9?!4JRZS@K\[$I)A^+,JB^5T($S"_"\BMJL];0BQV;">[*L?O*X=[DDAZ@_ MFH51+,Y@=6P:9'3"C;1/LWC60B8+;I5'3=.2((]B.'RI!JVBRN5>)AZ&:P'V M6(J8R'+,OPJX\TXXC!2HK(OJ.FH0EPO@W?M\$-';!BX1,8[ZZR3ZPT 5MSV'W^N18.FL:8MRN'KN CGA"XK;WH MBX&6+SG\2>YR4]R&JFVS;J<".2GV["]I8T6GL@LD]J+;*]RCGOZ,U:$#"?;6 M@AUTX*'*[2N6B@Y,D:E'NZR (VK\!;"E:T\_.(2D=[_+R;/0Z9EE]D7\Z)M4 M^(CB<^U+EE8W8]/-G674/CJ5*&=B#YK&1<&1 WAT;A$V+P27"IJFY#9(B!\# MHLUCGF^II%W#Q>\DU@KD.4=_J_DLN+\D?.!G0Q.<0FO*.GVQ)@X9VSY=<++= MZ%U)Z+IS!NZ[,R7P7M MB%HP92+3?Y@7:ZA?Z3#P4Q:V^[TB M7T,A'(LT*&YC8TS4N](>JWLL'W_O,*]E/II !]:^H[:E$&8^L$WFJB.<<#JP MS6T$-:0-VA9&TI+42G@,:A*E\$*>>R.WNE\WC)L3WZT75OI\5O3Z[P%PA42/3?M/O MO?'$W8!(F'//S5L^XQTC;9'N^CC]5W<"[=+G+Z-217JS*MUZ*%X?'DI4>_K5 M;SM%DE&)*7&V0>T.RM@M[?=$L2NN M'%?*[_31@H?)<]A96/O 3WW:]"4S+I]2<[%!JK3,%)2BKY)U,Z:=N'W7I4E M4"T\Y]-;2@GXVX%. /_H'R[/EV")X;=(J*.BV2I3-/S <;,G 34_]YK67@_; M-XBVU7T%[%V5'Z<-IE0!:,VP5@1RL9X.^-CLL7NCR.TVAVR5-^C TTS4/ONK MR<,BV+Q2'FJ4%;8M#ZPB_>C J;7 HY0Z^HP./MVY1\!>)UJ/8-#%JXLK&:8; M.*/60VN5QW?I ,<*Y# 23@=4W:\3RV:O$Z5KQGW/;GXK=*N4[M9YW"-\ C\; M:X@-L9#RGK?]U%HF)\;E-]]_7)6XT?WEX?;$U_2KOWI$WH;^/(B!#C9;=>;6 M0I("MM^9QM4+9O4],%N\X&G>_ZX?T=[ >3^'NWD$:0-#DV7'?G9"/8^*M9M" M'.LNP$MY8@2U<)!!Z\QX%S^6?MPM+'R.,9++9]L6\I@R-6V85;:7A1<+)6QP MGOI%!]X%_YFP64' PN/;J?T)&X]SJJ[+U+[V^'T M*G7I"KT]]^Q)<-J=R/BCG]2#YR^%U%2='-+/M3$WP]N@HN3^XQ%.D:T!#C9" M4+T8JNKO"5K2%K9%] !HK%5#A-L;AT(4_8M@37:T7IK*6U<2O,PJ62&IKC'. M_+1Q8JJ)?.OA41)C9W*%O=U5JO=-TR*?I0-US9Q#P>XRQ*69BF382J?">J4K=^KBO: MV9.Q;N>,L<&7";%?O?^'27HS5022Z"^&)2?$%WW$"CXO1$5)N8U4^^^6_O7PG /EWOX6%BB%75/S>M%/5I\U,\C_ET("?=;RDB*L;U,$,#LA[;P?!AZO[DT8:MII4N?;E2F;C.'#'PT59\:K8\/F&F&=KAM GWWN%VZ5 (#+EX\&VM%W/<=7RZ M_[Y2N8#7]X-NA_1JRZ]'06RHJXOKF]2+\LX0\A2UUQZ2+]GAU^0#[$S^0\Z" MLW].6S>28$E>#80_IYZ4F]_*X/"TR,#(R,#DS M,"YX'A3IO8KD=LG6JWCNY;U/:T@;;VO,V[\_/GY^?7QI+9KF/Z'C!P7^N.=0[I MOP4,M8?KUQ?P$_ZZ^&EP[SQ1ZY'RP=7%U97VGQ=OWUU=O;N^_B_M?V:?_W

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end

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 95 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 96 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 248 311 1 false 73 0 false 6 false false R1.htm 1001 - Document - Cover Page Sheet http://www.magnachip.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.magnachip.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.magnachip.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.magnachip.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 5 false false R6.htm 1006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 1007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 1008 - Disclosure - Business, Basis of Presentation and Significant Accounting Policies Sheet http://www.magnachip.com/role/BusinessBasisOfPresentationAndSignificantAccountingPolicies Business, Basis of Presentation and Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Inventories Sheet http://www.magnachip.com/role/Inventories Inventories Notes 9 false false R10.htm 1010 - Disclosure - Property, Plant and Equipment Sheet http://www.magnachip.com/role/PropertyPlantAndEquipment Property, Plant and Equipment Notes 10 false false R11.htm 1011 - Disclosure - Intangible Assets Sheet http://www.magnachip.com/role/IntangibleAssets Intangible Assets Notes 11 false false R12.htm 1012 - Disclosure - Leases Sheet http://www.magnachip.com/role/Leases Leases Notes 12 false false R13.htm 1013 - Disclosure - Accrued Expenses Sheet http://www.magnachip.com/role/AccruedExpenses Accrued Expenses Notes 13 false false R14.htm 1014 - Disclosure - Derivative Financial Instruments Sheet http://www.magnachip.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 14 false false R15.htm 1015 - Disclosure - Fair Value Measurements Sheet http://www.magnachip.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 1016 - Disclosure - Accrued Severance Benefits Sheet http://www.magnachip.com/role/AccruedSeveranceBenefits Accrued Severance Benefits Notes 16 false false R17.htm 1017 - Disclosure - Foreign Currency Loss, Net Sheet http://www.magnachip.com/role/ForeignCurrencyLossNet Foreign Currency Loss, Net Notes 17 false false R18.htm 1018 - Disclosure - Income Taxes Sheet http://www.magnachip.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 1019 - Disclosure - Geographic and Other Information Sheet http://www.magnachip.com/role/GeographicAndOtherInformation Geographic and Other Information Notes 19 false false R20.htm 1020 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.magnachip.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 20 false false R21.htm 1021 - Disclosure - Stock Repurchases Sheet http://www.magnachip.com/role/StockRepurchases Stock Repurchases Notes 21 false false R22.htm 1022 - Disclosure - Earnings (Loss) Per Share Sheet http://www.magnachip.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 22 false false R23.htm 1023 - Disclosure - Merger Agreement Sheet http://www.magnachip.com/role/MergerAgreement Merger Agreement Notes 23 false false R24.htm 1024 - Disclosure - Commitments and Contingencies Sheet http://www.magnachip.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 24 false false R25.htm 1025 - Disclosure - Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.magnachip.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.magnachip.com/role/BusinessBasisOfPresentationAndSignificantAccountingPolicies 25 false false R26.htm 1026 - Disclosure - Inventories (Tables) Sheet http://www.magnachip.com/role/InventoriesTables Inventories (Tables) Tables http://www.magnachip.com/role/Inventories 26 false false R27.htm 1027 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.magnachip.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.magnachip.com/role/PropertyPlantAndEquipment 27 false false R28.htm 1028 - Disclosure - Intangible Assets (Tables) Sheet http://www.magnachip.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.magnachip.com/role/IntangibleAssets 28 false false R29.htm 1029 - Disclosure - Leases (Tables) Sheet http://www.magnachip.com/role/LeasesTables Leases (Tables) Tables http://www.magnachip.com/role/Leases 29 false false R30.htm 1030 - Disclosure - Accrued Expenses (Tables) Sheet http://www.magnachip.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.magnachip.com/role/AccruedExpenses 30 false false R31.htm 1031 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://www.magnachip.com/role/DerivativeFinancialInstrumentsTables Derivative Financial Instruments (Tables) Tables http://www.magnachip.com/role/DerivativeFinancialInstruments 31 false false R32.htm 1032 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.magnachip.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.magnachip.com/role/FairValueMeasurements 32 false false R33.htm 1033 - Disclosure - Accrued Severance Benefits (Tables) Sheet http://www.magnachip.com/role/AccruedSeveranceBenefitsTables Accrued Severance Benefits (Tables) Tables http://www.magnachip.com/role/AccruedSeveranceBenefits 33 false false R34.htm 1034 - Disclosure - Geographic and Other Information (Tables) Sheet http://www.magnachip.com/role/GeographicAndOtherInformationTables Geographic and Other Information (Tables) Tables http://www.magnachip.com/role/GeographicAndOtherInformation 34 false false R35.htm 1035 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.magnachip.com/role/AccumulatedOtherComprehensiveLoss 35 false false R36.htm 1036 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.magnachip.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.magnachip.com/role/EarningsLossPerShare 36 false false R37.htm 1037 - Disclosure - Inventories - Summary of Inventories (Detail) Sheet http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail Inventories - Summary of Inventories (Detail) Details 37 false false R38.htm 1038 - Disclosure - Inventories - Changes in Inventory Reserve (Detail) Sheet http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail Inventories - Changes in Inventory Reserve (Detail) Details 38 false false R39.htm 1039 - Disclosure - Property, Plant and Equipment - Additional Information (Detail) Sheet http://www.magnachip.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail Property, Plant and Equipment - Additional Information (Detail) Details 39 false false R40.htm 1040 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) Sheet http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) Details 40 false false R41.htm 1041 - Disclosure - Intangible Assets - Additional Information (Detail) Sheet http://www.magnachip.com/role/IntangibleAssetsAdditionalInformationDetail Intangible Assets - Additional Information (Detail) Details 41 false false R42.htm 1042 - Disclosure - Intangible Assets - Summary of Intangible Assets (Detail) Sheet http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail Intangible Assets - Summary of Intangible Assets (Detail) Details 42 false false R43.htm 1043 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.magnachip.com/role/LeasesAdditionalInformationDetail Leases - Additional Information (Detail) Details 43 false false R44.htm 1044 - Disclosure - Leases - Supplemental Balance Sheet (Detail) Sheet http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail Leases - Supplemental Balance Sheet (Detail) Details 44 false false R45.htm 1045 - Disclosure - Leases - Components of lease cost (Detail) Sheet http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail Leases - Components of lease cost (Detail) Details 45 false false R46.htm 1046 - Disclosure - Leases - Other lease information (Detail) Sheet http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail Leases - Other lease information (Detail) Details 46 false false R47.htm 1047 - Disclosure - Leases - Aggregate future lease payment (Detail) Sheet http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail Leases - Aggregate future lease payment (Detail) Details 47 false false R48.htm 1048 - Disclosure - Accrued Expenses - Summary of Accrued Expenses (Detail) Sheet http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail Accrued Expenses - Summary of Accrued Expenses (Detail) Details 48 false false R49.htm 1049 - Disclosure - Derivative Financial Instruments - Additional Information (Detail) Sheet http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail Derivative Financial Instruments - Additional Information (Detail) Details 49 false false R50.htm 1050 - Disclosure - Derivative Financial Instruments - Details of Derivative Contracts (Detail) Sheet http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail Derivative Financial Instruments - Details of Derivative Contracts (Detail) Details 50 false false R51.htm 1051 - Disclosure - Derivative Financial Instruments - Fair Values of Outstanding Zero Cost Collar and Forward Contracts Recorded as Assets and Liabilities (Detail) Sheet http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail Derivative Financial Instruments - Fair Values of Outstanding Zero Cost Collar and Forward Contracts Recorded as Assets and Liabilities (Detail) Details 51 false false R52.htm 1052 - Disclosure - Derivative Financial Instruments - Offsetting of Derivative Assets and Liabilities (Details) Sheet http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails Derivative Financial Instruments - Offsetting of Derivative Assets and Liabilities (Details) Details 52 false false R53.htm 1053 - Disclosure - Derivative Financial Instruments - Impact of Derivative Instruments on Consolidated Statement of Operations (Detail) Sheet http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail Derivative Financial Instruments - Impact of Derivative Instruments on Consolidated Statement of Operations (Detail) Details 53 false false R54.htm 1054 - Disclosure - Derivative Financial Instruments - Cash deposits (Details) Sheet http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails Derivative Financial Instruments - Cash deposits (Details) Details 54 false false R55.htm 1055 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 55 false false R56.htm 1056 - Disclosure - Accrued Severance Benefits - Additional Information (Detail) Sheet http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail Accrued Severance Benefits - Additional Information (Detail) Details 56 false false R57.htm 1057 - Disclosure - Accrued Severance Benefits - Changes in Accrued Severance Benefits (Detail) Sheet http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail Accrued Severance Benefits - Changes in Accrued Severance Benefits (Detail) Details 57 false false R58.htm 1058 - Disclosure - Accrued Severance Benefits - Future Benefits Payments to Employees (Detail) Sheet http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail Accrued Severance Benefits - Future Benefits Payments to Employees (Detail) Details 58 false false R59.htm 1059 - Disclosure - Foreign Currency Loss, Net - Additional Information (Detail) Sheet http://www.magnachip.com/role/ForeignCurrencyLossNetAdditionalInformationDetail Foreign Currency Loss, Net - Additional Information (Detail) Details 59 false false R60.htm 1060 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 60 false false R61.htm 1061 - Disclosure - Geographic and Other Information - Additional Information (Detail) Sheet http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail Geographic and Other Information - Additional Information (Detail) Details 61 false false R62.htm 1062 - Disclosure - Geographic and Other Information - Schedule of Operating Segment (Detail) Sheet http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail Geographic and Other Information - Schedule of Operating Segment (Detail) Details 62 false false R63.htm 1063 - Disclosure - Geographic and Other Information - Net Sales by Region, Based on Location of Products are Billed (Detail) Sheet http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail Geographic and Other Information - Net Sales by Region, Based on Location of Products are Billed (Detail) Details 63 false false R64.htm 1064 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Detail) Sheet http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossScheduleOfAccumulatedOtherComprehensiveLossDetail Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Detail) Details 64 false false R65.htm 1065 - Disclosure - Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Income Loss (Detail) Sheet http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Income Loss (Detail) Details 65 false false R66.htm 1066 - Disclosure - Stock Repurchases - Additional Information (Detail) Sheet http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail Stock Repurchases - Additional Information (Detail) Details 66 false false R67.htm 1067 - Disclosure - Earnings (Loss) Per Share - Additional Information (Detail) Sheet http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail Earnings (Loss) Per Share - Additional Information (Detail) Details http://www.magnachip.com/role/EarningsLossPerShareTables 67 false false R68.htm 1068 - Disclosure - Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Loss Per Common Share (Detail) Sheet http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Loss Per Common Share (Detail) Details http://www.magnachip.com/role/EarningsLossPerShareTables 68 false false R69.htm 1069 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from the Computation of Loss Per Common Share (Detail) Sheet http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from the Computation of Loss Per Common Share (Detail) Details http://www.magnachip.com/role/EarningsLossPerShareTables 69 false false R70.htm 1070 - Disclosure - Merger Agreement - Additional Information (Details) Sheet http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails Merger Agreement - Additional Information (Details) Details 70 false false R71.htm 1071 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 71 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressAddressLine1 - d306034d10q.htm 9 d306034d10q.htm d306034dex101.htm d306034dex102.htm d306034dex103.htm d306034dex104.htm d306034dex105.htm d306034dex106.htm d306034dex107.htm d306034dex108.htm d306034dex109.htm d306034dex311.htm d306034dex312.htm d306034dex321.htm d306034dex322.htm mx-20220930.xsd mx-20220930_cal.xml mx-20220930_def.xml mx-20220930_lab.xml mx-20220930_pre.xml g306034g1103181052615.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 99 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d306034d10q.htm": { "axisCustom": 3, "axisStandard": 27, "contextCount": 248, "dts": { "calculationLink": { "local": [ "mx-20220930_cal.xml" ] }, "definitionLink": { "local": [ "mx-20220930_def.xml" ] }, "inline": { "local": [ "d306034d10q.htm" ] }, "labelLink": { "local": [ "mx-20220930_lab.xml" ] }, "presentationLink": { "local": [ "mx-20220930_pre.xml" ] }, "schema": { "local": [ "mx-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 548, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 4, "http://xbrl.sec.gov/dei/2022": 6, "total": 10 }, "keyCustom": 56, "keyStandard": 255, "memberCustom": 33, "memberStandard": 38, "nsprefix": "mx", "nsuri": "http://www.magnachip.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.magnachip.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Property, Plant and Equipment", "role": "http://www.magnachip.com/role/PropertyPlantAndEquipment", "shortName": "Property, Plant and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Intangible Assets", "role": "http://www.magnachip.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Leases", "role": "http://www.magnachip.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Accrued Expenses", "role": "http://www.magnachip.com/role/AccruedExpenses", "shortName": "Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Derivative Financial Instruments", "role": "http://www.magnachip.com/role/DerivativeFinancialInstruments", "shortName": "Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Fair Value Measurements", "role": "http://www.magnachip.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Accrued Severance Benefits", "role": "http://www.magnachip.com/role/AccruedSeveranceBenefits", "shortName": "Accrued Severance Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Foreign Currency Loss, Net", "role": "http://www.magnachip.com/role/ForeignCurrencyLossNet", "shortName": "Foreign Currency Loss, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Income Taxes", "role": "http://www.magnachip.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Geographic and Other Information", "role": "http://www.magnachip.com/role/GeographicAndOtherInformation", "shortName": "Geographic and Other Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.magnachip.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Accumulated Other Comprehensive Loss", "role": "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Stock Repurchases", "role": "http://www.magnachip.com/role/StockRepurchases", "shortName": "Stock Repurchases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Earnings (Loss) Per Share", "role": "http://www.magnachip.com/role/EarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Merger Agreement", "role": "http://www.magnachip.com/role/MergerAgreement", "shortName": "Merger Agreement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Commitments and Contingencies", "role": "http://www.magnachip.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "role": "http://www.magnachip.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Inventories (Tables)", "role": "http://www.magnachip.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Property, Plant and Equipment (Tables)", "role": "http://www.magnachip.com/role/PropertyPlantAndEquipmentTables", "shortName": "Property, Plant and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Intangible Assets (Tables)", "role": "http://www.magnachip.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "mx:SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Leases (Tables)", "role": "http://www.magnachip.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "mx:SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.magnachip.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Accrued Expenses (Tables)", "role": "http://www.magnachip.com/role/AccruedExpensesTables", "shortName": "Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Derivative Financial Instruments (Tables)", "role": "http://www.magnachip.com/role/DerivativeFinancialInstrumentsTables", "shortName": "Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.magnachip.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Accrued Severance Benefits (Tables)", "role": "http://www.magnachip.com/role/AccruedSeveranceBenefitsTables", "shortName": "Accrued Severance Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Geographic and Other Information (Tables)", "role": "http://www.magnachip.com/role/GeographicAndOtherInformationTables", "shortName": "Geographic and Other Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "mx:ScheduleOfComponentsOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "role": "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "mx:ScheduleOfComponentsOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Earnings (Loss) Per Share (Tables)", "role": "http://www.magnachip.com/role/EarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Inventories - Summary of Inventories (Detail)", "role": "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail", "shortName": "Inventories - Summary of Inventories (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "mx:ChangesInInventoryReservesTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryValuationReserves", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Inventories - Changes in Inventory Reserve (Detail)", "role": "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail", "shortName": "Inventories - Changes in Inventory Reserve (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "mx:ChangesInInventoryReservesTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "lang": null, "name": "mx:InventoryReserveChargedToCostsOfSales", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Property, Plant and Equipment - Additional Information (Detail)", "role": "http://www.magnachip.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail", "shortName": "Property, Plant and Equipment - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail)", "role": "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail", "shortName": "Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Intangible Assets - Additional Information (Detail)", "role": "http://www.magnachip.com/role/IntangibleAssetsAdditionalInformationDetail", "shortName": "Intangible Assets - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Intangible Assets - Summary of Intangible Assets (Detail)", "role": "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail", "shortName": "Intangible Assets - Summary of Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022_MaximumMembersrtRangeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "mx:RemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Leases - Additional Information (Detail)", "role": "http://www.magnachip.com/role/LeasesAdditionalInformationDetail", "shortName": "Leases - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022_MaximumMembersrtRangeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "mx:RemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - Leases - Supplemental Balance Sheet (Detail)", "role": "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail", "shortName": "Leases - Supplemental Balance Sheet (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "mx:SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "lang": null, "name": "mx:LeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "mx:OtherLeaseInformationTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Leases - Components of lease cost (Detail)", "role": "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail", "shortName": "Leases - Components of lease cost (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "mx:OtherLeaseInformationTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Leases - Other lease information (Detail)", "role": "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail", "shortName": "Leases - Other lease information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "mx:ScheduleOfFutureLeasePaymentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1047 - Disclosure - Leases - Aggregate future lease payment (Detail)", "role": "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail", "shortName": "Leases - Aggregate future lease payment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "mx:ScheduleOfFutureLeasePaymentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1048 - Disclosure - Accrued Expenses - Summary of Accrued Expenses (Detail)", "role": "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail", "shortName": "Accrued Expenses - Summary of Accrued Expenses (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1049 - Disclosure - Derivative Financial Instruments - Additional Information (Detail)", "role": "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "shortName": "Derivative Financial Instruments - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "role": "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022_ZeroCostCollarOneMemberusgaapDerivativeInstrumentRiskAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInceptionDates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1050 - Disclosure - Derivative Financial Instruments - Details of Derivative Contracts (Detail)", "role": "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail", "shortName": "Derivative Financial Instruments - Details of Derivative Contracts (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022_ZeroCostCollarOneMemberusgaapDerivativeInstrumentRiskAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInceptionDates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022_ZeroCostCollarsMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1051 - Disclosure - Derivative Financial Instruments - Fair Values of Outstanding Zero Cost Collar and Forward Contracts Recorded as Assets and Liabilities (Detail)", "role": "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "shortName": "Derivative Financial Instruments - Fair Values of Outstanding Zero Cost Collar and Forward Contracts Recorded as Assets and Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022_OtherCurrentLiabilitiesMemberusgaapBalanceSheetLocationAxis_ZeroCostCollarsMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "-3", "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022_ZeroCostCollarsMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1052 - Disclosure - Derivative Financial Instruments - Offsetting of Derivative Assets and Liabilities (Details)", "role": "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails", "shortName": "Derivative Financial Instruments - Offsetting of Derivative Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022_ZeroCostCollarsMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1053 - Disclosure - Derivative Financial Instruments - Impact of Derivative Instruments on Consolidated Statement of Operations (Detail)", "role": "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail", "shortName": "Derivative Financial Instruments - Impact of Derivative Instruments on Consolidated Statement of Operations (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022_CashFlowHedgingMemberusgaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_ZeroCostCollarsMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022_StandardCharteredBankKoreaLimitedMembersrtCounterpartyNameAxis_ZeroCostCollarAndForwardContractsMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarginDepositAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1054 - Disclosure - Derivative Financial Instruments - Cash deposits (Details)", "role": "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails", "shortName": "Derivative Financial Instruments - Cash deposits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022_StandardCharteredBankKoreaLimitedMembersrtCounterpartyNameAxis_ZeroCostCollarAndForwardContractsMemberusgaapDerivativeInstrumentRiskAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarginDepositAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_OtherCurrentLiabilitiesMemberusgaapBalanceSheetLocationAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1055 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)", "role": "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "shortName": "Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_OtherCurrentLiabilitiesMemberusgaapBalanceSheetLocationAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "2", "first": true, "lang": null, "name": "mx:EmployeesEligibleForSeveranceBenefitsPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1056 - Disclosure - Accrued Severance Benefits - Additional Information (Detail)", "role": "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "shortName": "Accrued Severance Benefits - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "2", "first": true, "lang": null, "name": "mx:EmployeesEligibleForSeveranceBenefitsPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock", "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PostemploymentBenefitsLiabilityCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1057 - Disclosure - Accrued Severance Benefits - Changes in Accrued Severance Benefits (Detail)", "role": "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail", "shortName": "Accrued Severance Benefits - Changes in Accrued Severance Benefits (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock", "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PostemploymentBenefitsLiabilityCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "mx:PostemploymentBenefitPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1058 - Disclosure - Accrued Severance Benefits - Future Benefits Payments to Employees (Detail)", "role": "http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail", "shortName": "Accrued Severance Benefits - Future Benefits Payments to Employees (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "mx:PostemploymentBenefitPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "us-gaap:ForeignCurrencyDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1059 - Disclosure - Foreign Currency Loss, Net - Additional Information (Detail)", "role": "http://www.magnachip.com/role/ForeignCurrencyLossNetAdditionalInformationDetail", "shortName": "Foreign Currency Loss, Net - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:ForeignCurrencyDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "role": "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "lang": null, "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1060 - Disclosure - Income Taxes - Additional Information (Detail)", "role": "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail", "shortName": "Income Taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R61": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_StandardProductsBusinessMemberusgaapStatementBusinessSegmentsAxis_TopTenCustomersMembersrtMajorCustomersAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1061 - Disclosure - Geographic and Other Information - Additional Information (Detail)", "role": "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "shortName": "Geographic and Other Information - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_StandardProductsBusinessMemberusgaapStatementBusinessSegmentsAxis_TopTenCustomersMembersrtMajorCustomersAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1062 - Disclosure - Geographic and Other Information - Schedule of Operating Segment (Detail)", "role": "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail", "shortName": "Geographic and Other Information - Schedule of Operating Segment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022_OperatingSegmentsMembersrtConsolidationItemsAxis_StandardProductsBusinessMemberusgaapStatementBusinessSegmentsAxis", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1063 - Disclosure - Geographic and Other Information - Net Sales by Region, Based on Location of Products are Billed (Detail)", "role": "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail", "shortName": "Geographic and Other Information - Net Sales by Region, Based on Location of Products are Billed (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022_KRsrtStatementGeographicalAxis_StandardProductsBusinessMemberusgaapStatementBusinessSegmentsAxis", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "mx:ScheduleOfComponentsOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1064 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Detail)", "role": "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossScheduleOfAccumulatedOtherComprehensiveLossDetail", "shortName": "Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "mx:ScheduleOfComponentsOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1065 - Disclosure - Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Income Loss (Detail)", "role": "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail", "shortName": "Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Income Loss (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn06_30_2022_AccumulatedTranslationAdjustmentMemberusgaapStatementEquityComponentsAxis", "decimals": "-3", "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "div", "us-gaap:TreasuryStockTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1066 - Disclosure - Stock Repurchases - Additional Information (Detail)", "role": "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail", "shortName": "Stock Repurchases - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:TreasuryStockTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1067 - Disclosure - Earnings (Loss) Per Share - Additional Information (Detail)", "role": "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail", "shortName": "Earnings (Loss) Per Share - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "3", "lang": null, "name": "mx:RedemptionOfRightsPerRight", "reportCount": 1, "unique": true, "unitRef": "Unit_BusinessLines", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1068 - Disclosure - Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Loss Per Common Share (Detail)", "role": "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail", "shortName": "Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Loss Per Common Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "INF", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1069 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from the Computation of Loss Per Common Share (Detail)", "role": "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail", "shortName": "Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from the Computation of Loss Per Common Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022_EmployeeAndNonEmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "decimals": "INF", "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1070 - Disclosure - Merger Agreement - Additional Information (Details)", "role": "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails", "shortName": "Merger Agreement - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": "-3", "lang": null, "name": "mx:MergerTerminationFee", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022_OtherCurrentAssetsMemberusgaapBalanceSheetLocationAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToSuppliers", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1071 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022_OtherCurrentAssetsMemberusgaapBalanceSheetLocationAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToSuppliers", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Business, Basis of Presentation and Significant Accounting Policies", "role": "http://www.magnachip.com/role/BusinessBasisOfPresentationAndSignificantAccountingPolicies", "shortName": "Business, Basis of Presentation and Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Inventories", "role": "http://www.magnachip.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d306034d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 73, "tag": { "country_KR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "KOREA, REPUBLIC OF", "terseLabel": "Korea [Member]" } } }, "localname": "KR", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "domainItemType" }, "country_VN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "VIET NAM" } } }, "localname": "VN", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r622" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "trueItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r619" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r621" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "mx_AcceleratedShareRepurchaseProgramAdjustmentShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated share repurchase program adjustment shares.", "label": "Accelerated share repurchase program adjustment shares", "terseLabel": "Accelerated stock repurchase, Shares" } } }, "localname": "AcceleratedShareRepurchaseProgramAdjustmentShares", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "mx_AcceleratedStockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated stock repurchase program.", "label": "Accelerated Stock Repurchase Program [Member]", "terseLabel": "Accelerated Stock Repurchase Program [Member]" } } }, "localname": "AcceleratedStockRepurchaseProgramMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_AccruedOutsideServiceFeesCurrent": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Outside Service Fees Current", "label": "Accrued Outside Service Fees Current", "terseLabel": "Outside service fees" } } }, "localname": "AccruedOutsideServiceFeesCurrent", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail" ], "xbrltype": "monetaryItemType" }, "mx_AcquiringPersonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquiring person.", "label": "Acquiring Person [Member]" } } }, "localname": "AcquiringPersonMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_AggregatePurchasePriceOfShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate purchase price of shares.", "label": "Aggregate Purchase Price Of Shares", "terseLabel": "Aggregate purchase price of shares" } } }, "localname": "AggregatePurchasePriceOfShares", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mx_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "mx_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mx_AsiaPacificOtherThanKoreaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asia Pacific Other Than Korea [Member]", "label": "Asia Pacific Other Than Korea [Member]", "terseLabel": "Asia Pacific (Other Than Korea) [Member]" } } }, "localname": "AsiaPacificOtherThanKoreaMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "domainItemType" }, "mx_CashCollateralForCoveringCreditExposureInDerivatives": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash collateral for covering credit exposure in derivatives.", "label": "Cash Collateral for Covering Credit Exposure In Derivatives", "terseLabel": "Cash collateral for credit exposure in derivatives" } } }, "localname": "CashCollateralForCoveringCreditExposureInDerivatives", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mx_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "stringItemType" }, "mx_ChangesInInventoryReservesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Changes In Inventory Reserves Table [Text Block]", "label": "Changes In Inventory Reserves [Table Text Block]", "terseLabel": "Changes in Inventory Reserve" } } }, "localname": "ChangesInInventoryReservesTableTextBlock", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "mx_ChinaAndHongKongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "China and Hong Kong [Member]", "label": "China and Hong Kong [Member]", "terseLabel": "CHINA, HONG KONG" } } }, "localname": "ChinaAndHongKongMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_CumulativeContributionsToNationalPensionFund": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cumulative contributions to national pension fund.", "label": "Cumulative Contributions To National Pension Fund", "negatedLabel": "The National Pension Fund" } } }, "localname": "CumulativeContributionsToNationalPensionFund", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "mx_CumulativeContributionsToSeveranceInsuranceDepositAccounts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cumulative contributions to severance insurance deposit accounts.", "label": "Less: Cumulative Contributions To Severance Insurance Deposit Accounts", "terseLabel": "Less: Cumulative contributions to severance insurance deposit accounts" } } }, "localname": "CumulativeContributionsToSeveranceInsuranceDepositAccounts", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "mx_CurrentOperatingLeaseLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Operating Lease Liabilities [Member]" } } }, "localname": "CurrentOperatingLeaseLiabilitiesMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "domainItemType" }, "mx_DeferredMergerTerminationFeeAsOtherReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred merger termination fee as other receivable.", "label": "Deferred Merger Termination Fee As Other Receivable" } } }, "localname": "DeferredMergerTerminationFeeAsOtherReceivable", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mx_DepositAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deposit assets.", "label": "Deposit Assets [Line Items]" } } }, "localname": "DepositAssetsLineItems", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails" ], "xbrltype": "stringItemType" }, "mx_DepositAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deposit assets.", "label": "Deposit Assets [Table]" } } }, "localname": "DepositAssetsTable", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails" ], "xbrltype": "stringItemType" }, "mx_DerivativeSettlementEndDateMonthYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Settlement End Date, Month Year", "label": "Derivative, Settlement End Date, Month Year", "terseLabel": "Month of settlement, end" } } }, "localname": "DerivativeSettlementEndDateMonthYear", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail" ], "xbrltype": "gYearMonthItemType" }, "mx_DerivativeSettlementStartDateMonthYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Settlement Start Date, Month Year", "label": "Derivative, Settlement Start Date, Month Year", "terseLabel": "Month of settlement, start" } } }, "localname": "DerivativeSettlementStartDateMonthYear", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail" ], "xbrltype": "gYearMonthItemType" }, "mx_DisplaySolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of display solutions.", "label": "Display Solutions [Member]", "terseLabel": "Display Solutions [Member]" } } }, "localname": "DisplaySolutionsMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "domainItemType" }, "mx_DueDateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due date.", "label": "Due Date [Axis]" } } }, "localname": "DueDateAxis", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "mx_DueDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due date.", "label": "Due Date [Domain]" } } }, "localname": "DueDateDomain", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mx_DueOnOrBeforeDecember232022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due on or before December 23, 2022.", "label": "Due on or Before December 23, 2022 [Member]" } } }, "localname": "DueOnOrBeforeDecember232022Member", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mx_EmployeeAndNonEmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee And Non Employee Stock Option [Member]", "label": "Employee And Non Employee Stock Option [Member]", "terseLabel": "Options [Member]" } } }, "localname": "EmployeeAndNonEmployeeStockOptionMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail" ], "xbrltype": "domainItemType" }, "mx_EmployeesEligibleForSeveranceBenefitsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees eligible for severance benefits percentage.", "label": "Employees Eligible For Severance Benefits Percentage", "terseLabel": "Percentage of employees eligible for severance benefits" } } }, "localname": "EmployeesEligibleForSeveranceBenefitsPercentage", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mx_FabThreeFoundryServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fab Three Foundry Services", "label": "Fab Three Foundry Services [Member]", "terseLabel": "Fab Three Foundry Services [Member]" } } }, "localname": "FabThreeFoundryServicesMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "domainItemType" }, "mx_FinanceLeaseRightOfUseAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease Right Of Use Assets [Member]" } } }, "localname": "FinanceLeaseRightOfUseAssetsMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "mx_FinanceLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Leases [Abstract]" } } }, "localname": "FinanceLeasesAbstract", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "stringItemType" }, "mx_ForeignCurrencyTransactionGainLossBeforeTaxIncludingIntercompanyBalances": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign Currency Transaction Gain Loss Before Tax Including Intercompany Balances", "label": "Foreign Currency Transaction Gain Loss Before Tax Including Intercompany Balances", "negatedTerseLabel": "Loss on foreign currency, net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTaxIncludingIntercompanyBalances", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mx_GroupSeveranceInsurancePlan": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Group severance insurance plan.", "label": "Group Severance Insurance Plan", "negatedLabel": "Group severance insurance plan" } } }, "localname": "GroupSeveranceInsurancePlan", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "mx_IncomeStatementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Statement.", "label": "Income Statement [Axis]", "terseLabel": "Income Statement [Axis]" } } }, "localname": "IncomeStatementAxis", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "stringItemType" }, "mx_IncomeStatementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income statement.", "label": "Income Statement [Domain]", "terseLabel": "Income Statement [Domain]" } } }, "localname": "IncomeStatementDomain", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "domainItemType" }, "mx_IncreaseDecreaseInInventoryReserve": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in inventory reserve.", "label": "Increase Decrease In Inventory Reserve", "terseLabel": "Provision for inventory reserves" } } }, "localname": "IncreaseDecreaseInInventoryReserve", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mx_IntercompanyLoan": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intercompany Loan", "label": "Intercompany Loan", "terseLabel": "Intercompany loan balances" } } }, "localname": "IntercompanyLoan", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ForeignCurrencyLossNetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mx_InventoryReserveChargedToCostsOfSales": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail": { "order": 1.0, "parentTag": "mx_InventoryValuationReservesChanges", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory reserve charged to costs of sales.", "label": "Inventory reserve charged to costs of sales", "negatedLabel": "Inventory reserve charged to costs of sales" } } }, "localname": "InventoryReserveChargedToCostsOfSales", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail" ], "xbrltype": "monetaryItemType" }, "mx_InventoryValuationReservesChanges": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory valuation reserves changes.", "label": "Inventory Valuation Reserves Changes", "negatedTotalLabel": "Change in reserve" } } }, "localname": "InventoryValuationReservesChanges", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail" ], "xbrltype": "monetaryItemType" }, "mx_InventoryValuationReservesChangesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory valuation reserves changes.", "label": "Inventory Valuation Reserves Changes [Abstract]", "terseLabel": "Change in reserve" } } }, "localname": "InventoryValuationReservesChangesAbstract", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail" ], "xbrltype": "stringItemType" }, "mx_InventoryValuationReservesForeignCurrencyTranslationAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory valuation reserves foreign currency translation adjustments.", "label": "Inventory Valuation Reserves Foreign Currency Translation Adjustments", "negatedLabel": "Translation adjustments" } } }, "localname": "InventoryValuationReservesForeignCurrencyTranslationAdjustments", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail" ], "xbrltype": "monetaryItemType" }, "mx_KoreasMandatoryRetirementAge": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Korea's mandatory retirement age.", "label": "Koreas Mandatory Retirement Age", "terseLabel": "Korea's mandatory retirement age" } } }, "localname": "KoreasMandatoryRetirementAge", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mx_LeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease Liabilities", "label": "Lease Liabilities", "verboseLabel": "Total lease liabilities" } } }, "localname": "LeaseLiabilities", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "monetaryItemType" }, "mx_LeaseLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Liabilities Current [Abstract]", "verboseLabel": "Current" } } }, "localname": "LeaseLiabilitiesCurrentAbstract", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "stringItemType" }, "mx_LeaseLiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Liabilities Noncurrent [Abstract]", "verboseLabel": "Non-current" } } }, "localname": "LeaseLiabilitiesNoncurrentAbstract", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "stringItemType" }, "mx_LeaseRightOfUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "lease right of use asset", "label": "Lease Right Of Use Asset", "verboseLabel": "Total lease assets" } } }, "localname": "LeaseRightOfUseAsset", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "monetaryItemType" }, "mx_LeasesAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "LeasesAssetsAbstract", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "stringItemType" }, "mx_LetterAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Letter agreement.", "label": "Letter Agreement [Member]" } } }, "localname": "LetterAgreementMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mx_LetterAgreementOutstandingAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Letter agreement outstanding amount.", "label": "Letter agreement outstanding amount" } } }, "localname": "LetterAgreementOutstandingAmount", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mx_MergerRelatedCosts": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Merger Related Costs.", "label": "Merger Related Costs", "negatedLabel": "Merger-related costs" } } }, "localname": "MergerRelatedCosts", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail" ], "xbrltype": "monetaryItemType" }, "mx_MergerTerminationFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Merger termination fee.", "label": "Merger Termination Fee" } } }, "localname": "MergerTerminationFee", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mx_MinimumSumOfQualifiedAndUnrestrictedCashAndCashEquivalents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Minimum sum of qualified and unrestricted cash and cash equivalents.", "label": "Minimum Sum Of Qualified And Unrestricted Cash And Cash Equivalents", "terseLabel": "Termination provisions for cash and cash equivalents" } } }, "localname": "MinimumSumOfQualifiedAndUnrestrictedCashAndCashEquivalents", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mx_NomuraFinancialInvestmentCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nomura Financial Investment Co Ltd [Member]", "label": "Nomura Financial Investment Co Ltd [Member]", "terseLabel": "Nomura Financial Investment (Korea) Co., Ltd. [Member]" } } }, "localname": "NomuraFinancialInvestmentCoLtdMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_NonCurrentoperatingLeaseLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Current Operating Lease Liabilities [Member]" } } }, "localname": "NonCurrentoperatingLeaseLiabilitiesMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "domainItemType" }, "mx_OperatingLeaseRightOfUseAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Right Of Use Assets [Member]", "verboseLabel": "Operating Lease Right Of Use Assets [Member]" } } }, "localname": "OperatingLeaseRightOfUseAssetsMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "domainItemType" }, "mx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationsAndTax": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossScheduleOfAccumulatedOtherComprehensiveLossDetail": { "order": 2.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other comprehensive income loss cash flow hedge gain loss after reclassifications and tax.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassifications and Tax", "terseLabel": "Derivative adjustments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationsAndTax", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossScheduleOfAccumulatedOtherComprehensiveLossDetail" ], "xbrltype": "monetaryItemType" }, "mx_OtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Countries [Member]", "label": "Other Countries [Member]", "terseLabel": "Others [Member]" } } }, "localname": "OtherCountriesMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "domainItemType" }, "mx_OtherLeaseInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Other Lease Information [Table Text Block]", "terseLabel": "Other Lease Information" } } }, "localname": "OtherLeaseInformationTableTextBlock", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "mx_OtherReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other receivable.", "label": "Other Receivable [Member]" } } }, "localname": "OtherReceivableMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mx_PassiveInstitutionalInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Passive institutional investor.", "label": "Passive Institutional Investor [Member]" } } }, "localname": "PassiveInstitutionalInvestorMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_PaymentsForGuaranteeDeposits": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for guarantee deposits.", "label": "Payments For Guarantee Deposits", "negatedLabel": "Payment of guarantee deposits" } } }, "localname": "PaymentsForGuaranteeDeposits", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mx_PercentageOfAssetsOrEarningPowerOfTheCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of assets or earning power of the company.", "label": "Percentage Of Assets Or Earning Power Of The Company", "terseLabel": "Percentage of assets or earning power of the Company" } } }, "localname": "PercentageOfAssetsOrEarningPowerOfTheCompany", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mx_PercentageOfPotentialUtilizationOfTaxableIncomeForTaxLossCarryForwardFiscalYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Potential Utilization of Taxable Income for Tax Loss Carryforward, Fiscal Year", "label": "Percentage Of Potential Utilization Of Taxable Income For Tax Loss Carry forward Fiscal Year", "presentationGuidance": "The net operating income carry forwards of the taxable income" } } }, "localname": "PercentageOfPotentialUtilizationOfTaxableIncomeForTaxLossCarryForwardFiscalYear", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mx_PostEmploymentBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Post Employment Benefit Payments Five Fiscal Years Thereafter.", "label": "Post Employment Benefit Payments Five Fiscal Years Thereafter", "terseLabel": "2028 \u2013 2032" } } }, "localname": "PostEmploymentBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostEmploymentBenefitPaymentsNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Post employment benefit payments next twelve months.", "label": "Post Employment Benefit Payments Next Twelve Months", "verboseLabel": "2023" } } }, "localname": "PostEmploymentBenefitPaymentsNextTwelveMonths", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostEmploymentBenefitPaymentsYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Post employment benefit payments year two.", "label": "Post Employment Benefit Payments Year Two", "terseLabel": "2024" } } }, "localname": "PostEmploymentBenefitPaymentsYearTwo", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostemploymentBenefitPaymentsRemainderOfFiscalYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Postemployment benefit payments remainder of fiscal year.", "label": "Postemployment Benefit Payments Remainder Of Fiscal Year", "terseLabel": "Remainder of 2022" } } }, "localname": "PostemploymentBenefitPaymentsRemainderOfFiscalYear", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostemploymentBenefitPaymentsYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Postemployment benefit payments year five.", "label": "Postemployment Benefit Payments Year Five", "verboseLabel": "2027" } } }, "localname": "PostemploymentBenefitPaymentsYearFive", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostemploymentBenefitPaymentsYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Postemployment benefit payments year four.", "label": "Postemployment Benefit Payments Year Four", "verboseLabel": "2026" } } }, "localname": "PostemploymentBenefitPaymentsYearFour", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostemploymentBenefitPaymentsYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Postemployment benefit payments year three.", "label": "Postemployment Benefit Payments Year Three", "verboseLabel": "2025" } } }, "localname": "PostemploymentBenefitPaymentsYearThree", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsFutureBenefitsPaymentsToEmployeesDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostemploymentBenefitsProvisions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Postemployment benefits provisions.", "label": "Postemployment Benefits Provisions", "verboseLabel": "Provisions" } } }, "localname": "PostemploymentBenefitsProvisions", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostemploymentBenefitsSeverancePayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Postemployment benefits severance payments.", "label": "Postemployment Benefits Severance Payments", "verboseLabel": "Severance payments" } } }, "localname": "PostemploymentBenefitsSeverancePayments", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "mx_PostemploymentBenefitsTranslationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Postemployment benefits translation adjustment.", "label": "Postemployment Benefits Translation Adjustment", "terseLabel": "Translation adjustments" } } }, "localname": "PostemploymentBenefitsTranslationAdjustment", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "mx_PowerSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of power solutions.", "label": "Power Solutions [Member]", "terseLabel": "Power Solutions [Member]" } } }, "localname": "PowerSolutionsMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "domainItemType" }, "mx_ProceedFromMergerTermination": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceed from merger termination.", "label": "Proceed From Merger Termination", "terseLabel": "Proceed from termination cost" } } }, "localname": "ProceedFromMergerTermination", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mx_ProceedsFromGuaranteeDeposits": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from Guarantee Deposits", "label": "Proceeds from Guarantee Deposits", "terseLabel": "Collection of guarantee deposits" } } }, "localname": "ProceedsFromGuaranteeDeposits", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mx_ReceiptOfTerminationAgreementAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Receipt of termination agreement amount.", "label": "Receipt Of Termination Agreement Amount", "verboseLabel": "Termination agreement amount Paid" } } }, "localname": "ReceiptOfTerminationAgreementAmount", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mx_ReclassifiedAsATreasuryStockFromAdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reclassified as a treasury stock from additional paid In capital.", "label": "Reclassified As A Treasury Stock From Additional Paid In Capital [Member]", "terseLabel": "Reclassified As A Treasury Stock From Additional Paid In Capital [Member]" } } }, "localname": "ReclassifiedAsATreasuryStockFromAdditionalPaidInCapitalMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_RedemptionOfRightsPerRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of rights per right.", "label": "Redemption Of Rights Per Right", "terseLabel": "Redemption of rights per right" } } }, "localname": "RedemptionOfRightsPerRight", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "decimalItemType" }, "mx_RemainingLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease agreements remaining lease term for finance and operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaining Lease Term", "verboseLabel": "Lease Agreements Remaining Term of Lease" } } }, "localname": "RemainingLeaseTerm", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mx_RepaymentOfFinancingRelatedToWaterTreatmentFacilityArrangement": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayment of financing related to water treatment facility arrangement.", "label": "Repayment Of Financing Related To Water Treatment Facility Arrangement", "negatedLabel": "Repayment of financing related to water treatment facility arrangement" } } }, "localname": "RepaymentOfFinancingRelatedToWaterTreatmentFacilityArrangement", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mx_RetirementAgeOfEmployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Retirement age of employees.", "label": "Retirement Age Of Employees", "terseLabel": "Retirement age of employees" } } }, "localname": "RetirementAgeOfEmployees", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mx_SaleOfPreviouslyReservedInventory": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail": { "order": 2.0, "parentTag": "mx_InventoryValuationReservesChanges", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sale of previously reserved inventory.", "label": "Sale of previously reserved inventory", "terseLabel": "Sale of previously reserved inventory" } } }, "localname": "SaleOfPreviouslyReservedInventory", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail" ], "xbrltype": "monetaryItemType" }, "mx_ScheduleOfComponentsOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Components of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Loss" } } }, "localname": "ScheduleOfComponentsOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "mx_ScheduleOfDepositAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of deposit assets.", "label": "Schedule Of Deposit Assets [Table Text Block]", "terseLabel": "Summary Of Cash Deposits" } } }, "localname": "ScheduleOfDepositAssetsTableTextBlock", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "mx_ScheduleOfFutureLeasePaymentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Schedule Of Future Lease Payments [Table Text Block]", "terseLabel": "Schedule Of Future Lease Payments" } } }, "localname": "ScheduleOfFutureLeasePaymentsTableTextBlock", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "mx_SecuresDeferredMergerTerminationFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Secures deferred merger termination fee.", "label": "Secures Deferred Merger Termination Fee" } } }, "localname": "SecuresDeferredMergerTerminationFee", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mx_SeriesA1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A1.", "label": "Series A1 [Member]" } } }, "localname": "SeriesA1Member", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_StandardCharteredBankKoreaLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Standard Chartered Bank Korea Limited.", "label": "Standard Chartered Bank Korea Limited [Member]", "terseLabel": "SC" } } }, "localname": "StandardCharteredBankKoreaLimitedMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails" ], "xbrltype": "domainItemType" }, "mx_StandardProductsBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Standard products business [Member]", "documentation": "Standard Products Business [Member].", "label": "Standard Products Business [Member]", "terseLabel": "Standard products business [Member]" } } }, "localname": "StandardProductsBusinessMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "domainItemType" }, "mx_StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Repurchase Program", "label": "Stock Repurchase Program [Member]" } } }, "localname": "StockRepurchaseProgramMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Supplemental Balance Sheet Information Related To Leases [Table Text Block]", "terseLabel": "Supplemental Balance Sheet Information Related To Leases" } } }, "localname": "SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "mx_TaxAssessmentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Assessment [Axis]" } } }, "localname": "TaxAssessmentAxis", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mx_TaxAssessmentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Assessment [Domain]" } } }, "localname": "TaxAssessmentDomain", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_TerminationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Termination Agreement [Member]" } } }, "localname": "TerminationAgreementMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mx_TerminationAgreementOutstandingAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Termination agreement outstanding amount.", "label": "Termination Agreement Outstanding Amount", "verboseLabel": "Termination agreement outstanding amount" } } }, "localname": "TerminationAgreementOutstandingAmount", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mx_ThresholdAmountCashCollateralForeignCurrencyExposure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign currency exposure.", "label": "Threshold Amount Cash Collateral Foreign Currency Exposure", "terseLabel": "Threshold amount of cash collateral" } } }, "localname": "ThresholdAmountCashCollateralForeignCurrencyExposure", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mx_TopCustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Top Customer One [Member]", "label": "Top Customer One [Member]", "terseLabel": "Top Customer One [Member]" } } }, "localname": "TopCustomerOneMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_TopCustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Top Customer Two [Member]", "label": "Top Customer Two [Member]", "terseLabel": "Top Customer Two [Member]" } } }, "localname": "TopCustomerTwoMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_TopTenCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Top Ten Customers [Member]", "label": "Top Ten Customers [Member]", "terseLabel": "Top Ten Customers [Member]" } } }, "localname": "TopTenCustomersMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mx_UnsettledCommonStockRepurchases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unsettled common stock repurchases.", "label": "Unsettled common stock repurchases", "terseLabel": "Unsettled common stock repurchases" } } }, "localname": "UnsettledCommonStockRepurchases", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mx_WeightedAverageDiscountRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Discount Rate [Abstract]", "terseLabel": "Weighted average discount rate" } } }, "localname": "WeightedAverageDiscountRateAbstract", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "stringItemType" }, "mx_WeightedAverageRemainingLeaseTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Lease Term [Abstract]", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "WeightedAverageRemainingLeaseTermAbstract", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "stringItemType" }, "mx_ZeroCostCollarAndForwardContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zero cost collar and forward contracts.", "label": "Zero Cost Collar And Forward Contracts [Member]", "terseLabel": "Zero Cost Collar and Forward Contracts [Member]" } } }, "localname": "ZeroCostCollarAndForwardContractsMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails" ], "xbrltype": "domainItemType" }, "mx_ZeroCostCollarFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zero Cost Collar Four", "label": "Zero Cost Collar Four [Member]", "terseLabel": "Zero Cost Collar Four [Member]" } } }, "localname": "ZeroCostCollarFourMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail" ], "xbrltype": "domainItemType" }, "mx_ZeroCostCollarOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zero Cost Collar One [Member]", "label": "Zero Cost Collar One [Member]", "terseLabel": "Zero Cost Collar One [Member]" } } }, "localname": "ZeroCostCollarOneMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail" ], "xbrltype": "domainItemType" }, "mx_ZeroCostCollarThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Zero Cost Collar Three [Member]", "terseLabel": "Zero Cost Collar Three [Member]" } } }, "localname": "ZeroCostCollarThreeMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail" ], "xbrltype": "domainItemType" }, "mx_ZeroCostCollarTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zero Cost Collar Two [Member]", "label": "Zero Cost Collar Two [Member]", "terseLabel": "Zero Cost Collar Two [Member]" } } }, "localname": "ZeroCostCollarTwoMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail" ], "xbrltype": "domainItemType" }, "mx_ZeroCostCollarsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zero cost collars.", "label": "Zero Cost Collars [Member]", "terseLabel": "Zero Cost Collars [Member]" } } }, "localname": "ZeroCostCollarsMember", "nsuri": "http://www.magnachip.com/20220930", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r124", "r267", "r272", "r280", "r400", "r401", "r406", "r407", "r531", "r615" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r124", "r267", "r272", "r280", "r400", "r401", "r406", "r407", "r531", "r615" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r124", "r175", "r188", "r189", "r190", "r191", "r193", "r195", "r199", "r267", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r277", "r279", "r280" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r124", "r175", "r188", "r189", "r190", "r191", "r193", "r195", "r199", "r267", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r277", "r279", "r280" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r61", "r64", "r122", "r123", "r283", "r294" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails" ], "xbrltype": "stringItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r205", "r304", "r307", "r585" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r259", "r261", "r262", "r263", "r282", "r293", "r325", "r328", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r582", "r586", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r259", "r261", "r262", "r263", "r282", "r293", "r325", "r328", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r582", "r586", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "http://www.magnachip.com/role/LeasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r205", "r304", "r307", "r585" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r201", "r261", "r262", "r304", "r305", "r548", "r581", "r583" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Products and Services [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r201", "r261", "r262", "r304", "r305", "r548", "r581", "r583" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Products and Services [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r249", "r259", "r261", "r262", "r263", "r282", "r293", "r312", "r325", "r328", "r354", "r355", "r356", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r582", "r586", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "http://www.magnachip.com/role/LeasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r249", "r259", "r261", "r262", "r263", "r282", "r293", "r312", "r325", "r328", "r354", "r355", "r356", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r582", "r586", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Range [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "http://www.magnachip.com/role/LeasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r63", "r64", "r122", "r123", "r283", "r294" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r3", "r126", "r127", "r128", "r129", "r130", "r133", "r134", "r135", "r136", "r138", "r139", "r140", "r141", "r142", "r143", "r159", "r217", "r218", "r380", "r447", "r451", "r452", "r453", "r505", "r526", "r527", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598" ], "lang": { "en-us": { "role": { "label": "Restatement [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r3", "r126", "r127", "r128", "r129", "r130", "r133", "r134", "r135", "r136", "r138", "r139", "r140", "r141", "r142", "r143", "r159", "r217", "r218", "r380", "r447", "r451", "r452", "r453", "r505", "r526", "r527", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598" ], "lang": { "en-us": { "role": { "label": "Restatement [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r3", "r126", "r128", "r129", "r130", "r133", "r134", "r135", "r136", "r138", "r139", "r141", "r142", "r159", "r217", "r218", "r380", "r447", "r451", "r452", "r453", "r505", "r526", "r527", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r137", "r143", "r257", "r326" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r202", "r203", "r304", "r306", "r584", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails", "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r202", "r203", "r304", "r306", "r584", "r600", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails", "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r137", "r143", "r257", "r326", "r536" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r321", "r528", "r529", "r530" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Korean Subsidiary [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AcceleratedShareRepurchaseProgramAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.", "label": "Accelerated Share Repurchase Program, Adjustment", "terseLabel": "Accelerated stock repurchase" } } }, "localname": "AcceleratedShareRepurchaseProgramAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Initial Price Paid Per Share", "terseLabel": "Sale of stock issue price per share" } } }, "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt", "terseLabel": "Accelerated Share Repurchases, Settlement (Payment) or Receipt" } } }, "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableOtherCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable, Other, Current", "terseLabel": "Other accounts payable" } } }, "localname": "AccountsPayableOtherCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r15", "r43" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r207", "r208" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r23", "r556", "r568" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Accrued income taxes" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses (Note 6)", "totalLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail", "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r19", "r244" ], "calculation": { "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r72", "r79", "r80", "r81", "r82", "r404" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Derivative Adjustments [Member]" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r66", "r70", "r71", "r72", "r468" ], "calculation": { "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossScheduleOfAccumulatedOtherComprehensiveLossDetail": { "order": 1.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossScheduleOfAccumulatedOtherComprehensiveLossDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r29", "r70", "r71", "r72", "r569", "r594", "r598" ], "calculation": { "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossScheduleOfAccumulatedOtherComprehensiveLossDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossScheduleOfAccumulatedOtherComprehensiveLossDetail", "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r79", "r80", "r489", "r490", "r491", "r492", "r493", "r495" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r69", "r72", "r79", "r80", "r81", "r126", "r127", "r128", "r405", "r527", "r589", "r590" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]", "verboseLabel": "Accumulated Other Comprehensive Loss [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r67", "r72", "r79", "r80", "r81", "r405", "r490", "r491", "r492", "r493", "r495" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustments [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r27" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r126", "r127", "r128", "r359", "r360", "r361", "r451" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r129", "r130", "r131", "r132", "r143", "r210", "r211", "r213", "r214", "r215", "r216", "r217", "r218", "r359", "r360", "r361", "r377", "r378", "r379", "r380", "r394", "r395", "r396", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r499", "r500", "r502", "r503", "r504", "r505", "r522", "r523", "r524", "r525", "r526", "r527", "r550", "r551", "r552", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r330", "r362", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r110", "r286", "r289", "r290", "r501" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt issuance costs and original issue discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r110", "r234", "r239" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense for intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Outstanding units and warrants excluded from computation of diluted loss per share/unit", "verboseLabel": "Conversion Of Exchangeable Notes" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail", "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r22", "r119", "r183", "r190", "r197", "r212", "r267", "r268", "r269", "r271", "r272", "r273", "r274", "r276", "r278", "r280", "r281", "r400", "r406", "r474", "r532", "r534", "r555", "r567" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r13", "r42", "r119", "r212", "r267", "r268", "r269", "r271", "r272", "r273", "r274", "r276", "r278", "r280", "r281", "r400", "r406", "r474", "r532", "r534" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r419", "r422" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and Related Structures [Member]" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r324", "r327", "r392" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail", "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails", "http://www.magnachip.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r324", "r327", "r390", "r391", "r392" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail", "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails", "http://www.magnachip.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r388" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Merger-related costs", "verboseLabel": "Merger Related Costs Income Net" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Merger Agreement" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r9", "r125", "r170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r114", "r115", "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Property, plant and equipment additions in other accounts payable" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r470", "r471" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value [Member]" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r10", "r17", "r112" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r105", "r112", "r117" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "End of the period", "periodStartLabel": "Beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r105", "r488" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging [Member]" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r24", "r25", "r26", "r118", "r119", "r147", "r150", "r151", "r153", "r155", "r163", "r164", "r165", "r212", "r267", "r272", "r273", "r274", "r280", "r281", "r291", "r292", "r295", "r296", "r297", "r474", "r624" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r50", "r559", "r573" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "verboseLabel": "Commitments and contingencies (Note 17)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r253", "r254", "r255", "r264", "r602" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r126", "r127", "r451" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r26", "r297" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance, Shares ending", "periodStartLabel": "Balance, Shares beginning", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r26", "r534" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.01 par value, 150,000,000 shares authorized, 56,234,774 shares issued and 44,579,075 outstanding at September 30, 2022 and 55,905,320 shares issued and 45,659,304 outstanding at December 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights", "terseLabel": "Common Stock, Voting Rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r75", "r77", "r78", "r87", "r563", "r577" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r86", "r95", "r562", "r576" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r168", "r169", "r205", "r472", "r473", "r601" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r168", "r169", "r205", "r472", "r473", "r599", "r601" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r168", "r169", "r205", "r472", "r473", "r599", "r601" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r168", "r169", "r205", "r472", "r473" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r168", "r169", "r205", "r472", "r473", "r601" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r243" ], "calculation": { "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress, Gross", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r91", "r548" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r166", "r205" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r365", "r366" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deposit Assets [Abstract]" } } }, "localname": "DepositAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r110", "r242" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expenses" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r110", "r178" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeCollateralRightToReclaimCash": { "auth_ref": [ "r56", "r60", "r62", "r434" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.", "label": "Derivative, Collateral, Right to Reclaim Cash", "negatedLabel": "Liability Derivatives, Gross amounts not offset in the balance sheets, Cash collateral pledged" } } }, "localname": "DerivativeCollateralRightToReclaimCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeCollateralRightToReclaimSecurities": { "auth_ref": [ "r56", "r60", "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to receive securities collateral under master netting arrangements that have not been offset against derivative liabilities.", "label": "Derivative, Collateral, Right to Reclaim Securities", "terseLabel": "Liability Derivatives, Gross amounts not offset in the balance sheets, Financial instruments" } } }, "localname": "DerivativeCollateralRightToReclaimSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet": { "auth_ref": [ "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net amount as of the balance sheet date of the fair value of derivative assets and derivative liabilities that in accordance with the entity's accounting policy were offset against collateral under a master netting arrangement.", "label": "Derivative, Fair Value, Amount Offset Against Collateral, Net", "terseLabel": "Liability Derivatives, Net amount after master netting" } } }, "localname": "DerivativeFairValueAmountOffsetAgainstCollateralNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r55", "r59", "r65", "r435" ], "calculation": { "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Liability Derivatives, Gross amounts of recognized liabilities", "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Amount Not Offset Against Collateral" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInceptionDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the entity entered into the derivative contract, in YYYY-MM-DD format.", "label": "Derivative, Inception Date", "terseLabel": "Date of transaction" } } }, "localname": "DerivativeInceptionDates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail" ], "xbrltype": "dateItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r64", "r420", "r421", "r427", "r430" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r442", "r455" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r417", "r420", "r427" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": { "auth_ref": [ "r441" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.", "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred", "terseLabel": "Estimated amount reclassified from accumulated other comprehensive income into income" } } }, "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r425", "r429" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Amount of Gain (Loss) Reclassified from AOCI into Statement of Operations (Effective Portion)", "verboseLabel": "Reclassification adjustment for loss (gain) on derivatives included in net income (loss)" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r426", "r439" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net", "verboseLabel": "Amount of Gain Recognized in Statement of Operations on Derivatives (Ineffective Portion)" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r55", "r59", "r64", "r469" ], "calculation": { "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "presentationGuidance": "Other non current liabilities", "terseLabel": "Derivative liabilities", "totalLabel": "Liability Derivatives, Net amounts of liabilities presented in the balance sheets" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails", "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset": { "auth_ref": [ "r54", "r411" ], "calculation": { "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to receive cash collateral under master netting arrangements offset against derivative liabilities.", "label": "Derivative Liability, Collateral, Right to Reclaim Cash, Offset", "terseLabel": "Liability Derivatives, Gross amounts offset in the balance sheets" } } }, "localname": "DerivativeLiabilityCollateralRightToReclaimCashOffset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability, Fair Value, Amount Not Offset Against Collateral [Abstract]", "terseLabel": "Liability Derivatives:" } } }, "localname": "DerivativeLiabilityFairValueNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r413", "r415" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Total notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r412", "r414", "r415", "r417", "r418", "r423", "r427", "r432", "r436", "r440", "r442" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsDetailsOfDerivativeContractsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail", "http://www.magnachip.com/role/DerivativeFinancialInstrumentsOffsettingOfDerivativeAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings (Loss) Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r88", "r133", "r134", "r136", "r137", "r138", "r145", "r147", "r153", "r154", "r155", "r159", "r160", "r452", "r453", "r564", "r578" ], "lang": { "en-us": { "role": { "definitionGuidance": "Basic earnings (loss) per common share\u2014", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic earnings (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "verboseLabel": "Basic Earnings (Loss) per Share" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r88", "r133", "r134", "r136", "r137", "r138", "r147", "r153", "r154", "r155", "r159", "r160", "r452", "r453", "r564", "r578" ], "lang": { "en-us": { "role": { "definitionGuidance": "Diluted earnings (loss) per common share\u2014", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted earnings (loss) per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted earnings (loss) per share" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r156", "r157", "r158", "r161" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r488" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 35.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "verboseLabel": "Effect of exchange rates on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Payroll, benefits and related taxes, excluding severance benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r79", "r80", "r81", "r126", "r127", "r128", "r130", "r139", "r142", "r162", "r216", "r297", "r299", "r359", "r360", "r361", "r379", "r380", "r451", "r489", "r490", "r491", "r492", "r493", "r495", "r527", "r589", "r590", "r591" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/CoverPage", "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r284", "r287", "r288", "r469" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Estimate of Fair Value Measurement [Member]" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r456", "r457", "r464" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r456", "r457", "r458", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Financial Assets and Liabilities Measured at Fair Value on Recurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r456", "r464" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r284", "r287", "r288", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r323", "r457", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value, Hierarchy [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r284", "r287", "r288", "r456", "r465" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r456", "r457", "r459", "r460", "r466" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r284", "r287", "r288", "r313", "r314", "r319", "r323", "r457", "r538" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs (Level 2) [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value, Measurement Frequency [Domain]", "terseLabel": "Fair Value, Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r284", "r287", "r288", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r323", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r462", "r466" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Measurements, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r419", "r423", "r437" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r509", "r513", "r520" ], "calculation": { "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "verboseLabel": "Interest on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r511", "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease, Interest Payment on Liability", "verboseLabel": "Operating cash flows from finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r507", "r519" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "verboseLabel": "Present value of future payments" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "verboseLabel": "Finance" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.", "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "verboseLabel": "Finance" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.", "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "totalLabel": "Finance Leases, Total future lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 8.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "verboseLabel": "Finance Leases, 2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 12.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "Finance Leases, 2027" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 11.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "Finance Leases, 2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 10.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "verboseLabel": "Finance Leases, 2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 9.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "verboseLabel": "Finance Leases, 2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 7.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.", "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year", "verboseLabel": "Finance Leases, Remainder of 2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r519" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Present value adjustment" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r510", "r515" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedLabel": "Repayment of principal portion of finance lease liabilities", "verboseLabel": "Financing cash flows from finance leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows", "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r506" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "verboseLabel": "Finance lease" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r509", "r513", "r520" ], "calculation": { "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "verboseLabel": "Amortization of right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r517", "r520" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "verboseLabel": "Finance leases" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r516", "r520" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "verboseLabel": "Finance leases" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r20", "r238" ], "calculation": { "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r235", "r236", "r238", "r240", "r549", "r553" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r238", "r553" ], "calculation": { "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Intangible asset, Gross amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r235", "r237" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r238", "r549" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Intangible assets, net", "totalLabel": "Intangible asset, Net amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets", "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency [Abstract]" } } }, "localname": "ForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyDisclosureTextBlock": { "auth_ref": [ "r487", "r497", "r498" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items.", "label": "Foreign Currency Disclosure [Text Block]", "terseLabel": "Foreign Currency Loss, Net" } } }, "localname": "ForeignCurrencyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ForeignCurrencyLossNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign Currency Exchange Rate, Translation", "terseLabel": "Exchange rates using first base rate" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ForeignCurrencyLossNetAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency Transaction [Abstract]" } } }, "localname": "ForeignCurrencyTransactionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r483", "r484", "r485", "r486" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "verboseLabel": "Foreign currency loss, net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r167", "r601" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r90", "r119", "r183", "r189", "r193", "r196", "r199", "r212", "r267", "r268", "r269", "r272", "r273", "r274", "r276", "r278", "r280", "r281", "r474" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit", "verboseLabel": "Total gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingAssetsCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the asset arising from a financial instrument or a contract used to mitigate a specified risk (hedge), and which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.", "label": "Hedging Assets, Current", "terseLabel": "Hedge collateral (Note 7)" } } }, "localname": "HedgingAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r84", "r183", "r189", "r193", "r196", "r199", "r554", "r560", "r565", "r579" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) before income tax expense" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r246", "r250" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r370", "r371", "r373", "r376" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r120", "r368", "r372", "r374", "r381", "r383", "r385", "r386", "r387" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r121", "r141", "r142", "r181", "r367", "r382", "r384", "r580" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense (benefit)", "verboseLabel": "Income tax expenses (benefits)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Accrued income taxes" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Increase (Decrease) in Other Accounts Payable", "terseLabel": "Other accounts payable" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current liabilities classified as other.", "label": "Increase (Decrease) in Other Current Liabilities", "terseLabel": "Other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other non-current liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other, net" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Other receivables" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPostemploymentObligations": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the current portion of the liability that represents various benefits due to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.", "label": "Increase (Decrease) in Postemployment Obligations", "terseLabel": "Payment of severance benefits" } } }, "localname": "IncreaseDecreaseInPostemploymentObligations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements": { "auth_ref": [ "r148", "r149", "r155" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity unit purchase agreements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements", "terseLabel": "Net effect of dilutive equity awards" } } }, "localname": "IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]", "terseLabel": "Intellectual Property Assets [Member]" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of nonoperating interest income (expense).", "label": "Interest Income (Expense), Nonoperating, Net", "terseLabel": "Interest expense" } } }, "localname": "InterestIncomeExpenseNonoperatingNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r103", "r106", "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r33" ], "calculation": { "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r11", "r39", "r534" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets", "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r35" ], "calculation": { "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r39", "r220" ], "calculation": { "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail": { "order": 5.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Less: inventory reserve", "negatedPeriodEndLabel": "Ending balance", "negatedPeriodStartLabel": "Beginning balance" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail", "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r34" ], "calculation": { "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Semi-finished goods and work-in-process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r219" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Write off" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/InventoriesChangesInInventoryReserveDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Land": { "auth_ref": [ "r18" ], "calculation": { "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r518", "r520" ], "calculation": { "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Abstract]", "verboseLabel": "Finance lease cost [Abstract]" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Operating Leases, Total future lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "Operating Leases, 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "Operating Leases, 2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "Operating Leases, 2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "Operating Leases, 2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "Operating Leases, 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r519" ], "calculation": { "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "verboseLabel": "Operating Leases, Remainder of 2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r519" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Present value adjustment" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r46", "r119", "r191", "r212", "r267", "r268", "r269", "r272", "r273", "r274", "r276", "r278", "r280", "r281", "r401", "r406", "r407", "r474", "r532", "r533" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r32", "r119", "r212", "r474", "r534", "r557", "r571" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r14", "r48", "r119", "r212", "r267", "r268", "r269", "r272", "r273", "r274", "r276", "r278", "r280", "r281", "r401", "r406", "r407", "r474", "r532", "r533", "r534" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r256", "r258", "r259", "r260", "r261", "r265", "r266" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MarginDepositAssets": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.", "label": "Margin Deposit Assets", "verboseLabel": "Margin Deposit Assets" } } }, "localname": "MarginDepositAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsCashDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r8", "r397" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Merger Agreement" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/MergerAgreement" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r105" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r105" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r105", "r107", "r111" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r7", "r73", "r76", "r81", "r85", "r111", "r119", "r129", "r133", "r134", "r136", "r137", "r141", "r142", "r152", "r183", "r189", "r193", "r196", "r199", "r212", "r267", "r268", "r269", "r272", "r273", "r274", "r276", "r278", "r280", "r281", "r453", "r474", "r561", "r575" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "auth_ref": [ "r72", "r82" ], "calculation": { "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "terseLabel": "Other comprehensive loss before reclassifications" } } }, "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offsetting [Abstract]" } } }, "localname": "OffsettingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "auth_ref": [ "r57", "r58" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.", "label": "Offsetting of Derivative Liabilities" } } }, "localname": "OffsettingLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r183", "r189", "r193", "r196", "r199" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r514", "r520" ], "calculation": { "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "verboseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesComponentsOfLeaseCostDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "verboseLabel": "Present value of future payments" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesAggregateFutureLeasePaymentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r507" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities", "verboseLabel": "Operating" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets", "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r507" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 31.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Non-current operating lease liabilities", "verboseLabel": "Operating" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets", "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r512", "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "verboseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r506" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Operating lease" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets", "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r517", "r520" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "verboseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r516", "r520" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "verboseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesOtherLeaseInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r188", "r189", "r190", "r191", "r193", "r199" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r125", "r144", "r170", "r410" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "verboseLabel": "Business, Basis of Presentation and Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/BusinessBasisOfPresentationAndSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Others" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r41", "r534" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "verboseLabel": "Other current assets (Note 17)" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r21" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent [Abstract]", "terseLabel": "Derivative adjustments" } } }, "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r398", "r399", "r404" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": { "auth_ref": [ "r68", "r70", "r424", "r438" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax", "terseLabel": "Fair valuation of derivatives" } } }, "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": { "auth_ref": [ "r68", "r70", "r424", "r428", "r438" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax", "verboseLabel": "Amount of Loss Recognized in AOCI on Derivatives (Effective Portion)" } } }, "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r74", "r77", "r398", "r399", "r404" ], "calculation": { "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Total other comprehensive loss", "verboseLabel": "Other comprehensive loss, net" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r419", "r437" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other Current Liabilities [Member]" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherGeneralExpense": { "auth_ref": [ "r93" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses.", "label": "Other General Expense", "terseLabel": "Other charges, net" } } }, "localname": "OtherGeneralExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventoryInTransit": { "auth_ref": [ "r36" ], "calculation": { "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.", "label": "Other Inventory, in Transit, Gross", "terseLabel": "Materials in-transit" } } }, "localname": "OtherInventoryInTransit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/InventoriesSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r47", "r534" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "verboseLabel": "Other current liabilities (Notes 7 and 8)" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 30.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "verboseLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r111" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Noncurrent Liabilities [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsFairValuesOfOutstandingZeroCostCollarAndForwardContractsRecordedAsAssetsAndLiabilitiesDetail", "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r94" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "verboseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "verboseLabel": "Other income, net [Member]" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other receivables (Note 16)" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForHedgeInvestingActivities": { "auth_ref": [ "r98", "r108" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 29.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.", "label": "Payments for Hedge, Investing Activities", "negatedLabel": "Payment of hedge collateral" } } }, "localname": "PaymentsForHedgeInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r96", "r98" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r100" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Acquisition of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r97" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 31.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Payment for intellectual property registration" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r97" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToSuppliers": { "auth_ref": [ "r101", "r102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of cash to suppliers for goods and services during the current period.", "label": "Payments to Suppliers", "verboseLabel": "Prepayments to suppliers" } } }, "localname": "PaymentsToSuppliers", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PostemploymentBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Postemployment Benefits [Abstract]", "terseLabel": "Postemployment Benefits [Abstract]" } } }, "localname": "PostemploymentBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PostemploymentBenefitsDisclosureTextBlock": { "auth_ref": [ "r310", "r311" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for postemployment benefits, which may include supplemental unemployment benefits, obligations recognized for all types of benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement. Disclosure may also include discussion that an obligation for postemployment benefits is not accrued in accordance with regulation only because the amount cannot be reasonably estimated.", "label": "Postemployment Benefits Disclosure [Text Block]", "terseLabel": "Accrued Severance Benefits" } } }, "localname": "PostemploymentBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PostemploymentBenefitsLiabilityCurrentAndNoncurrent": { "auth_ref": [ "r308", "r309", "r558", "r574" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.", "label": "Postemployment Benefits Liability", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "PostemploymentBenefitsLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PostemploymentBenefitsPeriodExpense": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Period expense related to postemployment benefits.", "label": "Postemployment Benefits, Period Expense", "terseLabel": "Provision for severance benefits" } } }, "localname": "PostemploymentBenefitsPeriodExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r12", "r40", "r222", "r223" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseNoncurrent": { "auth_ref": [ "r21" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.", "label": "Prepaid Expense, Noncurrent", "terseLabel": "Long-term prepaid expenses" } } }, "localname": "PrepaidExpenseNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromHedgeInvestingActivities": { "auth_ref": [ "r96", "r108" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.", "label": "Proceeds from Hedge, Investing Activities", "terseLabel": "Proceeds from settlement of hedge collateral" } } }, "localname": "ProceedsFromHedgeInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r99", "r358" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r7", "r73", "r76", "r81", "r104", "r119", "r129", "r141", "r142", "r183", "r189", "r193", "r196", "r199", "r212", "r267", "r268", "r269", "r272", "r273", "r274", "r276", "r278", "r280", "r281", "r398", "r402", "r403", "r408", "r409", "r453", "r474", "r565" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r248", "r603", "r604", "r605" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r18", "r243" ], "calculation": { "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail", "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]", "verboseLabel": "Property, Plant and Equipment, Net [Member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r245", "r534", "r566", "r572" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Property, plant and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets", "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentOtherTypesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Property, Plant and Equipment, Other Types [Member]", "terseLabel": "Others [Member]" } } }, "localname": "PropertyPlantAndEquipmentOtherTypesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Summary of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r72", "r82" ], "calculation": { "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss (income)" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationTypeAxis": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Information by type of reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Type [Axis]" } } }, "localname": "ReclassificationTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationTypeDomain": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Type of reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Type [Domain]" } } }, "localname": "ReclassificationTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r364", "r547", "r618" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r28", "r299", "r534", "r570", "r593", "r598" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Retained earnings", "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r126", "r127", "r128", "r130", "r139", "r142", "r216", "r359", "r360", "r361", "r379", "r380", "r451", "r589", "r591" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r83", "r119", "r174", "r175", "r188", "r194", "r195", "r201", "r202", "r205", "r212", "r267", "r268", "r269", "r272", "r273", "r274", "r276", "r278", "r280", "r281", "r474", "r565" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net sales", "verboseLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]", "terseLabel": "Net Sales [Member]" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsImpactOfDerivativeInstrumentsOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r168", "r205" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue, Net [Member]", "terseLabel": "Net Sales [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Summary of Accrued Expenses" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r72", "r494", "r495" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Changes in Accumulated Other Comprehensive Loss" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfLossPerCommonShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from the Computation of Loss Per Common Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r390", "r391", "r392" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.", "label": "Schedule of Costs of Retirement Plans [Table Text Block]", "terseLabel": "Changes in Accrued Severance Benefits" } } }, "localname": "ScheduleOfCostsOfRetirementPlansTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r420", "r427", "r431" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Impact of Derivative Instruments on Consolidated Statement of Operations" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Fair Values of Outstanding Zero Cost Collar and Forward Contracts Recorded as Assets and Liabilities" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r412", "r414", "r415", "r417", "r418", "r423", "r427", "r432", "r436" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Details of Derivative Contracts" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Computation of Basic and Diluted Loss Per Common Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Future Benefits Payments to Employees" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r235", "r237", "r549" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "terseLabel": "Summary of Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r16", "r36", "r37", "r38" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Summary of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail", "http://www.magnachip.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r89", "r204" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Net Sales by Region, Based on Location of Products are Billed" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r83", "r204" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r183", "r186", "r192", "r232" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r183", "r186", "r192", "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Operating Segments" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r329", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r171", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r188", "r189", "r190", "r191", "r193", "r194", "r195", "r196", "r197", "r199", "r205", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r251", "r252", "r581" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r171", "r172", "r173", "r183", "r187", "r193", "r197", "r198", "r199", "r200", "r201", "r204", "r205", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Geographic and Other Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r92" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r109" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Sale of stock issue price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r6", "r171", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r188", "r189", "r190", "r191", "r193", "r194", "r195", "r196", "r197", "r199", "r205", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r247", "r251", "r252", "r581" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/GeographicAndOtherInformationAdditionalInformationDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationNetSalesByRegionBasedOnLocationOfProductsAreBilledDetail", "http://www.magnachip.com/role/GeographicAndOtherInformationScheduleOfOperatingSegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r24", "r25", "r26", "r118", "r119", "r147", "r150", "r151", "r153", "r155", "r163", "r164", "r165", "r212", "r267", "r272", "r273", "r274", "r280", "r281", "r291", "r292", "r295", "r296", "r297", "r474", "r624" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r53", "r79", "r80", "r81", "r126", "r127", "r128", "r130", "r139", "r142", "r162", "r216", "r297", "r299", "r359", "r360", "r361", "r379", "r380", "r451", "r489", "r490", "r491", "r492", "r493", "r495", "r527", "r589", "r590", "r591" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/CoverPage", "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail", "http://www.magnachip.com/role/LeasesAdditionalInformationDetail", "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r126", "r127", "r128", "r162", "r548" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsAdditionalInformationDetail", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/EarningsLossPerShareAdditionalInformationDetail", "http://www.magnachip.com/role/LeasesAdditionalInformationDetail", "http://www.magnachip.com/role/LeasesSupplementalBalanceSheetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r52", "r285", "r297", "r298", "r299" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Exchange of exchangeable senior notes into common stock" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r297", "r299" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Settlement of restricted stock units, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r25", "r26", "r297", "r299", "r340" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Exercise of stock options, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r53", "r297", "r299" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Exchange of exchangeable senior notes" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r25", "r26", "r297", "r299" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Settlement of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r53", "r297", "r299" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock Repurchase Program, Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r25", "r26", "r297", "r299" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "verboseLabel": "Stock repurchased during period, Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r25", "r26", "r297", "r299" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Repurchase Of Common Stock", "terseLabel": "Aggregate purchase price" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r26", "r30", "r31", "r119", "r209", "r212", "r474", "r534" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance ending", "periodStartLabel": "Balance beginning", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccumulatedOtherComprehensiveLossChangesInAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.magnachip.com/role/ConsolidatedBalanceSheets", "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r496", "r535" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r496", "r535" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r496", "r535" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/MergerAgreementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits": { "auth_ref": [], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment.", "label": "Supplemental Unemployment Benefits, Severance Benefits", "terseLabel": "Accrued severance benefits, net" } } }, "localname": "SupplementalUnemploymentBenefitsSeveranceBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedSeveranceBenefitsChangesInAccruedSeveranceBenefitsDetail", "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Withholding tax attributable to intercompany interest income" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/AccruedExpensesSummaryOfAccruedExpensesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Sale of aggregate purchase price per share" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r51", "r301" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.magnachip.com/role/StockRepurchasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r51", "r301" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury stock, shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r26", "r297", "r299" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedLabel": "Acquisition of treasury stock, Shares" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockTextBlock": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Treasury Stock [Text Block]", "terseLabel": "Stock Repurchases" } } }, "localname": "TreasuryStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/StockRepurchases" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r51", "r301", "r302" ], "calculation": { "http://www.magnachip.com/role/ConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, 11,655,699 shares at September 30, 2022 and 10,246,016 shares at December 31, 2021, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r297", "r299", "r301" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Acquisition of treasury stock" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r129", "r130", "r131", "r132", "r143", "r210", "r211", "r213", "r214", "r215", "r216", "r217", "r218", "r359", "r360", "r361", "r377", "r378", "r379", "r380", "r394", "r395", "r396", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r499", "r500", "r502", "r503", "r504", "r505", "r522", "r523", "r524", "r525", "r526", "r527", "r550", "r551", "r552", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r146", "r155" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted", "verboseLabel": "Diluted weighted average common stock outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r145", "r155" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "presentationGuidance": "Basic weighted average common stock outstanding", "terseLabel": "Basic", "verboseLabel": "Basic weighted average common stock outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations", "http://www.magnachip.com/role/EarningsLossPerShareScheduleOfComputationOfBasicAndDilutedLossPerCommonShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "verboseLabel": "Weighted average number of shares\u2014" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magnachip.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r161": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r221": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r241": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r255": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r264": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/subtopic&trid=2208821" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410138&loc=d3e79691-111665" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410138&loc=d3e79708-111665" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410195&loc=d3e80090-111668" }, "r311": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r387": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r397": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80845-113994" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r455": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30885-110895" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r498": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r521": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r619": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226038-175313" }, "r620": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r621": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r622": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r623": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r624": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r625": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(dd)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r8": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.6)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "https://asc.fasb.org/topic&trid=2134417" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" } }, "version": "2.1" } ZIP 100 0001193125-22-280137-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-280137-xbrl.zip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